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The main aims of the series of studies comprising this thesis were to investigate the effect of altered 
endogenous carbohydrate (CHO) availability, achieved primarily by pre-exercise dietary 
manipulation and antecedent exercise exposure, on interindividual variability in metabolic and 
hormonal responses to dynamic, steady-state exercise. Further, this thesis examined the impact of 
altered blood glucose availability on fatigue development during prolonged exercise. In this regard, 
it was hypothesized that endogenous CHO availability and the associated metabolic sequelae 
would impact on effort perception during exercise and fatigue development. It was further 
hypothesized that prior fatiguing exercise and local muscle glycogen depletion would result in a 
neural or humoral signal, or both, that would alter resistance to fatigue. Finally, it is proposed that 
antecedent exposure to hypoglycemia would reduce neuroendocrine and metabolic responses 
during subsequent (next-day) prolonged exercise, and that this would translate into reduced effort 
perception and improved exercise performance. 
In the first study (Chapter 2) the effect of varying the glycemic index (GI) of the pre-exercise 
carbohydrate-rich meal, combined with CHO ingestion during exercise on metabolism and 
endurance exercise performance was examined. Varying the GI of the preexercise CHO-rich meal 
is known to alter substrate availability and hormonal responses (in particular insulin), and has been 
proposed to be of benefit to athletes in that it may improve endurance performance. In this study, it 
was hypothesized that a low GI preexercise meal would reduce postprandial hypoglycemia and 
hyperinsulinemia compared to a high GI meal, but when combined with the ingestion of relatively 
large amounts of CHO during exercise, would have no impact on exercise metabolism and 
performance. Seven, well-trained cyclists received, in a randomized, cross-over design, a low GI 
meal (pasta, LGI), or high GI meal (potato, HGI) providing 2 g CHO/kg body mass (8M) or artificially 
flavored jelly (placebo) 2 h before cycling at steady-state for 2 h at 70% of maximal oxygen 
consumption (V02 max). This was followed by a cycling time-trial (TT) consisting of time to complete 
300 kJ of work. Subjects ingested a total of 24 mVkg 8M of a 10% glucose polymer solution labeled 
with [U-14C]glucose immediately before and during the steady-state cycle. Despite differences in 
preexercise glucose, insulin and free fatty acid (FFA) concentrations between LGI and HGI trials, as 
soon as exercise commenced, these differences were negated. Varying the GI of the pre-exercise 
meal had no distinguishable effect on tracer-determined rate of exogenous CHO oxidation, or 
respiratory exchange ratio (RER); nor was exercise performance or rating of perceived exertion 
(RPE) altered. There was, however, a large range in variability in postprandial metabolic responses 
between individual subjects. It was concluded that when CHO is ingested during endurance 
exercise in amounts recommended by sports nutrition guidelines, then varying the GI of a 
preexercise CHO meal and the concomitant metabolic and hormonal responses it elicits have no 
effect on endurance (-2.5 h) exercise metabolism or performance. 
ii 
The interindividual variation in postprandial glycemic and insulinemic responses observed in the first 
study, combined with that noted in the GI literature, raised a question over the validity of using the 
GI in predicting glycemic-insulinemic responses, particularly in a trained population group where 
insulin sensitivity (and other metabolic and hormonal responses) are likely to be altered. 
Determination of the GI of CHO-rich foods have traditionally only been done on sedentary 
population groups, and large intra- and interindividual variability in blood glucose responses have 
been noted. Therefore, the first study was extended to investigate the effect of training status on 
intra- and interindividual variability in glycemic response after ingestion of the GI reference food 
(white bread, providing 50 g of available CHO), when food- and methodologically-related factors are 
stringently controlled for (presented under Addendum A). This study indicated that training status 
(and exercise) have little impact on altering the large inter- and intra-individual variability in glycemic 
response seen after ingestion of the GI reference (white bread). The large intra- and interindividual 
variability highlights the need for further investigation surrounding the use of the GI as a credible, 
reproducible clinical tool for use in nutrition intervention. 
The third study (Chapter 3) aimed to examine the role of local muscle glycogen depletion on fatigue 
development. A single limb exercise model was used to explore whether fatigue development, 
combined with local muscle glycogen depletion and the concomitant metabolic and neurohumoral 
responses elicited during exercise with the first limb affect exercise capacity of the second limb. To 
our knowledge, previous studies employing dynamic single limb protocols have not documented the 
effect on RPE and fatigue development when exercise is performed in a sequencial manner (i.e. 1 
leg immediately after the other). It was hypothesized that exercise and concomitant local muscle 
glycogen depletion will result in a neural or hormonal signal, or both, that would cause a reduction in 
exercise capacity of the second, previously rested limb. Six trained men performed a single trial 
consisting of cycling to exhaustion at 30% of peak sustainable workload with one leg at a time. At 
the point of exhaustion of each leg, a muscle biopsy was performed to assess muscle glycogen 
content. In an attempt to maintain plasma glucose concentrations during exercise, 300 ml of a 10% 
glucose polymer drink was ingested 30 min into the exercise time of each leg. Exercise time to 
fatigue was shorter with Leg 2 (55±5 min) compared to Leg 1 (60±6 min, p=0.03), whilst the muscle 
glycogen content at exhaustion in Leg 2 was higher in Leg 2 (51±21 mmoVkg wet weight (w.w» 
compared to Leg 1 (43±25 mmol/kg w.w., p=0.04). In contrast to Leg 1, FFA concentrations during 
exercise with Leg 2 increased over time (p<O.OOO) and were higher than that of Leg 1 from at 45 
min onwards (p<0.05), whilst RER-determined fat oxidation remained similar between legs. 
Epinephrine (0.7±0.6 vs. 0.2±0.2 nmol/L, p=0.06) and norepinephrine (4.1±1.5 vs. 2.1±0.4 nmoVL, 
p=0.02) concentrations were higher at the start of exercise with Leg 2 compared to Leg 1, 
respectively. Epinephrine concentrations remained higher at 30 min of exercise (1.3±0.4 vs. 
0.7±0.4 nmol/L, p=0.002) in Leg 2 compared to Leg 1, respectively. In contrast, heart rate, V02 and 
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RER remained constant over time and similar between legs. The rate of increase in RPE was 
similar between legs when expressed as % of elapsed time. However, since the exercise time was 
shorter in Leg 2, the absolute rate of increase in RPE in leg 2 was faster. It was concluded that the 
difference in exercise capacity between legs was unrelated to muscle glycogen depletion or 
development of hypoglycemia, but may be related to increased sympathetic nervous system 
activation at the onset of exercise, and a faster absolute rate of increase in RP E. 
Whilst the previous study examined the acute or instantaneous effect of local muscle glycogen 
depletion on exercise metabolism and performance during subsequent exercise, we sought to 
further examine the role of glycogen depletion, as achieved by glycogen-depleting exercise followed 
by a low CHO diet, on exercise metabolism and performance when combined either with or without 
exogenous CHO supplementation (Chapter 4). This allowed the opportunity to examine the effect 
of maintenance of glucose (fuel) supply compared to declining blood glucose concentrations on 
metabolism and exercise capacity in the face of reduced endogenous CHO stores. It was 
hypothesized that the declining blood glucose concentrations would reduce CHO oxidation and limit 
exercise capacity, whereas maintenance of euglycemia would maintain CHO oxidation and thereby 
enable subjects to complete the exercise task despite reduced muscle glycogen availability. In 
random order, 1 wk apart, 9 endurance-trained men underwent euglycemic (CI) or placebo (PI) 
clamps, whilst performing up to 150 min of cycling at 70% V02 max, after following a low CHO diet for 
48 h prior to the trial. The range in improvement in endurance capacity with glucose infusion was 
large (28±26%, p<0.05). The majority (n=5 of 9) subjects in CI failed to complete 150 min of 
exercise despite maintenance of euglycemia, whilst only 2 subjects in PI completed 150 min of 
exercise, despite being hypoglycemic «3.5 mmoVL). Total CHO oxidation, blood lactate and 
cortisol concentrations remained unaltered despite glucose infusion. Plasma glucose oxidation and 
insulin concentrations were elevated (p<0.05) only after the 80 min timepoint in CI. Muscle 
glycogen concentrations were equally low at the start (-80 mmoVkg w.w.) and end (-40 mmoVkg 
w.w.) of exercise in both trials. Hence, despite a longer exercise time in CI, the absolute amount of 
muscle glycogen used was similar between trials, perhaps suggesting muscle glycogen sparing with 
glucose infusion. Serum FFA concentrations at exhaustion were strongly correlated to endurance 
time in both the PI (r=0.87) and CI (r=0.83; p<0.005) trials. 
It was concluded that the maintenance of glucose concentrations at 5 mmol/L in the CHO depleted 
state may have an ergogenic effect, however, the effect is highly variable between subjects and 
independent of changes in the rate of total CHO oxidation. Further, despite maintenance of 
euglycemia in a glycogen-depleted state, the majority of these endurance-trained subjects still could 
not complete 2.5 h of exercise, suggesting that some other aspect, most likely related to intra-
hepatic or intra-muscular glycogen depletion and unrelated to fuel availability per se, could have 
contributed to fatigue development. These results suggests, but do not establish, that those 
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subjects with superior endurance capacity under glycogen-depleted conditions, are somewhat 
resistant to the potential ergolytic effects of declining blood glucose concentrations, and have a 
superior ability to utilize alternative fuel sources such as FFA's. 
Recurrent exposure to hypoglycemia has been shown to reduce gluco-counterregulatory responses 
during subsequent exposures and reduce subjective awareness of hypoglycemia, termed 
"hypoglycemia unawareness". It is not uncommon for endurance athletes to develop hypoglycemia 
during prolonged exercise with insufficient exogenous CHO supplementation. Hypoglycemia 
unawareness may explain the superior endurance capacity of the 2 subjects in the previous study 
who had the longest endurance times despite being hypoglycemic. However, to our knowledge, this 
phenoma has not been investigated in healthy, well-trained individuals. 
To explore the hypothesis of hypoglycemia unawareness and counterregulatory failure, the final 
study (Chapter 5) aimed to determine the effect of an antecedent exposure to two 80-min bouts of 
hypoglycemia (separated by 40 min of euglycemia), on the concomitant gluco-counterregulatory, 
symptomatic and cognitive function responses during each bout of hypoglycemia in healthy, well-
trained men. Furthermore, the impact of antecedent exposure to hypoglycemia on next-day 
metabolic, neuroendocrine and cytokine (IL-6 in particular, Chapter 6) responses during prolonged 
exercise, and how these responses relate to exercise performance, RPE, and cognitive function 
were assessed. Particularly, it was hypothesized that antecedent exposure to hypoglycemia would 
reduce neuroendocrine and metabolic responses to prolonged exercise, and in addition, reduce 
effort perception and thereby improve exercise performance. 
In this study, 10 healthy, trained men completed two, 2-day trials in random, counter-balanced 
order, repeated at least one month apart. On day 1, a hyperinsulinemic glucose clamp procedure 
was used to expose subjects to either 2 consecutive 80-min bouts of hypoglycemia (2.9 mmollL) 
separated by 40 min of euglycemia (HYPO tria!), on the other occasion, euglycemia was maintained 
throughout (5.2 mmoVL, EU trial). On day 2, subjects cycled for 90 min at 70% of V02 mlllC, with a 10 
kJ (-20 sec) sprint performed every 15 min after blood and RER sampling. At the end of 90 min, a 
cycling TT was performed consisting of time to complete 200 kJ of work. All experiments were 
performed after a 10-12 h overnight fast. Water (only) was ingested ad libitum during the 
experiments. Cortisol concentrations and symptomatic responses were significantly higher during 
the day 1 HYPO compared to EU trial, indicative of normal counterregulation and symptomatic 
awareness. There was a strong positive relation between individual cortisol response and 
symptomatic awareness i.e. those subjects with a low symptom score rating ("hypoglycemic 
unaware") also had a reduced cortisol response during Day 1 HYPO. During the day 2 exercise 
trial, plasma glucose concentrations were maintained (>4.5 mmol/L), and isotope-determined 
hepatic glucose output, RER, insulin, cortisol, and IL-6 responses were comparable between 
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antecedent HYPO and EU exposure. Individual assessment of the data revealed that 7 (of 10) 
subjects' average sprint times and 6 (of 10) subjects' TT performance were improved after 
antecedent HYPO vs. EU exposure, however. these differences were not statistically significant. 
These results indicate that prior exposure to hypoglycemia (and stimulation of the gluco-
counterregulatory response) in healthy. well-trained men has no effect on metabolic and 
neuroendocrine responses to a subsequent bout of hypoglycemia, nor to exercise performed within 
24 h, and that the ability to regulate blood glucose homeostasis is maintained. Furthermore, 
antecedent exposure to hypoglycemia has no impact on next-day exercise performance, RPE or 
cognitive performance. 
A common finding in studies in which cognitive function is impaired due to fatigue or alcohol 
intoxication is that slowing of responses on motor and attention tasks is accompanied by significant 
increases in the variability of responses. It has been demonstrated that changes in mean estimates 
of response speed between groups or between assessments arise as a consequence of an 
increased proportion of slow responses (or increased 'trial-to-trial variability') rather than any change 
in the maximum speed of responses. The contribution of alterations in response variability to the 
commonly observed slowing of motor and attentional speed during hypoglycemia is yet to be 
investigated. Hence. by using the cognitive data collected in the previous study, we sought to 
determine whether cognitive slowing commonly observed during hypoglycemia is associated with an 
increase in the proportion of slow responses in the reaction time distribution (i.e. increased 
skewness) (presented under Addendum B). The data indicated that the response slowing 
commonly observed on choice reaction time tasks in hypoglycemic individuals is not associated with 
increased skewness in the reaction time distribution. Rather, such dysfunction appears to result 
from a general slowing of responses. 
In summary, in accordance with our onginal hypothesis this thesis demonstrated that when 
commencing exercise with normal glycogen stores combined with CHO ingestion during exerCise, 
the altered metabolic (glucose, FFA) and hormonal (insulin) milieu elicited by preexercise CHO 
meals with differing GI is rapidly negated and has no impact on exercise metabolism and 
performance. However, it was demonstrated that there is a large variability in postprandial glucose 
responses between and within individuals. This variability may explain the inconsistent findings 
noted in the literature on the metabolic and performance effects of preexercise CHO intake, and 
questions the validity and clinical "usefulness" of the GI, particularly in sports nutrition education. 
It was also demonstrated that there is an individual range in sensitivity to declining blood glucose 
concentrations, which in tum differentially affects fatigue development. In addition, though this 
thesis supports evidence on the ergogenic effect of CHO supplementation, it indicates that the 
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ergogenic potential is highly variable between subjects, specifically when exercising in a CHO-
depleted state. In contrast to the original hypotheSis, CHO oxidation was similar in placebo and 
glucose infusion trial, and maintenance of glucose availability with glucose infusion did not enable 
the majority of well-trained subjects to complete 2.5 h of exercise in a glycogen depleted state. 
Hence, in contrast to what is commonly been suggested in the literature, these results indicate that 
ergogenic effect of CHO cannot simply be explained by the maintenance of euglycemia and CHO 
oxidation at a time when muscle glycogen concentrations are low. These data are in support of a 
different mechanism whereby glycogen content per se may affect fatigue development. 
Finally, it was demonstrated that exposure to acute bouts of hypoglycemia in well-trained athletes at 
rest results in a significant neuroendocrine and IL-6 response, and that individual symptomatic 
responsiveness and aspects of cognitive performance were significantly correlated to the cortisol 
response. Furthermore, prior exposure to hypoglycemia in well-trained athletes did not alter their 
ability to mount gluco-regulatory metabolic and neuroendocrine responses needed for effective 
maintenance of glucose homeostasis during subsequent (next-day) prolonged exercise, neither did 
it alter perceived exertion and exercise performance during or cognitive function immediately after 
prolonged exercise. 
THESIS FORMAT 
This thesis is presented in the form of a literature review (CHAPTER 1), followed by the 
presentation of the findings from 5 primary studies, presented as CHAPTER 2, 3, 4, 5, 6 and 
Addendums A and B. CHAPTER 7 contains the overall conclusions of the thesis, and CHAPTER 8 
contains the list of references used throughout the thesis. 
The two experimental chapters presented as Addendum A and B play an important role in the 
evolution of this thesis. Addendum A highlights the important methodological implications of the 
variability in postprandial glycemic responses, and further the interpretation of the findings from 
studies involving preexercise CHO ingestion. Addendum B furthers our understanding of short-term 
repeated bouts of hypoglycemia on cognitive function. These two chapters are placed as 
addendums at the end so that the flow of the dissertation and central hypotheses are not impeded. 
Each of the study chapters and addendums are presented in the form of a scientific journal 
publication with added detail, and in the format of an introduction (brief literature overview and 
stating the aims of the investigation), followed by a Methods, Results and Discussion section. 
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Maintenance of blood glucose concentrations is essential to ensure an adequate supply of 
substrate to the glucose-dependent brain, thereby maintaining cerebral metabolism and cognitive 
function 334, Contracting skeletal muscle is able to use carbohydrate (CHO) and fat-derived 
substrates to sustain prolonged exercise, With an increase in exercise intensity, there is a linear 
increase in contraction-induced muscle glycogenolysis and increased sympathetic nervous 
system activity, resulting in a shift in the balance of substrate utilization from fat to CHO 47, 
Hence, muscle glycogen and blood-borne glucose are the most heavily metabolized fuels during 
exercise performed at moderate to high intensities (>60 V02 max), accounting for at least 60 to 
70% of the total energy requirement 89,360,365,366, However, relative to fat, the CHO stores in the 
body are limited 20 and depletion of these CHO reserves may ultimately result in a reduction in 
blood glucose concentration 67 and glucose supply to the working muscle as well as the glucose-
dependent brain, which will challenge a series of glucoregulatory systems to restore euglycemia 
325, The full extent and interplay of these systems are not yet fully understood, especially as they 
operate during prolonged exercise; how it is influenced by short- and long-term nutrition 
intervention (known to alter metabolic and hormonal responses), and ultimately how exe'rcise 
peformance may be affected, 
Decades of research in the field of carbohydrate (CHO) metabolism during prolonged exercise 
have clearly demonstrated that CHO supplementation during prolonged (>90 min), moderate to 
high-intensity (>60% V02 max) exercise can delay the development of fatigue 19,67,73,74,89,91, The 
ergogenic effect of CHO has mainly been ascribed to the prevention of hypoglycemia and the 
maintenance of high rates of CHO oxidation throughout exercise 73,91, These findings have 
stimulated a wave of research investigating nutritional strategies to optimize bodily CHO fuel 
stores as well as formulating effective nutritional strategies for CHO supplementation 'during 
prolonged exercise to optimize exercise performance (for reviews see 76,220), However, the exact 
mechanisms whereby CHO metabolism is regulated, the interplay between fuel substrates; and 
the manner in which CHO affects endurance exercise capacity, still remain to be fully elucid~ted, 
Closer inspection of the literature reveals that CHO supplementation does not merely el'1hance 
performance via maintenance of euglycemia and high rates of CHO oxidation throughout 
exercise, as several studies have reported similar levels of glycemia and CHO oxidation between 
CHO supplemented and placebo trials (e,g, refs, 35,36,440,441), Indeed, in a very recent study, 
simply rinsing the mouth with a CHO solution then spitting it out appeared to have an effect on 
attenuating fatigue development during a 1-h cycle time-trial performance 61, In addition, there 
are studies in which the development 87,146,228,230,312, prevention 146 or reversal 73 of hypoglycemia 
had no significant effect on exercise performance, The ergogenic effect of CHO 
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supplementation between individuals also does not seem to be uniform as a range of metabolic 
responses and variable effects on performance within a study population are often seen. This 
seems to hold true even in apparently homogenous study populations (Le. controlled for training 
status, body mass, age). 
This literature review will aim to characterize and discuss factors known to be involved in the 
regulation of CHO metabolism and glucose homeostasis during prolonged exercise,' and 
specifically relate changes in CHO availability and the metabolic sequelae during exercise with 
resistance to fatigue. 
1.2 FACTORS AFFECTING GLUCOSE HOMEOSTASIS 
Glucose homeostasis is essential in order to ensure an adequate supply of substrate to the 
glucose-dependent brain. Therefore, blood glucose concentrations are tightly regulated with 
often redundant mechanisms of control, ostenSibly to prevent hypoglycemia and associated 
sequelae. 
Section 1.2 will focus on factors affecting glucose homeostasis predominantly under resting 
conditions, and section 1.4 will focus on the key factors involved in the regulation of glucose 
homeostasis during prolonged exercise. 
1.2.1 The glucose counterregulatory response 
In both fed and fasted states, insulin is one of the key factors that regulates glucose production 
and use. Insulin reduces endogenous glucose production, mainly by reducing hepatic glucose 
output via an increase in glycogen synthase and decrease in glycogenolysis 382. On the other 
hand, glucoregulatory hormones including glucagon, epinephrine, cortisol and growth hormone, 
all have biologic effects that can oppose those of insulin 27. 
When blood glucose concentrations decline, a series of counterregulatory responses are elicited 
in hierarchical fashion in order to restore euglycemia, mainly in aid of preserving brain function 
309. With an initial 0.6-0.8 mmol/L decline in blood glucose (below postabsorptive levels) to -4.0-
4.2 mmol/L, the first counterregulatory response involves suppression of endogenous insl,J1i11 and 
an increase in glucagon production in aid of stimulating endogenous glucose productiOI) 110. 
Thus, hypoglycemia may be defined as any decrease in plasma glucose concentration below 4.0 
mmol/L 27. The release of other counterregulatory hormones occurs after an additional similar 
decrease in plasma glucose to approximately 3.7 mmol/L 138,309,371. 
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There is evidence to suggest that the reduction in insulin secretion may be via a local re'sponse 
within the pancreatic islets, which responds directly to the reduction in blood glucose and also to 
central neurogenic signals 405, The control of glucagon secretion is less clear and remains 
controversial. There is evidence to suggest that local factors within the pancreas may be 
responsible for glucagon secretion by the alpha cells, It has been suggested that the pancreatic 
alpha cell may respond directly to the prevailing glucose concentration 106, and that the gluca,gon-
secreting pancreatic alpha cells may respond to the insulin secretory response of the beta ~lIs, 
however, evidence to support this is currently lacking (for review see 385), In addition, there is 
also evidence for central involvement in the glucagon response via activation of the sympathetic 
168 and parasympathetic 24 nervous systems, In further support of central control of glucagon 
secretion, neuroglycopenia has been shown to result in elevations in epinephrine and glucagon 
concentrations in aid of increasing systemic glucose production and glucose supply to the brain 
405 Furthermore, studies in dogs in which cerebral normoglycemia was maintained whilst 
inducing systemic hypoglycemia have shown a large attenuation in the glucagon-epinephrine 
counterregulatory hormone response 17,157, Glucagon and epinephrine are referred to as "rapid-
acting" hormones critical for glucose counterregulation in the early phase of hypoglycemia 27. 
When the initial insulin-glucagon response fails to restore blood glucose and concentrations 
d~cline further to -3.7 mmol/L, sympathetic activation and epinephrine secretion (both under 
neurological control) result in peripheral and hepatic responses to augment glucose 
concentrations via stimulation of glycogenolysis and gluconeogenesis 27. In addition, lipolysis is 
stimulated, resulting in enhanced free fatty acid release, thereby providing substrate for 
gluconeogenesis, whilst peripheral glucose uptake is reduced 157. The release of, growth 
hormone and andrenocorticotrophin hormone contribute to endogenous glucose productio~ and 
reduce peripheral glucose uptake 111,112. Their secretion and peripheral effects to augment 
glucose concentrations typically show a delay in response (also referred to as "slow-~cting" 
hormones), but their effects are longer-lasting and important in the long-term maintenance of 
blood glucose concentrations 27, As part of the counterregulatory response, a complex of 
hypoglycemic symptoms are elicited (for review see 27,385). Failure of these responses to cOrrect 
hypoglycemia may reduce glucose supply to the brain, which may alter cerebral metabolism and 
impair cognitive function 334, 
1.2.2 Glucose sensing 
Based on the involvement of the sympathetic centers and hypothalamic-pituitary-adrenal (HPA) 
a);(is in aid of correcting declining blood glucose concentrations, it seems clear that the series of 
responses initiated are largely centrally mediated 385, Furthermore, seeing that glucose supply to 
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the brain is so critical for sustaining normal cerebral function, it has been suggested that the 
brain would be the main organ for sensing reductions in blood glucose concentrations 385. 
1.2. 2. 1 The role of the brain as primary "glucose-sensor" 
Numerous studies indicate that the brain is the prominent organ or center for the sensing of 
hypoglycemia (for review see 27). Dogs in which insulin-induced hypoglycemia was induced 
peripherally whilst euglycemia was maintained in the brain, displayed near complete attenuation 
of counterregulatory responses compared to responses in dogs with brain neuroglycopenia ~7,157. 
These findings have lent support to the presence of a glucose sensor in the region of the 
cerebral and/or vertebral arteries. In contrast, other similar studies concluded that the response 
to moderate 57 or deep 58 hypoglycemia did not involve putative hypothalamic glucoreceptors nor 
receptors in the carotid perfused tissue. These studies 57,58 did, however, show some reduction 
in the epinephrine response to hypoglycemia. 
Recently, much effort has been invested in determining which specific area(s} of the brain may 
be involved in glucose-sensing. Livingston et al. 281 found that the glucose transporter isoform, 
GLUT -4, is expressed in the hypothalamus. The authors suggested that this brain region, which 
is outside the blood-brain barrier and therefore sensitive to circulating insulin concentrations,. may 
experience stimulation of glucose uptake in response to insulin. They further proposed tha~ this 
may allow regions of the hypothalamus to respond directly to elevated blood glucose, constituting 
a form of metabolic regulation by allowing circulating glucose (and therefore insulin) in concert 
with other mechanisms to maintain blood glucose homeostasis 281. Hence, this area of the brain 
may be a sensing mechanism which responds directly to blood glucose and/or insulin 
concentrations, which may, in turn, alter neurohormonal responses 281.385. Through a series of 
studies in rats, Borg and co-workers 31-33 demonstrated that the ventromedial hypothalamus 
triggers counterregulation during hypoglycemia, suggesting that, at least in rats, this area of the 
brain is one of the key sites acting as a glucose sensor. However, results from one. study 
suggest that various regions of the brain may be involved in glucose sensing and inducing the 
glucagon and epinephrine hormonal response to acute central nervous system fuel deprivation 
157 
Frizzell et al. 157 demonstrated that the humoral responses (cortisol, glucagon, catecholamines, 
and pancreatic polypeptide) to systemic hypoglycemia were minimally attenuated' when 
euglycemia was maintained in the carotid or vertebrobasilar arteries in dogs, whilst significant 
counterregulation occurred when hypoglycemia was induced in either of these circulations. 
These observations are in support of the hypothesis that more than one center is important in 
hypoglycemic counterregulation in the dog and that they are located in brain regions supplied by 
the carotid and vertebrobasilar arteries 157. These authors suggested that counterregulation 
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during hypoglycemia is probably directed by widespread brain regions that contain glucose-
sen~itive neurons such that the sensing sites may be redundant 157. 
1.,2.2.1.1 Glucose-sensing neurones 
It has also now been shown that there are populations of neurons that uniquely use glucose as a 
signaling molecule that may alter firing rate in response to changes in local glucose supply, 
rather than using it as metabolic substrate 388. These neurons comprise of subpopulations that 
are either glucose-sensitive i.e. respond to decreasing blood glucose concentrations, or glucose-
responsive i.e. responds to increasing blood glucose concentrations 385. Furthermore, changes 
in blood glucose concentration have been shown to alter neuronal release of neurotransmitters 
such as dopamine and gamma amino butyric acid in rats 126,276 and central nervous system 
(eNS) hormones involved in food intake and appetite regulation such as neuropeptide Y 304. 
Hypothalamic dopaminergic neurons are stimulated by reduced glucose supply and can regulate 
secretion of several glucoregulatory hormones 45, 
Evidence for similar involvement of these pathways in hypoglycemia counterregulation in 
humans is still lacking. However, results from human studies showing delayed onset and 
reduced magnitude of counterregulatory responses to hypoglycemia by provision of non-glucose 
substrates (especially ketones and lactate), provide support for locating the hypoglycemia-sensor 
in the brain (for review see 365), 
In addition, neural feedback from the working muscles may playa role in regulating ho~monal 
and metabolic responses to exercise 257. 
1.2.2.2 Glucose sensing by the liver 
Though evidence suggest that the brain is the primary glucose sensing organ, studies performed 
on dogs 121,122,181 suggest the existence of hepatic gluco-sensors involved in activating a 
sympathoadrenal response to hypoglycemia. A study on adrenalectomized, somatostatin-
infused dogs (Le. absence of counterregulatory hormone response) found that the ,liver 
stimulated hepatic glucose production during marked hypoglycemia (2 mmoIlL). Maintenan~ of 
brain euglycemia did not prevent the increase in hepatic glucose production, thus demonstrating 
autoregulation of hepatic glucose production and evidence that hypoglycemia must therefore be 
sensed within the liver as well 181, 
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1.2.2.3 Hepatic portal glucose sensing 
The portal vein, draining the gastrointestinal tract to the liver, has also been suggested as a 
potential site for monitoring ("sensing") glucose entry from the gastrointestinal tract into the 
circulation. Animal studies have indicated that cells in the region of the portal vein contain beta-
cell GLUT 2 transporters 50.51, and have demonstrated a reduction in hormonal respon~e to 
systemic hypoglycemia when glucose supply to the portal vein was maintained 208. Portal vein 
glucose sensing have not only been implicated in the hormonal responses to hypoglycemia, but 
also in the control of hepatic glucose uptake (perhaps via a portal-arterial glucose concentration 
gradient acting as a signal for an insulin-dependent net glucose uptake as measured in perfused 
rat liver) 165; and tissue glucose utilization 51, though the exact mechanism(s) remain unclear, 
Data from human studies are at present limited. Smith et al. 386 recently reported results in favor 
of a glucose sensor in the liver or hepatic portal vein in humans. Their data also suggested that 
portal vein glucose sensors in humans are the primary hypoglycemia sensors, which may, 
interact with and modulate the centrally mediated adrenergic responses. The portal signal'may 
be conveyed to the central sympathetic pathways via nerves 386. 
From the available literature it seems clear that glucose homeostasis is critical, primarily to 
ensure constant fuel supply to the glucose-dependent brain. The full extent and integration of 
the control and responses of the glucoregulatory systems in humans are not yet fully clear as in 
many of these experimental models one system has been controlled or blocked thereby influence 
tt"!e response of another system. However, several key components have been identified as 
playing a role in the maintenance of glucose homeostasis at rest including a) sensing of the 
prevailing blood glucose concentration and a component of central regulation; and b) a 
component of integration of a series of hormonal and neural responses in the periphery in aid of 
restoring euglycemia. In addition, there seems to be a component of redundancy· in the 
glucoregulatory mechanisms. The remainder of this literature review will explore how these 
gluco-regulatory components operate during exercise, how it is affected by certain dietary 
manipulations and ultimately aim to explore its impact on endurance exercise capa~ty or 
performance. 
1.3 BRIEF OVERVIEW OF FUEL SUBSTRATE SELECTION DURING PROLON~ED 
EXERCISE 
As previously noted, maintenance of glucose homeostasis is necessary to ensure constant fuel 
supply to brain. In addition, glucose is also an important fuel source to contracting skeletal 
muscle, and optimal glucose homeostasis and fuel supply has been linked to improved 
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endurance capacity (for review see 76). However, blood glucose is not the only fuel source 
utilized by the muscle. Muscle glycogen, blood-borne glucose (derived from liver glycogenolysis, 
gluconeogenesis and/or exogenous supply), and fat (intramuscular triglicerides (IMTG) and 
plasma free fatty acids (FFA)) have been identified as the major substrates utilized for energy 
production during prolonged exercise 220.233.360.393. The various types of substrates and .their 
relative contributions during exercise have been extensively researched and reviewed: (for 
reviews see 220,233,414). 
The relative contribution of these substrates to energy production during exercise is largely 
dependent on the intensity and duration of exercise 220,360,393, substrate availability 175, and 
training status 15. 
1.3.1 Effect of exercise intensity on substrate selection 
A classic study by Romijn et al. 360 on fuel utilization during various exercise intensities 
demonstrated that during exercise performed below 40% V02 max, plasma FFA were the ~ajor 
source of fuel for muscle contraction. CHO oxidation remained low at this low intensity an~ the 
liver was capable of supporting this relatively low rate of blood glucose utilization via 
gluconeogenesis. At higher exercise intensities (>60% V02 max) the contribution of fat to the 
overall energy demand decreased. Utilization of IMTG also decreased with increasing exercise 
duration 360. Though a progressive increase in FFA mobilization and oxidation was observed 
with increasing exercise duration, CHO remained the major source of fuel for muscle contraction 
when exercise was performed at higher intensities 360. 
CHO oxidation during exercise is influenced primarily by the exercise intensity, duration and 
CHO availability. It has been well established that with an increase in exercise intenSity, there is 
a linear increase in muscle glycogenolysis and muscle glucose uptake (for example see refs. 
220,414). Muscle glycogen and blood-borne glucose, as derived from endogenous (mainly' liver 
glycogenolysis and to a lesser degree gluconeogenesis) and exogenous sources, are the most 
heavily metabolized fuel during exercise performed at moderate to high intensities (above 60 to 
75% V02 max), accounting for at least 60 to 70% of the total energy requirement 69,360,365,366. This 
is largely due to contraction-induced increases in muscle glycogenolysis and glycolysis 217 as 
well as increased sympathetic nervous system activity 120. 
However, relative to fat, the CHO stores in the body are limited. Skeletal muscle can only 
provide 300 to 500 g and the liver 60 to 100 g of glycogen (dependent on body size and CHO 
content of the diet) 20. Depletion of these CHO reserves is often associated with impaired 
exercise performance and/or the development of fatigue 52,67,76. 
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1.3.2 Effect of CHO availability on fat oxidation 
The general view is that in exercising muscle, the state of the endogenous CHO stores and CHO 
availability affects FFA uptake and fat oxidation, whilst increased FFA availability enhances fat 
oxidation and inhibits CHO metabolism 393, 
Interestingly, in a recent study by Kjaer et al. 253 fatty acid kinetics and CHO metabolism during 
involuntary, electrically-induced leg cycling in spinal cord-injured individuals were compared to 
voluntary cycling exercise in healthy control subjects, They demonstrated a reduced fat 
metabolism in the absence of intact neural mechanisms during exercise, which underlines the 
importance of somatic afferent and efferent neural activity for regulation of lipolysis during 
exercise. Blood-borne mechanisms alone, including direct feedback on lipolysis by decreasing 
plasma FFA levels are not sufficient to elicit a normal increase in FFA mobilization during 
exercise 253. In addition, their results were in support of the view that in exercising muscle,' FFA 
delivery enhances FFA uptake and inhibits CHO metabolism whilst CHO oxidation inhibits FFA 
uptake. Their study illustrated that substrate availability is an important determinant of fuel 
selection during exercise, however, the exact mechanisms regulating this interplay still remain to 
be clarified 253. 
CHO (glucose) availability and the insulin response associated with preexercise CHO ingestion 
has been shown to regulate fat metabolism during exercise 93,211,212. Raised .insulin 
concentrations (10-30 IlUlml) reduce FFA appearance mainly by inhibiting adipose tissue 
lipolysis 28,58. However, it appears that a reduction in FFA availability per se is not the sole factor 
responsible for the reduced fat oxidation observed with increased CHO availability and raised 
insulin concentrations. In the study of Sidossis and Wolfe 379, CHO oxidation was accelerated 
by means of a hyperglycemic, hyperinsulinemic clamp whilst FFA concentrations were held 
constant with lipid-heparin infusion. Despite the maintenance of FFA availability, fat oxidation 
was inhibited likely due to a direct effect of elevated glucose or insulin concentrations 379. 
In contrast to the above, some studies have shown that despite a significant suppression of,FFA 
and glycerol concentrations, CHO ingestion during exercise had no effect on fat oxidation during 
the first 120 min of exercise at moderate- to high-intensity (65 to 75% V02 max) 89,91. This may be 
due to the effect of higher-intensity exercise on suppressing the insulin response 89. The 
suppression of the insulin response at higher exercise intensities may also explain the results of 
studies where CHO ingestion had no effect on CHO oxidation and muscle glycogenolysis 
38,38,89,91,440. In support of these findings, the study of Horowitz et al. 212 demonstrated that though 
ci-Io ingestion during 2 h of exercise at low intensity (25% V02 max) resulted in a 3-fold increase 
in insulin and a >50% reduction in lipolytic rate and plasma FFA concentration throughout the 
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final 1 h exercise, fat oxidation was not reduced until 80-90 min of exercise. CHO ingestion 
during 2 h of exercise at moderate- to high-intensity (68% V02 max) resulted in a small elevation 
(-3 ~U/ml) in insulin response in the second hour and a reduction in lipolysis and plasma:FFA 
concentration by -20-25% during this time, however, fat oxidation remained unaffected 
throughout the 2-h exercise bout. Despite suppression of lipolysis with CHO ingestion, plasma 
FFA availability was in excess of oxidation during both exercise intensities, indicating that 
reduced lipolysis and FFA availability were not solely responsible for the reduction in fat oxidation 
in the low-intensity exercise trial. Other additional mechanisms whereby increased gluCose 
availability and insulin may suppress fat oxidation may be related to the effects of insulin on 
increasing glucose uptake into the muscle 248, increasing glycolysis and glycolytic flux 377, and by 
controlling the rate of fatty acid oxidation by controlling the rate of long-chain fatty acid entrance 
into the mitochondria 378. It should be noted though, that the other gluco-regulatory hormones 
(glucagon, catecholamines, cortisol and growth hormone) are also important in the regulati<;>n of 
substrate utilization, mainly through their action on glucose homeostasis (for review see 434). , The 
effects of these hormones are discussed in more detail under various subsequent sections of this 
literature review. 
Fat 9xidation during exercise is also largely regulated by the status of the endogenous CHO 
stores 23.35.162,175,440,441,445. The studies by Weltan et al. 440,441 demonstrated an increase in fat 
oxidation when performing exercise in a glycogen-depleted state. Surprisingly, fat oxidation 
during exercise in the glycogen-depleted state remained elevated despite euglycemic 440 or 
hyperglycemic (-10 mmol/L) 441 glucose infusion. In contrast, when exercise was commenced 
and performed with normal 23,175,440,441 or supercompensated 35,162,175,445 glycogen stores, fat 
oxidation was reduced and muscle glycogen oxidation enhanced. These studies have also 
indicated that reduced muscle glycogen content does not alter the rate of plasma glucose 
oxidation 441, but rather results in an increase in fat oxidation to meet the energy dem~nds. 
35.440,441. It was hypothesized 440 that the shift towards fat oxidation during exercise with low 
muscle glycogen stores may be mediated by a muscle afferent pathway that ultimately results in 
an alteration in norepinephrine and insulin concentrations. 
1.3.3 Effect of training status 
Regular exercise training can alter the interplay in fuel substrate selection. Training results in, 
amongst other things, an increase in insulin sensitivity (e.g. ref. 200), an increased activity of 
oxidative enzymes, a higher proportion of type I skeletal muscle fibers, greater capillary density, 
higher skeletal muscle GLUT-4 protein expression (e.g. refs. 130,184), which enables enhahced 
glucose uptake by the contracting muscle 265 as well as an increase in the ability to oxidize fat as 
fuel with potential "sparing" of the limited CHO fuel stores 15,179,199,202,218. 
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When assessing the effects of training on CHO (glucose) metabolism, it has been noted that 
training reduces glucose flux at the same absolute workload (compared to pre-training), but not 
the same relative workload 154, In one of the very few longitudinal studies of the effect of training 
status on whole-body glucose kinetics during exercise 154, it was shown that training does not 
affect glucose kinetics (glucose appearance or disappearance) when expressed at a given 
relative power output. This is in contrast to results from cross-sectional designs where results of 
highly trained and untrained populations were compared 76, However, results of highly trained 
athletic populations may be confounded by speci'fic genetic characteristics related to substrate 
utilization, such as an increased ability to oxidize fat 154, However, irrespective of study 
population and/or design, it has been shown that even after training, endogenous CHO e~ergy 
sources are the predominant fuel for muscle contraction when exercising at intensities >50% V02 
max (for review see 47), Furthermore, even when the ability to oxidize fat is increased with training, 
there is still a limitation in the overall rate of fat oxidation 361, 
In this regard, Bergman et al. 14 investigated the effect of endurance training on IMTG oxidation 
by studying leg FFA and glycerol exchange during 1 h of cyding exercise at two intensities (45% 
and 65% V02 max) before training, and after training at 65% of pretraining V02 max (i,e. the same 
absolute workload), and 65% of posttraining V02 max (i.e. the same relative workload). Testing 
was conducted before and after 9 wks of cycling exercise. 5 times per wk at 75% V02 max. The 
power output that elicited -65% V02 max before training. elicited -54% V02 max after training 'd~e to 
a -15% increase in V02 max. Training significantly decreased pulmonary (whole-body) ,RER 
values at the same absolute intensity, but was the similar at the same relative intensity. After 
training. leg respiratory quotient (RQ) was not significantly different at either the same absolute 
or relative intensity. Measurements of leg RQ, net FFA uptake, and glycerol release by working 
legs indicated no change in leg FFA oxidation, FFA uptake, or IMTG lipolysis during cyding 
exercise that elicits 65% pre- and 54% posttraining V02 max. The authors concluded that training 
increases working muscle FFA uptake at 65% V02 max, but high RER and RQ values at all work 
intensities indicate that FFA and IMTG are of secondary importance as fuels in moderate and 
higher-intensity exercise 14. 
The limitation in fat oxidation during exercise at higher intensities may be due, partly, to reduced 
availability of blood-borne FFA (due to reduced adipose tissue blood flow). and partly due to 
other regulating mechanisms involved in fat oxidation such as inhibition of J3-oxidatioh by 
malonyl-CoA at higher exercising intensities 235.237. These mechanisms are not fully understood 
and disclJssion of this aspect is beyond the scope of this review (for detailed reviews on the topiC 
see refs. 235-237.392). 
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1.3.4 The "crossover concept" 
The above observations have contributed to the development of the "crossover concept" by 
Brooks 47,48 that explains the interplay between CHO and fat metabolism and oxidation during 
exercise in humans, 
According to this concept 48, endurance training results in biochemical adaptations that enhance 
fat oxidation during low to moderate-intensity exercise as well as decrease the symp~thetic 
nervous system (SNS) response to given submaximal exercise stresses. In contrast, an 
increase in exercise intensity is associated with an contraction-induced increase in muscle 
glycogenolysis, altered fiber-type recruitment patterns, and increased SNS activity, resulting in a 
shift ("crossover") in the balance of substrate utilization from fat to CHO, regardless of genotypic 
or phenotypic adaptations 47. Hence, it is proposed that the individual pattern of substrate 
utilization at any point in time depends, amongst other things, on the crossover between the 
exercise intensity-induced responses (such as SNS-related responses to increase CHO 
utilization) and the endurance training-induced responses (which promote fat oxidation) 48 .. The 
crossover point is defined as the workload (power output) at which oxidation of endogenous 
CHO-based fuels (liver and muscle glycogen, blood glucose, and liver, muscle and blood lactate) 
predominates over that derived from fat 48. As exercise intensity (power) increases, the relative 
contribution of energy derived from CHO-based substrates will increase and the relative 
contribution of energy derived from fat-based substrates will further decrease 48. In order to 
support the increased energy substrate flux rate needed to sustain muscle contraction during 
high-intensity exercise, SNS-mediated responses along with other hormonal responses {e.g. 
in'sulin and glucagon), blood lactate concentrations, nutritional strategies and training history will 
contribute to coarse and fine settings of substrate utilization patters during exercise of differing 
intensities 48. 
As evident from the literature, there is an extensive interplay between the various endogenous 
oxidative substrates capable of contributing to the energy demand by the working muSCle. 
However, 'from the various endogenous fuel stores, CHO oxidation seems paramount to sustain 
muscle contraction during prolonged exercise at moderate- to high-intensities. This setting, 
combined with limited endogenous CHO stores may ultimately result in a reduction in blood 
glucose concentration and glucose supply to the working muscle as well as the glu~se­
dependent brain, which will challenge glucoregulatory systems to restore euglycemia. 
1.4 KEY FACTORS INVOLVED IN THE REGULATION OF GLUCOSE 
HOMEOSTASIS DURING PROLONGED EXERCISE 
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During exercise, glucose homeostasis is mainly comprised of activation of liver and muscle 
glycogenolysis as well as up-regulation of insulin-dependent and insulin-independent glucose 
transport pathways. Several hormonal and humoral factors have been identified as key 
regulators of glucose homeostasis during exercise (discussed in detail below). In brief, with 
increased muscle contraction there is increased uptake of glucose, likely mediated via increased 
insulin signaling, as well as insulin-independent, contraction-stimulated increases in 5'AMP-
activated protein kinase (AMPK), which both result in increased translocation of the GLUT-4 
transporter protein and subsequent glucose uptake (for review see 250,447). With increased 
glucose uptake by the contracting muscles, hepatic glycogenolysis and hepatic glucose output 
are activated, and the subsequent hormonal responses involve changes in the gluco-regul~tory 
hormones such as a reduction in insulin, and an increase in glucagon, cortisol, growth hormone 
and catecholamines 457. Prolonged exercise and progressive glycogen depletion will result in a 
gradual decline in blood glucose concentrations and further changes in glucose 
counterregulatory hormones 404, whilst CHO supplementation during such exercise has been 
shown to attenuate these hormonal responses 44,180,275,277. 
1.4.1 Contribution of the liver to the maintenance of glucose homeostasis during 
exercise 
The liver is the predominant source of endogenous glucose production during exercise (via 
glycogenolysis and gluconeogenesis) and therefore plays an essential role in the maintenance of 
glucose homeostasis during exercise (for review see 252). 
Though several studies have aimed to investigate the effect of exercise intensity on the rates of 
hepatic glycogenolysis and gluconeogenesis, findings are contradictory and unclear 
(documented in Trimmer et al. 412). It seems that one of the main reasons for the discrepancy in 
results is related to the methodological limitation in the use of carbon tracers and corre~tion 
factors for estimations of rates of gluconeogenesis in vivo 412. However, a more sophisticated 
measurement technique has been developed 206,315 called the mass isotopomer distribution 
analysis (MIDA) technique, which enables a more true estimation of precursor pool enrichment 
without the need of correction factors 412. 
In a recent study, Trimmer et al. 412 employed the MIDA and isotope-dilution techniques to 
assess the relative contribution of gluconeogenesis and hepatic glycogenolysis to glucose 
production, and its ability to match the rate of peripheral glucose utilization during prolonged 
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exercise at moderate and high-intensity. In a randomized order (at least 5 days apart), 8 
overnight-fasted, endurance-trained men cycled for 90 min at either 45% or 65% V02 .ma". In 
agreement with previous findings 14,154,155.411, glucose production increased in an intensity-
dependent manner (rest, 2.0±0.1; 45%, 4.0±0.4; 65% V02 max, 5.8±0.6 mg/kg/min, p<0.05), 
however, the rate of peripheral glucose utilization exceeded rate of appearance during the last 30 
min of exercise at 65% V02 max. During high-intensity exercise, the fraction from 
gluconeogenesis decreased significantly to account for only 21 % of glucose production, and the 
highest sustained rate of gluconeogenesis observed was 1.2±0.3 mg/kg/min in lieu of a glu·cose 
utilization rate of >6.0 mg/kg/min. The use of the MIDA technique yielded results that are :-30-
45% higher that that obtained with similar study deSigns but with the use of the carbon tracer 
dilution technique. Hence, this study demonstrated that after an overnight fast, though the 
absolute rate of gluconeogenesis increases during exercise compared to rest, the relative 
contribution of gluconeogenesis (as a fraction of glucose production) remains the sa~e at 
mOderate-intensity exercise, and decreases with higher-intensity exercise (constituting -20-25% 
of glucose production). Hepatic glycogenolysis is more important in the maintenance of glu'cose 
homeostasis during exercise. However, in overnight-fasted state (Le. compromised hepatic 
glycogen content), neither increased glycogenolysis or gluconeogenesis (nor in combination) 
were sufficient to prevent a decline in plasma glucose concentration during 90 min of high-
intensity exercise (65% V02 max), despite an elevation in precursor (lactate and glycerol) Sl:Jpply 
412 
Hence, with prolonged exercise performed in a postabsorptive (fasted) state, especi~lIy at 
intensities >65% V02 max, maintenance of glucose homeostasis may be compromised 412. This 
will inevitably elicit a complex of gluco-regulatory systems, such as alterations in hormonal 
responses 271 in attempt to restore euglycemia. The key components of these regulatory 
systems, as they operate during exercise will be discussed below. 
1.4.2 Regulation of hepatic glucose output 
Hepatic glucose production at rest has been shown to be regulated primarily by feedback .from 
the extracellular glucose concentration, which has a direct glucoregulatory effect on hepatic 
glucose production 429. The extracellular glucose concentration has been shown to modulate the 
neural discharge from glucoreceptors in the liver, the hypothalamus and hind-brain, the intestine 
and pancreas (for review see ref. 429). However, during exercise, hepatic glucose production has 
been shown to be regulated by more complex interaction between hormonal and neural 
mechanisms, that often display a component of redundancy, but are as of yet not completely 
understood 252. 
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Initially it was thought that the well-established humoral feedback mechanism that regulates 
glucose homeostasis at rest, also operates during exercise 429. This thought was strengthened 
by studies in dogs demonstrating an initial (temporary) decline in blood glucose concentrations at 
the onset of moderate-intensity exercise, which may provide a feedback stimulus to increase 
hepatic glucose production to restore glucose homeostasis (for review see 429). Further support 
for a humoral feedback mechanism operating during exercise has come from studies during low 
to moderate intensity exercise in humans 13,224 and animals 430 demonstrating that the increase in 
hepatic glucose output during exercise can be prevented by an intravenous glucose infusion, or 
with glucose ingestion in trained men 297. These findings indicated that hepatic glucose outp.ut is 
subject to feedback regulation by the prevailing glucose concentration, causing alteratiot:'ls in 
glucagon and insulin concentrations 209,453. However, during high-intensity exercise, changes in 
glucagon and insulin are insufficient to account for the marked increase in hepatic glucose output 
77,380. Furthermore, glucose infusion during high-intensity exercise in rats reduced but did not 
completely suppress hepatic glucose output 446,448, indicating that metabolic (humoral) feedback 
mechanisms (arising from the prevailing blood glucose concentration) cannot entirely prevent the 
exercise-induced increase in hepatic glucose production during such exercise. The rapid 
increase in glucoregulatory hormonal responses and glucose production seen during exercise at 
higher intensities is unlikely to be due entirely to humoral feedback mechanisms 303.422. 
During high-intensity exercise, there is evidence for feed-forward activation as shown by a 
greater increase in the rate of glucose production than glucose uptake, and a subsequent 
in,crease in plasma glucose concentrations (particularly early in exercise) 192,213,258, Hence, 
during high-intensity exerCise, hepatiC glucose output may rather be regulated by neural feed-
forward mechanisms whereby motor centers in the brain may activate neuroendocrine responses 
that increase glucose production 258,430. The neural feed-forward mechanism has the benefit of a 
more rapid supply of glucose to meet the large increase in substrate need by the working 
muscle, as opposed to a slower rise in glucose from a humoral feedback mechanism 429, 
Recent studies have attempted to investigate the role of central neural control of metabo!ism in 
exercise. In this regard, Kjaer et al. 258 have shown that neuromuscular blockade in humans 
induced higher perceived exertion and a higher glucose production compared to controls 
exercising at the same absolute workload, which provided evidence of central command 
regulation of glucose mobilization in exercise. After conducting a series of experiments in: cats 
and humans, Vissing 429 presented compelling evidence that mobilization of glucose and 
secretion of glucoregulatory hormones are regulated primarily by neural mechanisms. ,It was 
suggested that this neural mechanism involves an efferent (central) component ..... associated 
with' a simultaneous drive of somatomotor and autonomic Circuitry from cerebral motor ce~ters, 
that in parallel stimulate locomotion, neuroendocrine activity and circulation" and hence stimulate 
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glucose mobilization; as well as "an afferent (peripheral) mechanism associated with reflex 
stimulation from working muscle" 429. Further, the author proposed that "the muscle reflex 
mechanism likely has a fast component caused by mechanoreceptor stimulation at the onset of 
exercise and a slower component related to muscle metaboreceptor stimulation during continued 
exercise" 429. Vissing suggested that these two components are likely integrated in the central 
nervous system. The potential chemical mediator responsible for eliciting the muscle reflex is 
still unclear, but there seems to be no direct correlation between sympathetic activation and the 
levels of acidity, lactate, inorganic phosphate and glycogen during exercise 429. Levels of nitric 
oxide and potassium are potential mediators in the muscle reflex mechanism (for review see 429). 
However, the results from this series of experiments by Vissing 429 should be interpreted and 
extrapolated with caution as it was conducted under non-physiological conditions in animals and 
diseased humans. Though it provides significant insights into potential mechanisms of hepatic 
glucose production and regulation of glucose homeostasis during exercise, further studies on 
healthy humans in a more physiological milieu should be conducted to reaffirm the results.' 
.In summary, though the humoral feedback mechanisms are efficient to adjust for small 
fluctuations in glucose homeostasis at rest, it is unlikely that they account for the dramatic 
increase in fuel (glucose) demand of the working muscle, especially during moderate to high 
intensity exercise. Rather, evidence suggests that direct neural control of neuroendocrine 
activity and subsequent glucose mobilization is responsible for a rapid delivery of glucose to 
match the increased metabolic demand of the working muscle. 
1.4.2.1 Role of glucose availability per se in the regulation of hepatic glucose output in humans 
exercising at moderate to high intensities 
A study by Howlett et al. 213 attempted to elucidate the relative importance of feedback and feed-
forward mechanisms for regulation of hepatiC glucose output during high-intensity exercise (40 
min cycling at -77% V02 max) in trained men. Glucose was infused during the exercise trial at a 
rate equal to the average hepatic glucose output as was measured during a control trial (without 
glucose infusion). Glucose concentrations in the control trial gradually increased from 5 to 6 
mmollL, and from -5-7 mmol/L with glucose infusion (p<0.05). Glucose infusion and an increase 
in glucose availability completely inhibited the rise in hepatic glucose output during exercise. 
Insulin, glucagon, epinephrine and norepinephrine concentrations were lower with glucose 
infusion, though not statistically significant. It was suggested that the lack of significance ~ight 
have been attributed to the small sample size (n=5) and inter-individual variability. The insulin to 
glucagon ratio was significantly higher throughout exercise with glucose infusion. The a.uthors 
concluded that metabolic feedback signals (arising from the prevailing blood glucose 
concentration) can override feed-forward activation of hepatiC glucose production during 
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strenuous exercise 213. Similar results were found in trained males exercising for 2 h at 70%' V02 
max when plasma glucose was increased to a level of 10 mmol/L, however, hepatic glucose output 
was reduced but not completely abolished during euglycemia 194. 
Glucose supplementation and increased glucose concentrations per se have been shown to 
directly inhibit hepatic glycogenolysis by decreasing glycogen phosphorylase and incre~sing 
glucokinase activity with a subsequent reduction in hepatic glucose output 362. However, in the 
studies of Howlett et al. 213, and Hawley et al. 194 alterations in the glucoregulatory hormone 
concentrations may also have played a role in altering hepatic glucose output 162. 
1.4.2.2 Role of pancreatic hormones on hepatic glucose output: Insulin and glucagon 
Glucose infusion results in alterations in the key glucoregulatory hormone concentrations 1~2. It 
has been shown in dogs and humans that hepatic glucose output during low- to moderate-
intensity exercise is mainly mediated by alterations in pancreatic hormones, insulin and 
glucagon, playing an essential role in the maintenance of glucose homeostasis (for review see 
434). The decline in insulin is responsible for the increase in glycogenolysis, whereas the rise in 
glucagon is responsible for the increase in gluconeogenesis when performing exercise at low-to 
moderate intensities 209.434. 
Recently, Coker et al. 79 investigated the importance of basal glucagon to the stimulation" of net 
splanchnic glucose output during exercise by means of a pancreatic islet clamp in healthy men. 
In one group (BG), glucagon was replaced at basal levels and insulin was adjusted to achieve 
euglycemia, and in another group (GO), only insulin was replaced at the identical rate USl;ld in 
BG, and basal glucagon was not replaced. In their study, exogenous glucose infusion was 
necessary to maintain euglycemia during exercise in BG. Arterial glucagon was at least twofold 
greater in BG than in GO throughout the pancreatic islet cell clamp. Splanchnic glucose output 
was greater in BG than in GO at 10 min of moderate exercise, most likely due to the residual 
effect of basal glucagon replacement. However, splanchnic glucose output increased slightly and 
remained similar throughout the remainder of moderate and heavy exercise in BG and GO.: The 
authors concluded that a mechanism independent of changes in pancreatic hormones and/or the 
level of glycemia contributes toward modest stimulation of glucose production during moderate 
and heavy exercise 79. 
Insulin and glucagon seem to be of lesser importance in humans exercising at higher intensities, 
where the alterations in glucagon and insulin are insufficient to account for the marked increase 
in hepatic glucose output 72,214,287.360. However, it has been noted that small changes in 
peripheral concentrations of these hormones might not reflect significant changes at the level of 
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the portal vein, which could account for the alterations in hepatic glucose output 214. It does 
seem though that with exercise at higher intensities, catecholamines become more important in 
the regulation of glucose homeostasis than the pancreatic hormones 287.380. 
1.4.2.3 Role of catecho/amines on hepatic glucose output: Epinephrine and norepinephrine 
With an increase in exercise intensity and duration, there is an exponential increase in plasma 
catecholamines concentrations and sympathetic neural activity 372. It has been shown'that 
catecholamines (particularly epinephrine) become important to maintain hepatic glucose output 
and prevent hypoglycemia when alterations in insulin and glucagon do not occur 286, suggesting 
that there is redundancy in the counterregulatory responses. 
The role of epinephrine in regulation of hepatic glucose output is not clearly defined. With high-
intensity exercise, a causal relationship between plasma epinephrine and hepatic glucose o~tput 
has been suggested, but not established, by those studies where an increase in plasma 
epinephrine was found to occur simultaneously with an increase in hepatic glucose output 
55.256.287,342.360.380 
Kjaer et al. 254 infused a high physiological dose of epinephrine in human subjects during intense 
exercise and observed an increase in hepatic glucose output. However, interpretation of these 
results is complicated not only because a non-physiological dose of epinephrine was used, but 
subjects had also undergone anesthetic blockade of the celiac ganglion, which impairs 
sympathetiC activity to the liver, pancreas and adrenal medulla, and these results can therefore 
not be extrapolated to normal physiological conditions. 
Howlett et al. 214 investigated the effect of epinephrine infusion on hepatiC glucose outp:ut in 
humans during exercise under more physiological conditions. In the control trial, six trained men 
cycled for 20 min at 40% V02 max followed by 20 min at 80% V02 max. In a second trial the 
subjects cycled for 40 min at 40% V02 max, with epinephrine infusion during the latter 20 min, 
which resulted in plasma concentrations similar to those measured during intense exercise in the 
control trial. Epinephrine infusion increased hepatiC glucose output at 40 min of exercise, th~ugh 
to a significantly lesser extent than that observed during the high-intensity exercise period in the 
control trial 214. These results indicate that though epinephrine can increase hepatiC g!ucose 
output during exercise in trained men, the epinephrine concentrations seen with high-intensity 
exercise (80% V02 max) cannot fully account for the rise in hepatiC glucose output. The results of 
this study 214 are in contrast to studies proposing that epinephrine is the main mediator of the rise 
in hepatiC glucose output during high-intensity (>80 V02 max) exercise 256.287,342.380. 
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Howlett et al. 214 noted that other glucoregulatory factors must contribute to the increase in 
hepatic glucose output during intense exercise. Sympathetic neural innervation of the liver has 
been proposed to play a role in regulating hepatic glucose output during exercise in human 
subjects 77.287.342.380. However, it seems unlikely that direct sympathetic neural innervation plays a 
major role in the regulation of hepatic glucose output during exercise, given that liver transplant 
patients display a normal exercise-induced increase in hepatic glucose output 255, and that 
hepatic glucose output is not reduced during intense exercise in normal subjects' when 
sympathetic activity was impaired by anesthetic blockade of the celiac ganglion 254. However, 
extrapolating findings from liver transplant patients to healthy individuals should be done. with 
caution 380. The study of Howlett et al. 213 suggests reduced sympathetic activity that may ~ave 
contributed, at least in part, to the decrease in hepatic glucose production. Hepatic neural 
activation may play a more important role during exercise performed at higher absolute or 
relative intensities 77, than those used in the above-mentioned studies. However, this aspect 
remains equivocal and warrants further investigation. 
In summary: At present it is yet unclear at which glucose concentration feedback inhibition can 
override feed-forward activation during exercise. It seems likely that hepatic glucose production 
during strenuous exercise (>70% V02 max) contains both a neural feed-forward and a humoral 
feedback component, and that whichever component dominates is determined by the interaction 
between exercise intensity (which also determines motor center activity) and prevailing plasma 
glucose and insulin concentrations. 
1.4.2.4 Role of hepatic glucose sensors in glucose homeostasis during exercise 
Seeing that hepatic glucose production is essential for the maintenance of glucose homeostasis 
during exercise, and since there is evidence that hepatic afferents (via the vagus nerve) !11qnitor 
the availability of liver glycogen and glucose metabolites that playa role in appetite regulation, it 
has been hypothesized that the liver may playa similar sensory role during exercise to elicit 
metabolic adjustments to sustain the high energy demand during exercise (for review see 271). 
It is postulated 271 that the sensory role of the liver during exercise would be similar to its role in 
controlling food intake in that a decrease in liver glycogen (or a related metabolic intermediate) is 
sensed by the liver, that sends a Signal to the central nervous system most likely via the afferent 
activity of the hepatic vagus nerve, where it contributes to metabolic and hormonal responses to 
exercise in order to alter substrate mobilization and/or utilization (for review see 271). For 
example, recent animal data pOints to the existence of a link between a decrease in liver 
glycogen concentration and an increase in FFA mobilization from adipose tissue during exercise 
88.271 There is currently no evidence that an afferent pathway from the liver directly influences 
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glucose or glycogen utilization by contracting skeletal muscle 271. However, there is evidence 
that hepatic denervation results in peripheral insulin resistance in animals 269. In this regard,it 
has been postulated that postprandial insulin release activates a hepatic parasympathetic reflex 
resulting in the release of a humoral factor by the liver termed hepatic insulin-sensitizing 
substance (HISS) that sensitizes skeletal muscle to insulin, or has a direct insulin-like action 
270.271. In a recent review of the data (predominantly animal research), Lautt 270 suggests that the 
glucose disposal effect of insulin after a meal is accounted for in equal measure by the direct 
action of insulin and the action of HISS on skeletal muscle to stimulate glucose storage. 
However, the existence of the HISS hypotheSiS has not yet been confirmed in humans. 
Further evidence for the existence of an afferent hepatic glucose sensor comes from studies 
where intraportal glucose infusion resulted in a twofold increase in insulin and an attenuated 
norepinephrine response during exercise compared with an equivalent peripheral vein glucose 
infusion 263. In addition, the normal responses in insulin, glucagon and norepinephrine during 
exercise were attenuated in hepatic-vagotomized compared with sham-operated rats 272. 
Though there is evidence to suggest the existence of hepatic sensors that may respond to 
decreasing liver glycogen or glucose intermediates and ultimately influence, likely through an 
afferent pathway, the hormonal responses and ultimately substrate mobilization / utilization 
during exercise, it has not been confirmed in human studies. The manner in which the human 
liver responds to acute exercise and regular training warrants further investigation. 
1.4.3 Potential role of interleukin 6 (/L-6) In glucose homeostasis 
Cytokines, such as IL-6, have traditionally been researched in respect to its involvement. in the 
immune response. More recently, IL-6 concentrations have been shown to markedly increase 
during exercise, and skeletal muscle has been identified as the major source of the circulating IL-
6 (for reviews see 143.337). The brain 327, peritendon 266 and adipose tissue 424 have also been 
identified as sites of IL-6 production in response to exercise. IL-6 has been shown to act on 
peripheral and central organs and have been suggested to act in a hormone-like manner to 
mobilize extracellular substrates and/or augment substrate delivery during exercise 337. 
Specifically, IL-6 seems to play an important role in Signaling between the muscles and other 
organs in order to maintain energy supply. IL-6 can enhance lipolysis and fatty acid mob!li~tion 
244,326,396,424 and might playa role in glucose homeostasis 140,396,400 via increased glycogenqlysis 
86:357 during exercise. 
Studies have shown that IL-6 can contribute to the hepatiC glucose output necessary to maintain 
blood glucose homeostasis during exercise 140,394,400. IL-6 is a potent activator of the HPA-axis 
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291,335, and may mediate blood glucose concentrations through its effect on raising gluCose-
regulating hormones such as cortisol 398 and epinephrine 317. IL-6 and its receptor are co-
expressed at similar sites in the human adrenal gland, which also seems to be an important 
source of IL-6 production 335. Path et al. 335 suggested that under conditions of prolonged ,stress 
when corticotrophin-releasing hormone and adrenocorticotrophin hormone (ACTH) release are 
suppressed by feedback inhibition due to raised circulating glucocorticoids, IL-6 may directly 
stimulate adrenocortical steroidogenesis via autocrine/paracrine mechanisms to raise cortisol 
concentrations. This may explain the high systemic cortisol levels in the absence of adequate 
plasma concentrations of ACTH observed in patients after long-term treatment with IL-6 335. 
The liver is also capable of producing IL-6, which seems to have a regulatory function by directly 
acting on hepatocytes to increase hepatic glucose release 357, thereby contributing further to 
glucose homeostasis. Thus, the liver may produce IL-6 to stimulate hepatic glucose output if 
blood glucose concentrations are compromised. In contrast, CHO ingestion during exercise has 
been shown to reduce or augment IL-6 production by the contracting skeletal muscle 144.394 .. 
However, the results of CHO ingestion during exercise on skeletal muscle IL-6 gene expression 
remain inconsistent. One study showed that CHO ingestion during prolonged exercise tended 
(p<O.07) to decrease skeletal muscle IL-6 mRNA levels 318, whereas three other studies 144,317.394 
found that CHO ingestion had no effect on skeletal muscle mRNA levels. Whilst the effect of 
CHO ingestion per se on muscle IL-6 mRNA is unclear, low muscle glycogen has been shown to 
increase muscle IL-6 mRNA concentrations up to 100-fold in response to exercise 201,245.397. This 
suggests that IL-6 release from the working muscle may be regulated by substrate availC!bility 
such as circulating blood glucose and muscle glycogen concentrations 170. 
IL-6 release from the contracting skeletal muscle has also been shown to enhance the IL-6 
production in adipose tissue 143,424. Adipocytes express the IL-6 receptor 335, and binding' of the 
IL-6 released from skeletal muscle may trigger adipose IL-6 gene induction, thereby enhancing 
IL-6 production in adipose tissue. Febbraio et al. 144 demonstrated that though CHO ingestion 
did not influence IL-6 gene expression in skeletal muscle, the release of IL-6 from the contracting 
skeletal muscle was attenuated. This may explain the decreased IL-6 gene expression in 
adipose tissue seen with CHO ingestion during exercise. Furthermore, it has been shown that 
IL-6 induces an increase in appearance and disappearance of free fatty acids (FFA) 244. The 
increased IL-6 production in adipose tissue late in exercise may provide a link from the 
contracting skeletal muscle to enhance fat metabolism, thereby contributing FFA oxidation to the 
er,lergy demand (at a time when glycogen stores are reduced). 
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In summary, these results indicate that IL-6 may play an important role in glucose homeostasis 
during exercise, mainly by mediating hepatic glucose production, but may also play a role in 
enhancing FFA release and fat oxidation late in exercise. In this regard, evidence sugges~ that 
IL-6 release from the working muscle may be regulated by substrate availability such as 
circulating blood glucose and muscle glycogen concentrations 170. Though recent studi~s are 
continually demonstrating a role for IL-6 beyond that played in immune system function, the full 
physiological range of these functions and their relative importance, as well as the mechanisms 
underlying these responses, especially during exercise, are not yet fully known. 
(The cerebral IL-6 response and potential involvement of IL-6 in fatigue development during 
prolonged exercise will be discussed under section 1.5.2.2.6.). 
1.4.4 Regulation of muscle glycogenolysis during exercise 
The primary regulators of muscle glycogenolysis during exercise include muscle glycOgen 
availability and exercise intensity. 
1.4.4. 1 Muscle glycogen availability 
Muscle glycogen concentration at the onset of exercise is an important determinant of m~scle 
glycogenolysis during exercise. It is now well-known that reduced muscle glycogen availability 
results in a lower rate of glycogenolysis during submaximal exercise 173,190, whilst higher 
concentrations of muscle glycogen at the onset of exercise increase muscle glycogenolysis 
during exercise 35,190,375. During the initial stages of exercise, the rate of muscle glycogenolysis is 
most rapid and contributes -85% to CHO oxidation 35,89, but as exercise duration increases and 
muscle glycogen is depleted, the rate of muscle glycogenolysis gradually declines 174,431 whilst 
plasma glucose oxidation increases 360. 
1.4.4.2 Exercise intensity 
As exercise intensity increases linearly, the rate of muscle glycogenolysis increases 
exponentially 366,425. An increase in exercise intensity results in greater sympathetic nerVous 
system activation 120 and greater contraction-induced muscle glycogenolysis and glycolysis 217, 
which consequently results in greater reliance on CHO fuel stores. 
In the study of Romijn et al. 360 5 endurance-trained men cycled on three separate occasions in 
random order for 120 min at 25 and 65% V02 max and 30 min at 85% V02 max' Stable isotope 
tracers and indirect calorimetry were used to determine the rate of endogenous CHO and fat 
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oxidation. The results indicated that muscle glycogen was not used at the lowest intenstty, but 
contributed -80-83% of the CHO oxidized when exercising at 65 and 85% V02 max 360. 
1.4.4.3 Training status 
An increase in glucose uptake during strenuous exercise in the glycogen-depleted state has 
been reported after 3 weeks of endurance training 265. This result was attributed to a training-
induced increase in GLUT-4 protein content. These findings are consistent with studies showing 
a greater plasma glucose uptake in well-trained subjects when commencing moderate-intensity 
exercise with low compared to high muscle glycogen content 391.450. In contrast, similar rates of 
glucose uptake were reported when moderately-trained subjects commenced moderate-intensity 
exercise with either low or high muscle glycogen content 35,190,440. The inconsistent findings from 
these studies may be related to the differences in training status of subject populations between 
studies. 
Recently Arkinstall et al. 10 employed a study design to assess the relative effects of exercise 
intensity and preexercise muscle glycogen content on rate of whole-body fuel oxidation in the 
same subjects (i.e. controlling for training status). Moderately-trained subjects performed, in 
random order, four 60 min rides, two at 45% and two at 70% of V02 max after exercise-diet 
intervention to manipulate muscle glycogen content at the start of exercise. All trials ~ere 
performed after a 10-12 h over-night fast. During lOW-intensity exercise (45% V02 max), .high 
preexercise muscle glycogen content resulted in greater rates of whole body CHO oxidation 
(glycogen and blood glucose oxidation) than exercising at the a higher intensity (70% V02 max) 
with low muscle glycogen concentration. The rate of plasma glucose uptake was similar when 
muscle glycogen content was elevated in both the 45 and 70% V02 max trials, as also shown in 
other studies with moderately-trained individuals. Rather, the additional energy required to 
perform the exercise was derived from the oxidation of fat 10. Thus, this study 10 indicated: that 
high preexercise muscle glycogen content increases CHO oxidation to a greater extent than an 
increase in exercise intensity from 46 to 70% V02 max and that glycogen availability does not 
influence the rates of plasma glucose disposal during exercise in moderately-trained individuals, 
in support of previous findings 35.190.440. 
1..4.4.4 Role of epinephrine on muscle glycogen utilization 
Muscle glycogenolysis is catalyzed by glycogen phosphorylase, existing in an active 'a'·and a 
less active 'b' form. During exercise, conversion of phosphorylase b to the active a form is 
regulated by increases in cytosolic Ca2+ (released during muscle contraction) an~ an 
epinephrine-mediated increase in cAMP 216. Additional factors linked to the energy state of the 
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cell (such as AMP and IMP) or substrates (such as glycogen and inorganic phosphate) then 
make further adjustments to the flux rate based upon the metabolic demands (for review s~e 239). 
The majority of studies have demonstrated that increased epinephrine results in increased 
muscle glycogen utilization during exercise in humans 142,222,353,356,437, however, others have not 
shown such an effect 63,442, The discrepancy in results may be related to the infusion of 
epinephrine in doses above physiological levels 222, and/or the differences in exercise intensities 
employed by these studies 63,142.437 or differences in the training status of the study population 
63,442 
Epinephrine infusion at physiological concentrations during moderate (65% V02 max) or int~nse 
exercise (80% V02 max) had no effect of the rate of muscle glycogenolysis when the study 
populations were untrained 63. In contrast, epinephrine infusion (-2 vs. 1 nmollL, epinephrine vs. 
control trial) in trained men exercising for 40 min at 70% V02 max resulted in increased muscle 
glycogen utilization, glycogenolysis and overall rate of CHO oxidation 142, Furthermore, when 
exercising at high intensities (>80% V02max) glycogenolysis may already be maximally activated, 
irrespective of further increases in epinephrine concentrations 437. 
The exact mechanism(s) whereby epinephrine exerts its action on CHO metabolism have not 
been fully established. In contrast to the potential stimulatory effect of epinephrine on muscle 
glycogenolysis and CHO oxidation 142, some evidence suggest that epinephrine inhibits skeletal 
muscle glucose uptake in exercising humans 215,222 whilst another study demonstrated an 
increase in glucose uptake during moderate-intensity exercise 264. 
In a more recent stUdy, Watt et al. 437 examined the combined effects of elevated plasma 
epinephrine and 20 min of exercise at -60% V02 max on skeletal muscle glycogenolysis, glucose 
uptake and pyruvate dehydrogenase (PDH) activation in moderately trained men. With 
increased glycolytic flux, an increase in pyruvate flux must also occur to facilitate a higher CHO 
oxidation. The entry of CHO into the oxidative pathways is regulated by PDH, and PHD 
activation is linked to exercise intenSity, substrate availability and intrinsic regUlators related to 
energy state of the cell (discussed in detail in ref. 437). The study of Watt et at 437 comprised of 
either saline or epinephrine infusion 5 min prior to and throughout exercise. Glucose kinetics 
were determined by the use of a 6,6-[2 H]glucose tracer and muscle samples were obtained 'prior 
to and at 1 and 20 min of exercise. Epinephrine infusion resulted an increase in total CHO 
oxidation by 18%, mainly due to greater skeletal muscle glycogenolysis (p<0.05) and PDH 
activation (p<0.05). Glucose rate of appearance was not different between trials, but the 
epinephrine infusion significantly decreased muscle glucose uptake, and elevated muscle 
glucose 6-phosphate (G-6-P) and lactate concentrations compared to saline infusion. No 
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changes were observed for pyruvate, creatine, phosphocreatine, ATP and the calculated' free 
concentrations of ADP and AMP. It was concluded that elevated plasma epinephrine 
cOncentrations during moderate exercise in untrained men increase skeletal muscle 
glycogenolysis and PDH activation, which results in greater CHO oxidation. The greater muscle 
glycogenolysis appears to be due to increased glycogen phosphorylase transformation whilst the 
increased PDH activity cannot be readily explained. Finally, the decreased glucose uptake 
observed during exercise with epinephrine infusion is likely to be due to the increased 
intracellular G-6-P and a subsequent decrease in glucose phosphorylation 437. 
In a subsequent study, Watt et al. 436 examined the effect of epinephrine on glucose disposal 
during 40 min of exercise at 60% V02 max when glycogenolytic flux was limited by low preexercise 
skeletal muscle glycogen availability in moderately trained men. Subjects cycled for 40 min at 
-60% V02 max either with saline or epinephrine infusion starting after 20 min of exercise. On the 
day before each experimental trial, subjects completed fatiguing exercise and then maintained a 
low CHO diet to lower muscle glycogen content. Muscle samples were obtained after 20 ~nd 40 
min of exercise, and glucose kinetics were measured using a 6,6-[2 H]glucose tracer. Exercise 
increased plasma epinephrine above resting concentrations in both trials, and plasma 
epinephrine was significantly higher during the final 20 min with epinephrine infusion compared 
to saline infusion. Muscle glycogen concentrations were low after 20 min of exercise (28±6 vs. 
29±5 mmol/kg w.w. for saline vs. epinephrine infusion, respectively). Under these conditions, 
epinephrine infusion over the next 20 min of exercise had no effect on net muscle glycogen 
breakdown or on muscle G-6-P concentrations. Plasma glucose increased with epinephrine 
infusion (Le. from 20-40 min), due to a decrease in glucose disposal (Rd) (40 min: 34±3 vs. ~1±5 
Jlmol/kg/min for saline vs. epinephrine infusion, respectively, p<0.05) as the exercise-induced 
rise in rate of glucose appearance was similar between trials. These results show that glucose 
Rd during exercise is reduced by elevated plasma epinephrine, even when muscle gl~cogen 
availability and utilization are low. In contrast to the previous findings 437, these results suggests 
that the effect of epinephrine does not appear to be mediated by increased G-6-P, secondary to 
enhanced muscle glycogenolysis, but may be linked to a direct effect of epinephrine on 
sarcolemmal glucose transport 436. 
Collectively taken, the bulk of the evidence suggests that epinephrine may increase 
glycogenolysis and increase CHO oxidation, whilst decreasing muscle glucose uptake during 
moderate-intensity exercise in trained athletes. However, other factors involved in muscle 
glycogenolysis such as exercise intenSity and energy status and demand of the muscle may at 
times dictate the rate of muscle glycogenolysis irrespective of epinephrine concentration. 
Although the underlying mechanism remains unclear, the results 436 suggest that, in contrast to 
situations in which preexercise glycogen content is normal 142,437, epinephrine may not enhance 
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muscle glyoogenolysis when commencing moderate-intensity exercise with low glycogen 
content. 
1.4.4.5 Effects of elevated FFA concentrations on CHO oxidation, and in particular, muscle 
glycogen utilization 
Studies in which intralipid and heparin were co-infused during exercise in order to increase FFA 
availability (to 1 to 2 mmoI/L), have demonstrated an increase in fat oxidation and a concomitant 
decrease in CHO oxidation, predominantly through reduced muscle glycogen utilization: (for 
example refs. 87,128,329,361), 
Costill et al. 87 elevated plasma FFA concentrations to -1.0 mmol/L with heparin infusion in 7 
endurance-trained men during 30 min of treadmill exercise (-70% V02 max) and demonstrated a 
40% reduction in muscle glycogenolysis compared to the control trial. The elevation of FFA in 
the study of Costill et al. 87 was also associated with an increase in blood glucose concentration, 
which the authors ascribed to a possible inhibitory effect of accumulated glucose 6-phosphate on 
hexokinase, thereby limiting the entry of glucose into the cell 166,433. 
In a 'study by Romjjn et ai, 361, intralipid and heparin infusion during 20 to 30 min of exerci$e at 
85% V02 max resulted in increased FFA availability and a 27% increase in fat oxidation ~ith a 
cencomitant 15% reduction in the rate of muscle glycogen utilization. This effect has been 
attributed to the inhibitory effect of citrate on phosphofructokinase 166. Increased FFA oxidation 
produces an accumulation of citrate in rat heart and skeletal muscle, thereby limiting the rate of 
glYCQlysis 167,354. However, this effect has not consistently been demonstrated in humans 129. 
Hargreaves et al. 189 found that lipid-heparin infusion during 1 h of knee extension exercise (80% 
of work capacity) increased FFA concentrations to 1.1 mmol/L, but had no effect on mLlscle 
glycogen utilization nor were muscle citrate release or G-6-P concentrations altered. They did 
demonstrate a 33% reduction in muscle glucose uptake. 
In a'study by Dyck et al. 129 lipid-heparin infusion raised FFA concentrations to -1.4 mmol/L 
during short-term (15 min) high-intensity exercise (85% V02 max) and this resulted in Significant 
m.uscle glycogen sparing, but with no differences in acetyl-CoA or citrate concentrations, or PDH 
activity. The authors suggested that the glycogen sparing effect may result from an attenuation 
at the level of glycogen phosphorylase. To investigate this mechanism, Dyck et al. 128 repeated 
the previous study and found that 7 of the 11 subjects demonstrated glycogen sparing, however 
glycogen phosphorylase transformation into the active a form was unaltered whilst the calculated 
free ADP, AMP and Pi oontents were lower. AMP is an allosteric activator of glyC?gen 
phosphorylase a, and Pi a substrate of glyoogen phosphorylase 128. In support of these findings, 
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Odland et al. 329 also demonstrated a 23% reduction in muscle glycogen utilization and reduced 
free AMP accumulation with lipid-heparin infusion during 60 min of moderate-intensity exercise 
(65% V02 max). In their study glycogen phosphorylase was not measured, but the glycogen 
sparing was associated with higher muscle citrate concentrations and a reduced muscle PDH 
activity in the more active a form 128. 
Though adaptations to long-term high fat diets are beyond the scope of this thesis, a series of 
studies by Helge et al. 199.202.203 on the interaction between diet and training on substrate 
metabolism have yielded very interesting results. It was shown that adaptation to a high .fat diet 
and exercise training for 7 wk, followed by 1 wk of high CHO intake in healthy men resulted in an 
increase in fat utilization and reduced muscle glycogenolysis compared to 8 wk on a high CHO 
training diet. It was demonstrated that even when muscle glycogen concentrations were 
elevated with the high CHO intake following prolonged high fat diet adaptation, muscle 
glycogenolysis during exercise appeared to be impaired, and that subjects were unable to fully 
make use of the muscle glycogen stores in that exhaustion was reached with large amourtts of 
glycogen left-over in the muscle 199. The molecular mechanism behind the impaired muscle 
glycogenolysis observed after prolonged adaptation to a high fat diet followed by a high CHO diet 
for 1 wk remains to be clarified. Additionally, in a subsequent study following a similar research 
design, it was demonstrated that leg glucose uptake during 60 min of exercise at 70% V02 max 
was reduced after prolonged adaptation to a high-fat diet followed by a shift to a high CHO diet 
for 1 wk 203. 
From the bulk of available data it is evident that increased FFA availability, specifically when FFA 
concentrations in the blood are> 1 mmol/L, can increase fat oxidation and reduce CHO oxidation, 
mainly through reducing the rate of muscle glycogen utilization and perhaps also reduced 
glucose uptake by the muscle. However, the regulatory factors involved in this effect remains to 
be fully elucidated. 
1.4.4.6 Effects of exogenous CHO supplementation during exercise on muscle glycogen . 
utilization 
CHO intake before exercise and a concomitant increase in insulin concentration have been 
shown to increase CHO oxidation and thus increase reliance on muscle glycogen for energy 87. 
The effect of pre-exercise CHO ingestion will be discussed in more detail in section 5.1, whereas 
this section will focus specifically on the effects of CHO ingestion during exercise on muscle 
glycogen utilization. 
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The intake of CHO during prolonged exercise has been shown to enhance CHO availability and 
to improve endurance exercise capacity when exercising at a constant speed or workload, and to 
improve performance during a high-intensity exercise test (time-trial) performed immediately after 
a prolonged intermittent or continuous, steady-state exercise bout (for review see 414). The 
exact mechanism(s) whereby CHO ingestion may delay fatigue has not been established, but the 
two major effects regarded as being responsible for the ergogenic effect of CHO 
supplementation, has been the maintenance of euglycemia and CHO oxidation throughout 
exercise, and/or a decreased rate of muscle glycogen utilization (discussed in detail under 
section 1.5.2). 
Whilst CHO ingestion during prolonged exercise has been shown to decrease the rate of muscle 
glycogen utilization in some studies 38,132,185,415,418,455,456, others demonstrated similar rat~s of 
muscle glycogenolysis with CHO or placebo ingestion 89,149,193,306. The discrepancy in results 
may be related to the ingestion of differing amounts of CHO, different exercise protocols (e.g. 
exercise intensity as discussed under section 4.3.1, or intermittent vs. steady-state exercise). 
The bulk of the studies have employed cycling as the mode of exercise 414. It appears: that 
exogenous CHO supplementation (-25 to 100 g/h) during steady-state cycling protocols (-70% 
V02 max) in trained, non-CHO loaded subjects has minimal effect on the rate of muscle glycogen 
oxidation 89,193,306. However, these results are not clear-cut as results from the studies of Coyle et 
al. 89, Erickson et al. 132 and Bosch et al. 38, performed under similar conditions, suggest the 
opposite. For example, in the study of Coyle et al. 89 trained, non-CHO loaded male subjects 
cycled to exhaustion at 70% V02 max firstly without CHO supplementation, and, on another 
occasion, with CHO supplementation (2 g CHO/kg at 20 min, followed by 0.4 g CHO/kg every 20 
min thereafter). CHO ingestion maintained plasma glucose concentration and enabled subjects 
to exercise for 4 h compared to 3 h in the placebo trial. The pattern of muscle glycogen 
utilization was similar between trials over the first 3 h of exercise and muscle glyC?gen 
concentrations were equal at the end of 3 h of exercise (-100 mmollkg w.w.). However, de~pite 
having a considerable amount of muscle glycogen left in the muscle, no further muscle glycOgen 
was used during the additional hour of exercise in the CHO ingestion trial, whilst CHO oxidation 
was maintained. These data suggest that CHO ingestion may have resulted in muscle glycogen 
sparing within the last hour of exercise. Similarly, in the study of Bosch et al. 38 trained, non-
CHO loaded male subjects ingested either 50 g/h of CHO or placebo whilst cycling for 180 min at 
70% V02 max' Total CHO oxidation was similar in the CHO-ingestion and placebo trials: and 
declined similarly during exercise. Muscle glycogen disappearance was identical during the first 
2 h of exercise in both groups and continued at the same rate in the placebo ingestion trial, 
however, no net muscle glycogen disappearance occurred during the final hour in the CHO-
ingestion trial. It was concluded that the ingestion of 500 mllh of a 10% CHO solution during 
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prolonged exercise in non-CHO loaded subjects has a marked liver glycogen-sparing effect, 
maintains plasma glucose concentration and has a muscle glycogen-sparing effect. Erickson et 
al. 132 demonstrated a reduction in the amount of muscle glycogen used over a somewhat shorter 
exercise period as that of Coyle et al. 89 and Bosch et al. 38. During 90 min of steady-state 
exercise at 65-70% V02 max the amount of muscle glycogen used was significantly lower after 
glucose ingestion (1 g/kg) compared to placebo ingestion (62 vs. 91 mmol/kg w.w. for glupose 
vs. placebo ingestion, respectively). 
Evidence of reduced muscle glycogenolysis with CHO supplementation during exercise has 
frequently been observed in studies where a variable-intensity or self-paced cycling 185,445,456, or 
60-100 min constant or intermittent running protocols were employed (reviewed in 414). 
A detailed revision of the literature on CHO ingestion and muscle glycogen utilization by Tsintzas 
and Williams 414 suggest that the magnitude of the insulin response in addition to an increase in 
blood glucose concentrations may determine whether glycogen sparing will take place or not. 
The magnitude of the insulin response may largely be influenced by the exercise intensity, as the 
greater catecholamines stimulation at higher exercise intensities result in greater suppression of 
insulin secretion compared with lower intensities 414. 
It is clear from the above evidence that the rate of muscle glycogen utilization is controlled and 
affected by a complex interplay of factors, of which exercise intensity and muscle glycogen 
availability at the onset of exercise perhaps are the main determinants of muscle glycogen use 
during exercise, and will to a large extent determine to what extent the other factors (sUch as 
CHO ingestion) will affect the ultimate rate of glycogen utilization. Though the ergogenic eff~ct of 
CHO supplementation may be explained by a reduction in the rate of muscle glycogen utilization 
during exercise, it cannot explain the ergogenic effect in the bulk of the studies where the rate of 
muscle glycogen utilization did not differ between CHO compared to placebo supplementation. 
Further research on the effect of CHO supplementation on muscle glycogen utilization is clearly 
warranted, specifically to investigate the effect of hormonal responses as elicited at varying 
exercise intensities and/or with varying nutritional strategies. Specifically, there is limited 
literature available on the effects of CHO supplementation on muscle glycogen utilization in 
humans commencing exercise in the CHO-depleted state. 
1.4.5 Regulation of muscle glucose uptake during exercise 
It is believed that glucose transport during exercise is mainly regulated by the contraction-
stimulated AMPK pathway and this effect lasts 3-6 h post-exercise 250,355. AMPK increases 
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GLUT -4 translocation from the intrasarcolemmal vesicles to the membrane to enable glucose 
uptake by the muscle cell 250,355,447. AMPK has been referred to as an intracellular "masterswitch" 
which activates fat oxidation and glucose uptake in relation to the increased rate of :ATP 
utilization during muscle contraction 401. However, this suggestion is not universally accepted as 
changes in muscle AMPK or components of this signaling pathway have not consistently shown 
to track changes in the substrate (fat) oxidation 1. 
Factors such as exercise intensity (with increasing exercise intensity, the rate of plasma glucose 
uptake and oxidation increases 89,220,360,365.393), glucose availability 92, prevailing epinephrine 
concentration, membrane transport and intracellular metabolism (as discussed in section 1.4.4.4) 
have also been identified as playing a regulating role in muscle glucose uptake during exercise. 
The bulk of the scientific literature indicate that the combination of insulin and exercise act 
synergistically (albeit via different mechanisms) to increase membrane GLUT -4 and glu.cose 
uptake by the muscle 457. In addition, studies using the isolated perfused rat hind-limb model 
have shown that increased muscle blood flow and increased glucose delivery may add to the 
effect of muscle contraction to increase glucose uptake 457. 
There is evidence to suggest that the rate of muscle glucose uptake is at least partially 
dependent on the prevailing plasma glucose concentrations. This has been shown in :men 
cycling at 73% V02 max when hyperglycemic (10-12 mmol/L) 92 and with CHO ingestion and 
subsequent increase in plasma glucose concentration during low-intensity 4 and prolonged 
strenuous exercise 299. 
1.4.6 Interaction between muscle glycogen availability and blood glucose uptake du~ing 
exercise 
Hargreaves et al. 191 studied six men during 40 min of cycling (65-70% V02 max) to examine the 
relationship between leg glucose uptake and muscle glycogen concentration. Like others 118,173, 
they observed a significant inverse relationship between muscle glycogen concentration. and 
glucose uptake during exercise, and suggested a possible regulatory in11uence of muscle 
glycogen on glucose uptake during the early stages of exercise. 
However, the effect of preexercise glycogen concentration on glucose uptake has yielded 
inconsistent results. Some studies found that tracer-determined rates of glucose uptake were 
unaffected by preexercise muscle glycogen availability during a similar 40 min cycling protocOl 190 
than that used by the study of Hargreaves et al. 191 mentioned above, as well as during a more 
prolonged exercise protocols (180 min, 70% V02 max) 35,440,441. However, with this experimental 
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approach where glycogen content is often manipulated after ingestion of either a low CHO (high 
fat) vs. high CHO diet, substrate availability and the hormonal milieu is typically altered 162,440,441, 
which may influence glucose uptake by the contracting muscles independent of glycpgen 
availability. For example, a high vs. low dietary CHO intake results in altered epinepnrine 
secretion 162, which has been demonstrated to influence glucose uptake 437. 
Another experimental approach used to determine the effect of glycogen content on glucose 
uptake during exercise is to deplete one leg of glycogen by dOing single-limb exercise 24 to 48 h 
prior to performing two-legged exercise. Studies employing this approach have demonstrated a 
higher glucose uptake in the leg that commenced exercise with lower glycogen content (due to 
prior exercise) compared to the previously rested leg that started exercise with normal glycogen 
content 23,173. This approach has the advantage of ensuring a similar substrate availability and 
hormonal milieu during the subsequent two-legged exercise trial. However, GLUT -4 transporter 
protein will most likely be increased in the limb that did prior exercise 449, which may in tum be 
responsible for the increase in glucose uptake during subsequent exercise, and not the glycogen 
c9ntent per 5e. GLUT-4 gene and protein expression were not measured during these studies 
23,173 
Steensberg et al. 399 aimed to clarify the effect of glycogen content on glucose uptake by 
performing two series of experiments. In the first series, 7 healthy subjects performed 4 h of. two-
legged knee extensor exercise, 16 h after performing 60 min of single-leg cycling in ord~r to 
deplete muscle glycogen content of one leg (series 1). In the second series, 6 subjects 
performed two trials of 3 h of two-legged knee extensor exercise: on the one occasion after 
performing 60 min of two-legged cycling 16 h prior to the trial followed by a low CHO diet, and on 
the other occasion with similar exercise followed by a high CHO diet (series 2). Glucose uptake, 
glycogen content and GLUT-4 gene and protein expression were measured. Muscle glycbgen 
was decreased by 40% when comparing the pre-exercised leg with the control (previ6usly 
rested) leg prior to exercise in series 1. In addition, muscle glycogen was decreased by the 
same magnitude when comparing the effects of the low vs. high CHO diet interventions in-series 
2. In series 1, glucose uptake was 3-fold higher in the pre-exercised leg (series 1) in the first 60 
min of exercise, in the presence of unchanged pre-exercise GLUT -4 protein compared to t~at in 
the control (previously rested) leg. These data suggest that it is the lower glycogen and not the 
exercise the day before that might have provided the stimulus for increased glucose uptake. 
Despite the same magnitude of difference in pre-exercise glycogen concentration when 
comparing series 1 with series 2, neither direct- nor isotope-determined rate of glucose uptake 
were altered when comparing the low vs. high CHO diet intervention in series 2. However, 
arterial concentrations of insulin and glucose were lower, while free fatty acids and epinephrine 
concentrations were higher in low CHO compared with high CHO diet intervention. These :data 
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suggest that pre-exercise glycogen content may influence glucose uptake during subsequent 
exercise. However, this is only the case when delivery of substrates and hormones remains 
constant. When delivery of substrates and hormones is altered, the potential effect of glycogen 
on glucose uptake is negated 399. 
F~om the results of Steensberg et al. 399 it seems likely that the metabolic and hormonal 
alterations elicited by a low CHO diet may bring about alterations in other parts of the gluco-
regulatory system (such as hepatic glucose output, glycolysis, glycogenolysis), as well as 
alterations in the availability of alternative oxidative substrates (e.g. FFA) which may alter the fuel 
selection and relative contribution of substrate oxidation within the muscle. 
In review of this section it is clear that glucose (derived from endogenous production or 
exogenous supplementation) is an important fuel source (for brain and skeletal muscle) during 
prolonged exercise. We know that during such exercise, muscle and subsequently liver 
glye<;>gen stores become depleted 76.91, which poses a challenge for the maintenance of glucose 
homeostasis. A complex of neuro-hormonal factors have been identified, mainly in· animal 
models, with some being confirmed in humans, as playing a role in the regulation of glucose and 
overall substrate metabolism at rest and during exercise, however, several of these factors and 
the interaction between them are not fully understood. It is clear that factors such as the status 
of the endogenous CHO stores, substrate availability and exercise intensity and duration play an 
important role in altering the neuro-humoral milieu, substrate selection and oxidation and 
ultimately glucose homeostasis. The full extent of the interplay of these factors is not yet fully 
understood. 
The following section of this literature review will consider the impact of interventions resuiting in 
alterations in endogenous CHO stores, hormonal milieu and substrate availability prior to and 
during prolonged exercise and how it affects gluco-regulatory responses, exercise metabolism 
and ultimately exercise performance. 
1,5 EFFECT OF ANTECEDENT NUTRITIONAL IN'rERVENTION ON GLUCOSE 
HOMEOSTASIS AND RELATED NEURO-HORMONAL RESPONSES AND 
FATIGUE DEVELOPMENT DURING PROLONGED EXERCISE 
1.5.1 Acute alterations in hormonal milieu: Effect of type and timing of CHO intake 
immediately prior to prolonged exercise on hormonal responses, substrate 
utilization and exercise performance 
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The depletion of muscle glycogen and development of hypoglycemia have been associated with 
fatigue development, and as a result CHO supplementation immediately before and during 
prolonged exercise have been identified as strategies that can contribute to substrate availability 
with potential performance-enhancing benefits (for review see 52,220). However, whilst the 
ergogenic potential of CHO supplementation during prolonged exercise is well established, the 
effect of preexercise CHO ingestion on exercise metabolism and performance is less clear. 
Though preexercise CHO ingestion can help to optimize liver and muscle glycogen, particularly 
where an overnight fast or previous exercise has reduced these bodily CHO stores 195,. this 
strategy has raised some concerns, particularly related to CHO consumed during the hour prior 
to exercise as it may result in hyperglycemia and hyperinsulinemia, and a potential fall in glucose 
(rebound hypoglycemia) during exercise 3,67,152,260,288. The rebound hypoglycemia at the onset of 
exercise is in consequence to the combined effects of relative hyperinsulinemia and muscle 
contraction on increasing glucose uptake and inhibition of the exercise-induced increase in 
hepatic glucose output 145,266. Other potential consequences of relative hyperinsulinemiainclude 
an increase in CHO oxidation and a reduction in the rate of fat oxidation (as discussed in detail 
under section 1.3.2), which in turn may lead to increased muscle glycogen oxidation 90. 
The development of hypoglycemia following preexercise CHO ingestion has been observed in 
some studies 67,152,167,260,266,305,426, however, this finding is not universally consistent 
69,114,147,171,166,279,286,294,346,374, Furthermore, whilst two studies on preexercise CHO (sugar) intake 
within the hour prior to exercise reported a large decline in blood glucose concentrations «3.5 
mmol/L) and an increase in muscle glycogen use during exercise 67,187, several others have 
found no effect on the rate of muscle glycogenolysis 147,171,166,259,279. One possible explanation for 
this discrepancy may be that the hypoglycemia in the latter studies 147,171,186,259,279 was not as 
pronounced compared to that found in the studies of Costill et al. 67 and Hargreaves et al. t87~ 
Though the metabolic and hormonal sequelae of preexercise CHO intake in the studies 
mentioned above have traditionally been associated with premature fatigue development during 
endurance exercise, when examining the effect of preexercise CHO ingestion on exercise 
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performance, whilst one study found an ergolytic effect 152, the bulk of subsequent studies 
reported either no effect 69,141,145,186,228,230,312,389,389,439 or an improvement in performance during 
endurance exercise 171,251,330,376,408, Based on these results, ingesting CHO within the hour :prior 
to exercise is a strategy that should not be discouraged as evidence for its potential ergogenic 
effect far outweigh evidence for a potential ergolytic effect. 
Whilst the discrepancies in the results may be related to differences in research design, CI r~cent 
series of systematic experiments by the same laboratory have indicated that "!,,hen 
methodological factors are controlled for, the amount of CHO ingestion (25; 75 or 200 g CHO 
228); timing of CHO feeding (15, 45 or 75 min prior to exercise 312); type of CHO intake (glucose, 
trehalose or galactose, 230); and intensity of exercise (40, 65 or 80% maximum work rate 2) have 
no effect on exercise performance. Furthermore, when the average group data were examined, 
none of the above factors resulted in rebound hypoglycemia (plasma glucose <3.5 mmoI/L). 
However, when examining the individual data in these studies, rebound hypoglycemia: was 
observed in some of the subjects. In particular, n=3 to 4 (of n=8) developed hypoglycemia when 
exercise intensity was varied between 40 to 80% of maximal work rate; n=2 vs. 3 vs. 5 (of n=8) 
developed hypoglycemia when CHO ingestion was delayed from 15 to 45 to 75 min before 
exercise, respectively; prevalence of hypoglycemia increased when high glycemic index 
(glucose, n=4 out of n=8) was ingested compared to trehalose (n=1) or galactose (n=O); and 4 to 
6 subjects (of n=9) when the amount of CHO ingested varied from 25 to 200 g. Kuipers et ~I. 266 
observed that hypoglycemia was more likely to occur when moderate-intensity exercise was 
commenced after ingesting small amounts of CHO (40-60 g). When 70 and 80 g of CHO was 
ingested preexercise, no hypoglycemia (plasma glucose <3.0 mmol/L) was observed 266. 
However, this is clearly not a given seeing that -50% of subjects demonstrated rebound 
hypoglycemia in the study of Jentjens et al. 228 when up to 200 g of CHO was ing~sted 
preexercise. 
It is not yet known why some individuals are predisposed to the development of rebound 
hypoglycemia following preexercise CHO ingestion and others not. It has been suggested that 
an increased insulin sensitivity (e.g, as a consequence of exercise training 34,200) may lead to the 
development of rebound hypoglycemia. Recently, this theory was discounted when it was sRown 
that subjects, varying in training status, who developed rebound hypoglycemia did not have a 
higher insulin sensitivity than those who did not develop rebound hypoglycemia 229. In fact', there 
was a similar range in insulin sensitivity index (lSI) between the group who developed 
hypoglycemia (2,1 to 6.0) and those who did not (2.6 to 7.4) 229. 
Kuipers et al. 266 proposed that rebound hypoglycemia may be more likely in those individuals in 
whom sympathetic-induced counterregulation is less activated. This effect may be related to 
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increased parasympathetic activity in trained athletes 62. In the study of Kuipers et al. 266 50 g of 
glucose was ingested after a 4-h fast and 30 min prior to 40 min of exercise at 60% maximal 
power output. Six subjects (of n=19) developed transient rebound hypoglycemia (hypo group, 
plasma glucose <3 mmol/L; n=10 with plasma glucose <3.5 mmol/L) during the first -30 min of 
exercise (and a return to basal levels towards the end of exercise), and displayed reduced 
norepinephrine concentrations throughout most of the exercise bout compared to the group of 
subjects who did not develop hypoglycemia (non-hypo group). Insulin concentrations were 
similar between the two groups. This study indicated that rebound hypoglycemia may not only 
occur after an over-night fast, but also when consuming CHO after a 4-h fast. Furthermore, 
though epinephrine concentrations were similar between groups, a large inter-individual variation 
was noted. Norepinephrine concentrations, on the other hand, were lower in the hypo-group 
compared to the non-hypo group, which reflects a lower activation of the sympathetic-mediated 
counterregulation. However, exercise intensity per se may activate the sympathetic system 
(separate from declining blood glucose concentrations) and improve blood glucose maintenance, 
as was shown when two of the subjects from the hypo-group repeated the protocol. but 
exercised at 75% of maximal power output without developing hypoglycemia. In contrast, the 
study by Achten and Jeukendrup 2 showed that occurrence of rebound hypoglycemia in 
susceptible individuals was unrelated to exercise intensity. 
Further research is needed to elucidate the extent of inter-individual variability in sympathetic 
activation and counterregulatory responses and the degree to which this may affect postprandial 
plasma glucose concentrations at rest and during exercise. 
In summary, it appears that in the majority of cases, any perturbations in glucose and insulin 
levels due to preexerclse CHO intake are transient and overridden by the metabolic response to 
exercise (for review see 195). However, a small percentage of athletes may be sensitive to 
exaggerated hormonal and metabolic responses to preexercise feedings of CHO, It is possible 
that these responses may be attenuated by choosing CHO sources which produce a minimal 
glycemic-insulinemic response 195, Such CHO sources include fructose 186 and CHO-ricti foods 
with a low glycemic index (GI). Ingestion of low-GI CHO foods produce less metabolic 
disturbances (reduced glycemiC and insulinemic response) postprandially, compared with the 
intake of the same quantity of high-GI CHO 226, A further benefit may be a more sust~ined 
glucose release during prolonged endurance events (e.g. swimming) or strenuous work 
environments (fire-fighting) where frequent CHO supplementation to maintain blood glucose 
concentrations may not be possible. 
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1.5.1.1 Type of CHO ingested preexercise: Role of Glycemic Index (GI) 
The GI is determined by the rate at which an ingested CHO is made available to intestinal 
enzymes for digestion and absorption 226. The GI is calculated as a percentage value based on 
the area under the blood glucose curve following the ingestion of a food containing 50' g of 
available CHO, divided by the area of the blood glucose response to 50 g CHO in a reference 
food, multiplied by 100 226• It has been suggested that the manipulation of the GI of meals may 
have application in the area of sports nutrition to manipulate metabolic and hormonal 
perturbations and to optimize CHO availability for exercise, particularly prolonged moderate 
intensity exercise 195. 
Thomas et al. 408 were the first to study the role of the GI of different CHO-containing foods and 
their effects on metabolism and exercise performance. They reported that the ingestion of a low 
GI CHO-rich meal (lentils), 1 h prior to exercise increased the time to exhaustion during the 
cycling trial at 67% V02 max, compared with the ingestion of an equal amount of CHO eaten in the 
form of a high GI CHO-rich food (potatoes). Time to exhaustion after ingestion of the low GI'food 
was increased compared to preexercise glucose feeding, or a water trial. These findings were 
attributed to lower glycemic and insulinemic responses to the low GI trial compared with the other 
CHO feedings. This promoted a more stable blood glucose response during exercise, increased 
FFA concentrations and also reduced exercise respiratory exchange ratio (RER) values. 
Although muscle glycogen was not measured, the authors suggested that glycogen sparing may 
have occurred with the low GI CHO trial 408. 
This study supports the view regarding the metabolic perturbations caused by CHO feedings in 
the hour before exercise, and suggests an alternative way to increase CHO availability 'during 
exercise while decreasing the likelihood of rebound hypoglycemia in response to preexercise 
CHO feedings. These findings have been widely publicized and are largely responsible, for the 
advice of some sports nutrition experts that athletes should choose preexercise meals bas~d on 
low GI CHO-rich foods and drinks. 
In contrast, a subsequent study by Febbraio and Stewart 145 reported no differences in the 
performance of a cycle time-trial conducted after 2 h of cycling at 70% V02 max, when preexercise 
meals eaten 45 min before the bout consisted of either a low GI CHO (lentils), high GI CHO 
(potatoes) or placebo (diet jelly). They reported no difference in total CHO oxidation between the 
two CHO treatments, and similar muscle glycogen utilization in all three trials. These findings are 
more consistent with the view that glycemic differences at the onset of exercise are short-lived 
and of little practical significance 195. 
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Other more recent studies with similar research designs have also failed to support the findings 
of the first investigation by Thomas et al. 408. Ingestion of a low GI compared to a high GI 
preexercise meal has been shown to reduce CHO oxidation during exercise in some 389,409,~9, but 
not all studies 145,210,251. Furthermore, in the few studies where muscle glycogen content was 
measured, a high versus a low GI preexercise meal either did not have any effect 145,251; or 
showed a tendency (p=0.07) towards augmenting the rate of muscle glycogenolysis 141. 
Interestingly, a recent study by Li et al. 280 demonstrated that a low GI (vs. high GI) meal ingested 
3 h prior to a 90 min treadmill run (70% V02 max) resulted in significantly higher plasma glucose 
concentrations between 15 to 45 min of exercise, but a reduced neutrophil/lymphocyte ratio, 
whilst cortisol, growth hormone and IL-6 concentrations were similar between trials. 
Febbraio et al. 141, by performing multiple biopsies, aimed to investigate if muscle glycogenolysis 
may be affected in a biphasic manner, i.e. altered rates of glycogenolysis early compared to late 
in exercise. It was hypothesized that a high GI meal will result in a more perturbed glycemic and 
insulinemic response, which would result in an enhanced rate of plasma glucose uptake and 
oxid~tion and reduce glycogenolysis early in exercise, but a reduced rate of glucose oxidation 
and an augmented rate of glycogenolysis later in exercise. A meal conSisting of a high or loW GI 
(1 g CHO/kg body mass (BM), isocaloric) or placebo was ingested 30 min prior to 120 min of 
steady-state exercise (70% V02 max) followed by a 30-min time trial. Glucose and insulin 
concentrations were Significantly higher and FFA concentrations more suppressed after the high 
GI preexercise meal, particularly in the 30 min postprandial period and over the initial -30 min of 
exercise, where after responses became more comparable between trials. Blood glucose 
concentrations during the high GI trial remained above -4.3 mmol/L. CHO oxidation was higher 
alJd fat oxidation lower after ingestion of the high GI compared to the low GI meal, however, 
exercise performance was unaffected. The increased rate of CHO oxidation in the high GI trial 
was most likely due to the increased rate of plasma glucose oxidation, as muscle glycogen 
utilization tended to be augmented, but not significantly so. In addition, the high GI meal made 
no difference to the rate of muscle glycogenolysis early in exercise. Their data also indicated 
that even when glucose and insulin concentrations returned to similar levels than in the lo:-v GI 
trial, the rate of glucose oxidation remained elevated and FFA's depressed, suggesting the 
persistent effect of hyperinsulinemia after insulin returns to normal levels during exercise 141. 
In contrast, in a similar study performed by the same laboratory 145, similar rates of muscle 
glycogenolysis and FFA concentrations were reported after ingestion of a low vs. a high GI meal. 
An explanation for the discrepancy in results posed by Febbraio et al. 141 is the possible variation 
in insulin sensitivity between study populations used in these studies. Where no difference in 
FFA concentrations were observed between the high and low GI trials, subjects may have been 
more sensitive to even just a small rise in insulin associated with the low GI trial, but enough to 
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blunt lipolysis to the same extent as the large rise in insulin associated with the high GI tri~1 141. 
However, direct measures of insulin sensitivity were not made and this suggestion ther~fore 
remains speculative. 
Lastly, when assessing the effect of a low compared to high GI preexercise meal on exercise 
performance, three studies reported an improvement in exercise performance (time to 
exhaustion) following a low GI 117,408 or moderate GI meal 249, whilst others found no effect on 
exercise performance when employing time to complete a set amount of work to assess 
endurance cycling 141,145,389,409 or running performance 439. It should be noted though that time to 
complete a set amount of work (or time-trial) as measure of performance is more representative 
of real-life racing conditions (where there is a defined end-point) as well as being a more reliable 
and reproducible measure of endurance exercise performance 232,301. 
Collectively taken, the results from the various studies discussed above suggests a wide inter-
individual range of metabolic responses to preexercise CHO ingestion, even when preexercise 
CHO ingestion is quantified in terms of glycemic index, the hormonal and metabolic responses 
remains complex and largely individual. However, despite potential alterations in the metabolic 
and hormonal response, exercise performance as measured by the time to complete a set 
amount of work, seems to be unaffected. 
1.5.2 Longer-term alteration in hormonal milieu: The effect of altering preexercise. 
glycogen availability via a low-CHO diet 
Muscle glycogen stores can be manipulated by alterations in dietary macronutrient in take' and 
exercise. A reduction in glycogen stores, for example by following a low CHO diet, has been 
shown to elicit an altered hormonal and metabolic milieu 440 such as an increase In glucagon, 
ACTH and cortisol concentrations, providing a stimulus for enhanced hepatic glycogenolysis and 
gluconeogenesis 223,440,441 and a shift towards fat oxidation 307. Furthermore, it seems that this 
altered metabolic response perSists during exercise even when fuel availability is maintained 
through exogenous CHO supplementation. In fact, Weltan et al. 441, demonstrated that, only 
ur:-tder conditions of insulin infusion or hyperglycemia in subjects starting exercise in a glycrigen-
depleted state, were the metabolic effects of a low CHO diet and low glycogen counteracted. 
CHO-Ioading diets have traditionally been associated with improved endurance capacity or 
performance, ascribed mainly to increased endogenous CHO availability and maintenance. of a 
high rate of CHO oxidation throughout exercise. Low CHO diets, on the other hand, have ~een 
associated with impaired endurance exercise capacity, mainly ascribed to the reduction of 
muscle glycogen availability and declining blood glucose concentration (developm~nt of 
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hypoglycemia) and a concomitant decrease in the rate of total CHO oxidation 
73.74.89.182.190.223.234.440 However, the exact mechanism(s) whereby reduced muscle glycogen 
and/or hypoglycemia affect endurance exercise capacity is not fully clear. 
1.5.2.1 Potential mechanisms for the purported association between muscle glycogen 
availability and fatigue development during exercise 
A strong relationship between muscle glycogen depletion and the onset of fatigue have peen 
documented in the literature 148. Furthermore, an interesting observation from the literatu,re is 
that the typical level of muscle glycogen below which fatigue usually sets in, is -40 mmol/kg w.w. 
It has long been believed that the main association between fatigue and glycogen depletion is 
the reduction in available fuel to sustain muscle contraction. Yet, no association between ATP 
(fuel) depletion at the point of fatigue have ever been demonstrated, in fact, minimal ATP 
depletion in the light of substantially depleted muscle glycogen and creatine phosphate stores 
have been reported 432. 
In studies employing steady-state cycling protocols performed to exhaustion at moderate-high 
exercise intensities (-70% V02 max), subjects commonly develop fatigue at muscle glycogen 
concentrations of -40 mmol/kg W.W. 35.37.73.89. This observation might be explained by recent 
evidence suggesting that muscle glycogen may act as a feed-forward metabolic signal that 
informs the individual at what point they should slow down or stop exercise to prevent the 
development of absolute substrate depletion 350. It has been suggested 328 that peripheral 
inhibitory input is conveyed from metabo- and chemo-receptors that are sensitive to chemical 
changes within the muscle, which may, via group III and IV afferents, affect supraspinal parts of 
the central nervous system which may then reduce central motor drive. Some evidence in 
support of this suggestion comes from studies demonstrating, for example, that group III a~d IV 
muscle afferents invoke circulatory and ventilatory reflexes during exercise 308 and provide 
feedback from metabolic disturbances such as lactic acid production 383, pain 85 and 
mechanoreception 308.340. 
Other mechanisms that have been explored to explain the relationship between muscle glycOgen 
depletion and fatigue development suggest that apart from a metabolic role, muscle glycbgen 
availability may also have a structural role in that it may be critical for excitation-contraction 
coupling 64.241.403. Low glycogen content has been associated with reduced calcium (Ca2+) uptake 
and release in animals 64.241,403 and humans 29. In this regard, reduced glycogen concentrations 
may relate to fatigue via its association with reduced Ca2+ release from the sarcoplasmic 
reticulum (SR), with a subsequent reduction in force production 29.64.241. The link between 
reduced glycogen (and creatine phosphate) concentrations and fatigue may be explained by the 
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concomitant increase in metabolites such as inorganic phosphate (Pi)' which is known to have an 
inhibitory effect on both Ca2+ release from the SR 159,241 as well as the contractile apparatus 148. 
It has also been hypothesized that the glycogen concentration per se exerts a protective action 
on excitation-contraction coupling 12,403. Barnes et al. 12 recently demonstrated that skinned rat 
muscle fibers from muscles with a higher glycogen content reached 50% rundown after a larger 
number of depolarizations and displayed consistently larger average response capacity values. 
It was concluded that skinned fibers originating from muscles with a higher glycogen content 
have an increased ability to respond to T-system depolarization when the effect of metabolite 
accumulation is minimized and the function of glycogen acting as an energy source is by-passed. 
These data provided direct support to the hypothesis that glycogen has a protective ro'le in 
maintaining fiber excitability 12. However, this hypothesis remains to be tested and confirmed in 
vivo in human skeletal muscle and with intact metabolic and neuro-humoral systems. 
Thus, the impact of altered glycogen concentrations on endurance exercise capacity and the 
mechanism(s) involved remain unclear. Furthermore, the effect of low starting muscle glyC?gen 
concentration on glucose uptake, substrate metabolism and fatigue development remains 
unclear. 
1.5.2.2 Potential mechanisms for the purported association between development of 
hypoglycemia and fatigue during exercise 
Blood glucose concentrations may decline during prolonged exercise as muscle and 
subsequently liver glycogen gets depleted 91 and hepatic glucose production fails to keep up with 
glucose utilization by the working muscles 148. 
1.5.2.2.1 Reduction in the rate of total CHO oxidation 
A decline in blood glucose concentrations during prolonged exercise has traditionally been 
associated with a reduction in exercise capacity, mainly ascribed to a concomitant decline in 
CHO oxidation 73,75,76. However, other more recent studies do not support this finding 36,100,298,416, 
indicating that the frequently-quoted decline in CHO oxidation when glycogen stores are 
compromised compared to when CHO are in plentiful supply, are not always observed. 
Alternative explanations for the ergogenic effect of CHO supplementation have come from 
McConell et al. 296, suggesting that CHO supplementation (compared to placebo) may enhance 
endurance exercise performance by lowering muscle inosine monophosphate levels (a marker of 
the rate of ATP degradation vs. resynthesis), thereby improving muscle energy balance. 
Similarly, though still controversial, it has also been suggested that CHO supplementation :may 
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enhance endurance exercise performance in some subjects via alternations in central nervous 
system function 100,326.394. 
1.5.2.2.2 Effect of hypoglycemia on the central nervous system, and its potential association 
with fatigue development during exercise 
With declining blood glucose concentrations during prolonged exercise (due to progressive 
muscle and liver glycogen depletion 91 and hepatic glucose production failing to keep up with 
glucose utilization by the working muscles 146), the development of fatigue (loss of· force-
generating capacity) may be related, in part, to central factors 163. In human studies it is often 
difficult to differentiate between the contribution of peripheral vs. central factors in fatigue 
development during exercise, and observations are often based on indirect measures al1d/or 
temporal associations. Ratings of perceived exertion (RPE) is often used as a subjective rating 
of the effort perception / sensation of fatigue, however, it cannot fully differentiate between 
aspects of peripheral and central fatigue. Nevertheless, it has been shown to be highly 
reproducible and are often employed as an assessment of central drive / central fatigue during 
exercise. Effort perception may primarily be a feedforward system that results from the 
interpretation of afferent sensations around the body. It is unclear how the brain interprets all this 
feedback, but it has been suggested that an integration of these sensory cues may indirectly and 
unconsciously influence effort perception during exercise, and thereby fatigue 182,331. 
Several studies have shown an association between the development of hypoglycemia and 
increased RPE, conversely, a lower RPE has been associated with a higher plasma glucose 
cc;mcentrations, higher CHO oxidation, and lower plasma cortisol during prolonged exercise 'after 
CHO compared to placebo supplementation despite no differences in muscle glycogen content 
420. These findings support a physiological link between RPE and CHO substrate availab"ility as 
well as selected hormonal regulation during prolonged exercise. In contrast, during an ultra-
marathon race a progressive increase in RPE was noted without an accompanying increase in 
heart rate nor a decrease in blood glucose 421. The authors concluded that during comp~itive 
self-paced exercise the perceptual responses may be mediated through other neurological and 
physiological mechanisms. 
Hence, central fatigue is essentially difficult to measure in humans and therefore difficult to fully 
elucidate. Only with the development of more sophisticated research and measurement 
techniques will central fatigue and its impact of central/neural drive and exercise performance 
be better understood and clarified. 
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1.5.2.2.3 Effect of hypoglycemia on central nervous system (eNS) activation 
Nybo 325 compared the affects of CHO supplementation vs. placebo on CNS activation of the 
skeletal muscles during prolonged exercise. In 8 endurance-trained males voluntary force 
production and central activation ratios, assessed by the twitch interpolation technique; were 
determined during a 2-min sustained maximal knee extension in a baseline condition and 
immediately after 3 h of constant-load cycling, either with or without CHO (glucose) 
supplementation. In the placebo trial, plasma glucose concentration declined from 4.5±0:2 to 
3.0± 0.2 mmol/L, whereas blood glucose homeostasis was maintained during the glucose-
supplemented trial. The development of hypoglycemia during prolonged exercise was associated 
with a significantly lower force production during the sustained maximal voluntary muscle 
contraction (MVC), and accompanied by a reduced level of CNS activation (p<0.05). 
Interestingly, the same force was developed at the onset of the isometric contraction, suggesting 
that hypoglycemia impairs the ability to sustain a high neural drive to the muscle rather than 
affecting the ability to mobilize maximal force for a limited period of time 325. Furthermore, the 
author noted that the lower force production after the prolonged exercise bout also involved 
peripheral fatigue, as the average force in the glucose-supplemented trial was lower compared to 
baseline whilst the level of CNS activation was similar between these two conditions. It was 
concluded that exercise-induced hypoglycemia attenuates CNS activation during a sustained 
maximal muscle contraction, resulting in a reduced force development, and that central fatigue 
appears to be effectively counteracted when hypoglycemia is prevented with CHO 
supplementation 325. Hence, this study is in support of the idea that the ergogenic effect of CHO 
supplementation during prolonged exercise is related to the prevention of hypoglycemia, and that 
this effect is, at least in part, due to the counteraction of central fatigue. 
1.5.2.2.4 Reduction in cerebral glucose availability and fatigue 
Hypoglycemia may affect central fatigue by reducing substrate (glucose) availability to the brain 
328 and/or altering the levels of certain neurotransmitters (discussed under section 1.5.2.2.5). It 
has been estimated that at least 50% of whole-body glucose uptake (at rest) is a result of 
noninsulin-dependent uptake of glucose by the brain 27. Animal research indicate that exercise 
results in the activation of several major brain regions such as the motor cortex, 
cardiorespiratory, vestibular and visual regions of the brain regulation 116. In healthy humans, 
rates of cerebral glucose uptake and cerebral metabolism may become impaired at a systemic 
glucose concentration of::; 3.6 mmol/L 40. Though glucose is the major energy source' fo'r the 
b~ain 334, the cerebral tissue also has the enzymatic capacity to metabolize other fuel so~rces 
such as lactate and ketones 285. It has been shown that during maximal exercise, cerebral 
uptake of lactate is increased 399. This supports the notion that cerebral metabolic function may 
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be maintained during exercise even in the presence of hypoglycemia, seeing that the lactate 
released from the exercising muscle substitutes for glucose as cerebral metabolic fuel s~urce 
146.427. However, during prolonged exercise blood glucose concentrations might decrease toyery 
low levels 146, and it is not yet known whether the rate of utilization of alternate fuel sources 
(lactate and ketones) is sufficient to compensate for the reduced blood glucose availability. 
Nybo et al. 326 investigated whether hypoglycemia-induced fatigue during 3 h of cycling at 60% 
V02 max could be related to alterations in cerebral metabolism. Blood glucose was maintained 
during the one trial, whilst it decreased from 5.2 to 2.9 mmol/L after 3 h in the placebo trial. .Wlth 
the development of hypoglycemia, cerebral glucose uptake decreased (from 0.34 ± 0.05 to 0.28 
± 0.04 J..lmol/g/min) whilst !3-hydroxy (OH) butyrate uptake was increased. However, according to 
the reduced cerebral oxygen consumption and reduced carbon dioxide production, the uptake of 
ketone bodies or other substrates was too small to compensate for the reduced blood glucose 
availability and cerebral uptake. The temporal association between increased RPE and reduced 
cerebral glucose uptake indicated that fatigue was related to inadequate substrate availability for 
the brain 326, 
1.5.2.2.5 Alterations in neurotransmitter release and fatigue 
Exercise-induced changes in cerebral serotonin concentrations has been associated with central 
fatigue 326, Serotonergic neurons has been shown to playa role in, amongst other things, 
activation of the HPA-axis, arousal, and locomotion 326. In addition, the ingestion of CHO during 
prolonged exercise has been proposed to postpone central fatigue by attenuating the release of 
serotonin in the brain 22. The "serotonin-fatigue hypothesis" has been reviewed in detail in refs. 
22.326 and is beyond the scope of this review and will therefore only be referred to in brief. 
The proposed mechanism involves the availability of free tryptophane which has the ability to 
cross over the blood-brain-barrier (in competition with branched-chain amino acid (I;3CAA) 
concentrations) into the brain, where it acts as a precursor for serotonin synthesis. In the 
systemic circulation, tryptophane may be bound to albumin (unable to cross the blood~brain­
barrier) or as free tryptophane (able to be transported into the brain). During prolonged exercise, 
BCAA concentration may decline, resulting in a higher free tryptophane:BCAA ratio and a 
situation where more free tryptophane can cross into the brain. A further consequence of 
prolonged exercise (particularly in the absence of CHO supplementation), is an increase in FFA 
concentrations, which also binds to albumin as a carrier protein, and may displace some of the 
albumin-bound tryptophane thereby also increasing the free tryptophane concentrations: 9HO 
supplementation during prolonged exercise can attenuate the rise in FFA's, thereby all0!Ying 
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more albumin to be bound to tryptophane, reducing the concentrations of free tryptophane and 
uptake into the brain and hence reducing serotonin synthesis (for reviews see 22.328). 
The review of the literature by Nybo and Secher 328 indicated that the though animal evidence are 
in support of the serotonin-fatigue hypothesis, the results from human studies are unconvincing. 
In humans, direct measures of tryptophane kinetics and cerebral serotonin concentrations cannot 
be assessed (for ethical reasons). However, tryptophane administration, resulting in 7-10 fold 
increase in systemic levels, failed to affect exercise time to exhaustion when cycling at 70% 
maximal power output 423, whilst it either had no effect 402 or improved endurance performan(fe 373 
during hjgh-intensity running. Furthermore, pharmacological manipulation of cerebral serotonin 
levels (Le. with serotonin inhibitors) also had inconsistent results of exercise performance (for 
review see 328). 
After detailed assessment of the available data by Nybo and Secher 328, it appears that the 
"serotonin-fatigue hypothesis" in humans does not become relevant unless the exercise is 
associated with marked elevations in FFA's and free tryptophane and perhaps only with :very 
prolonged endurance exercise. Nybo and Secher 328 suggested that the central effect of CHO 
(glucose) supplementation during exercise may primarily be related to a direct effect of increased 
glucose availability for the glucose-dependent brain (as discussed under sections 1.5.2.2.3 and 
1.5.2.2.4). 
1.5.2.2.6 Effect of prolonged exercise on IL-6 release and its potential role in fatigue 
development 
In section 1.4.3 the potential role of IL-6 in glucose homeostasis and fatty acid mobilization 
during exercise were highlighted. In addition to the large increase in circulating IL-6 
concentrations produced by skeletal muscle during prolonged exerCise, the brain has also been 
s~own to produce small amounts of IL-6 during exercise. Interestingly, whereas systemic' IL-6 
release is increased under glycogen-depleted conditions 201.245.397, cerebral IL-6 release is 
abolished with the development of hypoglycemia during exercise (e.g. exercising without CHO 
supplementation) 327. The reason for this response is not clear, but it has been suggested that 
cerebral IL-6 response may be attenuated as a consequence of cerebral dysfunction .due to 
hypoglycemia, or that the response may be blunted because the systemic IL-6 response d~ring 
exercise without CHO supplementation may be increased to an extent where it overrides the 
cerebral response 326. 
Spath-Schwalbe et al. 390 demonstrated that when low doses of rh-IL-6 were administered to 
healthy individuals at rest, the elevated IL-6 concentrations were associated with increased 
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cortisol and ACTH concentrations and an increased heart rate. In addition, subjects reported an 
increased sensation of fatigue, altered ability to concentrate and disrupted sleep pattems. 
Furthermore, when an IL-6 antagonist (humanized anti-IL-6 receptor antibody) was administered 
to patients diagnosed with IL-6 related immune-inflammatory diseases (Castleman's disease and 
rheumatoid arthritis), subjects reported an immediate attenuation of fatigue symptoms 320. 
Changes associated with elevated levels of plasma IL-6 include malaise, fatigue, elevated levels 
of adrenocorticotrophic hormone and cortisol, and increases in heart rate and core temperature 
217.351.417. It has therefore, at least in part, been sUggested that IL-6 may playa role.in the 
development or perception of fatigue. 
Gleeson 170 suggested that the large release of IL-6 from exercising skeletal muscle could act as 
a feedback mechanism contributing to the development of central fatigue. To investigate the role 
of IL-6 in fatigue development during exercise, Nybo et a!. 327 measured cerebral IL-6 balance 
during exercise with and without hyperthermia. It was hypothesized that the exercise-induced 
increase in IL-6 would result in cerebral uptake thereof, especially during exercise with 
hyperthermia, which is associated with central fatigue 327, At rest there was a net balance o{ IL-6 
across the brain, however, during exercise IL-6 was released rather than taken up by the Qrain, 
and in the face of systemic IL-6 concentrations that increased over 10-fold during the same 2 h 
exercise period. Cerebral release of IL-6 appeared to be more a function of exercise duration 
and not an increase in body temperature, as arterial and cerebral IL-6 responses were similar 
during hyper- and normothermia 327, 
Recent data obtained from an exercise performance-related study have indicated that IL-6:may 
playa role in affecting the sensation of fatigue during running in trained male athletes 359. In this 
study, recombinant human IL-6 was administered subcutaneously prior to a 10 km running time-
trial in amounts equivalent to those produced during 2 h of strenuous running (9±2 pg/ml vs, 
baseline concentrations of 1±O,5 pg/ml) 394, With IL-6 infusion (compared to placebo), subjects 
reported an increased sensation of fatigue, which ultimately resulted in a decrement in ru~ning 
performance. This has led to the conclusion that IL-6 may possibly act as a Circulating 
"fatiguogen" during exercise. In recent years, the role of the central nervous system (CNS) in the 
development during exercise has received increasing attention 59. It is suggested that afferent 
Signals relating the physiological and metabolic status of the body are relayed back to the CNS. 
Based on these signals, efferent signals from the CNS I brain are related back to the appropriate 
bodily structures, and in respect to exercising skeletal muscle, result in a de-recruitment of 
skeletal muscle (reduced exercise capacity) in order to maintain a homeostatic environment 183, 
Exercise induced changes In various brain neurotransmitters (serotonin, dopamine and 
acetylcholine) and neuromodulators (ammonia and various cytokines) have been suggested to 
be possible mediators in the onset of exercise related fatigue 59. Further studies are needed to 
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assess the range of physiological functions of IL-6 during exercise, especially pertaining to its 
potential effect on the development of central fatigue. 
1.5.2.2.7 Putative CHO receptors in the mouth and its relationship with central drive and 
exercise performance 
Further evidence for an alternate mechanism for the ergogenic effect of CHO, unrelated to mere 
maintenance of euglycemia / prevention of hypoglycemia and high CHO oxidation rates, cOmes 
from studies where CHO ingestion immediately before or during relatively short (-1 h), high-
intensity (>75% V02 max) exercise resulted in improved performance 9.11,60.61,131,231,316. Though 
again, this effect has not been universal amongst all studies 70.119,262.299. 
One suggestion for the improvement in performance observed under these exercise condi~ions 
have been the maintenance of a high rate of CHO oxidation, however, Jeukendrup et ~1. 231 
demonstrated that this effect is unlikely seeing that only 5-15 g of exogenous CHO were oxidized 
in the first hour of exercise and too small to affect CHO oxidation and performance. In fact, there 
does not seem to be a clear metabolic explanation for this effect 60.61. When glucose was infused 
at a rate of 1 g/min compared with saline during a 40-km (-1-h) simulated cycling time-trial (TT), 
there was a small but significant increase in CHO oxidation rate, however, 40-km TT 
performance was unaffected (Carter et aI., unpublished observations 2004, as reported in 61). 
An intriguing finding from a very recent study demonstrated an improvement in 1-h cycling TT 
performance by simply rinsing the mouth with a CHO-containing solution 61. Power output was 
higher in the CHO compared to placebo trial, but RPE remained similar. The fact that the CHO 
sC?lution was not swallowed makes it unlikely that the improvement in performance was related to 
a metabolic effect of CHO. Rather, the authors suggested the involvement of an alternate 
mechanism, such as the involvement of a central pathways, increasing central motor diive or 
motivation rather than having any metabolic cause 61. This effect may be mediated by receptors 
in the mouth that may be triggered by CHO and may result in the stimulation of the reward and/or 
pleasure centers in the brain 61. Though there is some animal evidence for the potential 
existence of CHO receptors in the mouth, the nature and role of these receptors remains to be 
fully explored and SUbstantiated. 
1.5.2.3 Variability in response to the development of hypoglycemia during exercise and its effect 
of exercise performance 
A number of studies have found that exogenous CHO supplementation, especially when 
endogenous glycogen concentrations are low, can maintain blood glucose and tota~ CHO 
oxidation and delay the onset of fatigue and thereby, in part, negate or 'over-ride' the potential 
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ergolytic effects of low endogenous glycogen stores 35,60,73,74,89. Furthermore, CHO 
supplementation during exercise appear to minimize the performance differences in studies in 
which subjects ingested different preexercise diets and therefore began exercise with diff~rent 
muscle and liver glycogen concentrations 53,445. 
These findings contributed to the popular premise that the improved endurance capacity 
associated with CHO-Ioading or CHO supplementation during exercise, or both, may result from 
the prevention of hypoglycemia 53,73,242,445. Indeed, some studies have demonstrated that CHO 
supplementation improved endurance exercise capacity only in the individuals who beCame 
hypoglycemic during the placebo treatment 19,91,92. For example, Coyle et al. 91 reported that 
CHO ingestion during prolonged exercise at 74% V02 max increased endurance time bY"'17%, 
but only in those subjects who developed hypoglycemia during the placebo trial. 
However, closer evaluation of the literature suggest that the ergogenic potential of maintaining 
CHO availability during exercise is not simply due to the prevention of hypoglycemia and a 
decline in CHO oxidation (as discussed previously). There are studies that demonstrated that 
CHO supplementation during exercise lowered RPE and improved endurance performance even 
in individuals who did not become hypoglycemic during the placebo trials 60,293,313, nor did the 
CHO supplementation alter the rate of CHO oxidation during exercise 36,60,100,132,298,313,416. 
Perhaps the most intriguing findings are from those studies that found that the development of 
hypoglycemia 87,146,228,230,312 or reversal of hypoglycemia 162 (plasma glucose <3.5 mmol/L) during 
exercise had little effect on exercise performance, nor were RPE any different between CHO and 
placebo supplementation trial. Similarly, as discussed in detail under section 1.5.1, a series of 
studies investigating the effect of type, amount and timing of preexercise CHO intake have 
in.dicated that some subjects are prone to the development of rebound hypoglycemia during 
subsequent exercise (for reasons yet unclear), yet the development of hypoglycemia had no 
effect on their exercise performance 228,230,312. 
Collectively taken, the results from the available literature suggest that the fatiguing effects of 
declining blood glucose concentrations differ between individuals. The nature of this differel1:C8 is 
not clear, but may relate to differences in cerebral sensitivity to reductions in blood glucose 
concentrations 7, and/or phenotypic differences in metabolism during exercise 2,172. The 
phenotypic differences seen might be related to genetic differences, or to differences in habitual 
dietary and training regimes 102,172, 
It has become apparent that (a) the ergogenic effect of improved endogenous and exogenous 
CHO availability on exercise capacity is not simply due to the prevention of hypoglycemia and 
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the maintenance of a high rate of CHO oxidation per se, and (b) the development of 
hypoglycemia does not necessarily have a negative impact on exercise performance; (c) that 
there is individual variability in the metabolic, hormonal and performance response to altered 
glucose availability, and finally (d) that the mechanisms by which improved or reduced ~HO 
availability may alter exercise performance still need to be fully elucidated. Clarity on these 
aspects may assist with development of specific dietary advice and strategies to enhance athletic 
performance, especially in strenuous training or competition situations where recovery time is 
limited and endogenous CHO stores may be compromised. 
1.5.3 Longer-term alteration in hormonal milieu: Metabolic and neuroendocrine 
responses to antecedent exposure to hypoglycemia and/or exercise 
1.5.3.1 Exercise-associated adaptation of the HPA-axis 
Exercise has been identified as a potent activator of the HPA-axis 275.276. An interesting 
observation in the literature is that endurance-trained men might develop an adaptation of the 
HPA-axis to repeated and prolonged exercise-induced increases in cortisol secretion (or 
repeated stimulations of the HPA-axis) 125. These adaptive mechanisms may include decreased 
sensitivity to cortisol to protect muscle and other glucocorticoid-sensitive tissues against the 
increased cortisol secretion commonly observed during and up to 2 h after exercise 124.125. The 
potential impact of such an adaptation in HPA-axis activity on glucoregulatory hormonal 
responses and maintenance of glucose homeostasis have not been fully explored. 
Though some researchers consider this blunting of the HPA-axis and cortisol response as a 
maladaptation or pathology in athletes 276, Viru et al. 428 examined the possibility that fatigue 
development per se may modify the hormone responsiveness to subsequent exercise. Twelve 
endurance-trained men ran for 2 h (blood lactate -2 mmol/L) in order to induce fatigue. "10-
min exercise bout at 70% V02max was performed before (1st test) and after (2nd test) the 2 h run 
to assess hormone responsiveness, the 10-min exercise test was followed by 10 min of rest, 
followed by a 1-min anaerobic power test to assess muscle power. The 1 st test resulted in a 
significant increase in cortisol and growth hormone, a decrease in insulin and no change in 
testosterone concentrations. The 2 h run caused decreases of insulin, increases of· growth 
hormone concentration and variable responses in the concentrations of cortisol and testosterone. 
The 2nd test decreased insulin concentration further, but responses of the concentrations of 
testosterone, growth hormone and cortisol were variable. In 6 subjects (group A) cortisol 
displayed an increase from baseline concentrations, while in the other 6 subjects (group B) a 
decrease or no change was seen. Growth hormone concentration was substantially higher in 
group A than group B following the 2nd test. In group A anaerobic muscle power was 
significantly higher, while in group B it was lower after the 2 h run than before the 2 h run 428. 
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The findings suggest that fatigue from prolonged endurance activity may introduce a resetting in 
the pituitary-adrenocortical component of the endocrine system, expressed either by intensified 
endocrine functions in some individuals or by suppressed endocrine functions in others. 
1.5.3.2 Hypoglycemia-associated counterregulatory fai/ure, hypoglycemia "unawareness" 
syndrome and the sensation of fatigue 
As discussed previously, with the development of hypoglycemia, a point may be reached where 
glucose transport from the circulation is no longer sufficient to meet cerebral metabolic demands, 
and a series of central and peripheral counterregulatory responses are elicited, as well as the 
development of warning symptoms which makes the person aware of hypoglycemia, all in aid of 
restoring euglycemia. It has been shown that the glycemic threshold for these counterregulatory 
(metabolic, hormonal and symptomatic) responses can be shifted to lower glucose 
concentrations following a single episode of hypoglycemia. A series of studies have now 
demonstrated that antecedent exposure to hypoglycemia can blunt subsequent 
counterregulatory responses to hypoglycemia (or related physiological stresses such as exercise 
160) in diabetic (for review see refs. 27.385 and healthy individuals 102.160.205. For exampl~, in 
healthy subjects, rates of brain glucose uptake were initially impaired at a systemic glucose 
concentration of 3.6 mmol/L, however, after 56 h of intermittent hypoglycemia (3.0 mmol/L) brain 
uptake was preserved at normal rates even when blood glucose was as low as 2.5 mmoVL 40. It 
was demonstrated that counterregulatory hormone and symptomatic responses were also 
triggered at lower glucose concentrations following recurrent hypoglycemia 40. 
As hypoglycemia and exercise trigger similar autonomic nervous system (ANS) and neuro-
endocrine responses, it has been suggested that exercise may also attenuate counterregulatory 
responses to other related physiologic stresses in non-diabetic populations, including exercise. 
Additionally, both hypoglycemia and exercise lead to elevated glucocortiCOid concentrations, and 
it has been demonstrated that prior elevations of cortisol (or challenge to the HPA-axis) produce 
blunted responses to subsequent hypoglycemia 102.106.107.160.205. 
Davis et al. 102 reported that antecedent hypoglycemia resulted in significant blunting of neuro-
endocrine (glucagon, insulin, catecholamines) and metabolic (endogenous glucose production, 
lipolysis, ketogenesis) responses during a subsequent exercise bout (the following dav) in 
healthy subjects. The group exposed to antecedent hypoglycemia required a 10 fold highe~ rate 
of glucose infusion in order to maintain euglycemia during the exercise bout, compared· to the 
antecedent euglycemic group 102. These results makes it difficult to elucidate whether the neuro-
endocrine and metabolic responses were caused by, or resulted in the high rate of glucose 
infusion required to maintain euglycemia. It is yet unclear how the neuro-endocrine and 
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metabolic responses would be affected when healthy individuals are left to regulate their Dlood 
glucose concentration (without exogenous glucose infusion intervention) during exercise :after 
antecedent hypoglycemic exposure. Speci'fically, these responses have not been systematically 
investigated in a population of well-trained individuals. 
In a subsequent study, Galassetti et al. 160 demonstrated that antecedent prolonged exercise with 
euglycemic glucose infusion in healthy individuals blunted neuro-endocrine and metabolic 
counterregulatory responses to subsequent hypoglycemia the following day. Again, blood 
glucose concentrations during exercise were manipulated with glucose infusion, which 
complicates interpretation of the subsequent glucose counterregulatory responses. 
Factors that have been identified as independent determinants of the magnitude of subsequent 
counterregulatory failure include depth of antecedent hypoglycemia 108, number of prior epis9des 
of hypoglycemia 103.108.205.444, and gender 105. Though the factors and mechanisms responsible 
for the phenomenon of counterregulatory failure and hypoglycemia unawareness have re~ived 
much focus in recent years, it still remains to be fully elucidated. 
1.5.3.2.1 Factors affecting the magnitude of counterregulatory failure 
1.5.3.2.1.1 Magnitude (depth) of antecedent hypoglycemia 
In men, neuroendocrine and SNS responses were sensitive to prior exposure of even modest 
(3.9 mmol/L) hypoglycemia 108. Antecedent exposure to hypoglycemia of 3.9 mmol/L for 2 h 
resulted in significantly blunted epinephrine, muscle sympathetic nerve activity, and gluq:lgon 
responses during next-day hypoglycemia (2.9 mmoIlL), whereas antecedent exposur~ to 
hypoglycemia of 3.3 mmollL resulted in additional significant blunting of pancreatic polypeptide, 
norepinephrine, growth hormone, endogenous glucose production, and lipolytic responses. 
Deeper antecedent hypoglycemia of 2.9 mmollL produced similar day 2 counterregulatory failure 
as qay 1 antecedent hypoglycemia of 3.3 mmollL. In summary, this study indicated that in 
healthy overnight-fasted men, mild antecedent hypoglycemia of 3.9 mmollL significantly blunted 
sympathoadrenal and glucagon, but not other forms of neuroendocrine counterregulatory 
responses to subsequent hypoglycemia. Antecedent hypoglycemia of 3.3 mmolll resulted in 
additional significant blunting of all major neuroendocrine and metabolic responses to 
subsequent hypoglycemia. The authors concluded that in normal humans, there is a hierarchy 
of blunted counterregulatory responses that are determined by the depth of antecedent 
hypoglycemia 108. 
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1.5.3.2.1.2 Duration and magnitude of antecedent hypoglycemia 
Significant blunting of counterregulatory responses during subsequent (next-day) exposure to 
hypoglycemia has been demonstrated after antecedent hypoglycemic exposure consisting of 2 h 
in the morning followed by 2 h in the afternoon 108, and with 30 min hypoglycemic exposure in the 
morning followed by a 2 h exposure in the afternoon 205. However, one single episode of 
antecedent hypoglycemia (3.0 mmol/L) of 2 h duration has been shown to produce a generalized 
reduction of the neuroendocrine and symptomatic responses to subsequent hypoglycemia (2.8 
mmol/L) in healthy men 205. 
Peters et al. 338 investigated whether subsequent neuroendocrine and symptomatic responses 
are attenuated after short-term hypoglycemic episodes of less than 1-h duration in healthy men. 
They studied hypoglycemia on 4 consecutive days and after an 8-day pause. Plasma glucose 
was reduced to < 2.8 mmol/L on study days 1, 2, 3, 4, and 12 after intra venous insulin boluses 
(0.04 Ulkg). Counterregulatory hormone concentrations increased similarly during: the 
hypoglycemic episodes in all instances, and maximal concentrations on study day 4 were not 
attenuated. On each study day, symptoms of hypoglycemia were produced after induction of 
hypoglycemia, and there was no decrease in the degree of symptom responses on subsequent 
days. The multivariate analysis of variance showed no day-to-day differences in plasma glucose, 
counterregulatory hormones, or hypoglycemic symptoms. It was concluded that with short-term 
«1 h) hypoglycemic episodes, the neuroendocrine and symptomatic responses remain 
completely intact in healthy individuals 338. 
Davis et al. 103 investigated the effect of two identical episodes of short-duration, intermediate-
duration and prolonged hypoglycemia each performed during a 2 h moming and aftemoon 
experiment in healthy humans. In all the hypoglycemic experiments, blood glucose was initially 
reduced from baseline to 2.9 mmol/L over a 30 min period. Thereafter, in the short-duration 
hypoglycemia experiment blood glucose was maintained at 2.9 mmol/L for 5 min then rapidly 
restored to euglycemia for the remainder of the 2 h. With intermediate hypoglycemic exposure, 
blOOd glucose was maintained at 2.9 mmol/L for 30 min, and with prolonged hypoglycemia it was 
maintained at 2.9 mmol/L for 90 min and rapidly restored to euglycemia for the remaining' 2 h. 
The same procedure was repeated in the afternoon. Euglycemia was maintained for: 2 h 
between the morning and afternoon experiments. The following day involved a single 2 h 
hypoglycemic (2.9 mmol/L) clamp experiment. Epinephrine, norepinephrine, glucagon, growth 
hormone and muscle sympathetic nerve activity responses were similarly significantly blunted by 
all differing-duration hypoglycemic experiments (compared to euglycemia). Plasma cortisol 
responses were reduced in a step-wise manner from -745 nmol/L after antecedent euglycemia 
tQ -580, -611 and -497 nmol/L in short-, medium and prolonged-duration antecedent 
hypoglycemia, respectively. Endogenous glucose production was similarly significantly blunted 
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and glucose infusion rates (to maintain day 2 hypoglycemia) increased after all differing-dtlration 
hypoglycemia experiments. Hypoglycemic symptom scores (principally autonomic symptoms) 
were significantly reduced after intermediate- and prolonged-duration hypoglycemia, but were 
unaffected by prior short-duration hypoglycemia 103. 
The study by Davis et al. 103 ruled out the possibility that short-duration antecedent hypoglycemia 
could selectively blunt some but not all subsequent neuroendocrine responses. Furthermore, 
muscle sympathetic nerve activity was similarly significantly blunted even after short-duration 
antecedent hypoglycemia, which indicates the sensitivity of the sympathetic nervous system to 
the deleterious effects of even minimal antecedent hypoglycemia. 
1.5.3.2.1.3 Effect of gender 
Davis et al. 105 demonstrated that whilst prolonged (90-min) antecedent hypoglycemia exposure 
at 3.3 or 3.9 mmol/L significantly blunted counterregulatory reposes in healthy men, it· had 
virtually no effect in healthy women. Antecedent hypoglycemia of 2.9 mmol/L in women: was 
needed to produce significant blunting of subsequent counterregulatory responses 105. In support 
of these findings, Galassetti et al. 161 also demonstrated a sexual dimorphism in the 
counterregulatory response to antecedent hypoglycemia, with a significantly greater attenuation 
of response in men, when compared to women. 
D~vis et al. 104 demonstrated that differential glycemic thresholds are not the cause of the s~xual 
dimorphism present in counterregulatory responses to hypoglycemia, but that it is rather a 
reduced eNS efferent input that underlies the mechanism responsible for lowered 
neuroendocrine responses to hypoglycemia in women. They also demonstrated that the 
physiological counterregulatory responses (neuroendocrine, cardiovascular, and autonomic 
nervous system) are reduced across a broad range of hypoglycemia in healthy women compared 
with healthy men 104. 
1.5.3.2.1.4 Role of cortisol in the pathogenesis of reduced counterregulatory responses 
The exact mechanism(s) responsible for the reduced neuroendocrine and autonomic-
adrenomedullary responses observed after repeated exposure to hypoglycemia (or re~ated 
physiological stresses) in healthy 103,103,109,205 and insulin-treated diabetic patients 25,96,101,385, are 
not fully known. 
One. possibility might be related to the role that glucocorticoids play in protecting the body against 
its own defense mechanisms, which might cause damage if allowed to proceed unregulated (for 
example reducing the inflammatory response). Glucocorticoids have been shown to reduce the 
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autonomic-adrenomedullary response to a variety of differing stress in animals and humans 
261,267, Tappy et al. 406 demonstrated that dexamethasone administration resulted in a r~duced 
norepinephrine response during hyperinsulinemic-euglycemia in humans. Komesaroff and 
Funder 261 reported that prior dexamethasone administration resulted in reduced autonomic-
adrenomedullary responses to hypoglycemia in sheep. Furthermore, bilateral adrenalectomy 
with resultant glucocorticoid deficiency has been shown to result in exaggerated autonomic 
responses to stress exposures such as surgery in nonhuman primates 419 and cold exposure in 
rats 341. 
These studies gave rise to the study of Davis et al. 106 who aimed to investigate if hypogly~mia­
associated autonomic failure is caused by antecedent increases of plasma cortisol. He~lthy 
subjects underwent two separate, 2-day experiments. On day 1 subjects underwent either two 2-
h bouts of hyperinsulinemic hypoglycemia (2.9 mmol/L) separated by 2 h of euglycemia (-5 
mmoI/L), or 2 bouts of hyperinsulinemic euglycemia followed by a 2 h bout of hypoglycemia (2.9 
mmol/L) on day 2. In another group of subjects day one consisted of similar 2-h bouts of 
euglycemia with cortisol infusion to simulate concentrations reached during clamped 
hypoglycemia, followed by similar day 2 hypoglycemia. Their results indicated that antecedent 
physiologic increases of plasma cortisol resulted in significantly reduced autonomic nervous 
system (ANS) responses (epinephrine, norepinephrine, glucagon, and muscle sympathetic nerve 
activity) to subsequent hypoglycemia. The magnitude of reduction in ANS responses was similar 
to that observed with antecedent hypoglycemia. It was concluded that increased plasma cortisol 
is the suggested mechanism underlying the effect of antecedent hypoglycemia on subsequent 
hypoglycemia-associated autonomic failure 106. Similar findings and conclusions were reported 
in a more recent study by McGregor et al. 300. 
In the study of Davis et al. 106, the magnitude of reduction in the glucagon response was greater 
after antecedent hypoglycemia compared to antecedent cortisol infusion. As dis.cussed 
previously, glucagon secretion may be controlled by the sympathetic 168 and parasympathe~ic 24 
nervous systems. The results of Davis et al. 106 are in support of the ANS as well as alpha-cell 
glucose sensing in regulating glucagon release seeing that hypoglycemia would impair both ANS 
input into as well as direct glucose sensing by the alpha cell, resulting in a greater suppression of 
gluq:lgon secretion, Whereas antecedent cortisol would only impair ANS input into the pancreas 
whilst leaving direct glucose sensing by the alpha cell intact and hence less suppressi6n of 
glucagon secretion. 
Along similar reasoning, the different magnitude of the glucagon responses could explain why 
antecedent hypoglycemia resulted in greater suppression of hepatic glucose production 
compared to antecedent cortisol infusion 106. 
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In a subsequent study, Davis et al. 107 assessed whether prevention of the plasma co'rtisol 
response during antecedent hypoglycemia preserves autonomic nervous system 
counterregulatory responses during subsequent hypoglycemia in healthy humans.' They 
demonstrated that the prevention of an increase in cortisol during antecedent hypoglycemia 
preserved many critical ANS counterregulatory responses to subsequent hypoglycemia. It· was 
concluded that hypoglycemia-induced increases in plasma cortisol levels are a major mechapism 
responsible for causing subsequent hypoglycemic counterregulatory failure, and that other 
mechanisms, apart from cortisol, do not playa major role in causing hypoglycemia-associated 
autonomic failure 107. 
In contrast to these findings, Raju et al. 345 more recently demonstrated that elevations in cortisol 
(for 2.5 h in the morning and afternoon during euglycemia) to levels that occur during 
hypoglycemia did not reduce sympathoadrenal or neurogenic symptom responses to subsequent 
hypoglycemia in healthy humans. The study population and duration of the elevation in cortisol 
concentrations were comparable between studies, hence the reason for the discrepancy in 
results are not readily apparent. 
Interestingly, De Galalan et al. 113 tested whether antecedent elevations in epinephrine 
concentrations (for 1 h) plays a role in hypoglycemia-associated autonomic failure during 
subsequent hypoglycemia (induced 3 h later) in healthy humans. The subsequent bout of 
hypoglycemia induced similar counterregulatrory hormonal responses as well as similar 
autonomic, neuroglycopenic and cognitive function responses compared to prior saline infusion 
113. Their results indicated that prior elevation in epinephrine plays a limited role in the concept of 
hypoglycemia-associated autonomic failure. 
Collectively taken, there is literature to suggest that prior elevations of cortisol can exert a 
restraining effect of ANS activity with reductions in neuroendocrine responses and hepatic 
glucose production and hence impaired maintenance of glucose homeostasis during subsequent 
e,:,posure to a variety of stress that may increase cortisol concentrations 106,107. However, there 
are also research to suggest that neither prior elevations of cortisol 345 nor epinephrine 113 are 
responsible for causing hypoglycemia-associated autonomic failure. Hence, the mechanism 
behind the concept of hypoglycemia-associated autonomic failure remains to be fully elucidated. 
1.5.3.2.2 Dissociation between the degree of counterregulatory hormone failure and 
symptomatic response and cognitive function 
1.5.3. 2. 2.1 Symptomatic response 
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The recognition or symptomatic response to hypoglycemia is one of the key responses elicited in 
the defense against the development of even more severe hypoglycemia. Symptomatic 
awareness of hypoglycemia is key to stimulate food intake and hence restore euglycemia and 
ultimately, prevent neuroglucopenia 385. There seems to be a distinct hierarchy of responses to 
decrements in plasma glucose, such that the threshold for activation of counterregul~tory 
hormone secretion occurs at higher plasma glucose levels than that for initiation of autonomic 
warning symptoms, which in turn occurs at higher plasma glucose levels than that for onset of 
neuroglycopenic symptoms and deterioration in cerebral function 309. 
Though there is good agreement in the literature that neuroendocrine responses are blunted by 
prior hypoglycemia of differing durations in normal healthy humans (e.g. refs. 102,103,105,108,205,444), 
the effect on the symptomatic response and cognitive function seem less clear. 
In this regard, studies in humans with insulin dependent diabetes mellitus (100M) demonstrated 
that neuroendocrine failure is not always associated with symptomatic response faih~re. and 
cognitive impairment. Studies have reported that prior hypoglycemia had either no effec;:t on 
thresholds for hypoglycemic symptoms 71,443 or significantly reduced the glucose level at which 
symptoms were provoked 95,443. Furthermore, Oagogo-Jack et al. 97 reported that rigorous 
avoidance (3-4 wks) of hypoglycemia in type 1 diabetics resulted in a return of hypoglycemic 
symptoms but not neuroendocrine responses to subsequent hypoglycemia. Additionally, several 
studies have shown a blunting of neuroendocrine responses, yet cognitive function' was 
preserved in 100M 98 and healthy humans 219. 
In the study of Oavis et al. 103 2 episodes (1 in the morning and 1 in the afternoon) of. short-
duration hypoglycemia (5 min at 2.9 mmol/L and 20 min of lowering and raising between 2.9 and 
3.9 mmol/L) in healthy humans resulted in similar magnitude of neuroendocrine and muscle 
sympathetic nerve activity blunting than 2 prior episodes of intermediate (30 min) and prolonged 
(QO min) hypoglycemia. However, hypoglycemic symptoms (particularly autonomic symptoms) 
were blunted by intermediate and prolonged antecedent hypoglycemia, but unaffected by prior 
short-duration hypoglycemia 103. It therefore appears that duration of antecedent hypoglycemia 
can produce a hierarchy of blunted physiological responses during subsequent hypoglycemia, 
with hypoglycemic symptom awareness less vulnerable than neuroendocrine responses 103,~,385. 
Furthermore, cardiovascular responses were unaffected by prior hypoglycemia (of any dur~tion) 
103 It therefore seems that prior hypoglycemia may blunt some but not all autonomic nervous 
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system responses during subsequent hypoglycemia, as has also been observed by Paramore et 
al. 333. 
1.5.3.2.2.2 Cognitive function 
Though neuroendocrine changes after induction of hypoglycemia, in patients with diabetes and 
healthy persons, are thoroughly investigated, cognitive adaptation processes are still not fully 
understood 282. It has generally been shown that cognitive functioning becomes impaired when 
blood glucose falls below 3.1 mmol/L 156,158, and that altered cognitive functioning is often related 
to development of neuroglycopenic symptoms 158. However, it has been demonstrated that the 
there are regional differences in the susceptibility to neuroglycopenia within the brain, with the 
cerebral cortex being most sensitive while deeper structures are more resistant 156,282. 
Furthermore, the degree of dysfunction differs in various areas of the brain and a battery of 
psychometric tests is usually required to assess impairment of cognitive function during 
hypoglycemia. Complex, attention-demanding and speed-dependent responses are most 
impaired with accuracy often preserved at the expense of speed (reviewed in detail by Frier :156). 
Evans et al. 135 examined the time course for the onset of, and recovery from,. acute 
hypoglycemia in healthy subjects in 8 healthy males after plasma glucose was allowed to fall 
rapidly to -2.65 mmol/L and maintained for 90 min before euglycemia was rapidly restored (vs. 
euglycemia throughout). Cognitive function assessed by a battery of sensitive tests (4:"ctioice 
reaction time (RT), Stroop word, and color-word test) became significantly impaired immediately 
at onset of hypoglycemia compared to the euglycemic experiment. Counterregulatory hormone 
responses (epinephrine, norepinephrine, glucagon, cortisol, and growth hormone) and 
symptomatic awareness of hypoglycemia (assessed by a questionnaire) were relatively delayed, 
being detected 20 min after the onset of hypoglycemia. There was no diminution (adaptat10.n) of 
any responses, cognitive, humoral, or symptomatic during the 90 min of sustained hypogly~mia. 
During recovery, the 4-choice RT continued to be abnormal even after symptomatic awareness 
was restored. It was concluded that cognitive performance during hypoglycemia may become 
impaired before symptomatic awareness. Furthermore, during recovery from hypoglycemia, 
recovery of cognitive function lags behind the restoration of glucose concentrations symptomatic 
awareness 135,156,282. 
In· a study on healthy men where cerebral use of alternate fuel sources (FFA's) during 
hypoglycemia was assessed 134 by means of intra lipid-heparin infusion, the raised FFA, glycerol, 
and beta-hydroxybutyrate concentrations significantly reduced epinephrine and growth hormone 
responses. These hormonal responses were also delayed from a blood glucose threshold of 3 
mmoVL to 2.8 mmol/L, with a trend toward reduced cortisol responses. Similarly, hypoglycemic 
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symptom scores were significantly diminished during intralipid infusion. However, there was no 
significant effect on the deterioration in four-choice RT, one measure of cognitive deterioration. 
With intralipid-heparin infusion during euglycemic clamping, there was no rise in hormones, four-
choice RT, or symptoms other than hunger and tiredness. Hence, raised concentrations of FFA 
and glycerol were able to reduce neurohumoral responses to hypoglycemia, but could not protect 
cognitive function. This suggests that regional differences exist in human brain metabolism 
between glucose-sensing and cognitive areas of the brain, which may be important in the 
understanding of the mechanisms of glucose sensing and in the genesis of hypoglycemia 
unawareness 134. 
Similar to the reduction in neuroendocrine and symptomatic responses that may follow exposure 
to a single, recent bout of hypoglycemia, a single episode of mild antecedent hypoglycemia (3.1 
mmol/L) has also been shown to attenuate several aspects of cognitive dysfunction during 
subsequent hypoglycemia 18-24 h later 158. Fruehwald-Shultes et al. 158 reported that cognitive 
performance, assessed by auditory-evoked brain potentials (AEBPs) and reaction time during a 
vigilance task and short-term memory recall, deteriorated during stepwise hypoglycemia. 
However, after subsequent exposure to hypoglycemia 18 - 24 h later, the hypoglycemia-ind~ced 
decrease in the amplitude of the P3 of the AEBP was distinctly reduced, and short-term memory 
and reaction time performance was less impaired in the prior-hypo compared to the control. group 
158. These results may be explained by data indicating that cerebral adaptations may occur that 
allow for normal brain glucose uptake and cerebral function to be maintained during recurrent 
systemic hypoglycemia 42. 
To test whether the glycemic thresholds for hypoglycemic cognitive dysfunction, like those for 
neuroendocrine responses to and symptoms of hypoglycemia, shift to lower plasma glucose 
concentrations after recent antecedent hypoglycemia, Hvidberg et al. 219 exposed 16 healthy 
subjects (7 women and 9 men) to 2 h of hypoglycemia (2.6 mmol/L) vs. euglycemia on d~y 1, 
followed by exposure to stepped hypoglycemia (4.7,4.2,3.6,3.0,2.8,2.5, and 2.2 mmol/L) the 
fallowing morning (day 2) whilst neuroendocrine, symptomatic, and cognitive responses were 
assessed. Cognitive function tests included measures of information processing (Serial 
Addition), attention (Stroop Arrow Word), pattern recognition and memory (Delayed Non~Match 
to Sample), and declarative memory (Paragraph Recall). As expected, plasma glucagon, 
epinephrine, and pancreatic polypeptide responses to stepped hypoglycemia were significantly 
reduced, and symptomatic responses tended to be reduced after day 1 hypoglycemia compared 
to euglycemia. Performance on the cognitive function tests deteriorated Significantly during day 
2 stepped hypoglycemic Clamps, but there were no significant overall effects of ante~dent 
hypoglycemia on hypoglycemic cognitive dysfunction. Although deterioration was reduced from 
the 2.8 mmol/L to the 2.5 mmol/L steps on the Serial Addition and Delayed Non-Match to Sample 
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tasks after day 1 hypoglycemia, comparable differences were not found on the Stroop Arrow 
Word or Paragraph Recall tasks. These data indicated that glycemic thresholds for 
hypoglycemic cognitive dysfunction, unlike those for neuroendocrine responses to and symptoms 
of hypoglycemia, do not seem to shift to substantially lower plasma glucose concentrations after 
recent antecedent hypoglycemia in healthy humans 219. 
The exact site(s) and mechanism(s) responsible for hypoglycemia-associated autonomic failure 
are still not clear. In particular, it is unclear whether the mechanism(s) of counterregulatory 
failure act at multiple sites or one co-coordinating center within the brain, and what impact it has 
on symptomatic response and the magnitude of cognitive impairment. It is also yet unknown 
how these potential alterations in neuroendocrine, metabolic, symptomatic and cognitive 
responses may affect the sensation of fatigue and exercise performance in a setting where 
exercise is performed after antecedent exposure to hypoglycemia and/or performed without 
exogenous CHO supplementation. In the studies where either antecedent hypoglycemia 
resulted in reduced neuroendocrine and metabolic responses to subsequent, next-day 
endurance (90 min) exercise 102, or where antecedent exercise produced a blunting of these 
responses to next-day hypoglycemia, measurements of perceived exertion, exercise 
performance and cognitive function were not reported. 
1.5.4 Potential effects of prolonged exercise on cognitive functioning 
Measurement of cognitive function has been shown to be impaired during exposure to 
hypoglycemia 135, but a single episode of mild antecedent hypoglycemia (3.1 mmol/L) in healthy 
men can attenuate several aspects of cognitive dysfunction during subsequent hypoglycemi~ 18-
24 h later 158. 
An improvement in cognitive function (such as simple and choice reaction time tasks) have been 
reported when performed during or immediately after exercise lasting >20 min up to an hour 
66.80.81. It has been suggested that the effect of exercise (including duration and intensitY) on 
cognitive function follows an inverted U-shaped curve (termed the Inverted U-Hypothesis)-'with 
optimal arousal corresponding to an intermediate arousal level 46, which is as of yet not clearly 
defined. When arousal exceeds this "optimal" level, cognitive performance may decline. 
The improvement in cognitive functioning is suggested to be the result of an increa~e in 
metabolic load which induces an increase in arousal level that would improve cog~itive 
functioning 46.177. Other suggested mechanisms for the improvement in cognitive performan'ce is 
an increase cerebral blood flow, or neurotransmitter (catecholamines / endorphin) release, 
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although, the exact mechanism(s) supporting a functional link between these factors are still 
unknown 46. 
Results on the effect of prolonged (>1 h in duration) exercise on cognitive functioning are limited. 
During such exercise, cognitive functioning may be confounded by the development of fatigue 
symptoms, hypoglycemia and individual motivation (for review see 46). During prolonged 
exercise, apart from marked increases in metabolic load, symptoms of central (e.g. reduced 
neural drive) and peripheral (e.g. decreased muscle excitability) fatigue are also commonly 
reported 177, and it is yet unclear. what relationship exists between cognitive function, metabolic 
and hormonal responses, perceived exertion and endurance exercise performance. Muscle 
glycogen depletion and hypoglycemia have been related to the development of peripheral and 
central fatigue 52.76 and CHO ingestion has been shown to delay the onset of fatigue 52.76 and 
attenuate the perception of effort towards the latter stages of prolonged exercise 46.420. Except 
for one study 221, other studies have demonstrated that CHO ingestion during -2 h of cycli~g 352 
and running 61 performed at 60-75% V02 max may benefit cognitive functioning. Hence, CHO 
ingestion can minimize the negative effect of central fatigue induced by prolonged exercise 46, 
perhaps via and attenuation of free tryptophane concentrations and ultimately reduced serotonin 
release in the brain and reduced central fatigue 100, however, more research is needed to 
investigate the role of other central factors on cognitive performance 46. 
Grego et al. 177 recently demonstrated that P300 components were affected by prolonged 
exercise (3 h at -66% V02 max) in trained male cyclists. P300, a component of event-related 
brain potentials, has been related to neural activity underlying basic aspects of cognition 177. 
P300 amplitude has been related to the amount of memory and attentional resources empl!lyed 
in the processing capacity of a given task, whereas P300 latency relates to the spee:d of 
cognitive processing 177. In this study 177, exercise resulted in a progressive increase in FFA, 
heart rate and RPE (after 108 min), and glycerol, epinephrine and cortisol (after 144 min) and a 
significant decrease in blood glucose (after 108 min) and insulin (144 min). However, blood 
glucose remained above 4 mmol/L. The results showed a temporary increase in P300 amplitude 
between the 1st and the 2nd hour (an indication of an improvement in cognitive function)'and an 
increase in latency after the 2 h of exercise concomitant with some hormonal changes, incll,lding 
an increase in cortisol and epinephrine and a decrease in blood glucose (an indication of an 
alteration of information processing speed with fatigue). These findings suggest a combined 
effect of arousal and central fatigue on electrocortical indices of cognitive function during acute 
physical exercise 177. 
M.ost recently, Grego et al. 176 examined the influence of 3 h of cycling at 60% V02 max on simple 
and complex cognitive performance in 8 well-trained male subjects before, during, and 
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immediately after the exercise task. A significant improvement in speed of response' and a 
decrease in error number during the map recognition task were recorded between 80 min and 
120 min when compared with the first 20 min of exercise. After 120 min the number of recorded 
errors was significantly greater indicating a shift in the accuracy-speed trade-off. These re~ults 
provide some evidence for exercise-induced facilitation of cognitive function. However this 
positive effect disappears during prolonged exercise - as evidenced by an increase in errors 
during the complex task and an alteration in perceptual response (Le. the appearance of 
symptoms of central fatigue) 176. 
During prolonged exercise, apart from marked increases in metabolic load, symptoms of central 
(e.g. reduced neural drive) and peripheral (e.g. decreased muscle excitability) fatigue are also 
reported 176, and it yet unclear what relationship exists between cognitive function, metabolic and 
hormonal responses, perceived exertion and endurance exercise performance. In addition, it is 
not yet clear how cognitive function may be affected at the end of prolonged exercise and after 
prior recent exposure to hypoglycemia (which may alter neuro-endocrine and metabolic 
responses) in well-trained men. 
1.6 IN CONCLUSION 
When blood glucose concentrations decline, a series of counterregulatory responses are elicited 
in hierarchical fashion in order to restore euglycemia, mainly to preserve brain function 309. : 
Based on the involvement of the sympathetic centers and HPA-axis in aid of correcting declining 
blood glucose concentrations, it seems clear that the series of responses initiated are largely 
centrally mediated 385. There seems to be a component of redundancy in the gluco-regulatory 
mechanisms which may account for the discrepancy in results obtained from different studies 
where one component of the glucoregulatory system was altered or blocked, causing a variable 
response in the other systems. In addition, the central and peripheral integration of these neural, 
metabolic and hormonal counterregulatory responses are not yet fully understood. 
Muscle glycogen, blood-borne glucose (derived from endogenous and/or exogenous supply), 
and lipids (IMTG and FFA's) have been identified as the major substrates utilized for e'1ergy 
production during prolonged exercise 380. CHO oxidation during exercise is influenced pril1)arily 
by the exercise intensity, duration and CHO availability. An increase in exercise intenSity results 
in a shift in the balance of substrate utilization from fat to CHO, regardless of genotypiC or 
phenotypic adaptations 47. This is largely due to contraction-induced increases in muscle 
glycogenolysis and glycolysis 217 as well as increased sympathetic nervous system activity 120. 
Hence, sufficient CHO supply is paramount for sustaining muscle contraction during prolonged 
exercise at moderate- to high-intensities (>60% V02 max). 
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With increased glucose uptake by the contracting muscles, hepatic glycogenolysis and hepatic 
glucose output are activated, and the subsequent hormonal responses involve changes in the 
gluco-regulatory hormones such as a reduction in insulin, and an increase in glucagon, cortisol, 
growth hormone and catecholamines 457. More recently. IL-6 has also been identified as playing 
a role in glucose homeostasis 140 via its potential effects on increasing hepatic gluCose 
production 88 and increasing lipolysis and fatty acid mobilization 244,326,357,396,396,400,424 during 
exercise. Prolonged exercise and progressive glycogen depletion will result in more pronounced 
changes in glucose counterregulatory hormones 404. whilst CHO supplementation during such 
exercise has been shown to diminish these hormonal responses 44,160,275.277. Furthermore, 
metabolic and hormonal alterations elicited by preexercise CHO intake (short- or long-term):may 
bring about alterations in parts of the gluco-regulatory system (such as altered insulin. cortisol, 
catecholamines; altered hepatic glucose output, glycolysis. glycogenolysis). as well as alterations 
in the availability of alternative oxidative substrates (e.g. FFA) which may alter the fuel selection 
and relative contribution of substrate oxidation within the muscle 399, It is clear that factors such 
as the status of the endogenous CHO stores. substrate availability and exercise intensitY and 
duration play an important role in altering the neuro-humoral milieu. substrate selection: and 
oxidation and ultimately glucose homeostasis, The full extent of the interplay of these factors is 
not yet fully understood. 
Muscle glycogen depletion and hypoglycemia have been related to the development of 
peripheral and central fatigue 52,76,163 and CHO ingestion has been shown to delay the onset,of 
fatigue 52.76 and attenuate the perception of effort. increase CHO oxidation, and reduce plasma 
cortisol towards the latter stages of prolonged exercise 46,420. These findings support a 
physiological link between RPE and CHO substrate availability as well as selected hormonal 
regulation during prolonged exercise. 
Furthermore, the observation of a temporal association between increased RPE and red~ced 
cerebral glucose uptake and metabolism suggests that fatigue may be related to inadequate 
substrate availability for the brain 326. In addition, hypoglycemia has been shown to result in 
reduced CNS activation accompanied by a significantly lower force production 325, Hence, the 
ergogenic effect of CHO supplementation during prolonged exercise and prevention of 
hypoglycemia, may be related, in part. to the counteraction of central fatigue 325, 
Though a strong association between CHO (liver and muscle glycogen) depletion and fatigue 
development during prolonged submaximal exercise has been observed. the findings are not 
universal and the exact mechanisms regarding CHO regulation and its ergogenic potential are 
still not fully understood. For example. some studies demonstrated that the development of 
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hypoglycemia 87.146.228.230.312 had no effect on exercise performance. Furthermore, though ~rbo­
loading and CHO supplementation during exercise have been shown to be ergogenic (for review 
see 76), it is not always as a result of augmented blood glucose concentrations and/or rates of 
CHO oxidation compared to the placebo treatments (e.g. refs. 35.38,440,441). There seems to be an 
individual range in metabolic and hormonal responses, and that this ultimately has a variable 
impact on the individual's sensation of fatigue and endurance capacity. 
Factors that may contribute to individual alterations in the metabolic and hormonal milieu may 
include an adaptation of the HPA-axis to repeated and prolonged exercise-induced increases in 
cortisol secretion 125. In this regard, prolonged endurance training may introduce a resetting in 
the pituitary-adrenocortical component of the endocrine system, expressed either by intensified 
endocrine functions in some individuals or by suppressed endocrine functions in others 426. 
Furthermore, it has been demonstrated that repeated exposure to physiological stresses' that 
activates the HPA-axis (e.g. hypoglycemia or exercise) may result in a reduction in subsequent 
metabolic, hormonal, and symptomatic counterregulatory responses in diabetic 25.96,101,385 and 
healthy individuals 102,103,109.160,205. The exact mechanism(s) responsible for the reduced 
neuroendocrine and autonomic-adrenomedullary responses observed after repeated exposure to 
hypoglycemia (or related physiological stresses) are not known, and the impact of these 
responses on gluco-regulatory responses in healthy, trained athletes remain to be investigated, 
It seems clear that fatigue development during prolonged exercise may be the result of a more 
complex interaction between peripheral and central factors, at times difficult to measure directly 
with current research techniques. Though alterations in bodily CHO reserves and hormonal 
milieu (e,g. via dietary manipulation) can affect several metabolic responses and result:in a 
complex interplay between metabolic and hormonal responses, it is not always clear how this 
may ultimately affect fatjgue development or exercise performance. Further research is needed 
to clarify metabolic, hormonal and performance effects of various dietary and hormonal 
alterations, and to explore the individual variability in responses. 
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AIMS AND OBJECTIVES OF THIS THESIS 
The main aims of this thesis were to investigate the effect of altered endogenous glycogen 
availability, achieved primarily by pre-exercise dietary manipulation and antecedent exercise 
exposure, on inter-individual variability in metabolic and hormonal responses to dynamic, steady-
state exercise. Further, this thesis examined the impact of altered glucose availability (and the 
related metabolic and endocrine responses) on fatigue development during prolonged exercise. 
We hypothesized that endogenous CHO availability and the associated metabolic sequelae 
would impact on effort perception during exercise and fatigue development. We further 
hypothesized that prior fatiguing exercise and local muscle glycogen depletion would provide 
some neural and/or humoral signal, thereby altering resistance to fatigue. Finally we proposed 
that antecedent exposure to hypoglycemia will alter the counterregulatory responses (such as an 
alteration in HPA-axis (cortisol) response) during subsequent (next-day) prolonged exercise, and 




THE EFFECT OF ALTERING THE GLYCEMIC INDEX OF THE PRE~ 
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2.1 INTRODUCTION 
CHO supplementation immediately before and during prolonged exercise have been identified as 
strategies that can increase CHO availability during prolonged exercise with potential 
performance-enhancing benefits 188.240.292. Though preexercise CHO ingestion can he~p to 
optimize liver and muscle glycogen, this strategy has raised some concerns, particularly related 
to CHO consumed during the hour prior to eXercise as it may result in hyperglycemia and 
hyperinsulinemia, and a potential fall in glucose (rebound hypoglycemia) during exercise 
3.87.152.280.288. Other potential consequences of relative hyperinsulinemia include a reduction in the 
rate of fat oxidation 171 and an increase in CHO oxidation 171, which in turn may lead to increased 
muscle glycogen oxidation 90. 
In examining the studies which have measured performance after CHO ingestion in the hour 
prior to exercise, only one study reported a decrement in endurance performance when subjects 
consumed glucose 30 min before exercise 152. The results of this study were widely public,ized, 
leading to recommendations that athletes should avoid pre-exercise CHO intake, for fear of 
rebound hypoglycemia shortly after the onset of exercise, and premature depletion of glycOgen 
stores during exercise. These fears have persisted despite the subsequent publication of 
several studies that observed no significant effect 145.186.389.439 or an improvement in performance 
during prolonged, moderate intensity exercise with preexercise CHO ingestion 171,251,330,376. 
The diversity in results are likely due to differences in the quantity of CHO ingested, andl.or to 
rate of digestion and oxidation of the ingested meal, which will in turn alter glucose and insulin 
responses, These metabolic disturbances may be attenuated by choosing CHO sources, which 
produce a minimal glycemic-insulinemic response 195, 
The glycemic index (GI) is determined by the rate at which an ingested carbohydrate is made 
available to intestinal enzymes for digestion and absorption and has been utilized as a system to 
rank CHO-rich foods according to their glucose- and insulin responses 226. It has been 
suggested that the manipulation of the GI of meals may have application in the area of 'sports 
nutrition to manipulate metabolic and hormonal responses, thereby optimizing CHO availability 
particularly during prolonged moderate-intensity exercise. However, results of .stl:ldies 
investigating the effect of varying the GI of the pre-exercise meal on exercise metabolism, and 
performance have yielded inconsistent results. 
Thomas et al. 408 were the first to study the role of the GI of different CHO-containing foods and 
their effects on metabolism and exercise performance, They reported that the ingestion of a low 
GI CHO-rich meal (lentils), 1 h prior to exercise increased the time to exhaustion during the 
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cycling trial at 67% of maximal oxygen consumption (V02 max), compared with the ingestion of an 
equal amount of CHO eaten in the form of a high GI CHO-rich food (potatoes). These 'findings 
were attributed to lower glycemic and insulinemic responses combined with increased FFA 
availability and fat oxidation with the low GI trial compared with the other CHO feedings 408. 
These findings have been widely publicized and have resulted in popular advice that athletes 
should choose pre-exercise meals based on low GI CHO-rich foods and drinks 408. 
In contrast, a subsequent study by Febbraio and Stewart 145 reported no differences in the 
performance of a cycle time-trial conducted after 2 h of cycling at 70% V02 max, when preexercise 
meals eaten 45 min before the bout consisted of either a low GI CHO (lentils), high GI CHO 
(potatoes) or placebo (diet jelly). They reported no difference in total CHO oxidation between the 
two CHO treatments, and similar muscle glycogen utilization in all three trials. These finding~ are 
more consistent with the view that glycemic differences at the onset of exercise are short-lived 
and of little practical significance 195. It should be noted though that the lentil and potato meals 
used in the studies of Thomas et al. 408 and Febbraio and Stewart 145 were not equivalent in 
macronutrient (protein) composition, nor were they isocaloric 409. Hence, it is not known what the 
contribution of the protein per se was to the insulinemic, glycemic and other metabolic responses 
seen after ingestion of the lentil meal. 
Subsequent studies found that the ingestion of a low GI, isocaloric pre-exercise meal reduced 
CHO oxidation 141,389,409,439 whilst others found no difference in CHO oxidation 145,210,251 or rate of 
muscle glycogenolysis 141,251 compared to a high GI pre-exercise meal. Whilst some of t~ese 
studies reported an improvement in exercise performance (time to exhaustion) when the GI of 
the pre-exercise meal was lowered 117,249,251,408, others found no effect on exercise performance 
when employing time to complete a set amount of work to assess performance 141,145,389,409,439. 
The latter measure of performance is more representative of real-life racing conditions (where 
there is a defined end-point) as well as being a more reliable and reproducible measure of 
performance 232,301. 
Another nutritional strategy commonly employed by endurance athletes is to ingest CHO during 
the endurance exercise bout or competition. Though the interaction between preexercise CHO 
intake combined with CHO ingestion during endurance exercise has received some attention 454, 
little is known about the interaction between varying the GI preexercise CHO meal combined with 
CHO ingestion during exercise. Therefore, the purpose of this investigation was to e"xamine 
whether the GI of pre-exercise CHO intake has any impact on exercise metabolism: and 
subsequent performance when sufficient amounts of CHO are consumed during the exercise 
session. The conditions of the study were chosen to be representative of competitive sport (Le. 
performance was measured with a defined end-point time-trial as opposed to being open-ended), 
67 
as well as being representative of sport nutrition guidelines for optimal pre- and during exercise 
feeding. We hypothesized that a low GI preexercise meal would reduce postprandial 
hypoglycemia and hyperinsulinemia compared to a high GI meal, but when combined with the 
ingestion of relatively large amounts of CHO during exercise, will have no further impact on 
exercise metabolism and performance. 
2.2 METHODS 
2.2.1 Subjects 
Six healthy, endurance-trained male cyclists (23±6 yr, 72±10 kg, 67±9 ml/kg/min) volunteered to 
participate in this investigation, which was approved by the Research and Ethics Committ~e of 
the Faculty of Health Sciences of the University of Cape Town (South Africa). All subjects ~ere 
racing competitively and were included on the basis of completing a local 105 km cycle raCe in 
under 3 h. Because tracer amounts of [U-14C]glucose were ingested and blood samples were 
taken, the risks were carefully explained to the subjects before their written consent was 
obtained. The total radiation dose received by each subject was -20 mrem. The radiation dose 
accepted as safe in South Africa is 500 mrem/yr or 130 mrem/13 wk 35. 
2.2.2 Preliminary testing 
2.2.2. 1 Peak power output (WpeaJ and maximal oxygen consumption (V02 maJ 
One to 2 weeks prior to the start of the study, subjects were tested for maximal oxygen uptake 
(V02 max) and peak sustained power output (Wpeak) 210 on an electronically braked ~ycle 
ergometer (Lode, Groningen, The Netherlands) modified with clip-on pedals and raCing handle 
bars. After a -15 min warm-up period, the Wpeak test was started at a workload equivalent. to 3.3 
Watts/kg BM and increased first by 50 Watts (W) after 150 sec and then by 25 W every 150 sec 
until the pedaling frequency dropped below 50 revolutions/min. Wpeak was defined as the highest 
exercise intensity the subject completed for 150 sec in W, plus the fraction of time spent in the 
final workload multiplied by 25 W. This information was used to adjust the intensity and work 
rate in the experimental trials so that each subject performed at 70% of V02 max' 
Throughout the maximal test, subjects wore a face mask attached to an Oxycon Alpha 
automated gas analyzer (Jaeger, The Netherlands). Before each test the gas analyzer. was 
calibrated using a Hans Rudolf 5530 3-litre syringe and a 5% CO2:95% N2 gas mixture. Ana!yzer 
outputs were processed by a computer which calculated minute ventilation (Vi), oxYgen 
consumption (V02) and rates of carbon dioxide production (VC02) using conventional equations. 
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2.2.3 Experimental design 
Each subject undertook three trials, separated by 7 days, in a randomized, counter-balanced 
order. On each occasion one of the following test meals was ingested 2 h before cycling at:70% 
of V02 max; a high GI CHO-rich meal (HGI) of instant mashed potato (GI=87, where glucose = 
100, ref. 151), a low GI CHO-rich meal (LGI) of lightly cooked pasta (GI=37, ref. 151), or a control 
meal (CON) consisting of low-energy jelly. The CHO-rich meals provided 2 g CHO/kg 8M, and 
the water content of all meal was standardized so that each provided - 1100 ml of fluid (Table 
2.1 ). 
Table 2.1. Characteristics of the pre-exercise meals 
Meal Description 
HGI meal 130 g dried potato mix 
+ 250 ml skim milk 
+ 625 ml hot water 
+ 240 g tomato-based pasta sauce 
Total fluid: 1070 ml 
Energy 
2730 kJ 
LGI meal 165 g dry pasta cooked in water 2770 kJ 
+ 250 g tomato based pasta sauce 
+ 500 ml water as drink 
Total fluid: 1068 ml 
CON meal 1 packet low energy jelly 
+ 500 ml water 
+ 570 ml water as drink 
Total fluid: 1070 ml 
These meals are designed for a 70 kg subject. 
135 kJ 
Nutrient analysis 
CHO Protein Fat 
143 g 23 g 1.5g . 
139 g 23 g 2g 
1 g 7g o g. 
Food intake and training were standardized for the 24 h before each trial. Subjects were 
provided with guidelines for CHO-rich meals and were requested to record their dietary intake on 
the day before the first trial. Identical food was consumed before the subsequent trials,. with 
dietary records being continued to check compliance. Additionally, subjects were aske:d to 
abstain from alcohol, caffeine and strenuous exercise for at least 24 h before each trial. On the 
morning of an experiment, subjects reported to the laboratory in an overnight fasted state, and 
their food and training diaries were examined to ensure that all instructions had been followed. 
Thereafter a flexible 18-gauge catheter was inserted into a forearm vein and attached to a 3-way 
stopcock for the sampling of blood. The catheter was kept patent throughout the experiment with 
periodic injection of heparinized saline. 
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2.2.3. 1 Pre-exercise dietary intake 
After a fasting blood sample was taken, the subjects were given 15 min to consume their test 
meal and rested for 2 h. Fifteen min before exercise, the subjects consumed 4 ml/kg BM of.a 10 
g/100 ml [U-14CJglucose solution (Amersham International, Buckinghamshire, UK) with a sp~cific 
radio-activity of 0.17 ~Ci/g (6.3 kBq/g). The [U-14CJglucose label was added to the drink so that 
the rates of ingested glucose oxidation could be calculated. A total of 3.3 ml/kg BM of the 
labeled drink was ingested every 20 min during the steady-state cycle, for a total of 24 ml/kg BM 
each trial (2.4 g of CHO/kg BM). 
2.2.3.2 Exercise protocol 
Immediately before the start of exercise, subjects voided, were weig hed, and the cycle ergometer 
was set up to suit their preferred cycling position. Exactly 2 h postprandially the subjects started 
their steady-state ride at -70% of V02 max (245±18 W). The steady-state ride was performed to 
allow for metabolic data to be collected at steady state, and at an intensity that is representative 
o~ race-pace (moderate-high intensity). As part of the 2 h cycle, a warm-up period was alloWed; 
exercise started at 100 W for 5 min, after which the workload was increased by 50 W 160 sec until 
the final workload was attained. During the trials, the subjects were cooled with an electric fan, 
while the laboratory was maintained at a constant temperature (-20°C) and relative humidity 
(-55%). On completion of the 2 h steady-state ride, the subjects were given 1 min to rest before 
they started the performance ride, which consisted of the time to complete 300 kJ (time~trial, 
IT). During the time-trial, subjects were kept blind to time; the only feedback given was the 
completion of each 50 kJ of work. After subjects had completed 275 kJ they received information 
about each successive 5 kJ until the end of the ride. No performance results were provided to 
any subject until the completion of the entire study. 
2.,2.3.3 Blood sampling and analysis 
A fasting blood sample was collected before ingestion of the experimental meal where after 
blood sampling was undertaken 30, 60, 90 and 120 min postprandially. During the steady-state 
ride, blood was sampled at successive 20 min intervals, commencing after 20 min of the start of 
the ride. Approximately 6 ml of blood was drawn at each sampling of which 2 ml was placed in a 
tU.be containing potassium oxalate and sodium fluoride for the later analysis of plasma gluCose 
concentrations. The remaining 4 ml was placed in a tube containing gel and clot activator and 
allowed to clot for 15 min at room temperature for the later analyses of serum insulin arid FFA 
concentrations. All samples were kept on ice during the duration of the trial before the plasma 
and serum were separated by centrifugation (2,000 rev/min) at 4 °C and stored at -18 °C.until 
subsequent analyses. Plasma glucose concentrations were determined by the glucose oxi~ase 
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method (Glucose Analyzer 2, Beckman Instruments, Fullerton, CA, USA). Serum insulin 
concentrations were determined by the use of a commercially available radio-immunoassay kit 
(Count-A-Coat Insulin, Diagnostic Products Corporation, CA, USA). Serum total FFA 
concentrations were determined by an enzymatic colorimetric assay (Half-micro test, Boehringer 
Mannheim, Germany). 
2.2.3.4 V021 VC02 and 14C02 measurements 
Immediately after each blood sample was taken during the steady-state ride, gas exchange (V02, 
VC02) was measured for 5 min. In addition CO2 was trapped by passing a sample of expired air, 
collected in a ambulatory bag, through a solution containing 1 ml of 1 N hyamlne hydroxide in 
methanol (United Technologies, Packard, III., USA), 1 ml of 96% ethanol (SAARCHEM, 
Krugersdorp, RSA) and 2-3 drops of phenolphthalein (SAARCHEM). The expired air was 
bubbled through the trapping mixture until the solution became clear, at which point exactly 1 
mmol of CO2 had been absorbed. Liquid scintillation cocktail (Ready Gel, Beckman Instruments 
Inc., Fullerton, USA) was added, and 14C02 radioactivity in dpm was counted In an Insorb 460C 
Automatic Liquid Scintillation Counter (United Technologies, Packard, 111., USA). 
2.2.3.5 Calculation of total and ingested drink carbohydrate oxidation 
Instantaneous rates of CHO oxidation during exercise were calculated (g/min) using the formulae 
of Frayn 153, assuming a nonprotein respiratory exchange ratio, assuming no increase in basal 
amino acid and protein degradation during exercise: 
Total CHO oxidation = 4.55 VC02 - 3.21 V02 
Where VC02 is the volume of CO2 in the expired air in Llmin; and V02 is the corresponding 
oxygen uptake in Llmin. 
Total CHO oxidation during the 120 min of steady-state exercise was estimated from the 'area 
under the CHO oxidation versus time curve for each subject. The rates of ingested CHO 
oxidation were calculated from the following equation: 
Glucoseox = {14C02 x 6/[(SAcHoICHOo) x 180]} x VC02 x 1.35 
where glucoseox is the amount of ingested CHO oxidized in g/min ; 14C02 x 6 is the 1~C02 
dpm/mmol value multiplied by 6 as there are 6 carbon atoms per molecule of 14C glucose tracer 
added to the ingested solution; SAcHO is the specific activity of the ingested solution in dpmlml; 
CHOo is the CHO content of the drink in gIL; 180 is the molecular mass of glucose; VC02 is the 
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volume expired CO2 in Umin; and 1.35 is the number of grams of glucose oxidized to produce 1 
L of CO2• 
2.2.3.6 Rating of perceived exertion 
During all three trials subjective ratings of perceived exertion (RPE) were obtained using the 
modified Borg scale 30. At the end of the study subjects were asked by questionnaire which of 
the pre-exercise meals provided their best performance and which they would choose to 
consume before a competition. 
2.2.4 Statistical analyses 
The statistical software package STATISTICA 7.0 (2004; StatSoft, Inc., Tulsa, OK, USA), was 
used for the statistical analysis of the data. GraphPad PRISM software package, version 3.0 for 
Windows (GraphPad Software, San Diego, CA, USA) were used to calculate area under the 
curve. Data are presented as mean±SD, unless where otherwise indicated. Data from the three 
trials were compared using a two-factor (diet and time) analysis of variance (AN OVA) with 
repeated measures. Simple main effects analyses and Scheffe's post-hoc tests were undertaken 
when ANOVA revealed a significant interaction. CHO oxidation over the 2 h of steady-state 
exercise, and time trial performances were compared using one-way ANOVA with Scheffe's 
post-hoc tests. Significance was accepted when p<0.05. All data are reported as mean ± SD. 
2.3 RESULTS 
Records kept by each subject during the 24 h before each trial indicated compliance to the 
standardized preparation protocol; reported CHO intake on the day before the three trials was 
479±125 g, 465±151 g, 460±127 g for the HGI, LGI and CON trial respectively (NS), and all 
subjects refrained from exercise during that day. 
2.,3.1 Plasma glucose, serum Insulin and FFA concentrations 
Figure 2.1 shows plasma glucose, serum insulin and serum FFA concentrations for the 2 h 
period following ingestion of each test meal and for the subsequent 120 min of steady-state 
exercise. There was a significant interaction of diet and time for all parameters (p<0.05). At 30 
min after ingestion of the HGI meal, plasma glucose concentrations were significantly incre~sed 
above fasting values (p<0.05) (Figure 2.1 A). At this timepoint, plasma glucose concentrations 
were greater in both HGI and LGI trials (7.9±1.5 and 6.6±1.2 mmol/L) compared to the CON trial 
(4.4±0.6 mmoIlL). Thereafter, plasma glucose concentrations declined and were back to 
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baseline levels by 60 min (-5.0-5.5 mmol/L) after each of the CHO meals. Plasma glucose 
concentrations did not fall below baseline values in any of the trials, and were maintained .>5.0 
mmol/L throughout the study period. Plasma glucose concentrations rose slightly with the 
ingestion of the CHO drink (starting 15 min before the start of exercise) and at the onset of 
exercise, and remained at euglycemic levels (5.0-6.0 mmol/L) throughout the steady-state ride in 
all trials. Plasma glucose concentrations during exercise were similar between trials (Figure 
2.1A). 
The serum insulin response after ingestion of the HGI meal was significantly greater (p<O.05) 
during the 2 h postprandial period compared to that after the LGI meal (Figure 2.1 B). Serum 
insulin concentrations at 30 min were higher in the HGI trial than in the LGI trial (74.1±24.2 vs. 
43.9±21.4 ~U/ml), and remained elevated above those in the LGI trial at 60 and 90 min. Serum 
insulin concentrations remained at fasting values «10 ~U/ml) in the CON trial until 90.min; 
however at 120 min there was an increase in insulin concentrations in response to the inge~tion 
of the glucose drink 15 min before the start of exercise. In the LGI trial, serum insulin 
concentration peaked at 30 min after the meal and then declined thereafter, with the feeding of 
the bolus of the glucose drink causing a small rise. During the bout of steady state exercise, 
despite the intake of significant amounts of CHO, serum insulin fell to fasting concentrations in all 
trials. Insulin concentrations in the HGI trial were still elevated above those in the CON trial at 20 
min of exercise; thereafter there were no differences in the serum insulin concentrations during 
exercise between any of the trials. 
Both the CHO meals suppressed serum FF A concentrations to <0.1 mmol/L, which persisted 
until· the start of the exercise (Figure 2.1 C). During the CON trial, FF A concentrations were 
maintained at fasting levels throughout the pre-exercise phase. However, intake of CHO drink at 
the onset of exercise caused a small drop in FFA concentration after 20 min of exercise. During 
exercise, despite ingestion of the CHO drink, serum FFA concentrations gradually increased in 
all three trials so that concentrations during the last 60 min of exercise were significantly greater 
(-0.25 mmol/L) than at the start of exercise (p<0.05). 
2.3.2 Substrate oxidation 
Metabolic data from 120 min of steady-state exercise are presented in Fig 2.2. There was no 
significant interaction of diet and time for RER (Figure 2.2A), total CHO oxidation (Figure 2.2B) 
and ,oxidation of the ingested CHO drink (Figure 2.2C). The decline in RER over the120 min of 
steady-state exercise was not significant. Oxidation of CHO from the glucose drink increased 
throughout the 120 min of exercise from -0.3 g/min after 20 min to -0.8 g/min at 120 min In all 
three trials. At 20 min, oxidation of the ingested CHO drink was significantly lower in the LGI trial 
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than in CON (p<0.05); however, there were no differences at any of the other timepoints. Overall 
the drink provided -16% of total CHO oxidation for the 120 minutes of exercise, and was similar 
for all trials (Figure 2.3). Total CHO oxidation was -380 g during the 120 min of steady-state 
exercise and did not differ between trials. 
2.3.3 Exercise performance and perceived exertion 
Performance during the IT undertaken at the end of the 120 min of steady-state exercise did not 
differ between trials. Time to complete 300 kJ was 947±56; 953±85; and 970±63 sec for HGI, 
LGI and CON, respectively. 
Subjects' rating of perceived exertion (RPE) rose steadily throughout the steady-state cycle and 
did not differ between trials. 
The results of the questionnaire showed that 3 subjects felt they performed best on the LGI meal, 
whereas 2 chose the HGI meal and 1 the control meal. All subjects reported that, from f:he 3 
study meal selections, the LGI meal would be their preferred choice of meal before an important 
competition I race event. Furthermore, the pre- and during exercise feeding schedules were 
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Figure 2.1 Plasma glucose (2.1A). serum insulin (2.18) and serum free fatty acid (2.1C) concentrations 
for the 2 h period postprandial and during the 2 h of steady-state exercise *Different from CON; # different 
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Figure 2.2 Respiratory exchange ratio (RER) (A). total carbohydrate (CHO) oxidation (8) and ingested 
CHO oxidation (C) during the 2 h steady-state exercise. *Significantly different from CON; a different from 
the start of exercise for HGI; b different from start of exercise for HGI, LGI and CON; C different from start of exercise 




E 400 o 












HGI LGI CON 
Figure 2.3 Total carbohydrate (CHO) oxidation and ingested CHO oxidation during 2 h of steady-state 
exercise calculated from area under oxidation curves (Values are mean±SD of 6 subjects). NS. 
2.4 DISCUSSION 
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The main finding of the present study was that the ingestion of CHO during exercise in amounts 
supported by current sports nutrition guidelines 321.84.196, minimizes the postprandial metabolic 
responses elicited by preexercise CHO meals of variable GI. Furthermore, with CHO ingestion 
during exercise, varying the GI of the preexercise CHO meal has no effect on endurance cycling 
performance. 
This study was carried out in view of the historical controversy regarding CHO intake before 
prolonged submaximal exercise. There has been considerable focus on the metabolic 
disturbances caused by the rise in insulin concentration which accompanies pre-exercise CHO 
intake 152.171,187,260. Elevations in plasma insulin have been shown to suppress lipolysis during 
subsequent exercise 211; and increase CHO oxidation resulting in a decrease in plasma giucose 
and/or an accelerated rate of muscle glycogen utilization. Indeed, Foster et al. 152 reported 
impaired cycle time to exhaustion at 80% of V02 max when 75 g of glucose was fed 30 min before 
exercise, and based on these findings athletes were advised to avoid CHO intake during the,hour 
before endurance exercise. These recommendations have persisted despite evidence from 
several more recent studies that CHO intake during the hour before exercise enhances .. or at 
least fails to affect endurance exercise performance (for reviews see 188,195). 
The recent application of the GI to sports nutrition 384 has revived the debate regarding metabolic 
perturbations associated with pre-exercise CHO intake. Thomas et al. 408 were the firSt to 
propose that consumption of a low GI preexercise meal as a practical means of avoiding the 
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potential negative effects of a hyperglycemic-insulinemic postprandial response. In their study, 
exercise time to fatigue was improved when subjects consumed 1 g of CHO/kg 8M from a low GI 
food (lentils), 1 h before cycling at 67% of V02 max, compared with an equal amount of CHQ eaten 
as a high GI food (potatoes). This benefit was attributed to lower glycemic and insulinemic 
responses to the low GI meal compared with the high GI meal, maintaining blood gluCose 
concentrations during exercise. increasing FFA concentrations and reducing exercise RER 
values. 
Although this study 408 has led to widespread advice that endurance athletes should choose, pre-
exercise meals based on low GI CHO-rich foods and drinks 43, others investigations have fi=liled 
to demonstrate that metabolic alterations translate into performance effects when employing time 
to complete a set amount of work to assess endurance cycling 141,145,389,409 or running 
performance 439. 
A second study conducted by the Thomas et al. group 97 utilized the same pre-feeding' and 
exercise protocol; on this occasion the test meals consisted of isocaloric low GI and a high GI 
powdered food, and a low GI and a high GI breakfast cereal. They reported a correlation 
between the meal GI and the subsequent depression of blood glucose and FFA concentrations 
during exercise in that low GI meals were associated with higher glucose and FFA 
concentrations after 90 min than the high GI meals. Thus, low GI meals appeared to provide a 
sustained source of CHO throughout the exercise bout and later during recovery 97. Ho~ever 
there were no differences in exercise time to exhaustion between trials. and no correlation 
between exercise time and the GI of the meal 97. It should be noted that the measurement of 
performance used in both the Thomas et al. studies (exercise time to exhaustion at a fixed 
submaxlmal work rate) has a high (-25%) coefficient of variation 232,30\ which increases the 
possibility of Type 2 error. 
Subsequent to that study, Febbraio and Stewart 145 found no differences in the performance of a 
time-trial conducted after 2 h of cycling at 70% V02 max, when pre-exercise meals consisted of 
either a low GI CHO-rich food (lentils). high GI CHO-rich (potatoes) or a placebo (low-energy 
jelly). The meals were eaten 45 min before exercise and in the case of the CHO meals, 
provided an intake of 1 g of CHO/kg 8M. Data from Febbraio and Stewart 145 and others showed 
no differences in total CHO oxidation 145,210,251 between the two CHO treatments. and similar 
muscle glycogen utilization in all trials 145.251. These findings are consistent with the view that 
glycemic differences at the onset of exercise are short-lived and unimportant for the performance 
of most athletes 409.141.145,389,43srhe advantage of the exercise protocol employed by Febbraio and 
Stewart 145 is that it provides a more sports-specific and reliable measurement of perform~nce 
· 78 
232, preceded by a period of steady-state exercise during which comparison of the meta'bolic 
responses to treatments can be made. 
In agreement with other studies, we found that the ingestion of a high GI CHO-rich meal 
produced a greater postprandial glycemic and insulinemic response compared with a low GI 
CHO-rich meal 141.145,249,389,406,409. The rise in insulin concentration following both CHO-rich meals 
resulted in a suppression of FFA concentrations in the 2 hrs postprandially. The most effective 
and common strategy used by endurance athletes to promote CHO availability during exercise is 
to ingest CHO-rich drinks or foods during the event. CHO ingestion during exercise is important 
for endurance performance because it maintains euglycemia and high rates of CHO oxidation 
when endogenous CHO stores have become limited 76. The data from the present study 
demonstrated that despite alterations in insulin and FFA concentrations induced by the 
preexercise high and low GI meals, CHO ingestion during exercise minimized any potential 
differences in either circulating blood metabolites or substrate oxidation during the 2 h bout of 
exercise. These findings are consistent with the view that glycemic differences at the onset of 
exercise are short-lived and unimportant for the performance of most athletes 141,145,389,409.439 •• 
Though the large standard deviation (SD) values for the glucose and insulin responses in the 2 h 
postprandial period suggest an inter-individual range in metabolic responses, there was no 
evidence of rebound hypoglycemia in any of the subjects, as is typically seen with the pre-
exer~ise intake of glucose 69,114,152.166,167,260, or medium and high GI CHO-rich foods 210.211,389.406. 
Blood glucose concentrations were maintained >4 mmol/L throughout the 2-h postprandial period 
(at rest) and throughout exercise in all trials, likely due to the combined effects of CHO ingestion 
2 h prior to exercise combined with ingestion of the CHO drink 15 min before, and at 20-min 
intervals during exercise. Furthermore, CHO oxidation rates were maintained throughout the 
exercise bout without any differences between trials or over 2 h exercise period. The tracer-
determined rates of ingested CHO oxidation were similar to those reported in other studies which 
have used a pre-exercise bolus feeding and serial feedings throughout exercise (for review, see 
19~). Irrespective of the choice of the pre-exercise meal, the ingested CHO drink contributed -60 
g, or -16% of the total CHO oxidized. Given similar patterns of substrate utilization and 
availability during exercise between the three trials, it was not surprising to find similar 
performances during the timed performance rides, which followed the steady-state exercise. 
Wright et al. 454 examined the interaction of CHO intake before and during exercise. They f~und 
that compared with no CHO intake at all, cycling time to exhaustion and total work output at 70% 
of V02 max were improved by the ingestion of 5 g of CHO/kg BM 3 h before exercise, or by. intake 
of 2.6 g of CHO/kg BM in serial feedings during the trial. Enhancement of the performance 
measures was -18% and 33% (p<0.05) for the pre-exercise CHO and during-exercise CHO 
• 
79 
intake, respectively. When undertaken together, the two strategies improved performance 'by -
45%. While this suggests that the combination of CHO intake strategies was superior to either of 
the feeding strategies alone, performances during the combined trial were not significantly 
different to the pre-exercise CHO trial or the during-exercise CHO trial 454. Similarly, "in the 
current investigation, while there was no significant difference in cycling time between trials, 5 of 
the 6 subjects achieved their best performance with a combination of CHO before exercise {HGI 
or LGI trial) and CHO intake during exercise, compared with the CON trial (CHO intake d~ring 
exercise alone). 
Although most subjects were able to correctly identify which trial had produced their best 
performance, they stated that they would not necessarily choose this meal if they were to 
compete in an important competitive event. The most popular preexercise meal selected" was 
pasta (LGI meal), as it was rated as the most palatable and familiar choice of food. Clearly, 
practical and personal preferences are important in determining the athlete's choice of pre-event 
meal. 
An important consideration in the interpretation and practical implication of the findings from this 
study is that the subjects consumed the preexercise CHO meals 2 h prior to the start of exercise, 
cc;>mbined with optimal CHO intake during exercise in terms of amount (-170 g/120 min or -1.4 g 
CHO/min) and timing (a loading bolus 15 min preexercise and at 20 min intervals throughout 
exercise). This feeding strategy maintained plasma glucose concentrations during exercise, 
negated preexercise metabolic perturbations due to HGI and LGI CHO intake, and resulted in 
similar performance effects. Furthermore, all subjects reported that for an important competition 
they would choose to eat a preexercise meal that was most familiar. Hence, in practical t~rms 
and contrary to popular advice that low GI CHO-rich foods are the preferred pre-exercise choice 
43, athletes may be advised that in the light of an optimal CHO feeding strategy during ex~rcise, 
the choice of the preexercise CHO-rich meal may be of HGI or LGI, depending on their personal 
preference and previous experience. 
In conclusion, this study demonstrated that the ingestion of sufficient amounts of CHO during 
prolonged moderate-intensity exercise according to current sports nutrition guidelines minimizes 




EFFECTS OF ANTECEDENT FATIGUING EXERCISE ON SUBSTRATE 
METABOLISM, EFFORT PERCEPTION AND EXERCISE 
PERFORMANCE DURING SINGLE-LIMB EXERCISE 
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3.1 INTRODUCTION 
In the previous chapter, we examined the effects of CHO ingestion, prior to and during exercise 
on substrate oxidation, and specifically, exercise performance. Despite differences in the 
endocrine response to high or low glycemic index preexercise meals, the provision of exogenous 
CHO throughout exercise negated any specific effects of the differences in glycemic index. In 
the present study, we examined the effect of local muscle glycogen depletion following single-leg 
exercise to exhaustion. 
Previous studies have attempted to determine the factors affecting rating of perceived exertion 
(RPE) and fatigue development during dynamic submaximal, steady-state exercise. No single 
mechanism has been identified, and in fact, evidence suggests that multiple factors may be 
involved (for review see ref. 148). Despite this, fatigue during submaximal steady-state exercise 
has commonly been attributed to reduced CHO availability during exercise, specifically muscle 
glycogen depletion and/or development of hypoglycemia (for review see refs. 220,240). 
A strong relationship between musde glycogen depletion and the onset of fatigue have been 
documented in the literature 148,240. Furthermore, an interesting observation from the literature is 
that the typical level of muscle glycogen below which fatigue usually sets in, is -40 mmollkg wet 
weight (w.w.). It has long been believed that the main association between fatigue and glycogen 
depletion is the reduction in available fuel to sustain muscle contraction. Yet, ATP (fuel) 
depletion at the point of fatigue during dynamic exercise has not been demonstrated, in fact, 
minimal ATP depletion in the light of substantially depleted musde glycogen and creatine 
phosphate stores has been reported 432. Another suggested mechanism for the link between 
reduced glycogen concentrations and fatigue may be the concomitant increase in metabolites 
such as inorganic phosphate (Pi), which is known to have an inhibitory effect on both Ca2+ 
release from the SR 159,241 as well as the contractile apparatus 148. It has also been hypothesized 
by Barnes et al. 12 that the glycogen concentration per S9 exerts a protective action on excitation-
contraction coupling 12,403. These factors may explain the development of fatigue . under 
conditions where blood glucose availability and CHO oxidation are maintained. However, studies 
in support of these suggestions in intact human muscle are lacking. 
More recently, other causes of fatigue have also been hypotheSized such as the circulation of 
humoral substances that may act as afferent signal(s) to the brain, which may in turn reduce 
central nervous system activation and ultimately reduce force output 148,322, 
The use of the single-limb exercise model provides a potential means to investigate the role of 
local muscle glycogen depletion and/or production of a Circulating humoral response in fatigue 
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development during dynamic steady-state exercise under physiological conditions. Previous 
single-limb steady-state exercise models have documented the effects of single-limb exercise on 
resting muscle metabolism and substrate dynamics 5; compared single-limb exercise responses 
to that of two-legged exercise 314; or compared responses between a trained and untrained limb 
367. No previously published study has to our knowledge considered single-limb exercise to 
exhaustion performed in sequential manner, to assess the impact of the previous exercise .'bout 
and the concomitant physiological changes on the exercise performance of the second, 
previously rested limb. 
A study from this laboratory (Bosch et aI., unpublished observations) employed a single:-limb 
exercise model to assess whether dynamic exercise to exhaustion with one limb (and pa~sive 
rotation of the opposite limb) and the consequent metabolic responses affected the exercise time 
to fatigue during a similar exercise task in the previously rested, second limb. This study design 
allowed assessment of the impact of lowered local muscle glycogen concentration reached at 
exh~ustion with the first exercising limb, on exercise capacity of the second limb. The main 
finding was that exercise time to fatigue was significantly longer with the first leg compared to the 
second. Muscle biopsies (performed at the point of exhaustion for each limb) revealed: that 
exhaustion was reached at similarly low muscle glycogen concentrations (-40 mmol/kg w.w.), 
and it was concluded that fatigue was related to muscle glycogen depletion. However, EMG 
recordings revealed partial recruitment in the passively revolving leg i.e. it was not completely 
inactive. Hence, one possible explanation for the results is that there was increased muscle 
glycogen utilization in the "passively" revolving leg. Another possible explanation may be the 
release of a humoral substance during exercise with the first limb, Circulating throughout the body 
and perhaps causing increased glycogen depletion in the inactive muscle. This suggestion is 
supported by evidence from Ahlborg et al. 5 indicating that several metabolic alteration's take 
place in the non-exercising muscle during submaximal low intenSity arm or single-leg exercise 
such as an increase in blood flow and oxygen uptake, partly as a consequence of motor 
activation; and a shift in substrate utilization from predominant FFA uptake in the basal state to a 
greater utilization of CHO. 
Based on the findings of the investigation by Bosch and colleagues (unpublished data) and 
Ahlborg et al. 5, the aim of this study was to further explore the impact of local muscle glycogen 
depletion on fatigue development and perceived exertion. Furthermore, to assess whethe'r the 
local muscle glycogen depletion and metabolic responses in consequence to exercise witf.l the 
first leg (and "seen" by the whole body) set up events that predisposes the second limb to fatigue 
prematurely. A single-limb, open-looped exercise protocol, where one leg cycles at· a set 
intensity to fatigue, followed by exercise to exhaustion of the second, previously rested legwould 
be u'sed. This model allows the opportunity to assess, within a physiological milieu, what ~ffect 
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the metabolic responses elicited during exercise with the first leg (and circulating througho~t the 
whole body) have on RPE, and exercise capacity of the second, previously rested leg. We 
hypothesized that exercise and concomitant local muscle glycogen depletion will result in a 




Six healthy, physically active males aged between 18 and 20 years were recruited to participate 
in this study (age 19±1 yrs; Weight 8?±? kg, body fat 15±2 %). The subjects were all recruited 
from a local university rugby (football) club. Exclusion criteria included any chronic diseases, 
intercurrent illnesses, history or current signs of knee pathology that would influence exercise 
performance or be negatively affected by the exercise. Each volunteer gave their Written, 
informed consent before participation in the study, which was approved by the Research and 
Ethics Committee of the Faculty of Health Sciences of the University of Cape Town (South 
Africa). 
3.2.2 Study design 
Each subject performed a single trial consisting of cycling to exhaustion at 30% of individual pre-
determined peak sustainable workload (Wpeak) with one leg at a time on a stationary recumbent 
cycle ergomer. The starting leg was randomly assigned. 
3.2.3 Preliminary testing 
3.2.3.1 Anthropometry 
Mass and stature were predetermined and body mass index (BMI) was calculated for subjects 
participating in the study. Body fat was measured from the sum of seven skinfolds (biceps, 
triceps, subscapularis, abdominal, thigh and calf) and calculated using the equation of Durnin & 
Womersley 127. 
3.2.3.2 Peak sustained power output (Wpeak) test 
Subjects performed an incremental cycle test to exhaustion (with both legs) in order to determine 
each subject's individual working capacity (peak sustained power output (W peak) test). On "arrival 
at the cycle laboratory, a full anthropometric analysis was performed (as mentioned above), 
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followed by a 10 min warm-up exercise bout on an electronically-braked cycle ergometer (Lode, 
Groningen, The Netherlands). After the warm-up, the Wpeak test was started at a workload 
equivalent to 3.3 Watts/kg body mass and increased first by 50 Watts (W) after 150 sec and:then 
by 25 W every 150 sec until the pedaling frequency dropped below 50 revolutions/min. PPO was 
defined as the highest exercise intensity the subject completed for 150 sec in W, plus the fraction 
of time spent in the final workload multiplied by 25 W. This information was used to adjust the 
work rate in the experimental trial so that each subject performed single limb cy.cling 
corresponding to 30% of Wpeak. 
3.2.4 Experimental procedure 
Subjects reported to the laboratory in the morning after a 10-12 hour overnight fast. Upon arrival, 
an 18-gauge Teflon cannula (Jelco; Johnson and Johnson, Halfway House, South Africa)' was 
placed into the subject's right forearm vein and connected to a three-way stopcock (Un,iflex; 
Mallinckrodt Medical, Hennef-Sieg, Germany), and a baseline blood sample was collected. 
3.2.4.1 Single leg exercise protocol 
Before exercise was started, the seating position on the recumbent cycle ergometer' was 
adjusted to that chosen by the subjects as most comfortable for his cycling performance. Each 
subject was given 5 minutes to warm up and settle into a comfortable seating position (3 min at 
20 W followed by 2 min at 40 W). After 5 min, the workload was set at 30% of each subject's 
individual Wpeak and single-limb cycling to exhaustion followed. While the one leg was strapped 
into the pedal (around the toe and heel using inelastic adhesive tape), the other leg remain~d in 
a rested state, positioned in a comfortable position on a small bench placed next to the cycle 
ergometer. Care was taken that the resting limb should remain as inactive as possible. 
Measurement of EMG activity of the quadriceps muscle of the inactive leg revealed muscle 
recruitment of <5% of pre-determined maximal voluntary contraction. At exhaustion of the 
starting leg (Leg 1), a muscle biopsy was performed (explained below) in that leg. Immediately 
thereafter, the same protocol was performed on the previously rested leg (Leg 2). Exhaustion 
was defined as the point at which the subject could no longer maintain 30% of individual Wpeak 
power and were unable to raise the power output after two verbal warnings. During exercise, 
subjects were cooled by an electric fan, and could consume water ad libitum. Thirty minutes into 
the exercise time of each limb, 300 ml of a flavored 10% glucose polymer drink (i.e. 30 g CHO) 
was provided in order to prevent the development of hypoglycemia. 
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3.2.4.2 Muscle biopsy 
A muscle biopsy was obtained from the vastus lateralis muscle at the pOint of exhaustion of !3ach 
limb, using the method of Bergstrom 16 as modified by Evans et al. 136. The muscle bi~psy 
samples were immediately placed in liquid nitrogen, then stored at -80 DC for later determination 
of muscle glycogen concentration (as per wet weight) using conventional methods 35. 
3.2.4.3 Blood sampling and analysis 
Blood sampling was repeated at 15 min intervals during the single-leg cycling protocol. After 
each blood sample was taken, the cannula was kept patent by flushing it with sterile saline. 
Aliquots of the blood sample were separated into tubes containing potassium oxalate and sodium 
fluoride (Midran; Novo Nordisk, Johannesburg, South Africa) for later analysis of plasma glucose 
and lactate concentrations; tubes containing gel and clot activator (Beckton-Oickinson) for 
determination of serum free fatty acid (FFA) concentrations; and tubes containing lithium heparin 
(Beckton-Oickinson, South Africa) for determination of plasma catecholamine concentrations. 
Tubes were immediately placed on ice and, after 60 min, centrifuged at 3 500 rpm for 12 min at 4 
°C, and the supernatants were then stored at -80°C for later analysis. Plasma glucose 
concentrations were determined by the glucose oxidase method using a glucose analyzer 
(Glucose analyzer 2; Beckman) and lactate concentrations were determined, by 
spectrophotometric (model 35; Beckman, Fullerton, CA) enzymatic assays (Lactate PAP; Bio 
Merieux, Marcy-L'Etiole, France), FFA concentrations were measured using an enzymatic 
colorimetric assay (Half-micro test; Boehringer Mannheim). Catecholamine concentrations were 
determined by high-pressure liquid chromatography (HPLC) with electrochemical detection using 
the method described by Forster and Macdonald 150, (HPLC column speCifications: Phenomenex 
Hypersil31J OOS C18 100mm X 2.0 mm, Part no. 000-0145-BO). 
3.2.4.4 V02 and VC02 measurements 
At baseline (fasting) and at 15 min intervals during exercise, V02 and VC02 were determined on-
line using a computerized system (Oxycon Alpha, Jaeger-Mijnhart, The Netherlands). Prior to 
each test, the flow meter of the Oxycon Alpha analyzer was calibrated using a Hans Rudolph 3 
liter syringe, and the gas analyzer was calibrated using a two-point calibration of fresh air and a 
4% CO2, 96% N2 gas mixture as per manufacturer speCifications. The reliability of the Oxycon 
Alpha analyzer was tested on a weekly basis using the combustion of absolute ethanol '(99 % 
Analytical Report, Associated Chemical Enterprises (Pty.) Ltd., Glenvista, South Africa) and its 
concomitant respiratory exchange ratio (RER) as a reference. 
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Rates of total CHO and fat oxidation were calculated (g/min) using the formulae of Frayn 153, 
assuming a nonprotein respiratory exchange ratio, assuming no increase in basal amino acid 
and protein degradation during exercise: 
Total CHO oxidation = 4.55 VC02 - 3.21 V02 
Total fat oxidation = 1.67 (V02 - VC02) 
Where VC02 is the volume of CO2 in the expired air in Umin; and V02 is the corresponding 
oxygen uptake in Umin. 
3.2.4.5 Perceived exertion and Heart Rate 
Each subject's perception of effort (rate of perceived exertion, RPE) was measured at 5-min time 
intervals from the start to the end of the single-limb exercise protocol. Two scales were used to 
quantify the subject's level of exertion: 1) the validated Borg 15-point RPE scale, and 2) the 
validated Borg category-ratio 10-point scale 30. The subjects were asked to use these scal~s to 
give a subjective rating of 1) general or "whole-body" exertion, and 2) give a subjective rati~g of 
exertion pertaining particularly to the exercising leg. A printed scale and instructions were given 
to familiarize subjects, and a verbal explanation of each scale and a description of how the 
scales should be used were given. Heart rate was recorded at 5-second intervals throughout 
exercise by means of a Poiar™ heart rate monitor. 
3.2.5 Statistical analysis 
The statistical software package STATISTICA 7.0 (2004; StatSoft, Inc., Tulsa, OK, USA) was 
used for the statistical analysis of the data. All results are presented as means ± SO. Statistical 
significance (p<0.05) of between-limb differences was assessed by a two-way analyses of 
variance (AN OVA) for repeated measures over time for the first 30 to 40 min (complete 'data 
sets, n=6), depending on the variable measured. In order to determine which means were 
significantly different, Tukey's HSO post-hoc analysis was used. Subjects fatigued and dropped 
out at different time points after 40 min. Paired t -Tests were performed for between limb 
comparisons of variables beyond 40 min, and for comparisons at the point of exhaustion (end of 
exercise). 
3;3 RESULTS 
As indicated in Table 3.1, the subjects had moderate V02 max and peak work rate (Wpeak) values, 
consistent with being moderately trained. 
Table 3.1: Subject characteristics 
Age (years) 
Body mass (kg) 
Body fat (%) 
Peak sustained power output (Wpeak) (Watts) 
V02m8l( (ml/kg/min) 







The cycling time to fatigue in Leg 1 was -5 min longer compared to that of Leg 2 (60±6 vs. 55±7 
min, Leg 1 vs. Leg 2, respectively, p=0.03). All subjects completed at least 50 min of exercise 
with Leg 1 and 40 min with Leg 2. 
3.3.2 Muscle glycogen concentrations (Table 3.2) 
Muscle glycogen concentrations at the point of exhaustion in Leg 1 were significantly lower.than 
at the pOint of exhaustion in Leg 2 (43±25 vs. 51±21 mmol/kg W.W., Leg 1 vs. Leg 2, respecti~ely, 
p=0.04). . 
Table 3.2: Exercise time and muscle glycogen concentrations at exhaustion 
n=6 Leg 1 Leg 2 *p 
Exercise time to exhaustion (min) *60±6 55±7 0.03 
Muscle glycogen concentration (mmol/kg w.w.) *43±25 51±21 0.04 
Values presented as Mean ± SO. p = level of statistical significance. ·Significant difference between Leg 
1 vs. Leg 2 (p<O.05). 
3.3.3 Blood glucose concentrations (Figure 3.1A) 
Plasma glucose concentrations at the start of exercise in Leg 1 were -4 mmol/L and incre~sed 
over time to 4.5 mmol/L at the point of exhaustion (NS over time). Plasma glucose 
concentrations at the start of exercise in Leg 2 were significantly higher (5.3±0.7 mmol/~) than 
that at the start of Leg 1 (p=0.007). This was likely due to the cessation of exercise (point of 
exhaustion) in Leg 1 and a decline in glucose uptake 457, with a resultant increase in blood 
glucose concentrations between cessation of exercise in Leg 1 (-10 min) and start of exercise in 
L~g 2. The increased catecholamine concentrations at the start of exercise in Leg 2 mai also 
have increased blood glucose concentrations via its effects on increasing hepatic glucose output 
(glycolysis and gluconeogenesis) and reducing glucose uptake 214.222. However, as soon as 
exercise was started in Leg 2, blood glucose concentrations declined to similar concentrations to 
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that observed after 15 min of exercise in Leg 1. likely due to contraction-induced uptake of ~Iood 
glucose uptake by the working muscle 450. 
At the 15 min timepoint. glucose concentrations were similar between legs (-4.1 mmoI/L). where 
after glucose concentrations displayed a similar decline to -3.7 mmol/L at 30 min of exercise. In 
Leg 1. glucose concentrations then returned to baseline levels (4.0±0.5 mmol/L) at 45 min of 
exercise. most likely due to the ingestion of 300 ml of the 10% glucose polymer drink at 30 min of 
exercise. However. ingestion of an equivalent amount of CHO drink at 30 min of exercise in Leg 
2 did not result in an increase in glucose concentration between the 30 and 45 min period as it 
did in Leg 1. Hence. glucose concentrations remained at -3.6±0.3 mmoVL between the 30 and 
45 min exercise period in Leg 2. Glucose concentrations in Leg 2 tended to be lower than that of 
Leg 1 at the 45 min timepoint. but these differences did not reach statistical significance. After 
the 45 min timepoint, glucose concentrations in the remainder of subjects increased to -4.5 
mmol/L in both legs (NS). At the point of exhaustion. glucose concentrations were slightly lower 
in Leg 2 (4.1±0.6) compared to Leg 1 (4.5±0.4). but were not significantly different. 
The individual data were examined to explore the potential contribution of hypoglycemia on 
fatigue development (exercise capacity) (Table 3.3). 
Table 3.3: Individual data for plasma glucose concentration at the pOint of fatigue and exercise 
time for Leg 1 and 2. respectively. 
Subjects Glucose at point of Exercise time Performance time 
exhaustion (mmoI/L) (min) differences 
Leg 1 Leg 2 Leg 1 Leg 2 % Decline 
A 5.1 3.4 60 60 0 
B 4.4 4.9 67 64 -4 
C 4.3 3.6 53 51 -4 
D 4.7 4.8 61 53 -13 
E 3.9 4.2 67 59 -12 
F 4.5 3.8 52 41 - 21 
Note: % Decline = decline in exercise capacity with Leg 2 compared to Leg 1. 
Hypoglycemia is typically defined as blood glucose concentrations below 3.5 mmol/L 27. ·When 
applying this definition. then one subject (subject A) was hypoglycemic at the pOint of exhaustion 
in Leg 2. However. his exercise capacity was apparently unaffected by the presen~e of 
hypoglycemia as his exercise time for Leg 2 was identical to that of Leg 1. In two of the 6 
subjects (C and F). exhaustion was reached earlier than in Leg 1 and at lower plasma gluCose 
concentrations (a 4% and 21% decline in exercise capacity with Leg 2 for subject C and F. 
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respectively). In contrast, in two of the subjects (8 and E), exhaustion was reached earlier in Leg 
2 and at higher plasma glucose concentrations (a 4% and 12% decline in exercise capacity for 
subject 8 and E, respectively). Despite the small sample size, these data show that there is no 
clear relationship between low blood glucose concentrations and fatigue development (or 
exercise capacity) in the current experimental model. 
3.3.4 Serum FFA concentrations (Figure 3.1 B) 
80th legs started exercise with similar resting FFA concentrations. During exercise with Leg 1, 
FFA concentrations remained fairly constant over time with a slight, yet non-significant increase 
towards the point of exhaustion. FFA concentrations in Leg 2 were similar to Leg 1 over the first 
-30 min of exercise, but increased significantly over time (p=O.OOO) from 30 min onwards and 
were significantly higher than that of Leg 1 at 45 min (p=0.07), 60 min (p=0.03, n=4) and at the 
point of exhaustion (p=0.05). 
5.5 ___ Leg 1 
:::r ~Leg2 
~ 5 0 
I E 1# E 4.5 - ! CD III 4 ! 8 = (4) c;, 3.5 
nil 
E 3 III 
nil 
0: , 
Rest 15 30 45 60 END 
B 1.4 * ___ Leg 1 
I * :::r 1.2 ~Leg2 * L ~ 0 1 E (4) E 0.8 -cr: 
0.6 LL. LL. 
I E 0.4 I = ~ CD 0.2 U) 
0 , 
Rest 15 30 45 60 END 
Figure 3.1 A and B: Plasma glucose (A) and Serum FFA (8) concentrations at rest and during single~leg 
exercise to exhaustion. ·Significant difference between Leg 1 vs. Leg 2 (p<0.05). #Significant change' 
over time from rest. n=6, otherwise as indicated in brackets. 
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3.3.5 Plasma lactate concentration 
Apart from a significant change over time, there was no significant difference in plasma lactate 
concentrations between Leg 1 and 2. Plasma lactate concentrations increased from -1.5 to 3.8 
mmol/L in Leg 1 and from 2.5 to 4.0 mmol/L in Leg 2 from rest to exhaustion (NS). 
3.3.6 Serum epinephrine and norepinephrine concentrations (Table 3.3) 
Serum epinephrine concentrations were lower at the start of exercise (0.22±0.16 vs. 0.65±0.55 
nmol/L, p=0.06) and at 30 min of exercise (0.66±0.37 vs. 1.30±0.43 nmol/L, p=0.002) in ~eg 1 
compared to Leg 2, respectively. Serum norepinephrine concentrations were significantly I~wer 
before the start of exercise in Leg 1 compared to Leg 2 (2.06±0.43 vs. 4.05±1.52 nmol/L, 
respectively, p=0.02). 
Tabl,e 3.3: Serum epinephrine and norepinephrine concentrations 
n=6 Leg 1 Leg 2 
Rest 30 min END Rest 30 min EN!i) 
Epinephrine 





7.95±3.04 *4.05±1.52 5.96±1.76 7. 72±2.43 
Values presented as Mean ± SO. *Significant difference between Leg 1 vs. Leg 2 (p<O.05). END = at the 
point of exhaustion 
3.3.7 Gas exchange data and rates of substrate oxidation 
Apart from a significant increase over time in both legs, there were no significant differences 
between legs in V02 and RER (CHO and fat oxidation). In both legs, RER decreased from -0.93 
measured at 15 min of exercise to -0.87 at the point of exhaustion. In both legs, fat oxidation 
inGreased from 0.2 g/min at 15 min of exercise to 0.4 g/min at exhaustion. CHO oxidation during 
exercise decreased similarly in both legs from -1.8 g/min (15 min) to -1.6 g/min at exhaustion 
(NS). 
3.3.8 Ratings of perceived exertion (RPE) (Figure 3.4 A & S) 
At the start of exercise (5 min timepoint), whole body RPE was significantly higher in Leg 1 
(11±2) compared to that of Leg 2 (8±2, p=0.013), but were comparable between legs thereafter 
(Figure 3.4 B). Whole body RPE during exercise increased significantly over time in both legs, 
and was rated at -17 at the point of exhaustion (the maximum rating being 20). 
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Leg RPE tended to be lower in Leg 2 over the first 30 min of exercise compared to Leg 1, but did 
not reach significance. In both Leg 1 and Leg 2, Leg RPE increased significantly over 'time 
(p<0.05) and was rated at maximum (a rating of 10) at the pOint of exhaustion. These data 
demonstrate that despite shorter exercise time in Leg 2, the rate of increase in RPE was similar 
between legs 
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Figure 3.4 A & B: Whole body RPE (A). Leg RPE (8) during single-limb exercise to exhaustion (END). 
Complete data sets (n=6) up to the 40 min timepoint. ·Significant difference between Leg 1 vs. Leg 2 
(p<0.05). #Significant change over time for both Leg 1 and Leg 2 (p<0.05). 
3.3.9 Heart rate (Figure 3.3) 
The heart rate response of both Leg 1 and Leg 2 remained fairly constant and comparable 
(124±23 vs. 121±18 beats/min for Leg 1 vs. Leg 2, respectively). 
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Figure 3.3: Heart rate response during single-limb exercise to exhaustion (END). Complete data sets up 
to 40 min of exercise (n=6), where after subjects fatigued at different timepoints as indicated by the supject 
numbers in brackets. "Significant difference between Leg 1 vs. Leg 2 (p<0.05). 
3.4 DISCUSSION 
This study aimed to investigate whether the local muscle glycogen depletion, and metabolic and 
hormonal response elicited during Single limb, steady-state exercise to exhaustion affects the 
rating of perceived exertion and exercise performance during exercise to exhaustion of the other, 
previously rested limb. The key finding of this investigation was that exercise performance of the 
second leg was significantly shorter, whilst exercise in the second limb was terminated with a 
significantly higher muscle glycogen content than that at exhaustion during the first limb. This 
suggests that local muscle glycogen played a minor role in fatigue development of the second 
limb. The performance difference may be related, in part, to increased sympathetic nervous 
system activation, and possible differences in muscle recruitment (reported elsewhere). 
In the present study subjects fatigued at plasma glucose concentrations ranging from 3.4 to 5.1 
mmollL and with no clear pattern between plasma glucose concentration and exercise time to 
exhaustion. Though the sample number is small, the results indicated that fatigue development 
in this exercise setting could not simply be ascribed to low plasma glucose concentrations Qr the 
development of frank hypoglycemia alone. 
Fatigue in Leg 1 was reached at a muscle glycogen concentrations of -40 mmollkg W.w. 
Fatigue in Leg 2 was reached at a significantly higher muscle glycogen concentration of -50 
mmollkg W.W., and after a significantly shorter exercise time. Again, there was no clear<psttem 
between muscle glycogen content at the point of fatigue and exercise capacity of indMdual 
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subjects. In the literature it has commonly been noted that fatigue coincided with muscle 
glycogen concentration of s;40 mmol/L 35.37.73.89. Hence, whilst local muscle glycogen depletion to 
a level of -40 mmol/kg w.w. could be linked to fatigue development in Leg 1, local muscle 
glycogen depletion per sa (in Leg 2) cannot explain the earlier fatigue development observed in 
Leg 2. Recent evidence from Rauch et al. 350 suggested that muscle glycogen content may act 
as a feed-forward metabolic signal that informs the individual at what point they should slow 
down or stop exercise to prevent the development of absolute substrate depletion. It may be that 
the local muscle glycogen depletion in Leg 1 contributed to fatigue development in Leg 2 by 
augmenting central command, perhaps via stimulation of Group III and IV afferents (Shown to be 
sensitized by metabolic byproducts during muscle contraction) 198,383.383. 
In the present study, catecholamine concentrations were significantly higher prior to the start of 
exercise in the second compared to the first leg. Though this might be due, in part, to the stress 
response following the muscle biopsy procedure, the epinephrine concentrations rem~ined 
significantly higher after 30 min of exercise in Leg 2. The 30 min of exercise that had lapsed 
would most likely have overridden the stress response caused by the muscle biopsy procedure 
68. It is well known that sympathoadrenal activation and increased epinephrine concentrations 
are increased with exercise intenSity and duration 68. 
It has previously been shown that increased sympathoadrenal activation results in increased 
intramuscular glycogen utilization 68, most likely due to enhanced glycogen phosphorylase 
activity as a result of Il-adrenergic stimulation 356. Augmented effects of raised epinephrine 
concentrations on CHO oxidation and lactate production have also been observed 142,437 •. In the 
present study, the raised epinephrine concentrations had no effect on altering CHO oxidation and 
circulating lactate concentrations. It is, however, difficult to evaluate the effect of increased 
sympathoadrenal activation on muscle glycogen utilization in the second limb compared to the 
first, as we only measured muscle glycogen at the point of exhaustion, and subjects cycled fOr-5 
min shorter with the second leg. It seems unlikely that the raised epinephrine concentrations 
enhanced glycogenolysis in the present study as glycogen concentrations were significantly (-10 
mmol/kg w.w.) higher at exhaustion in Leg 2 compared to Leg 1, and total CHO oxidation and 
lactate concentrations similar between legs throughout exercise. This is in accordance with three 
studies where epinephrine infusion (at physiological levels) during exercise did not enhance 
muscle glycogenolysis 63,436,442, nor RER 438, However, it should be noted that these studies 
employed a different mode of exercise (2-legged cycling), higher exercise intensities (85% and 
70% of V02 max) and different exercise duration (90 min and 40 min) 63.438.442, and in two of the 
studies subjects started exercise in a non-fasted state 63.442, The reason for the disparate results 
in the literature is not yet clear, Nevertheless, from these observations it seems unlikely that the 
earlier fatigue development of the second leg was related to a substrate-depletion mechar.'llsm. 
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Specifically, fatigue development in the second leg was unrelated to local muscle glycogen 
depletion, and unrelated to alterations in CHO oxidation or lactate metabolism. 
It the present study, it may be that the increased sympathetic activation that occurred during 
exercise (as judged by the increased nor-epinephrine concentrations), combined with :Iocal 
muscle glycogen depletion and the sensation of fatigue with Leg 1 (but circulated and 
"experienced" by the whole body), elicited an alteration in central command and motor unit 
activity to maintain the same (set) force production with the second limb. This may also explain 
the observation that RPE followed the same rate of increase in Leg 2, and ended at the ~ame 
maximal levels as Leg 1, despite a significantly shorter exercise time. The measuremen.ts of 
muscle recruitment patterns during exercise (to be reported in detail elsewhere) may aid in 
verifying the likeliness of the suggested alteration in central command and muscle recruitment 
mentioned above, and may ultimately provide a further explanation for the reduced exercise 
capacity with the second limb. 
FFA concentrations were maintained between 0.3 - 0.5 mmol/L in Leg 1. This is comparaQle to 
values found during single-limb cycling at 40% of 2-legged V02 max 5. However, FFA 
concentrations increased significantly over time from 0.3 - 0.9 mmol/L in Leg 2, and were 
significantly higher than during exercise with Leg 1 from 45 min to the point of exhaustion. This 
was unexpected since 30 g of CHO was ingested at 30 min of exercise in both legs, which is 
known to suppress FFA release 438. Hence, equivalent amount and timing of CHO ingestion in 
Leg 2 did not seem to have any effect on FFA release during exercise in Leg 2. This: may 
suggest that CHO ingestion during exercise in Leg 2 was insufficient to over-ride the overall 
effect of exercise duration and the metabolic and hormonal responses elicited on FFA release. 
Epinephrine has been shown to be a potent stimulus for lipolysis and could therefore have 
accounted for the increased FFA concentrations seen during exercise with Leg 2 290. How~ver, 
despite significantly higher circulating FFA concentrations during exercise with Leg ~, fat 
oxidation remained comparable to that of Leg 1. A possible explanation for this may be that due 
to the low exercise intensity and low energy demand, and due to CHO ingestion and 
maintenance of euglycemia, the need to oxidize lipid for fuel remained low and similar between 
trials. 
In order to make a distinction between the subject's sensation of whole-body and muscle-specific 
(local) fatigue, we employed a 20-point validated Borg RPE scale to assess whole-body RPE and 
the 10-point validated category-ratio Borg scale to assess leg (local) RPE. Surprisingly,. whole 
body RPE was significantly lower at 5 min of exercise in Leg 2 compared to that of Leg 1. One 
possible explanation for this might be related to the significantly higher blood glucose 
concentrations immediately prior to the start of exercise in Leg 2 compared to Leg 1. An inverse 
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relationship between glucose availability and RPE has been demonstrated before 243, however, 
mechanisms for this effect still remains to be fully elucidated. It has been shown that a n·umber 
of sensory cues (both cardiopulmonary and peripheral) may control effort perception. Kang et al. 
243 demonstrated that ingesting CHO vs. placebo during prolonged exercise signi"ficantly lowered 
overall ratings of perceived exertion, however ratings were not different between trials at thE! end 
of the exercise session 243. This study suggests that in endurance exercise, CHO avail~bility 
may be a sensory cue, but there are other physiological processes contributing to effort 
perception that may contribute to perceptual cues towards the end of endurance exercise. 
Despite the significant differences in blood glucose concentrations and whole body RPE that 
existed at the onset of exercise in the present study, these differences were minimized within the 
first 15 min of exercise and remained similar thereafter. 
Leg RPE tended to be lower in Leg 2 compared to Leg 1 but did not reach statistical significance. 
Interestingly, there was a linear relationship between RPE and exercise duration, and both legs 
exhausted at maximal exertion levels (rating of 10), whilst whole body RPE was rated at high, yet 
submaximal levels -17, maximal being 20). This suggests localized fatigue and therefore the 
local leg RPE seems to be the dominant effort sensation for this dynamic type of exercise. It 
appears that perceived exertion does not reflect whole body metabolism but is rather related to 
local metabolic or mechanical changes. It has been shown that sensations of strain· in the 
exercising limbs play a role in fatigue, suggesting proprioceptor (such as mechanoreceptor) 
feedback within the exercising muscle that relates a message of strain and ultimately fatigue 302. 
Furthermore, studies have reported RPE to be higher during cycling at lower cadences de.spite 
similar values for ventilation, V02 and heart rate 54.332. Subjects in the present study were 
unaccustomed to single-leg cycling and found it difficult to maintain a smooth rhythmic ~dence 
at the point of exhaustion. Though speculative, a contributing factor to the development of 
fatigue in this study may have been mechanical strain, which was sensed independent of any 
metabolic changes. 
In conclusion, from these observations it seems unlikely that the earlier fatigue development of 
the second leg was related to a substrate-depletion mechanism per se. Specifically, fatigue 
development in the second limb was unrelated to local muscle glycogen depletion, nor to 
alterations in CHO oxidation or lactate metabolism. The overall RPE in the previouslyr~sted 
limb (Leg 2) followed the same pattern of increase and ended at the same near-maximal .RPE 
ra.ting despite a significantly shorter exercise time. This study demonstrates that antecedent 
single-limb exercise to fatigue elicits an altered physiological milieu (altered catecholamine 
concentrations at the onset of exercise and significant increase in sympathetic activation), which 
may be responsible for the reduced exercise capacity of the second limb. 
97 
4.1 INTRODUCTION 
In the previous study we demonstrated that fatigue development during sequential single limb 
exercise was unrelated to blood glucose concentrations, in fact, blood glucose concentrations at 
the pOint of exhaustion between limbs were highly variable between subjects. Furthermore, the 
reduced exercise capacity of the second limb was unrelated to local muscle glycogen depletion, 
nor to alterations in CHO oxidation or lactate metabolism. In this study, we aimed to further 
investigate the impact of whole-body glycogen depletion (achieved by following a low CHO diet) 
on inter-individual exercise metabolism and endurance capacity when blood glucose 
concentrations are maintained (-5 mmol/L) with glucose infusion, or allowed to decline with 
placebo (saline) infusion in endurance-trained men. 
Research in the field of metabolism and performance during prolonged exercise has highlighted 
a strong relationship between the status of bodily carbohydrate (CHO) stores (blood glucose, 
liver and muscle glycogen) and endurance exercise capacity 35.73-75,89,440. Muscle glycogen 
contributes approximately 85% of the total CHO oxidation early in exercise 35,89, but as exercise 
duration increases and muscle glycogen is depleted, there is a gradual shift toward blood 
glucose as the predominant carbohydrate energy source 35.73.89.440. However, this effect m~y be 
limited by declining plasma glucose concentrations late in exercise 73,89. 
Whereas CHO-Ioading diets are associated with improved endurance capacity or performance, 
ascribed mainly to increased endogenous CHO availability and maintenance of a high rate of 
CHO oxidation throughout exercise, low CHO diets have been shown to impair endurance 
exercise capacity, which has been ascribed to the reduction of endogenous CHO availabilitY and 
decreased rate of CHO oxidation 73,74,89,162,190,223,234,440. However, the relationship between 
muscle glycogen availability and blood glucose uptake remain unclear. 
Muscle glycogen concentration at the onset of exercise is an important determinant of m,:,scle 
glycogenolysis during exercise. Reduced muscle glycogen availability results in a lower ra.te of 
glycogenolysis during submaximal exercise 190, and similarly, increased glycogen stores are 
associated with higher rates of glycogenolysis 35,190,375. Additionally, Hargreaves et al. 191 
observed a significant inverse relationship between muscle glycogen concentration and glucose 
uptake during 40 min of cycling exercise (65-70% V02 max), and suggested a possible regulatory 
influence of muscle glycogen on glucose uptake during the early stages of exercise. However, 
subsequent studies found that tracer-determined rates of glucose uptake were unaffected by' pre-
exercise muscle glycogen availability during a similar 190 and more prolonged exercise protocol 
(180 min, 70% V02 max) 35. The above studies were, however, performed in the absence of 
exogenous CHO supplementation during the exercise bout. 
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A number of studies have found that exogenous CHO supplementation, especially when mlJscle 
glycogen concentrations are low, can maintain blood glucose and total CHO oxidation and delay 
the onset of fatigue and thereby, in part, negate or 'over-ride' the potential ergolytic effects of low 
endogenous glycogen stores 36.60.73.74,89. Furthermore, CHO supplementation during exercise 
appear to minimize the performance differences in studies in which subjects ingested different 
pre-exercise diets and therefore began exercise with different muscle and liver glYC9gen 
concentrations 53.445. In studies employing steady-state exercise regimes, this effect is ~ore 
likely the result of changes in blood glucose concentration than in the rate of muscle glycogen 
oxidation, since evidence suggests that CHO supplementation during steady-state exercise 
(-70% V02 max) has minimal effect on the rate of muscle glycogen oxidation 35. EVide'nce of 
muscle glycogen sparing with exogenous CHO supplementation has typically only been 
observed in studies where a variable intensity or self-paced exercise protocol were employed 445. 
Yet, results from Coyle et al. 91 and Bjorkman et al. 19 have indicated that CHO supplementation 
improved endurance exercise capacity only in those subjects who became hypoglycemic ,during 
the placebo treatment. In other studies, however, CHO supplementation during exercise 
improved endurance capacity, lowered ratings of perceived exertion and improved performance 
in individuals who did not demonstrate significant decreases in blood glucose concentrations and 
CHO oxidation rates during the placebo trial 60.293.313. Perhaps the most intriguing finding~ are 
from those studies that found that the development of hypoglycemia 87.146.228.230.312 or reversal of 
hypoglycemia 162 (plasma glucose <3.5 mmoVL) during exercise had little effect on exercise 
capacity. Similarly, a series of studies investigating the effect of type, amount and timing of pre-
exercise carbohydrate intake have indicated that some subjects are prone to the development of 
rebound hypoglycemia during subsequent exercise (for reasons yet unclear), yet, the 
development of hypoglycemia had no effect on their exercise performance 228.230.312. 
Thus, the specific effects of alterations in blood glucose concentrations on endurance exercise 
capacity remain unclear, especially under conditions where endogenous glycogen stores are low. 
Furthermore, the effect of low starting muscle glycogen concentration on glucose uptake and 
substrate metabolism also remains unclear. Clarity on these aspects may assist: with 
development of specific dietary advice and strategies to enhance athletic performance, especially 
in strenuous training or competition situations where recovery time is limited and endogenous 
CHO stores may be compromised. 
Accordingly, the aim of this study was to examine the effect of glucose infusion to maintain 
euglycemia, vs. saline (placebo) infusion on endurance exercise capacity in persons whose 
glycogen stores had been lowered by prior exercise and a low CHO diet. We chose glucose 
infusion as the mode of CHO administration (as opposed to ingestion) partly to negate inter-
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individual differences in the rate of intestinal glucose absorption, as well has being able to ensure 
constant euglycemia. We expected that the saline infusion would result in a decline in blood 
glucose concentration during exercise and offer an opportunity to examine the effect of decrining 
blood glucose concentrations on metabolism and exercise capacity as compared to euglycemic 
conditions. Differences in exercise metabolism and endurance capacity provide a meaSure of 
the impact of altered blood glucose concentrations have on liver and muscle glycogen 
metabolism and to the development of fatigue in persons who begin exercise with low muscle 
and liver glycogen concentrations. Furthermore, if the metabolic effects of lowered glYC9gen 
stores persist despite the maintenance of euglycemia, then it would indicate that the responses 
are related specifically to reduced intramuscular or intrahepatic CHO availability. It was 
hypothesized that the declining blood glucose concentrations would reduce CHO oxidation rates 
and limit exercise capacity, whereas euglycemia would maintain CHO oxidation and enable 




Nine endurance-trained male CYClists volunteered to partiCipate in the study, which was approved 
by the Research and Ethics Committee of the Faculty of Health Sciences of the University of 
Cape Town (South Africa). Cyclists were selected who regularly trained ~200 kmlwk arid who 
had completed a 105-km cycle race in <3.5 h. Subject characteristics are given in Table 1. The 
~xperimental procedures and potential risks of the study were explained to the subjects, and·their 
informed, written consent was obtained. Each subject repeated the experimental proced4f9 in 
random, single blind fashion on two separate occasions, at least one week apart: One trial with 
glucose infusion during the experimental ride in order to maintain elJglycemia, and a second with 
saline (placebo) infusion. 
4.2.2 Preliminary testing and manipulation of muscle glycogen content 
Two days prior to the experiment proper, subjects reported to the laboratory in the moming after 
ingestion of their habitual breakfast. On arrival the subject was weighed, where after they began 
a 10 min warm-up exercise bout on an electronically braked cycle ergometer (Lode, Groningen, 
The Netherlands). This was followed by an incremental test to exhaustion in order to deter!,"ine 
each subject's peak sustained power output (Wpeak). The Wpeak test was performed o~ the 
el~ctronically braked cycle ergometer at a workload equivalent to 3.3 W/kg body mass' and 
increased first by 50 W after 150 sec and then by 25 W every 150 sec until the pedaling 
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frequency dropped below 50 revolutions/min. This information was used to adjust the work rate 
in the subsequent phases of the trial so that each subject exercised at an intensity corresponding 
to 70% of peak rate of oxygen consumption (V02 max), which this corresponds to -63% of Wpeak 
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After the W peak test, subjects rested for 20 min and then cycled for a further 90 min at 63% of 
Wpeak. Every 20 min, a 5 min interval was performed at 83% of Wpeak (90% of V02max) to reduce 
the muscle glycogen content of the exercising muscles. After this procedure, subjects were 
instructed to follow a low carbohydrate diet for the next 48 h. They were given a list of Jood 
choices that would provide an energy intake of -6,800 kJ (16% CHO). They were also instructed 
to perform only 1 h of light training (e.g. low-intensity cycling) on the second day. The low CHO 
diet and light training were designed to limit muscle and liver glycogen resynthesis, while 
allowing recovery from the fatiguing effects of the depletion ride. 
4.2.3 Experimental trial 
After the 48 h period on the low CHO diet, subjects were instructed to eat a small breakfast 
(-1,200 kJ, 30 g CHO) 3 h before arrival at the laboratory. On arrival at the laboratory, an 18-
gauge Teflon cannula (Jelco; Johnson and Johnson, Halfway House, South Africa) was pl~ced 
into the subject's right forearm vein and connected to a three-way stopcock (Uniflex; Mallinckrodt 
Medical, Hennef-Sieg, Germany) and a resting blood sample was drawn (see details of blood 
sampling later). 
4.2.3.1 Leg muscle glycogen disappearance. 
After the resting blood sample was collected, a muscle sample was obtained from the vc;1stus 
lateralis muscle before the start of, and immediately on completion of exercise using the method 
of Bergstrom 16 as modified by Evans et al. 136. The samples were immediately frozen in liquid 
nitrogen and stored at -80°C for later determination of muscle glycogen concentration using 
conventional methods 35. 
4.2.3.2 Exercise protocol 
Ten min before the start of exercise, subjects ingested a 300 ml bolus of water containfng [U-
14C]glucose tracer (Amersham International, Buckinghamshire, UK) (providing 30 /-lCi per liter of 
drink). Subjects cycled on an electronically-braked cycle ergometer for up to a maximum of 150 
min at 70% of V02 max. During the ride subjects ingested 500 mllh in divided doses of the r~dio-
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labeled drink for determination of the rate of plasma glucose oxidation. Subjects were cooled 
with an electric fan and environmental conditions in the laboratory were controlled (20°C). 
4.2.3.3 Blood sampling and analysis 
A baseline blood sample was collected, and then repeated at 20 min intervals during exercise 
(-12 ml of blood was drawn at each time-point). After each blood sample was taken, the cannula 
was kept patent by flushing with 1 ml sterile saline. Aliquots of the blood sample were placed 
into tubes containing potassium oxalate and sodium fluoride (Mid ran; Novo Nordisk, 
Johannesburg. South Africa) for subsequent analysiS of plasma glucose. [U-14C]glucose specific 
activity and lactate concentrations. Another aliquot of blood was placed into a tube containing 
gel and clot activator (Beckton-Dickinson, South Africa) for determination of serum free fatty 
acids (FFA), l3-hydroxybutyrate, cortisol and insulin concentrations. The tubes were immediately 
placed on ice and, after 20 min, centrifuged at 3 500 rpm for 12 min at 4 oC, and the 
supernatants were then stored at -20°C for later analysis. Plasma glucose concentrations were 
determined by the glucose oxidase method using a glucose analyzer (Glucose analyzer 2; 
Beckman, Fullerton, CAl. Lactate concentrations were measured by spectrophotometric (model 
35; Beckman, Fullerton, CAl enzymatic assays (Lactate PAP; Bio Merieux, Marcy-L'Etiole, 
France). Serum insulin concentrations were determined using a radio-immunoassay technique 
(Coat-A-Count Insulin, Diagnostic products, Los Angeles, CAl. FFA concentrations were 
measured using an enzymatic colorimetric assay (Half-micro test; Boehringer Mannheim). 
Circulating l3-hydroxybutyrate concentrations were analyzed at time points 0 (rest), at BO min and 
at the end of exercise (100% of time), and were determined in neutralized perchloric acid 
extracts of serum using enzymatic spectrophotometric assays. Serum cortisol concentrations 
were measured using a radio-immunoassay 289. 
4.2.3.4 Euglycemic glucose clamp procedure and placebo (saline) infusion 
A second 1B-gauge Teflon cannula was placed in the opposite (left) forearm vein for infusion of 
glucose (CI) or saline (PI) during the 150 min of cycle ergometer exercise at 70% of V02 max-
Blood samples were obtained at 5 min intervals during exercise in both trials to measure blood 
glucose concentrations using a pocket glucometer (Accutrend; Boehringer Mannheim, 
Mannheim, Germany). The accuracy of the glucometer was verified by comparison with a 
Beckman glucose analyzer (Glucose analyzer 2; Beckman Instruments, Fullerton, CAl. Plasma 
glucose concentration during exercise in CI was maintained at euglycemic level (between -5.0-
6.0 mmollL) by adjusting the rate of glucose infusion (20% mass/vol glucose solution) 35 by using 
calibrated automatic syringe pumps (Travenol Laboratories, Hooksett, NJ). The protocol 
replicated that utilized by Weltan et al. 440 where the rate of glucose infusion needed to maintain 
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euglycemia in the CHO-depleted state ranged from 0.25 to 0.75 g/min towards the end of the 
exercise bout. 
4.2.3.5 V02, VC02, and 14C02 measurements during exercise 
At 20 min intervals during exercise, V02 and VC02 were determined on-line using a 
computerized system (Oxycon Alpha, Jaeger-Mijnhart, The Netherlands). Prior to each test, the 
flow meter of the Oxycon Alpha analyzer was calibrated using a Hans Rudolph 3 liter syringe, 
and the gas analyzer was calibrated using a two-point calibration of fresh air and a 4% CO2, 96% 
N2 gas mixture as per manufacturer specifications. The reliability of the Oxycon Alpha analyzer 
was tested on a weekly basis using the combustion of absolute ethanol (99 % Analytical Report, 
Associated Chemical Enterprises (pty. Ltd., Glenvista, South Africa) and its concomitant 
respiratory exchange ratio (RER) as a reference. 
Expired air was trapped for the later determination of 14C02 specific activity. The 14C02 trapping 
mixture consisted of 1 ml 1 N hyamine hydroxide in methanol (United Technologies, Packard, 
Meriden, CT), 1 ml 96% ethanol (SAARCHEM, Krugersdorp, South Africa), and 2 drops of 1 % 
phenolphthalein indicator (Saarchem, Krugersdorp, South Africa). Expired air was bubbled 
through the trapping mixture until the turn point of the indicator (solution became clear), at which 
point 1 mmol of CO2 has been absorbed by the trap mixture. Liquid scintillation cocktail (10 ml 
Ready Gel, Beckman, Fullerton, CA) was then added, and 14C02 radioactivity counted in a liquid 
scintillation counter (Packard Tri-Carb 4640, Downer's Grove, IL). All 14C counts were 
automatically corrected for quenching and background radioactivity. 
4.2.3.6 Rates of plasma glucose oxidation 
Rates of plasma glucose oxidation were measured using HPLC-purified [U-14C]glucose tracer 
(Amersham International, Buckinghamshire, UK). Three hundred ~L of tracer (containi~g a 
negligible amount of glucose) was added to 2 L of water, giving a specific activity of 2.2 
MBq/300~L of tracer (60 ~Ci/300 ~L). This amounted to 30 ~Ci per liter of drink. Five min before 
the start of exercise, subjects drank 300 ml bolus of the drink, then 500 ml/h in divided doses 
during the 150 min of exercise. A 0.5 ml aliquot of each of the plasma samples collected at 20 
min intervals for glucose determination (described above), were used for the determination of 
plasma [U-14C]glucose specific activity and rate of plasma glucose oxidation 440. The 0.5 ml 
aliquot of each of the plasma samples used for glucose determination was deproteinized by 
addition of 35 ~I of HCI04 (3.5 M), which also served to drive off [14C]bicarbonate as 14C02. The 
samples were then centrifuged at 4°C, and the protein-free supernatant was removed and kept 
cold. The precipitate was then twice resuspended in 0.35 ml of 0.13 M HCI04 and recentrifuged, 
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and the supernatant was added to that previously saved. The pH of the combined supern~tant 
was then adjusted to between pH 7.0 and 8.0 with -75 l.tI of 3 M K2C03 in 0.01 M Tris buffer (pH 
8), resentrifuged and passed through 500 mg exchange columns (SAX; Bakerbond, CapeTown, 
South Africa) that were preconditioned with 20 ml ethanol followed by 20 ml distilled water, 
adjusted to pH 8 with trace amounts of NaOH. Glucose was fully eluted into a scintillation vial 
with 3 ml of distilled water (pH 8). Lactate was subsequently eluted into a second scintillation vial 
with 2 ml CaCI2 (1 mol/L) adjusted to pH 2 with HC/. Eluates were evaporated to near dryness 
(-0.3 ml) at 60°C over -20 h, before liquid scintillation cocktail (Ready Gel; Beckman) was 
added for 14C radioactivity determination (disintegrations per minute (dpm)) using a liquid 
scintillation counter (Packard Tri-Carb 4640). During each round of the analysis procedure, a 
non-labeled plasma sample was spiked with a known quantity of [U-14C]glucose and analyzed 
simultaneously to correct the measured dpm values for the percent recovery. Such recov~ries 
exceeded 80% for all samples. Since there were negligible counts in the lactate fraction, no 
corrections were made for the contribution to V14C02 from 14C-lactate oxidation. The rate of 
glucose oxidation (Rox) was calculated from the equation: 
Where 14C02 x 6 is the expired CO2 specific activity (dpm/mmol) multiplied by 6 (6 carbon atoms 
per molecule of glucose), SA<;lu is the plasma [14C] glucose speCific activity (dpm/mmol); VC02 is 
the volume of expired CO2 (Umin); and 1.35 is the number of grams of glucose oxidized to 
produce 1 liter of CO2. 
4.2.3.7 Rates of total CHO and fat oxidation 
Rates of total CHO and fat oxidation were calculated (g/min) using the formulae of Fr~yn 153, 
assuming a nonprotein respiratory exchange ratiO, assuming no increase in basal amino acid 
and protein degradation during exercise: 
Total CHO oxidation = 4.55 VC02 -- 3.21 V02 
Total fat oxidation = 1.67 (V02 -- VC02) 
Where VC02 is the volume of CO2 in the expired air in Umin; and V02 is the corresponding 
oxygen uptake in Llmin. 
4.2.4 Statistical Analyses 
The statistical software package STATISTICA 7.0 (2004; StatSoft, Inc., Tulsa, OK, USA) was 
used for the statistical analysis of the data. All results are presented as means ± SO. Statistical 
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significance (p<0.05) of between-group differences was assessed by a two-way analyses of 
variance (ANOVA) for repeated measures over time for the first 80 min (complete data sets, 
n=9). In order to determine which means were significantly different, Tukey's HSD post-hoc 
analysis was used. Subjects fatigued and dropped out at different time pOints after 80 min. 
Statistical analyses were not performed beyond the 80 min timepoint due to declining subject 
numbers. Paired t -Tests were performed for comparisons between groups of variables at the 
point of exhaustion (end of exercise or 100% of time). Pearson's correlations were performed 
between continuous variables such as plasma glucose and serum cortisol concentrations. 
However, for correlations with endurance time, which was censored data, the Kendall tau 
technique was used, which calculates the differences between the probability that the observed 
data are in the same order for the two variables versus the probability that the observed data are 
in different orders for the two variables. 
4.3 RESULTS 
As indicated in Table 4.1, the subjects had moderately high V02 max and peak work rate values, 
consistent with being well-trained, but not elite cyclists. 
4.3.1 Exercise duration (Table 4.1) 
The time to fatigue in the CI trial was significantly longer than in the PI trial (137±14 vs. 1.12±29 
min, p<0.05). All subjects completed at least 80 min of exercise in PI and 120 min in the CI trial, 
where after subjects stopped exercising at different timepoints. The overall percentage 
improvement in endurance time with the CI trial was 28±26%, showing a large range betWeen 
subjects. Only 2 of 9 subjects in the PI, and 4 of 9 in the CI trial completed 150 min of steady-
state exercise. Exhaustion was determined as the inability to maintain the required power output 
whiilst pedaling at a rate of >40 rpm after two verbal warnings; or if the subjects stopped cycling 
outright. 
Table 4.1: Subject characteristics 
n=9 
Age (years) 
Body mass (kg) 
Peak sustained power output (watts) 
V02max (mllkg/min) 







*137 ± 14 
*112 ± 29 
% Improvement 28 ± 26 
Values presented as Mean ± SO. *Significant difference between trials (p<O.05). 
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4.3.2 Muscle glycogen concentrations (Table 4.2) 
Muscle glycogen concentrations were equally low at the start (74±21 vs. B3±15 mmol/kg ~.w.) 
and at the end of exercise (39±12 vs. 44±15 mmol/kg w.w.) for the CI and PI trials, respectively. 
The total amount of muscle glycogen used was similar in both trials (40±15 vs. 41±12 mmol/kg 
w.w.). 
Table 4.2: Muscle glycogen concentrations 
Muscle glycogen concentration PI CI 
(mmol/kg w.w.) 
Pre-exercise 83±15 74±21 
Post-exercise 44±15 39±12 
4.3.3 Blood glucose concentrations (Table 4.1A) 
Blood glucose concentrations at the start of the trials were similar in both groups. Blood glu'cose 
concentrations were maintained between 5-6 mmol/L throughout the CI trial (due to glucose 
infusion), but declined in the PI trial to 4.2±0.7 mmol/L over the first BO min, with a significantly 
decline over time to the point of exhaustion (3.B±0.7 mmol/L; p<0.05). Blood glucose 
concentrations were significantly higher in the CI trial between 20 to BO min and at exhaustion 
























































Figure 4.1 A and B: Plasma glucose (A) and serum free fatty acid (FFA) (8) concentrations during 
steady-state exercise. n=9 up to end of solid line, subject numbers indicated in brackets thereafter. 
·Significant difference between treatments (p<0.05). END = value at exhaustion (100% of time). 
There was a significant inverse relationship between exercise dUration and plasma glu~ose 
concentrations at exhaustion in PI (Figure 4.2) (rho= -0.63; p=0.02). Hence, subjects' who 
exercised the longest, tended to terminate exercise with the lowest plasma glucose 
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Figure 4.2: Relationship between plasma glucose concentrations at exhaustion and endurance Jime. 
n=9. (Values of individual subjects). ·Significant inverse relationship between endurance time and plasma 
glucose concentration at exhaustion in the PI trial (p<O.02). 
4.3.4 Serum insulin and cortisol, and plasma lactate concentrations 
Apart from a significant change over time, there were no significant differences between tri~ls in 
the concentrations of serum cortisol (Table 4.3) or plasma lactate (Figure 4.3). Plasma lactate 
concentrations increased from -1 to 3 mmollL during exercise in both trials. 
Resting serum cortisol concentrations were above normal values (-500 nmollL) in both trials, 
most likely due to the established effects of a low CHO diet 440. Over the first 80 min of exercise, 
serum cortisol increased by 30% in the CI trial compared to 48% in the PI trial, and by 93 and 
102% at exhaustion, in CI and PI trials, respectively (non significant, NS). Serum cortisol 
concentrations at exhaustion were Significantly Inversely correlated with plasma glucose 
concentrations reached at exhaustion in the PI trial (r= -0.71; p<0.05). Subjects in the PI trial 
who completed 150 min of exercise tended to have lower serum cortisol concentra~ions 
throughout the exercise period. 
Serum Insulin concentrations (Table 4.3) were similar between trials over the first 80 min of 
exercise, but were significantly higher at the end of exercise in the CI compared to the PI trial 
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Figure 4.3: Plasma lactate concentrations during steady-state exercise. n=9 up to end of solid line, 
subject numbers indicated in brackets thereafter. END = value at exhaustion (100% of time). 
Table 4.3: Serum insulin and serum cortisol concentrations during steady-state exercise. 
Time (min) 
0 20 40 60 80 100 120 140 END 
(n=9) 
Insulin (JlUlml) 
9.9±7.8 6.2±2.2 5.6±1.8 5.2±1.1 5.7±1.7 5.0±1.9 4.6±1.3 5.2±2.0(S) ·*4.2±1.3 
8.8±2.8 4.6±1.5 4.4±1.3 4.3±1.1 3.5±1.1 3.8±1.0(6) 3.9± 0.1(4) 3.3±0.4(3) :*3.2±1.0 
Cortisol (nmoIlL) 
507±200 431±170 430±207 481±192 596±265 708±307 866±336 792±249(S), 906±312 
473±165 450±157 466±156 547±240 663±254 711±346(6) 805±332(4) 846±71 (3) 901±234 
END = value at exhaustion (100% of time). *Significant difference between trials (p<0.05). n=9, otherwise 
as indicated in brackets. 
4.3.5 Serum free fatty acid (FFA) concentrations (Figure 4.1 B) 
Serum FFA concentrations were similar in both groups at rest (-0.5 mmollL) and up to 80 min of 
exercise (-0.6 mmoIlL). At 100 min, FFA concentrations were significantly higher in PI th~n CI 
(0.9 :I: 0.2 vs. 0.6 :I: 0.2 mmollL, respectively; p<0.05, n=6), and increased progres~ively 
thereafter to concentrations of above 1.0 mmollL. FFA concentrations at exhaustion were '-0.4 
mmollL higher in the PI (1.1 :I: 0.6 mmollL) than the CI trial (0.8 :I: 0.3 mmollL) (p=0.09). The FFA 
concentrations at exhaustion were significantly correlated to endurance time in both the PI 
(rho=0.87; p=0.001) and CI trials (rho=0.83; p=0.005). Hence, in both trials, the subjects with the 
highest FFA concentrations (>0.8 mmollL) had the longest endurance times. 
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4.3.6 Serum fJ-hydroxybutyrate concentrations (Figure 4.4) 
Serum j3-hYdroxybutyrate concentrations were significantly higher (p=0.02) in PI (0.26 ± O.OB 
mmollL) than in CI (0.1B ± 0.05 mmol/L) at BO min, and tended to remain higher in PI at the end 
of exercise (p=0.07). Additionally, there was a significant inverse relationship between 13-
hydroxybutyrate and plasma glucose concentrations reached at exhaustion in the PI trial :(r= -
0.70; p<0.05). Endurance time was significantly correlated to serum j3-hydroxybutyrate 
concentrations at BO min in PI trial (rho=0.94; p=0.0001) and to serum j3-hydroxybutyrate 
concentrations at exhaustion in both CI and PI trials (rho=0.65 and rho=O.BO, respectively, 
p<0.05). 
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Figure 4.4: Serum p-hydroxybutyrate concentrations at rest, at 80 min during steady-state exercise and at 
END (value at exhaustion). n=9. *Significant difference between treatments (p<0.05). 
4.3.7 Gas exchange data (Figure 4.5) and rates of substrate oxidation (Table 4.4) 
RER (Figure 4.5) remained between 0.B6 and O.BB within the first BO min of exercise in both the 
CI and PI trials. RER were maintained in this range beyond BO min of exercise in the CI trial, 
whilst It declined to between 0.B4 and 0.B6 in those subjects who exercised beyond BO min in the 
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Figure 4.5: Respiratory gas exchage ratio (RER) during exercise. n=9 up to end of solid line, subject 
numbers indicated in brackets thereafter. *Slgnlficant difference between treatments (p<0.05). END = 
value at exhaustion (100% of time). 
V02 (Table 4.4) remained constant during the CI trial, but increased significantly over time jn PI 
(p<0.05). reaching significantly higher values compared to CI from 40 to 80 min a~d at 
exhaustion (p<0.05). The rate of total CHO oxidation (Table 4.4) remained constant between 
-2.2-2.4 g/min during both exercise trials. In the CI trial, the rate of fat oxidation (Table 4.4) 
remained fairly constant (-0.6 g/min) throl.1ghout the first 120 min of exercise, with an increase to 
0.8 g/min at 140 min in the 5 subjects who sustained that duration of exercise. During the first 20 
min of exercise. the rate of fat oxidation in the PI trial was similar (-0.6 g/min) to that of tlie CI 
trial, but showed a significant increase over time (p=0.004) to 0.9 ± 0.3 g/min towards the end of 
exercise. From 40 min onwards, the average rate of fat oxidation was significantly higher in the 
PI compared to the CI trial (p=0.03). 
Table 4.4: Steady-state gas exchange data and rates of fat and total CHO oxidation during 
exercise. 
Time (min) 
20 40 60 80 100 120 140 END 
V02 Umin 
CI 3.1±O.6 3.0±0.6 3.0±0.6 3.1±O.6 3.1±0.6 3.1±0.5 3.3±0.4(5) 3.2±0.5 
PI 3.0±0.4 *3.3±0.4 *3.3±0.3 *3.4±0.2 3.3±O.3(6) 3.5±0.3(4) 3.5±O.4(3) *3.3±O.3# 
Fat oxidation (g/mln) 
CI 0.6±0.2 0.7±0.2 0.7±0.2 0.7±0.1 0.7±0.2 0.6±0.2 0.8±O.2(5) 0.7±O.2 
PI 0.6±0.3 0.8±0.3 0.8±0.3 0.9±O.3 0.9±0.2(6) 0.9±0.3(4) 0.9±0.3(3) 0.8±Q.3# 
CHO oxidation (g/mln) 
CI 2.4±0.4 2.2±0.4 2.2±0.5 2.3±0.5 2.4±0.7 2.4±0.7 2.2±0.6(5) 2.4±O.8 
PI 2.3±0.5 2.2±0.5 2.2±0.6 2.3±0.6 2.1±0.6(6) 2.2±0.7(4) 2.1±0.i3) 2.3±0.8 
END = value at exhaustion (100% of time). * Significant difference between trials. #Significant change over 
time (p<0.05). n=9, otherwise as indicated In brackets. 
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4.3.8 Plasma glucose oxidation 
In both trials, plasma glucose oxidation (Figure 4.6) rose steadily from -0.2 g/min at 20 min, to 
0.4 g/min in PI and 0.5 g/min in CI at 80 min of exercise .. Thereafter, the rate of plasma glucose 
oxidation increased significantly over time towards the end of exercise in the CI trial (-0.8 g/min), 
reaching significantly higher values compared to that of the PI trial from 40 min onwards (up to 
100% of time; p<0.05). In the PI trial, the rate of plasma glucose oxidation were maintained 
around 0.3 g/min from 80 min onwards and at end of exercise (100% of time). Endurance:time 
tended to be inversely correlated to the rate of plasma glucose oxidation at exhaustion in the PI 
trial (rho= -0.63; p=0.07). This suggests that plasma glucose oxidation is low in those subjects 
who are able to complete 140 min of exercise under PI conditions. 
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Figure 4.6: Tracer-determined rate of plasma glucose oxidation during exercise. n=9 up to end of solid 
line, subject numbers indicated in brackets thereafter. *Significant difference between treatments (p<0.05). 
END = value at exhaustion (100% of time). 
4.4 DISCUSSION 
The study was designed to investigate the effect of declining blood glucose concentrations 
compared to euglycemic conditions on metabolism and exercise capacity in subjects starting 
exercise with low glycogen stores. Thus, the first important finding of this study was that glu,cose 
infusion increased the mean endurance time of subjects starting exercise with low glyC?gen 
stores by an overall 28±26% (p<0.05), Only 2 (of 9) subjects completed the 150 min of exercise 
in the PI trial. Yet, despite the maintenance of euglycemia in the CI trial, the majority of subjects 
(5 of 9) still could not complete the given 150 min of exercise at 70% V02 peak, a task that would 
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be regarded as manageable for an endurance-trained cyclist 441. This indicates that aspects 
independent of blood glucose concentration per se hampered exercise capacity under these 
exercise conditions. Interestingly, the individual range in endurance time improvement: was 
large, varying from 0% (in the 2 subjects that finished both the PI and CI trial) to 63%. It is 
conceivable that the measured effect of glucose infusion on endurance time might have been 
even greater if the duration of the exercise bout was longer or had not been censored (to 150 
min). However, we specifically chose a defined limit time trial since open-ended trials are 
notoriously unreliable due to the large coefficient of variation (-27%) in performance that they 
produce 232. 
Muscle glycogen concentrations were equally low in both trials at the start and end of exercise 
(Table 4.2). Hence, despite a significantly longer exercise time in CI (-26 min), a similar amount 
of muscle glycogen was used. One possible explanation for this result may be that the glucose 
infusion and increased glucose availability resulted in a slowing of muscle glycogenolysis i~ the 
CI trial. However, with muscle biopsies taken only at the start and end of exercise, it is difficult to 
speculate on the potential impact of the glucose infusion on altering the rate of muscle glycogen 
utilization. Furthermore, the majority of studies employing similar steady-state exercise protocols 
(-70% V02peak) demonstrated that CHO supplementation during exercise has a minimal effect on 
the rate of muscle glycogen oxidation 36.89. Interestingly, Coyle et al. 89 demonstrated that CHO 
ingestion (compared to placebo) during exercise did not influence the rate of muscle glycOgen 
oxidation, so that muscle glycogen concentrations were equally depleted (-40 mmollkg w.w.) 
after 3 h of exercise despite CHO ingestion. However, CHO ingestion extended the exercise by 
a further -60 min, with little reliance on muscle glycogen. It was concluded that with CHO 
feeding, highly trained endurance athletes are capable of oxidizing CHO at relatively high rates 
from sources other than muscle glycogen during the latter stages of prolonged exercise an~ that 
this postpones fatigue 89. Therefore, similar to Coyle et al. 89, the rate of glycogen utilization in 
the present study may have been similar between trials, but, whereas subjects in the PI trial 
started fatiguing after -80 min and with muscle glycogen of -40 mmollkg W.W., the euglycemic 
glucose infusion extended exercise by an additional -26 min, with little further reliance on muscle 
glycogen oxidation. 
As expected, saline infusion in subjects with lowered glycogen stores resulted in a gradual 
decline in plasma glucose concentrations during the exercise bout compared to the euglycemic 
glucose infusion. A decline in blood glucose concentrations during prolonged exercise has 
traditionally been associated with a reduction in exercise capacity, mainly ascribed to a 
concomitant decline in total CHO oxidation 73.75.89. However, in the present study, despite an 
increase in plasma glucose oxidation late in exercise when euglycemia was maintained~ the 
overall rate of CHO oxidation remained unaltered.. More recent studies support the finding that 
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the frequently-quoted increase in CHO oxidation with CHO vs. placebo supplementation is not 
always observed 36,100,298,416, Alternative explanations for the ergogenic effect of CHO 
supplementation have come from McConell et al. 298, suggesting that CHO supplementation 
(compared to placebo) may enhance endurance exercise performance by lowering muscle 
inosine monophosphate levels (a marker of the rate of ATP degradation vs. resynthesis), thereby 
improving muscle energy balance. Similarly, though still controversial, it has also been 
suggested that CHO supplementation may enhance endurance exercise performance in some 
subjects via alternations in central nervous system function 100.326.394. 
In the present study, it is difficult to draw conclusions from the observed data beyond the 80 min 
timepoint due to declining subject numbers and a censored end-point. Nevertheless. comparison 
between trials of the values reached at the pOint of exhaustion (n=9), indicate that glucose 
infusion resulted in a significant increase in insulin concentrations and a significant (two-fold) 
increase in plasma glucose oxidation from -0.3-0.4 g/min (at 80 min in PI and CI, and at 
exhaustion in PI), to -0.8 g/min (at exhaustion in CI). which might have contributed, at le~st in 
part. to the increased endurance capacity 89. However, despite the Significant increase in plasma 
glucose oxidation in CI, the majority of subjects still failed to complete the exercise task. 
Furthermore, there were no notable differences in the rates of plasma glucose oxidation between 
subjects whose exercise capacity was increased most (relative to PI) and those who did not 
show a large improvement as a result of glucose infusion. Peak rates of plasma glucose 
oxidation of -0.8 g/min with euglycemic infusion in subjects starting exercise with low glycOgen 
status have been noted previously 440.441, whilst plasma glucose oxidation rates of 1.0-1.5 g/min 
have been reported in studies where euglycemia was maintained via CHO ingestion 38 or with 
hyperglycemic glucose infusion 440 and with concomitant insulin concentrations of >5 IJUlml. 
Thus it is possible that glucose infusion at the rate to merely maintain euglycemia in subjects 
starting exercise with low glycogen reserves (as in the present study), is inadequate to incr~ase 
Insulin and plasma glucose oxidation suffiCiently (or above 0.8 g/min), so as to enable all 
subjects to finish the exercise task. Unfortunately. results on the individual rates of glucose 
infusion needed to maintain euglycemia are not available. This data could have provided more 
inSight into the individual responses observed in exercise capacity with glucose infusion. 
The gradual decline in plasma glucose during the PI trial (and significantly lower rate of plasma 
glucose oxidation at exhaustion) likely reflects the inability of hepatic glucose production to keep 
pace with glucose uptake by the working muscle. Liver glycogen content would be low, as it has 
been shown to decrease to 22-55 mmollkg w.w. after 3 days on a low CHO diet 319. Even with 
ingestion of 30 g of CHO 3 hours prior to the trial, if 29% 247 of the CHO ingested was taken up 
by the splanchnic tissues, with a liver mass of 1.8 kg, liver glycogen content would remain low at 
49-82 mmollkg w.w. Under such conditions, glucagon, ACTH and cortisol concentrations are 
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known to rise, providing a stimulus for enhanced hepatic glycogenolysis and gluconeogenesis 
223.307.440.441 and a shift towards fat oxidation. However, the euglycemic glucose infusion had no 
effect on the concentrations of lactate, insulin, FFA and cortisol during the initial 80 min of 
exercise compared to saline (placebo) infusion. These findings can be explained by Weltan et al. 
441, who demonstrated that only when insulin was infused or hyperglycemia maintaine~ (in 
subjects starting exercise after a similar glycogen lowering protocol), were the metabolic effects 
of a low CHO diet and lowered glycogen counteracted. This indicates that, at least during the 
initial 80 min of exercise, euglycemic glucose infusion had little effect on altering the hormonal 
and metabolic effects that are typically seen as a consequence of low glycogen content at the 
onset of exercise 162.190.194.204.223.440. 
The variability in endurance capacity when glycogen concentrations are low at the start of 
exercise could be the individual's ability to oxidize alternative substrates, specifically FFA and 13-
hydroxybutyrate, to contribute to the energy demand. This is strengthened by the Significant 
correlation between serum FFA concentrations at exhaustion and endurance time in bot~ the 
trials. A large variability in substrate (particularly fat) oxidation and fatigue resistance bet\yeen 
individuals have been noted previously 2.172. This variability may be linked to the existence of a 
metabolic phenotype, but may also be influenced by diet and/or training status 172. 
An important, but unexpected finding, was that the glucose infusion did not enhance endurance 
exercise capacity simply by preventing a decline in blood glucose concentrations. There are two 
lines of reasoning to explain this conclusion. First, there was a surprising inverse relationship 
between exercise duration and blood glucose concentrations at exhaustion in PI (Figure 4.2). 
Hence, subjects who exercised for the shortest duration during PI, terminated exercise with the 
highest blood glucose concentrations and their exercise capacity was enhanced the most by 
glucose infusion, and vice versa. Indeed, some subjects (4 of 9) who terminated exercise early 
(-80 min) in the PI trial had blood glucose concentrations of >4 mmollL and hence were not 
hypoglycemic according to the usual definition 7. Blood glucose concentrations at eXhaustibn in 
the placebo infusion trial ranged from 2.7 to 4.5 mmol/L. The results of this study are in contrast 
to those stUdies supporting the hypothesis that increased resistance to fatigue associated with 
CHO-Ioading or CHO supplementation during exercise, or both, may result from the prevention of 
hypoglycemia 53.73.242.445, It is also in contrast to those studies which have demonstrated that 
CHO supplementation improved endurance exercise capacity only in the individuals who became 
hypoglycemic during the placebo treatment 19.91,92, For example, Coyle et al. 91 reported that 
CHO ingestion during prolonged exercise at 74% V02 max increased endurance time by ,-17%, 
but only in those subjects who developed hypoglycemia during the placebo trial. The present 
findings are in agreement with studies demonstrating that CHO supplementation during exercise 
improved endurance performance in individuals who did not become hypoglycemic during the 
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placebo trials 60,293,313, and demonstrating that CHO supplementation did not alter total CHO 
oxidation rates during exercise 36,60,100,132,298,313,416, Furthermore, these results are supported by 
studies in which the development of hypoglycemia had no effect on exercise capacity or 
performance 87,146,228,230,312, Collectively taken, these results suggest that the "fatiguing effects" of 
declining blood glucose concentrations differ between individuals, The nature of this difference is 
not clear, but may relate to differences in cerebral sensitivity to reductions in blood glucose 
concentrations 7, and/or phenotypic differences in metabolism during exercise 2,172, The 
phenotypic differences seen might be related to genetiC differences, or to differences in habitual 
dietary and training regimes 102,172, 
Secondly, the majority of subjects (5 of 9) terminated exercise prematurely in the CI trial even 
when euglycemia was maintained, When euglycemia is maintained by glucose infusion in 
subjects with lowered glycogen stores, then glucose that disappears from the circulation is 
replaced with infused glucose, and hence the CHO energy demand is met. Thus, the impaired 
exercise capacity cannot be attributed to a shortage of available CHO for oxidation, 
Furthermore, glucose infusion should prevent any metabolic or hormonal effects ~s a 
consequence of inadequate extramuscular and extrahepatic CHO availability, Yet, the metabolic 
and ergolytic effects of low glycogen reserves described in this and other studies 162,204,223,440 
persisted despite the maintenance of euglycemia, which indicates that the responses might 
rather be related to reduced intramuscular or intrahepatic CHO availability, Interestingly, in both 
the CI and PI trials the subjects fatigued at muscle glycogen concentrations of -40 mmollkg'w,w, 
This has also been observed in other studies employing steady-state cycling protocols performed 
to exhaustion at similar exercise intensities (-70% V02max ) 73,89, 
Though still speculative, the above observations might be explained by recent evidence 
suggesting that muscle glycogen may act as a feed-forward metabolic signal that informs the 
individual at what point they should slow down or stop exercise to prevent the developme.nt of 
absolute substrate depletion 340,350,383,440,441, It has been suggested 328,440,441 that peripheral 
inhibitory input is conveyed from metabo- and chemo-receptors that are sensitive to chemical 
changes within the muscle, which may, via group III and IV afferents, affect supraspinal parts of 
the central nervous system which may then reduce central motor drive, Evidence in support of 
this suggestion comes from studies demonstrating, for example, that group III and IV mtlscle 
afferents invoke circulatory and ventilatory reflexes during exercise 308 and provide inhibitory 
feedback from metabolic disturbances such as lactic acid production 383, pain 85 and 
mechanoreception 308,340, In addition, there is also evidence to suggest that apart from a 
metabolic role, muscle glycogen availability may also have a structural role in that it may be 
critical in the regulation of excitation-contraction coupling 12,64, 
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In summary, the findings of this study provide additional evidence for the ergogenic effect of 
CHO supplementation during prolonged exercise in subjects with reduced glycogen content, 
however, this effect is highly variable between individuals and independent of changes in the rate 
of total CHO oxidation. Furthermore, despite euglycemic glucose infusion and an increase in 
plasma glucose oxidation, the majority of these well-trained endurance subjects still could not 
complete the prescribed 150 min of exercise. This study establishes that some aspect of intra-
muscular and/or intra-hepatic glucose metabolism influences the endurance capacity of subjects 
who begin exercise with low glycogen content. The exact link between plasma glucose 
concentration and endurance capacity remains unclear as subjects whose blood glu'cose 
concentrations did not change markedly during placebo infusion, demonstrated the greatest 
benefit from glucose infusion with regard to increased endurance capacity. It appears that those 
individuals with a high rate of fat oxidation (>1 g/min) and a decreased sensitivity to declining 
blood glucose concentrations and hypoglycemia are more likely to sustain exercise for longer 
than 80 min under these conditions. Further investigation into the existence of a met~bolic 
phenotype and the influence of diet and training status in altering individual substrate metabc:>lism 
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5.1 INTRODUCTION 
There is a substantial body of scientific and medical literature concerning carbohydrate (CHO) 
metabolism during exercise, particularly in relation to the onset of fatigue during more prolonged 
exercise bouts (for reviews see 220). However, there are many key aspects of the regulation of 
CHO metabolism, and the importance of maintaining euglycemia during exercise in delaying the 
onset of fatigue that remain unresolved and in some cases, appear paradoxical. 
A number of studies have found that maintenance of blood glucose concentrations, especially 
towards the latter stages of prolonged (>90 min) exercise, is a key factor for delaying fatigue and 
improving performance 35,73.74,89, and that a decline in blood glucose (from 5.2 to 2.9 mmol/L) 
after 3 h of exercise is related to an increase in perceived exertion 326. Conversely, others 146,162 
found that the prevention or reversal of hypoglycemia (plasma glucose <2,5 mmol/L) during 
exercise had little effect on endurance capacity or perceived exertion. For example, in the study 
of Felig et al. 146 plasma epinephrine was inversely related to blood glucose concentrations 
(p<0,01) and was three times higher in the hypoglycemic subjects (p<0.05). The ingestion of 
glucose (40 or 80 g/h) prevented the hypoglycemia and resulted in a smaller rise in plasma 
epinephrine concentrations, but did not alter perceived exertion or consistently delay exhaustion. 
These results demonstrated that hypoglycemia resulted in an exaggerated rise in plasma 
epinephrine concentrations, but failed to effect endurance capacity, and its prevention did not 
consistently delay exhaustion 146, Thus, the exact effects of alterations in blood glucose 
concentrations on exercise performance remain unclear, 
The previous study (Chapter 4) demonstrated that glucose infusion increased the endur~nce 
capacity of CHO-depleted subjects by an average of 28% (p<0.05) compared to a placebo 
(saline) infusion. However, the inter-individual variability for improvement in endurance ~pacity 
was large, ranging from either no improvement (i.e. similar endurance time for both trials), up to 
63% improvement with glucose infusion. The most surprising finding was the inverse 
relationship between exercise duration and blood glucose concentrations at exhaustion iri the 
placebo infusion trial (r =-0.63, p=0,02). Hence, subjects who became the most hypoglycemic 
managed to exercise the longest, whilst others who exercised for the shortest duration, 
terminated exercise with blood glucose concentrations of >4 mmol/L (i.e. not hypoglycemic). 
These results suggested that the fatiguing effects of hypoglycemia may differ between 
individuals. The nature of this difference is not clear, but may relate to phenotypic differen~s in 
metabolism 172 or perhaps to different nutritional strategies before and during exercise whic~ can 
p~edispose the individual to develop hypoglycemia. It is not uncommon for endurance athletes to 
experience low blood glucose levels during long, strenuous training sessions due to insufficient 
CHO supplementation. 
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It has been shown that mild, recurrent, hypoglycemia impairs or reduces the capacity of the 
individual to recognize symptoms of hypoglycemia at the physiological threshold of -3 mmor/L 26. 
The in vivo mechanisms responsible for this phenomenon have not been fully clarified, but 
reduced neuro-endocrine and symptomatic responses to subsequent hypoglycemia after one 
(recent) episode of hypoglycemia have been demonstrated in patients with type 1 diabetes, at 
rest 39.95.101.349.444 and during exercise 39.370, as well as in nondiabetic, healthy individuals 205. 
Several studies have now shown that a variety of other stresses, sufficient to result in raised 
glucocorticoid concentrations, have the ability to blunt neuroendocrine and autonomic nervous 
system (ANS) responses during subsequent exposures 106.261.267.341. Raised cortisol has been 
shown to play a key role in the pathogenesis of deficient counterregulatory responses to 
subsequent hypoglycemia in healthy individuals 106.205, As hypoglycemia and exercise can both 
lead to elevations in glucocorticoids and elicit similar neuro-endocrine and ANS responses, it has 
been suggested that these two forms of stress may reciprocally blunt their respective 
counterregulatory responses 160, 
In a study by Kuipers et al. 266 some subjects (6 out of 19) developed rebound hypoglycemia 
(plasma glucose <3.0 mmollL) after ingestion of 50 g of CHO, 30 min prior to starting 40 min of 
exercise at 60% of maximal power output. These subjects (n=6) displayed a Significantly lower 
norepinephrine response throughout most of the exercise bout compared to the group of subjects 
who did not develop hypoglycemia (n=13), which reflects a lower activation of the sympathetic-
mediated counterregulatory response in the hypo-group. Insulin concentrations remained similar 
between groups, however, insulin sensitivity per se was not measured. Furthermore, though 
epinephrine concentrations were similar between groups, a large inter-individual variation. was 
noted 266. 
A further interesting observation in the literature is that endurance-trained men might devE!lop an 
adaptation of the HPA-axis to repeated and prolonged exercise-induced increases in cortisol 
secretion (or repeated stimulation of the HPA-axis) 125. These adaptive mechanisms may include 
decreased sensitivity to cortisol to protect muscle and other glucocorticoid-sensitive'tis'sues 
against the increased cortisol secretion commonly observed during and up to 2 h after exercise 
124.125. The findings by Viru et al. 428 suggested that fatigue from prolonged endurance activity 
may introduce a resetting in the pituitary-adrenocortical component of the endocrine system, 
expressed either by intensified endocrine functions in some individuals or by suppressed 
endocrine functions in others. The potential impact of these alterations in HPA:-axis 
responsiveness on glucoregulatory hormonal responses and maintenance of glu~se 
homeostasis have, to our best knowledge, not been fully investigated. 
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Reduced counterregulatory responses may, in part, explain the observation noted in the literature 
that some individuals show altered metabolic and hormonal responses in relation to alteratio.ns in 
blood glucose concentrations 266. Furthermore, the reduced symptomatic responses (referr~d to 
as "hypoglycemia unawareness") that may accompany the deficient counterregulatory responses 
may explain the situations where exercise performance, particularly during prolonged exercise, 
remains unaffected despite the development of hypoglycemia (as described in Chapter 4). 
Indeed, Davis et al. 102 reported that antecedent exposure to hypoglycemia resulted in significant 
blunting of neuro-endocrine (glucagon, insulin, catecholamine) and metabolic (endogenous 
glucose production, lipolysis, ketogenesis) responses during a gO-min exercise bout (the 
following day) in healthy subjects. The group exposed to antecedent hypoglycemia required a 
10-fold higher rate of glucose infusion in order to maintain euglycemia during the exercise bout, 
compared to the antecedent euglycemic group. However, the euglycemic glucose infusion 
during exercise makes it difficult to elucidate whether the neuro-endocrine and metabolic 
responses were caused by, or resulted in the high rate of glucose infusion required to maintain 
euglycemia. 
In a subsequent study, Galassetti et al. 160 demonstrated that antecedent prolonged exercise 
under euglycemic conditions blunted neuro-endocrine and metabolic counterregulatory 
responses to subsequent hypoglycemia. Furthermore, Galassetti et al. 161 demonstrated a 
sexual dimorphism in the counterregulatory response to antecedent hypoglycemia, with a 
significantly greater attenuation of response in men, when compared to women. Again, in both 
these studies, glucose was infused during exercise to maintain euglycemia, which complicates 
interpretation of the blunted counterregulatory response. It is unclear what the metabolic and 
hormonal responses would be if blood glucose concentrations during exercise were leff free to 
vary and without exogenous manipulation. In addition, the responses of well-trained individUals, 
with presumably enhanced insulin sensitivity (for review see 34) and altered sympathetic and 
parasympathetic activation as a result of regular exercise training 62,266, are unknown. 
In the above-mentioned studies by the Davis group, exercise performance per se was not 
measured. Seeing that glucose is a major fuel for the brain and important to sustain cognitive 
metabolism, hypoglycemia may impair cognitive performance 156. Nybo et al. 326 recently 
investigated whether hypoglycemia-induced fatigue during 3 h of cycling at 60% V02 max could be 
related to alterations in cerebral metabolism. A temporal association between increased 
perceived exertion and reduced cerebral glucose uptake suggested that fatigue was related to 
inadequate substrate availability for the brain 326. 
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Measurement of cognitive function per se (such as choice and simple reaction time) has been 
shown to be impaired during exposure to hypoglycemia 135,158, but a single episode of mild 
antecedent hypoglycemia (3,1 mmol/l) in healthy men can reduce the magnitude of cognitive 
impairment during a subsequent exposure to hypoglycemia (within 18-24 h) 158. This might be 
explained by data indicating that cerebral adaptations may occur that allow for normal brain 
glucose uptake and cerebral function to be maintained during recurrent systemic hypoglycemia 
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The limited available literature seem to indicate that prolonged (2-3 h), moderate-intensity «60-
75% V02 max) exercise may be associated with an increase in cognitive performance 81,177,352. 
This effect is suggested to be the result of an increase in metabolic load, specifically, to the rate 
of increase in catecholamine concentrations which increases CNS activation and in turn, results 
in an increase in arousal level 46,66,177. The increase in arousal and cognitive functioning have 
also been linked to an increased heart rate and an increased rating of perceived exertion 46. 
Prolonged exercise may also increase cerebral blood flow, or neurotransmitter (catecholami~es I 
endorphin) release, however, the exact mechanism for the enhanced cognitive functioning i~ still 
unknown 46. 
During prolonged exercise, the development muscle glycogen depletion and hypoglycemia have 
been related to the development of peripheral and central fatigue 52,76 which may also impair 
cognitive functioning 46. Conversely, CHO ingestion has been shown to delay the onset of 
fatigue 52,76 and attenuate the perception of effort towards the latter stages of prolonged exercise 
46,420, and minimize the negative effect of central fatigue induced by prolonged exercise 46. The 
findings of Grego et al. 177 recently suggested a combined effect of arousal and central fatigue on 
electrocortical indices of cognitive function during 3 h of exercise 177, however, more research is 
needed to investigate the role of central factors on cognitive performance 46. 
It is yet unclear if the blunted neuroendocrine and metabolic responses seen after antecedent 
exposure to physiological stress (e.g. hypoglycemia or exercise 102,160) may affect muscle 
recruitment, perceived exertion, cognitive function and ultimately endurance exercise 
performance. Specifically, It is also not known if the altered HPA-axis activation (and reduced 
sympathetic activation) may result in reduced central command, thereby potentially affe.cting 
force production (muscle recruitment), perceived exertion cognitive function and exercise 
performance. 
It is also conceivable that if the symptomatic response to hypoglycemia is blunted during 
subsequent stressful exposures 311, then exercise performance per se may actually be improved 
as the individual will be able to exercise for longer before "sensing" symptoms of hypoglycemia 
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which may translate into symptoms of fatigue. Effort perception may primarily be a feedforward 
system that results from the interpretation of afferent sensations around the body. It is undear 
how the brain interprets this feedback, but it has been suggested that an integration of these 
sensory cues may indirectly and unconsciously influence effort perception during exercise, and 
thereby fatigue 182.331. 
In summary, there is disparate evidence as to how the development of fatigue during prolonged 
exercise is affected by decreased CHO availability and the associated neuro-hormonal response. 
It is also not clear as to how these central and peripheral (feedforward and feedback) responses 
are integrated, and to what extent it may vary between individuals. Accordingly, the aim of this 
study was to determine the effect of an antecedent bout of hypoglycemia on counterregulatory 
responses, metabolism, liver glucose outpu~ perception of effort and endurance performance 
during endurance exercise. We hypothesized that antecedent exposure to hypoglycemia would 
reduce neuroendocrine and metabolic responses to prolonged exercise, and in addition, reduce 
effort perception and thereby improve exercise performance. 
5.2 METHODS 
5.2.1 Subjects 
Ten healthy, endurance-trained males aged between 19 and 35 years were recruited to 
partiCipate in this study (subject characteristics are presented in Table 1). None were taking any 
medication or had any previous significant medical history, nor had any personal or family history 
of diabetes mellitus. Each volunteer gave their written, informed consent before participation in 
the study, which was approved by the Research and Ethics Committee of the Faculty of Health 
Sciences of the University of Cape Town (South Africa). 
5.2.2 Research design 
Each subject underwent two, 2-day experimental trials separated by at least one month. The 
order of the experimental trials was randomized and performed in a single-blind, counter-
balanced fashion. On day 1, subjects were either exposed to two aO-min bouts of hypoglycemia 
(HYPO trial) separated by 40 min of euglycemia, on the other occasion, euglycemia was 
maintained throughout (EU trial). On day 2, subjects performed 90 minutes of cyding exercise at 
70% of V02 max followed by a cycling time trial consisting of time to complete 200 kJ of work. No 
blood glucose manipulations were done during day 2. Subjects ingested water only (ad lib), and 
a primed, continuous infusion of [3-3H]glucose was started at ~O min and continued for 90 min 
in order to measure hepatic glucose output during steady-state exercise. Studies were identical 
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other than the plasma glucose profiles on day 1 of testing (detailed below). Subjects were 
blinded to the order of the studies as well as their plasma glucose concentration at all times. On 
the day prior to each test day, subjects were required to abstain from alcohol and exercise, and 
were asked to keep a detailed food diary, which were to be repeated the day prior to the second 
experimental trial. During the course of the study subjects were instructed to maintain their 
habitual exercise schedule and diet. 
5.2.3 Preliminary testing 
5.2.3.1 Anthropometry 
At least one week prior to the experiment proper, each subject's height and weight were 
recorded and body mass index (BMI) was calculated. Body fat was determined from the sum of 
seven skinfolds (biceps, triceps, subscapularis, abdominal, thigh and calf) and calculated using 
the equation of Durnin & Womersley 127. 
5.2.3.2 Peak sustained power output (Wpe.,J test 
The anthropometric assessment was followed by a 10-min warm-up exercise bout on a 
stationary cycle ergometer (Lode. Groningen. The Netherlands). This was followed by an 
incremental test to exhaustion in order to determine each subject's peak sustained power output 
(Wpeak). The Wpeak test was performed on the electronically braked cycle ergometer at a workload 
equivalent to 3.3 W/kg body mass and increased first by 50 W after 150 sec and then by 25 W 
every 150 sec until the pedaling frequency dropped below 50 revolutions/min. This information 
was used to adjust the work load during the exercise trial so that each subject exercised at an 
intensity corresponding to 70% of peak rate of oxygen consumption (V02 max), which this 
corresponds to -63% of Wpeak 197. 
5.2.3.3 Cognitive function baseline testing 
A computerized software program (CogStateT~ was used in the cognitive testing. CogState™ is 
a software program comprising five non-verbal computerized neuropsychological tests assessing 
reaction time, decision making, sustained and divided attention, working memory and new 
learning 82. This test battery requires the participant to respond manually (via the keyboard) to 
playing cards presented on the computer screen. Although the physical response remains 
consistent between tasks (the same 2 keys are used), each of the tasks is set in a different 
context and requires use of different cognitive processes. For example, the simple reaction time 
(SRT) task requires participants to press a key as soon as the presented card turns face-up. The 
choice reaction time (ChRT) task requires partiCipants to press one of two keys depending upon 
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the color of the presented card. Thirty accurate responses are required to complete each task. 
These computerized tasks are highly reliable when administered serially to healthy adults and 
children83, and have documented sensitivity to mild cognitive changes caused by concussion 284, 
fatigue 137, alcohol 284, early neurodegenerative disease 99, coronary surgery 381 and childhood 
mental illness 310. The effects of practice 82 and its correlation with conventional paper-and-pencil 
tests 83 have been documented. Table 5.1 lists the cognitive assessment tasks employed in the 
present study. 
Table 5.1. Cognitive assessment battery used in this study. 
Task name Abbreviation Cognition assessed 
Simple Reaction Time SRT Motor function 
Choice Reaction Time ChRT Decision making 
Monitoring task DIVA Divided attention 
One-Back OBK Working memory 
Continuous Learning LEARN Learning & memory 
One to two weeks prior to the experiment proper, all participants completed a baseline cognitive 
test conSisting of a practice trial and a baseline trial. Eight of ten participants completed a 
second baseline test, performed 2 weeks after completion of the study. Baseline testing was 
conducted in a quiet, well-lit environment and was supervised by one of the study investigators. 
5.2.4 Day 1 experiments: Blood Glucose Clamping Procedure 
On the morning of each trial (8:00 A.M.), subjects reported to the testing laboratory after a 10-
hour overnight fast. Two intravenous catheters were inserted into the non-dominant arm. One 
cannula was placed in retrograde fashion distally in the forearm for blood sampling and kept 
patent with a slow infusion of normal saline. The other cannula was placed in the antecubital 
fossa to enable administration of insulin and glucose. The forearm was then placed in a heated 
box (55-60°C) to arterialize the venous blood samples. The heated box was exchanged for a 
heating blanket during the 5-min it took to perform the computerized cognitive test. A primed, 
continuous intravenous infusion of regular insulin (Human Actrapid, Novo Nordisk), which was 
made up to 55 ml in 0.9% sodium chloride to which 2 ml of the subject's blood had been added, 
was infused at a maintenance rate of 1.5 mU/kg BM/min. A stopwatch was started as soon as 
0.5 ml of the insulin solution had been delivered. Plasma glucose (measured at the bedside 
every 5 minutes (Glucose analyzer 2; Beckman Instruments, Fullerton, CA» was maintained at 
the required concentration during HYPO and EU using a variable-rate intravenous infusion of 
20% dextrose 94. Plasma glucose was maintained at euglycemia (5 mmol/L) for the first 40 
minutes of each of the glucose clamping trials (HYPO and EU). In the HYPO trial plasma 
glucose was reduced (by reducing the glucose infusion rate) to 2.9 mmol/L and maintained at 
126 
this level for 80 min. This was followed by 40 min of euglycemia (5 mmollL), and a subsequent 
second 80-min bout of hypoglycemia (2.9 mmoI/L). The clamp lasted a total of 240 min. In the 
EU trial, euglycemia (5 mmoUL) was maintained throughout the 240 min. 
On completion of the trials (at 240 min), the insulin infusion was stopped. The plasma glucose 
was restored to euglycemia if necessary, and subjects were given a meal to consume. Plasma 
glucose monitoring continued until euglycemia was maintained spontaneously, after which all 
lines were withdrawn and subjects could return home. 
5.2.4.1 Measurements during Day 1 experiments 
5.2.4.1.1 Blood sampling 
Apart from bed-side determination of plasma glucose concentration every 5 min, a -12 ml blood 
sample was collected at baseline and at 20-min intervals and separated into tubes containing gel 
and clot activator (Beckton-Dickinson, South Africa) for determination of serum insulin and 
cortisol concentrations, and a tube containing lithium heparin (Beckton-Dickinson, South Africa) 
for determination of plasma catecholamine concentrations. The tubes were immediately placed 
on ice and, after 20 min, centrifuged at 3500 rpm for 12 min at 4 oC, and the supernatants were 
then stored at -80 °C for later analysis. Serum insulin concentrations were determined using a 
radio-immunoassay (RIA) technique (Coat-A-Count Insulin, Diagnostic products, Los Angeles, 
CA). Serum cortisol concentrations were assayed using the Clinical Assays Gamma Coat RIA kit 
(Diagnostic Products, Los Angeles, CA). Plasma catecholamines were measured using HPLC 
with electrochemical detection using the method described by Forster and MacDonald 150 
(however, due to technical delays the catecholamine data will not be reported here). 
5.2.4.1.2 Blood pressure 
Systolic blood pressure remained similar between the HYPO and EU trails, and remained 
unchanged throughout the clamping experiments. Diastolic blood pressure was significantly 
lower in the HYPO compared to the EU trial at the 100, 220 and 240 min timepoints (p<0.05). In 
the HYPO trial, diastolic blood pressure was significantly lower at 100 and 120 min (end of the 
first HYPO exposure; -58±7) and at 200, 220 and 240 min (end of second HYPO exposure; 
-58±5) compared to baseline (68±8). 
5.2.4.1.3 Symptomatic responses 
Subjective ratings of hypoglycemic symptoms were assessed by the use of a questionnaire 
(administered every 20 min), asking subjects to rank sweating, warmth, palpitations, tingling, 
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anxiety, trembling, hunger, blurred vision, drowsiness, confusion, weakness, headache, difficulty 
speaking, dizziness, and irritability individually on a linear analog scale. Autonomic symptom 
scores were derived from the first 7 symptoms listed, and neuroglycopenic scores from the latter 
S symptoms with symptoms being ranked from 0 (not at all) to 6 (very severe/maximal) 
throughout each of the trials 207. 
5.2.4.1.4 Cognitive testing 
Two of the cognitive tests, SRT and ChRT, were administered towards the end of the first SO min 
bout of hypoglycemia (HYPO 1, at time 115 min), and again at the end of the second bout of 
hypoglycemia (at time 230 min), before euglycemia was restored, and at equivalent time points in 
the EU trial. The administration of the SRT and ChRT tests took -5 min. These two tests were 
included to enable comparisons of cognitive function between the two bouts of hypoglycemia 
(HYPO 1 vs. HYPO 2), combined with comparisons to euglycemic clamp experiment (EU) at the 
equivalent time points. Only two of the full battery of 5 tests was administered during the clamp 
(at 115 min) as it was short enough to minimize subject strain and minimize disruption of the 
clamping procedure. The full battery of 5 tests was administered towards the end of each 
glucose clamp experiment, i.e. at 225 min during the HYPO and EU experiment, respectively and 
took -12-15 min to complete. 
5.2.5 Day 2: Exercise experiment 
The morning after the glucose clamp procedure, subjects reported to the laboratory after a 10-
hour overnight fast. One 1S-gauge cannula was placed in a forearm vein to enable blood 
sampling. A second 21-gauge cannula was placed in the contralateral arm to enable infusion of 
the [3-3H]glucose tracer for isotopic determination of glucose production and utilization during 
steady-state exercise. After insertion of the cannulae, subjects remained at rest for 60 min 
during which the primed (35 IlCi), continuous (0.25 IlCi/min) infusion of the [3-3H]glucose tracer 
was started (Amersham Intemational, Buckinghamshire, UK). The isotope infusion was 
continued during the 90 min of steady-state exercise and stopped prior to the start of the time 
trial. After resting for 60 min, subjects started a 10-min warm-up cycling bout, 5 min at 100 W 
followed by 5 min at 150 W, on an electronically braked cycle ergometer (Lode, Groningen, The 
Netherlands). This was followed by 90 min at cycling at 60% of their individual pre-determined 
maximal work capacity (Wpeak; equivalent to -70% V02max). At 15-min intervals (and after blood 
and respiratory gas exchange measurements were completed), subjects performed a sprint, 
which consisted of completing 10 kJ of work in as fast a time as possible (-20 sec). At the end of 
the 90-min ride, subjects rested for 1 min, followed by the performance time-trial conSisting of 
completing 200 kJ of work in as fast a time as possible (-15-20 min). During exercise the 
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subjects could ingest water ad lib and were cooled with an electric fan. Environmental conditions 
in the laboratory were controlled at 20 (lC. 
5.2.5.1 Measurements during Day 2 experiments 
5.2.5.1.1 Blood sampling and analysis, V02 and VC02 measurements 
Blood, on-line respiratory gas exchange (done for 5 min at a time; Oxycon Alpha computerized 
system, Jaeger-Mijnhart, The Netherlands) were sampled at baseline, at 15 min intervals during 
steady-state cycling (before performing the sprint), and at the end of the time trial. After each 
blood sample was taken, the cannula was kept patent by flushing with 1 ml sterile saline. 
Aliquots of the blood sample were placed into tubes containing potassium oxalate and sodium 
fluoride (Midran; Novo Nordisk, Johannesburg, South Africa) for subsequent analysis of plasma 
glucose, [3-3H]glucose specific activity, and lactate concentrations. Another aliquot of blood was 
divided into a tube containing gel and clot activator (Beckton-Dickinson, South Africa) for 
determination of serum free fatty acids (FFA), cortisol and insulin concentrations, and a tube 
containing lithium heparin (Beckton-Dickinson, South Africa) for determination of plasma 
catecholamine concentrations (not reported here). The tubes were immediately placed on ice 
and, after 20 min, centrifuged at 3 500 rpm for 12 min at 4°C, and the supematants were then 
stored at -80°C for later analysis. Plasma glucose concentrations were determined by the 
glucose oxidase method using a glucose analyzer (Glucose analyzer 2; Beckman, Fullerton, CA). 
Lactate concentrations were measured by spectrophotometric (model 35; Beckman, Fullerton, 
CAl enzymatic assays (Lactate PAP; Bio Merieux, Marcy-L'Etiole, France). Serum insulin 
concentrations were determined using a RIA technique (Coat-A-Count Insulin, Diagnostic 
products, Los Angeles, CAl. FFA concentrations were measured using an enzymatic 
colorimetric assay (Half-micro test; Boehringer Mannheim). Serum cortisol concentrations were 
assayed using the Clinical Assays Gamma Coat RIA kit (Diagnostic Products, Los Angeles, CAl. 
Catecholamine concentrations were determined by HPLC (however, due to technical delays the 
catecholamine data will not be reported here). 
5.2.5.1.2 Rating of perceived exertion and heart rate measurements 
Subjective ratings of perceived exertion (RPE) was measured at 15-min time intervals during 
exercise (before performing the "'20 sec sprint). Two scales were used to quantify the subject's 
level of exertion: 1) the validated Borg 15-point RPE scale, and 2) the validated Borg category-
ratio 10-point scale 30. The subjects were asked to use these scales to give a subjective rating of 
1) general or "whole-body" exertion, and 2) give a subjective rating of exertion pertaining 
particularly to how their head and exercising legs "feel". A printed scale and instructions were 
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given to familiarize subjects, and a verbal explanation of each scale and a description of how the 
scales should be used were given prior to the start of exercise. 
Heart rate was recorded before and immediately after the -20 sec sprint that was performed 
every 15 min during the 90 min cycle and by means of a Polar™ heart rate monitor. 
5.2.5.1.3 Analysis of isotope samples 
HPLC-purified [3-3Hlglucose was infused to assess rate of hepatic glucose output during 
exercise. Since the radioactivity in the blood samples had to be divided by plasma glucose 
concentration to determine specific activity (disintegrationslml plasma + mmol glucose/ml of 
plasma), blood was collected in the same way as for a determination of plasma glucose 
concentration. Since proteins would interfere with the efficiency of radioactivity counting, a 1 ml 
aliquot of the plasma was taken and the concentration of HCI04 needed to deproteinize the 
sample with the minimum of added volume was determined by experimentation. Thus 0.1 ml of 
3.5 M HCI04 was added to deproteinize the sample. The sample was then centrifuged at 4 °C 
and the protein-free supernatant was removed and kept cold. It was found that the precipitate 
contained around 10% of the total 3H-glucose dpm. Thus it was resuspended in 0.4 ml of distilled 
water, re-centrifuged and the supernatant added to that previously saved. This resulted in 
removal of almost all of the radioactivity in the precipitate. The supernatant was finally collected 
in a 20 ml glass vial. In order to (a) minimize the presence of 3H20 (which accounted for -5% of 
the glucose radioactivity counts) from the metabolism of [3-3Hlglucose in the glycolytic pathway 
and (b) reduce the water/liquid scintillation cocktail ratio for radioactivity counting, the eluates 
(-6 ml) were evaporated to near dryness (-0.3 ml) at 70°C over approximately 20 h. One ml of 
distilled water was then added to redissolve the residue and this solution was then mixed with 15 
ml of Ready Gel (Beckman, Fullerton, USA) liquid scintillation cocktail for 3H determinations 
(dpm) by dual-channel counting (Packard Tri-Carb 4640, Illinois, USA). As small losses of 
radioactivity during processing are inevitable, whenever samples were processed, a control 
plasma sample was spiked with a known amount of [3·3H]glucose and processed concurrently so 
that the dpm/min values of experimental samples could be corrected for the percentage 
recovery. Recovery was around 90%. Since the 0.5 ml aliquot of plasma used for radiation 
counting was from the same plasma sample as previously used for the determination of glucose 
concentration, the specific activity in dpml mmol glucose could be calculated. 
5.2.5. 1.4 Calculation of glucose rate of appearance 
The rate of appearance of glucose from the liver (Rahepatic glucose) was calculated using Steele's 
equations for non-steady-state exercise 395, validated by Radziuk et al. 344 and are shown below: 
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RahePatic glucose = (I - (pV x [Glu] x dSAldt»/SA 
where, RahepatiC glucose is the rate of appearance of glucose from the liver in mmol/min; I is the 
infusion rate of [3-3H]glucose in dpm/min; p is the pool fraction (0.75) in which rapid changes in 
glucose concentration and specific activity take place 224.344; V is the glucose distribution volume 
(19.6% of body mass in liters at rest 224; [Glu] is the mean plasma glucose concentration in 
mmol/L in consecutive samples; dSAIdt is the change in plasma [3-3H]glucose specific activities 
in dpm/mmol over the sample interval in minutes; and SA is the mean dpm/mmol [3-3H]glucose 
specific activity in successive samples. 
5.2.5.1.5 Cognitive testing 
The full battery of 5 tests (as explained under the preliminary testing section) was repeated at the 
end of the cycling TT. 
5.2.6 Statistical analysis 
The statistical software package STATISTICA 7.0 (2004; StatSoft, Inc., Tulsa, OK, USA) was 
used for the statistical analysis of the data. All results are presented as means ± SO for n=10 
subjects. 
5.2.6.1 Metabolic, hormonal and exercise performance data 
Statistical significance (p<0.05) of between trials (HYPO vs. EU) was assessed by a two-way 
analyses of variance (AN OVA) for repeated measures over time (n=10) during the blood glucose 
clamp procedure and exercise protocol. In order to determine which means were significantly 
different, Tukey's HSD post-hoc analysis was used. Paired t- Tests were performed for between 
trial comparisons of variables such as total amount of glucose infused during clamp experiments, 
total amount of hepatic glucose production during exercise experiments, average sprint time and 
TT performance time. 
5.2.6.2 Cognitive function data 
The mean RT on each task was used to express the speed of performance. For each 
participant, anticipatory responses (defined as responses faster than 100 ms) were counted as 
errors and excluded from further analysis. Inspection of the distributions of RTs indicated a 
positive skew in all distributions. This is a common feature of RT distributions 283. Data for each 
participant was therefore logarithmic base 10 (log10) transformed prior to statistical analysis, to 
ensure that data met the assumptions of normality and heterogeneity of variance. 
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For each individual participant, change from baseline on each outcome variable was expressed 
using a difference score. This was calculated by subtracting performance during each 
experimental condition from performance at the first baseline test, and dividing the difference by 
the group mean within subject standard deviation (WSD) calculated from the two baseline 
assessments 21. The resulting statistic is interpreted as a z-score, with values greater than 1.64 
(p<0.05 one-tailed) considered a significant dedine. A composite cognitive score was then 
calculated by summing the z-scores from all 5 individual tasks (Maruff et ai, submitted). A series 
of paired sampled Students' t-tests were then undertaken to compare the performance on each 
outcome variable under the HYPO and EU conditions. 
5.3 RESULTS 
As indicated in Table 5.2, the subjects had moderately high V02 max and peak work rate values, 
consistent with being well-trained, but not elite cydists. 
Table 5.2: Subject characteristics 
Age (yrs) 
Body mass (kg) 
BMI (kglm2) 
Sum of 7 sklnfolds (mm) 
Body fat (%) 
Peak sustained power output (Watts) 
V02 max (mllkglmln) 
Values presented as Mean:l:: SO. 








5.3.1.1 Plasma glucose and serum insulin concentrations 
Arterialized plasma glucose concentrations during the euglycemic clamp was maintained at 
5.1±0.2 mmol/L. During the hypoglycemic clamp, arterialized plasma glucose was maintained at 
2.8±0.1 mmoVL during the first bout of hypoglycemia (HYPO 1) and at 2.9±0.1 mmollL during the 
second bout of hypoglycemia (HYPO 2). In response to the insulin infusion, serum insulin 
concentrations reached 81.4±25.3 and 81.8±25.7 J.1U/ml at the end of HYPO 1 (120 min) and 
HYPO 2 (240 min), respectively; and 92.0±17.3 (120 min) and 83.6±16.5 (240 min) during the 
EU clamp. 
132 
5.3.1.2 Rate of glucose infusion 
Table 5.3: Total amount of glucose infused and glucose infused per kg of body mass during the 
hypoglycemia (HYPO) and euglycemia (EU) experiment. 
Subjects Total amount of glucose Glucose infused per kg body 
(n=10) Infused (g) weight (g/kg) 
HYPO EU HYPO EU 
A 82 238 1.2 3.5 
B 134 237 1.5 2.9 
C 90 225 1.6 3.7 
0 144 224 1.5 3.0 
E 101 215 1.9 3.0 
F 109 307 1.4 3.9 
G 114 264 1.4 3.3 
H 171 293 2.2 3.7 
I 92 207 1.4 3.0 
J 100 236 1.5 3.6 
114x28 244x33 1.6~.3 3.4~.4 
5.3.1.3 Cortisol concentrations 
Serum cortisol concentrations were significantly higher during the HYPO compared to EU trial 
(p<0.05) (Figure 5.1). After 120 min serum cortisol concentrations showed a decline, likely due 
to re-establishment of euglycemia for 40 min from 120 to 160 min. At 160 min glucose 
concentrations were again reduced to 2.9 mmol/L whilst serum cortisol continued declining over 
the next 40 min of hypoglycemia up to 200 min, where after it again increased over the last 40 
min of the second aO-min hypoglycemic bout (indicating a delayed response). Apart from the 
delay in cortisol response during the initial 40 min of the second hypoglycemic bout (and after 40 
min of euglycemic restoration), the cortisol response over the last 40 min of HYPO 2 increased to 
similar levels than that reached toward the end of HYPO 1. 
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Figure 5.1 Serum cortisol concentrations from arterialized venous blood during the blood glucose clamp 
experiments on Day 1. HYPO 1 and HYPO 2 represent the 2 bouts of hypoglycemia (plasma glucose 2.9 
mmoUL) preceded (0-40 min) and interspersed (120-160 min) by euglycemia (plasma glucose 5 mmoIlL). 
5.3.1.4 Systolic and diastolic blood pressure 
Systolic blood pressure was maintained similarly during hypoglycemia and euglycemia 
experiments (Table 5.4). Diastolic blood pressure was significantly lower in the HYPO compared 
to the EU trial at the 100,220 and 240 min timepoints (p<0.05). In the HYPO trial, diastolic blood 
pressure was significantly lower at 100 and 120 min (end of the first HYPO exposure; -5S±7) and 
at 200, 220 and 240 min (end of second HYPO exposure; -5S±5) compared to baseline (6S±S; 
p<0.05). 
Table 5.4: Systolic and diastolic blood pressure during Day 1 hypoglycemia (HYPO) and 
euglycemia (EU) experiments. 
Blood 
Time (min) pressure 
o 20 40 60 80 100 120 140 160 180 200 220 240 
Systolic 125 122 124 122 125 125 125 120 119 121 122 123 127 
±SD ±10 ±10 ±12 ±11 ±12 ±10 ±10 ±11 ±16 ±10 ±9 ±11 ±8 
Diastolic 68 66 64 62 62 58' *58' 59 59 62 59' *57' *58' 
±SD ±8 ±8 ±9 ±8 ±7 ±7 ±6 ±7 ±7 ±7 ±4 ±4 ±5 
EU: 
Systolic 120 118 121 120 123 122 123 126 122 126 123 124 125 
±SD ±10 ±9 ±12 ±9 ±10 ±10 ±10 ±11 ±9 ±7 ±11 ±10 ±11 
Diastolic 68 63 65 62 64 64 66 65 65 65 65 66 68 
±SD ±6 ±6 ±10 ±7 ±6 ±7 ±9 ±10 ±5 ±8 ±6 ±9 ±9 
*Significant difference between HYPO and EU experiments. 'Significant difference from baseline. 
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5.3.1.5 Symptomatic responses 
Subjective ratings of the symptoms related to autonomic and neuroglycopenic responses to 
hypoglycemia remained similar throughout the euglycemic clamp experiment (Table 5.5), 
whereas it increased over time from 60 min onwards in the hypoglycemic clamp experiment 
(p<0.05). 
Autonomic symptom ratings were significantly higher in the hypoglycemic compared to 
euglycemic experiment from 60 min onwards, and neuroglycopenic symptoms from 80 min 
onwards. Neuroglycopenic symptoms were not Significantly different between experiments at the 
140 and 180 min timepoints, likely due to the 40 min of euglycemia that was re-established in-
between the first and second bout of hypoglycemia (from 120 to 180 min). 
When comparing the symptom ratings between the first and second bout of hypoglycemia 
(HYPO), the second bout of HYPO elicited significantly higher ratings of autonomic symptoms 
compared to the first bout of HYPO (p=0.04). The neuroglycopenic symptom ratings, however, 
did not differ significantly between the first and second HYPO bout. 
Table 6.6: Hypoglycemic symptom ratings during Day 1 hypoglycemic (HYPO) and euglycemic 
(EU) clamp experiments. 
Symptoms Time (min) 
0 20 40 60 80 100 120 140 160 180 200 220 
HYPO: * * * * * * * 
Autonomic 2±1 1±1 1±1 5±7 7±7 8±7 8±7 6±4 5±3 4±2 10± 12±7 
10 
Neuroglyco- * * * 






Autonomic 2±2 1±1 1±1 2±2 2±2 2±2 2±1 2±2 2±2 2±2 2±2 2±2 2±2 
Neuroglyco- 1±1 1±2 1±2 1±2 2±2 2±3 3±2 3±2 3±2 3±3 3±3 3±3 
paniC 
Values mean ± SO. ·Significant difference between HYPO and EU experiments. 'Significant difference 
from baseline. 
There was a large range in inter-individual symptom ratings in the HYPO experiment, as is 
evident from the large SD's. Table 5.6 displays the sum of symptom ratings for individual 
subjects, ranging from 28 to 220 for autonomic symptoms and 12 to 239 for neuroglycopenic 
symptoms. The individual sum of symptom ratings was strongly correlated to the individual area 
under the curve for serum cortisol concentrations in the HYPO experiment (r=0.81 and r=0.71 , 
for autonomic and neurglycopenic symptom ratings, respectively. p<0.05). Individual inspection 
2±3 
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of the data suggest that those subjects with the lowest symptom ratings, also have a cortisol 
response that are in the lowest end of the range, and vice versa. 
Table S.6: Sum of symptom ratings and area under the serum cortisol response curve for 
individual subjects during Day 1 hypoglycemia (HYPO) and euglycemia (EU) experiments. 
Subjects Sum of Sum of Cortisol response curve 
(n=10) Autonomic symptom Neuroglycopenic (AUC) 
ratings s~m~tom ratings 
HYPO EU HYPO EU HYPO EU 
A 35 10 33 8 2407 1641 
B 57 23 54 27 1907 2235 
C 220 16 239 63 5070 2941 
D 52 6 73 11 2321 1908 
E 82 24 43 4 2994 1156 
F 121 51 116 60 3432 1980 
G 100 48 31 41 3166 2819 
H 28 5 12 1 2331 1739 
I 51 2 30 6 3742 2180 
J 62 48 48 56 3632 2715 
Mean:l:SD 81:t:57 23:1:19 88:t87 28:1:25 3100::J:931 2132:t:588 
, 0.81 0.71 0.74 
r=signlficant (p<0.05) correlation between symptom rating and area under serum cortisol response curve. 
In addition to rating the various hypoglycemic symptoms (autonomic and neuroglycopenic), 
subjects were also asked to answer "YES" or "NO" to whether they feel hypoglycemic (individual 
data presented in Table 5.7). Based on the large number of "NO" answers and relatively low 
composite symptomatic scores, subjects were for the largest part "unaware" of being 
hypoglycemic. The subject with the most number of "YES" answers also had the highest 
composite symptomatic score. However, no clear individual patterns in responses emerged that 
allowed for statistical comparisons of this data. Nor was there a clear pattern between the 
hypoglycemic "awareness" and symptomatic data obtained during Day 1 compared with Day 2 
exercise performance data (Table 5.7) (performance data are discussed in more detail under 
section 5.3.4). 
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Table 5.7: Subjective symptomatic awareness of hypoglycemia during the Day 1 HYPO clamp procedure. 
Time Awareness of hypoglycemia 
Subjects (n=10) 
A B C D E F G H J 
0 No No No No No No No No No Yes 
40 No No No No No No No No No No 
80 No No Yes No No No No Yes No No 
120 No No Yes No Yes No No No Yes No 
160 No No No No No No No No Yes No 
200 No No Yes No No Yes No No No No 
240 No Yes Yes No Yes Yes No No No No 
Composite symptomatic 11 30 49 16 15 35 20 8 14 9 
score out of 114 (max) 
during the Day 1 HYPO 
experiment 
Day 2 Sprint Improved Improved Improved Reduced Improved Reduced Improved Improved Improved Reduced 
performance after Day 1 
HYPO exposure 
Day 2 time-trial Improved Reduced Improved Reduced Reduced Improved Reduced Improved Improved Improved 
performance after Day 1 
HYPO ex~osure 
Symptomatic awareness of hypoglycemia: In addition to rating the various hypoglycemia symptoms (autonomic and neuroglycopenic), subjects were also asked to 
answer YES or NO to whether they feel hypoglycemic. 
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5.3.1.6 Cognitive function data 
Difference scores for each cognitive outcome measure are shown in Table 5.8 (and Figure 5.10). 
Inspection of Table 5.8 reveals that reaction time slowing occurred under the HYPO condition for 
all 6 outcome variables. However, only the SRT task were significantly reduced compared to 
baseline (p<O.05). The magnitude of this slowing was mild for the DIVA and LEARN tasks, 
moderate for the OBK and SRT tasks, large for the ChRT task and very large for the composite 
score. In contrast, under the EU condition, reaction time became faster on five of six outcome 
variables (the exception being the SRT task). These changes were all of mild magnitude. 
Comparison of difference scores between the HYPO and EU experiment using paired t tests 
revealed significant differences on the ChRT (p=O.023) and composite variables (p=O.015), and 
an almost Significant difference on the OBK task (p<O.056). 
Table 5.8. Change from baseline during Day 1 HYPO and EU conditions on 6 cognitive outcome 
measures. 
EU condition HYPO condition p 
Mean SD Mean SD 
change change change change 
SRT 0.31 0.71 0.95 1.16 0.114 
ChRT -0.04 0.71 1.43 1.86 0.023 
OBK -0.36 1.71 0.74 1.80 0.056 
DIVA -0.33 1.35 0.32 1.86 0.204 
LEARN -0.09 1.01 0.30 1.13 0.376 
COMPscore -0.51 2.37 3.74 4.71 0.015 
Note: EU = euglycemia; HYPO = hypoglycemia; SRT = simple reaction time task; ChRT = choice reaction 
time task; OSK = one-back task; DIVA = divided attention task; LRN = learning task: COMP = composite 
cognitive score.; p=level of significance comparing HYPO to EU experiment. 
Performance on the SRT task at the end of the HYPO clamp were positively correlated to 
autonomic (r=O.7) and neuroglycopenic (r=O.79) symptom ratings (p<O.05). There was no 
significant relationship between autonomic and neuroglycopenic symptoms and any of the other 
cognitive function tests. Furthermore, as was found with the symptomatic responses, there was 
also a strong positive correlation between performance on the SRT and ChRT tasks and the 
cortisol response (measured as area under the cortisol response curve). 
5.3.2 DA Y 2: Exercise experiment 
5.3.2.1 Plasma glucose, lactate and serum free fatty acid (FFA) concentrations 
Plasma glucose concentrations were equivalent at the start of exercise after Day 1 hypoglycemia 
(4.8±O.3 mmollL) or euglycemia (4.6±OA mmoI/L). During the exercise trial (Day 2), plasma 
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glucose concentrations were similarly maintained at euglycemic levels (>4.5-5.5 mmolll) after 
Day 1 HYPO or EU exposure (Figure 5.2 A). Furthermore, antecedent exposure to HYPO 
compared to EU had no effect on the concentrations of plasma lactate or serum FFA at baseline 
or during exercise (Figure 5.2 B, C). 
5.3.2.2 Hormonal responses 
Serum insulin concentrations were similar at baseline (7.5±5.9 vs. 6.7±5.1 ~U/ml) and displayed 
a similar decline over time (p<0.05) after Day 1 HYPO vs. EU exposure, respectively (Figure 
5.3). 
Day 1 HYPO vs. EU exposure resulted in similar serum cortisol concentrations at baseline (-17 
nmoVl), followed by a similar decline (-13 nmoVl) over the first 30 min of exercise, where after it 
increased similarly towards the end of 90 min of exercise (17.9±4.8 vs. 19.9±6.2 nmol/l), and at 
the end of the TT (19.8±5.9 vs. 22.4±6.8 nmol/l, HYPO vs. EU, respectively, p<0.05) (Figure 
5.4). 
When individual cortisol responses for day 2 were assessed, 5 subjects displayed a significant 
increase in cortisol responses from baseline to the end of the TT (group A), whilst in 5 subjects 
the cortisol concentrations were similar between baseline and the end of the TT (group B). 
5.3.2.3 Isotopic determination of hepatic glucose output 
There was no significant difference in hepatic glucose output during exercise after HYPO vs. EU 
antecedent exposure (Figure 5.5). Hepatic glucose output increased from 18±8 IJmol/kglmin 
over the first 15 min of exercise to 27±9 IJmollkg/min at the 45 min timepoint in antecedent HYPO 
compared to virtually no change from 22±8 to 24±5 IJmoVkg/min at equivalent times in the 
antecedent EU trial. Over the last 45 min of exercise, hepatic glucose output was increased to 
29±8 IJmol/kg/min in the antecedent HYPO trial, whilst it was maintained at -25±8 IJmol/kg/min at 
the end of exercise in the antecedent EU trial (NS between trials). 
The rate of glucose disappearance displayed a significant increase over time from the 45 min 
timepoint onwards up to the end of the 90 min exercise bout (Figure 5.5.) in the antecedent 
HYPO trial (from 18±8 at 15 min, to 25±9 at 45 min, to 30±6 IJmollkg/min at 90 min). In the 
antecedent EU trial, the rate of glucose disappearance showed a similar yet more gradual 
increase from 19±8 IJmol/kglmin at 15 min of exercise to 29 IJmoVkg/min at 90 min (end) of 
exercise, and only reached a level of significance (compared to 15 min) at the 90 min timepoint 
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Figure 5.2: Plasma glucose (A), Lactate (B) and serum FFA concentrations during the exercise trial on 
Day 2 after Day 1 hypoglycemic (HYPO) vs. euglycemic (EU) exposure. End TT represent measurements 
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Figure 5.3: Serum insulin concentrations during the exercise trial on Day 2 after Day 1 hypoglycemic 
(HYPO) vs. euglycemic (EU) exposure. End TT represent measurements taken immediately after 
completion of the time trial (TT)' #Significant change from baseline (p<0.05). 
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Figure 5.4: Serum cortisol concentrations during the exercise trial on Day 2 after Day 1 hypoglycemic 
(HYPO) vs. euglycemic (EU) exposure. End TT represent measurements taken at the end of the time trial. 
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Figure 5.5: Effect of 90 min of exercise at 70% V02 max on glucose kinetics on Day 2 after Day 1 
hypoglycemic (HYPO) vs. euglycemic (EU) exposure, #Significant change from the 15 min value (p<0.05). 
5.3.2.4 Gas exchange data and reates of total CHO and fat oxidation 
There were no differences in V02, respiratory exchange ratio (RER) or rates of total CHO or fat 
oxidation during exercise between antecedent HYPO and EU exposures. 
5.3.2.5 Exercise perfonnance data 
Time-trial performance, measured as time to complete 200 kJ of work, was not significantly 
different between antecedent HYPO (687±62 sec) compared to EU exposure (696±73 sec). 
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Figure 5.6: Day 2 time trial performance (sec) of individual subjects (n=10) after Day 1 exposure to 
hypoglycemia (HYPO) compared to euglycemia (EU). 
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Total sprint time (sum of the 6 sprints, measured as time to complete 10 kJ of work as fast as 
possible) was not statistically different between antecedent HYPO vs. EU exposure. 
Though not statistically significant, n=6 (of 10) TT performance and n=7 subjects' average sprint 
time performance were improved after the HYPO compared to EU antecedent exposure. Lack of 
statistical power in this regard is probably due to the much larger magnitude of improvement in 
TT performance in those 4 subjects who performed better after EU vs. HYPO exposure. 
When the performance data are analyzed according to the cortisol groupings (group A and B 
mentioned under 5.3.2.2), then there was no correlation between the TT performance and 
cortisol responses between group A (increased cortisol response) and group B (cortisol response 
unchanged between baseline and end of the TT). 
5.3.2.6 Heart rate and RPE 
Heart rate responses during the Day 2 exercise experiment were similar between Day 1 HYPO 
vs. EU exposures (Figure 5.7). 
Similar ratings of perceived exertion (RPE) were reported for general, head and legs during 
exercise after HYPO vs. EU exposure (Figure 5.8). 
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Table 5.9: Effects of antecedent hypoglycemia (HYPO) and euglycemia (EU) on average sprint 
time and time-trial (TT) performance the following day, 
Subjects 'Average sprint time 
(n=10) (sec) 
HYPO EU 
A 115 122 
B 117 124 
C 129 135 
D 131 94 
E 116 130 
F 148 128 
G 123 126 
H 122 124 
I 99 101 
J 141 133 
124::t14 1221:13 
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Figure 5.7: Heart rate (beats/min) responses measured before and after the -20 sec sprints performed 























































Figure 5.8: Ratings of perceived exertion (RPE) during Day 2 exercise. TT=time-trial. #Significant change 
from baseline (p<0.05). 
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5.3.2.7 Cognitive function data 
During Day 1 experiments, though performance on all cognitive function tasks showed a decline 
during HYPO compared to EU exposure, only SRT performance showed a significant reduction 
compared to baseline performance, and only ChRT performance was significantly reduced at the 
end of Day 1 HYPO compared to EU exposure (Figure 5.9). 
Further inspection of Figure 5.9 reveals that reaction time became faster following Day 2 
exerase after both antecedent HYPO and EU exposure (the exception being the SRT task 
following antecedent hypoglycemia). These changes were all of mild magnitude. Performance 
on the OBK and LEARN tasks were significantly faster at the end of exerase after Day 1 HYPO 
compared to baseline; and so was performance on the ChRT, OBK and LEARN tasks at the end 
of exercise after Day 1 EU compared to baseline (p<0.05). Day 1 antecedent exposure to 
hypoglycemia compared to euglycemia had no significant impact on cognitive performance tasks 
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Figure 5.9: Cognitive performance data at the end of Day 2 exerase. 
Note: Day 1 = glucose clamping experiments, HYPO = hypoglycemia; EU = euglycemia; Day 2 = Exercise 
experiment; SRT = simple reaction time task; ChRT = choice reaction time task; OBK = one-back task; 
DIVA = divided attention task; LRN = learning task: COMP = composite cognitive score; a=Significant 
decline after Day 1 HYPO clamp compared to baseline; b=significant difference between Day 1 HYPO vs. 
EU experiment; c=significant improvement after Day 2 exercise experiment compared to baseline. for 
antecedent HYPO and EU exposure trials, respectively; significance = p<O.05. 
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5.4 DISCUSSION 
The main aim of this investigation was to determine the effects of antecedent hypoglycemic 
exposure on neuroendocrine and metabolic responses, as well as perceived exertion and 
exercise performance during moderate to high-intensity exercise performed the following day in 
well-trained, healthy males. The results indicate that prior, recent exposure to two SO-min bouts 
of hypoglycemia (and stimulation of the gluco-counterregulatory response) in healthy, well-
trained men had no effect on subsequent responses to prolonged exercise, and that the ability to 
counterregulate and maintain blood glucose homeostasis (in the absence of external blood 
glucose manipulation) is effectively maintained. 
5.4. 1 Day 1 blood glucose clamp experiment 
In addition to the main aim mentioned above, a secondary aim was to determine whether a 
second exposure (SO-min bout) of moderate hypoglycemia (plasma glucose 2.9 mmolll) in short 
succession (40 min) to the first exposure would alter cognitive function and/or symptomatic 
responses compared to the first exposure. To our knowledge, though other stUdies have 
employed similar protocols where two bouts of hypoglycemia (of various durations) were elicited 
within one day, the symptomatic and cognitive responses thereof have traditionally only been 
compared to responses during next-day exposure to hypoglycemia 71,96,443. These studies 
reported that prior hypoglycemia had either no effect on thresholds for hypoglycemic symptoms 
71,443 or produced a significant blunting of symptomatic awareness during subsequent exposure 
(for review see ref. 96). Additionally, blunting of neuroendocrine responses have been observed 
whilst cognitive function was preserved 98,219. In the present study, each bout of hypoglycemia 
produced a comparable cortisol response, which was significantly higher than that observed 
during the euglycemic clamp. Hence, there was no evidence of a blunting effect on cortisol 
responses. A limitation to the study is that the responses of the other gluco-counterregulatory 
hormones (glucagon and catecholamines in particular) were not available. These results would 
have provided a more comprehensive picture of the effect of repeated bouts of hypoglycemia on 
subsequent counterregulatory responses. However, as shown in previous studies, the effect of 
the cortisol response seems paramount in the phenomena of counterregulatory failure in healthy 
humans 106.107. In contrast, the present study demonstrated that raised cortisol concentrations 
during the initial bout of hypoglycemia did not attenuate the cortisol response during the 
subsequent bout of hypoglycemia. 
The present study further indicates that a second SO-min exposure to moderate hypoglycemia, 
elicited within short (40-min) succession to an identical prior exposure, results in a significant 
increase over time in autonomic symptom awareness. Furthermore, autonomic symptom scores 
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were significantly higher at the end of the second bout compared to the first bout of 
hypoglycemia, whilst neuroglycopenic symptom awareness as well as attentional slowing 
(indicated by the choice RT cognitive test) were statistically equivalent at the end of the two 80-
min exposures to hypoglycemia. These findings are interesting in the light of other studies where 
prior (previous-day) exposure to hypoglycemia resulted in a blunting of subsequent (next-day) 
autonomic symptom awareness. The role played by the duration of prior hypoglycemia, the time 
period between exposures and the differential effects on the magnitude of autonomic and 
neuroglycopenic symptomatic awareness or "unawareness" thereof needs further investigation. 
Neuroglycopenic symptom awareness, on the other hand, was significantly increased above that 
in the euglycemic trial only after the second 80-min bout of hypoglycemia was induced. This is in 
agreement with the results by Towler et al. 410 which demonstrated that the awareness of 
hypoglycemia is largely, perhaps exclusively, the result of perception of autonomic rather than 
neuroglycopenic symptoms, mediated to a large extent by muscarinic cholinergic mechanisms. 
Performance on an attention test (choice RT) completed at the end of 2 consecutive 80-min 
bouts of hypoglycemia was significantly slower than that observed during both baseline and 
euglycemic conditions. In contrast, no differences were observed on a psychomotor task (simple 
RT), suggesting that acute, moderate hypoglycemia affects attention, but not motor speed, in 
healthy young individuals. These findings are consistent with previous research suggesting that 
choice RT tasks are more sensitive to exposure to moderate hypoglycemia than simple RT tasks 
(for discussion see ref. 8). However, impaired motor function has previously been noted during 
hypoglycemia 41,42, unlike our findings where motor function was unaltered. One explanation for 
this discrepancy is that the depth of hypoglycemia induced during the two bouts of hypoglycemia 
in the present study (2.9 mmoVL) was insuffiCiently low to induce motor impairments. Evans and 
colleagues 134 observed that the glucose threshold for motor speed impairment (using the Finger 
tapping task) was below 2.2 - 2.4 mmol/L during acute hypoglycemia, while others have 
observed that the blood glucose threshold for dysfunction on choice reaction time tasks to be 
2.8-3.1 mmollL 133,285. In the present study, symptoms indicative of neuroglycopenia were 
Significantly increased above that observed in the euglycemic trial only at the end of the second 
bout of hypoglycemia, Overall, cognitive test results were statistically unrelated to either 
autonomic or neuroglycopenic symptom responses, 
A large inter-individual variability in symptom ratings and cognitive function were noted during the 
hypoglycemic clamp experiment. This finding is consistent with prior research suggesting that 
the blood glucose threshold for cognitive impairment during hypoglycemia may vary between 
individuals 139, and that prior exposure to hypoglycemia may result in cognitive adaptation 158, A 
further interesting finding is the strong positive correlation between individual symptom ratings 
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and individual cortisol responses, indicating that those individuals with the lowest symptom 
ratings have the lowest cortisol responses (expressed as area under the cortisol curve) and vice 
versa. This would further lend support to the suggestion that some individuals display altered 
gluco-counterregulatory hormonal responses combined with altered symptomatic "awareness" of 
hypoglycemia. However, a larger sample size than that recruited in the present study is required 
to adequately investigate this hypothesis. 
5.4.2 Day 2 Exercise experiment 
In this study, the antecedent exposure to two 80-min bouts of moderate hypoglycemia (2.9 
mmol/L) compared to euglycemia did not alter the hormonal (insulin, cortisol) and metabolic 
responses (hepatic glucose production, blood glucose, lactate and FFA concentrations, total 
CHO and fat oxidation) during 90 min of exercise (at 70% V02 max) performed the next day. 
Blood glucose was effectively maintained at euglycemic levels throughout the exercise bout 
without exogenous manipulation. These results are in contrast to studies suggesting that prior 
elevations in cortisol may result in blunted subsequent counterregulatory responses in healthy 
humans 102.106.107,160,300. Rather, these results are in agreement with studies showing that prior 
elevations in cortisol concentrations have no effect on subsequent counterregulatory responses 
in healthy humans 345. 
In a similar study to the present, Davis et al. 102 demonstrated that two 2-h episodes of 
hypoglycemia (2.9 mmol/L) in healthy individuals resulted in a substantial (-50%) reduction in 
exercise-induced counterregulatory hormone and metabolic responses performed the next day. 
In this study 102, subjects (n=8 male; n=8 female) underwent (in random order), two bouts of 
hyperinsulinemic, hypoglycemic clamps (2.9 mmollL) each lasting 2 h, separated by 2 h of 
euglycemia, compared to equivalent euglycemic periods (5 mmoIlL). The following day, subjects 
performed 90 min of steady-state exercise at 50% V02 max, whilst euglycemia was maintained via 
exogenous glucose infusion. The group exposed to antecedent hypoglycemia displayed 
significant blunting of neuroendocrine (glucagon, insulin, catecholamine) and metabolic 
(endogenous glucose production, lipolysis, ketogenesis) responses to exercise and required a 
10-fold higher rate of glucose infusion in order to maintain euglycemia during the exercise bout, 
compared to the antecedent euglycemic experiment 102. The euglycemic glucose infusion during 
exercise makes it difficult to interpret whether the neuro-endocrine and metabolic responses 
were caused by, or resulted in the high rate of glucose infusion required to maintain euglycemia. 
A subsequent study by the same group 160 further demonstrated that two 90-min antecedent 
bouts of prolonged exercise (90 min at 50% V02 max) with euglycemic glucose infusion can 
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produce a similar reduction in neuro-endocrine and metabolic counterregulatory responses to 
subsequent (next-day) hypoglycemia (2 h at 2.9 mmoVL). 
There may be a couple of explanations for the discrepancy in results between the present study 
and those of Davis et al. 102. Firstly, there was a substantial difference in training status between 
the subject populations used in these studies. The subjects of Davis and co-workers 102.160 
ranged from sedentary to actively participating in competitive sports, with an average V02 max of 
43±3 ml/kg/min (range 21 to 54), whilst subjects in the present study constituted a homogenous 
group of lean (9±3 % body fat), endurance-trained cyclists with an avercllge V02 max of 64±3 
mllkg/min (range 60 to 70), indicative of a superior training status. Previous studies have 
demonstrated that highly trained individuals have enhanced insulin sensitivity (for review see 34) 
and an altered sympathetic and parasympathetic activation in consequence to frequent 
strenuous exercise bouts 62,266. Furthermore, training status have been shown to affect metabolic 
responses, amongst these are an increased ability to oxidize fat combined with a decreased 
dependency on the limited CHO fuel stores 15,179.218. 
Secondly, subjects in the present study exercised at a higher intensity (70% as opposed to 50% 
V02 max 102), and performed a maximal sprint (lasting 15-20 sec) every 15 min. Exercise intensity 
in itself can strongly activate the sympathetic system 1 and as a result, independently activate the 
counterregulatory system and enhance blood glucose regulation and maintenance 266. 
Lastly, an important difference between these studies is that Davis et aL 102 infused glucose to 
maintain euglycemia during the exercise bout whilst in the present study we chose not to infuse 
glucose in order to assess the responses under physiological conditions when blood glucose was 
left free to vary. When exogenous glucose is infused, it seems likely that the normal 
neuroendocrine and metabolic responses involved in glucose counterregulation would not be 
elicited (as it is not needed). This could explain the 50% reduction observed in counterregulatory 
responses 102, An alternate explanation for the near 10-fold higher rate of glucose infusion 
needed after hypoglycemic compared to euglycemic exposure, may be related to an enhanced 
insulin sensitivity and glucose uptake by the periphery (muscles) in consequence to 
hypoglycemia, and not because of counterregulatory failure per se. It is interesting to speculate 
that in highly trained individuals (as in the present study), where insulin sensitivity is already 
increased and glucose uptake during exercise already optimized (above threshold) 449.450, the 
effect of antecedent hypoglycemic exposure to potentially increase glucose disposal may be less 
pronounced, and could hence explain the similar responses seen during exercise in the present 
study after antecedent hypoglycemic compared to euglycemic exposure. 
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In addition, the higher exercise intensity in the present study may have been sufficient to fully 
activate the sympathetic system 1, thereby activating the counterregulatory system (as reflected 
by similar neuroendocrine and metabolic responses between antecedent HYPO and EU 
exposures) and similar maintenance of blood glucose during subsequent exercise in the present 
study. 
Measurement of cognitive function (such as choice and simple RT) has been shown to be 
impaired during exposure to hypoglycemia 135, but a single episode of mild antecedent 
hypoglycemia (3.1 mmollL) in healthy men can attenuate several aspects of cognitive 
dysfunction during subsequent hypoglycemia 18-24 h later 158. In contrast to this finding, the 
present study demonstrated that cognitive function at the end of the exercise protocol performed 
within 24 h after antecedent hypoglycemic exposure was improved. This finding is in agreement 
with evidence indicating that prolonged exercise may be associated with an increase in cognitive 
performance, possibly due to increase in metabolic load which is associated with increased 
arousal, as well as a possible increase in cerebral blood flow, or neurotransmitter 
(catecholamines I endorphin) release, however, the exact mechanism is still unknown 46,46. 
Grego et al. 177 investigated the effect of prolonged exercise (3 h at -66% V02 max) on hormonal, 
metabolic and cognitive function in trained male cyclists. Exercise resulted in a progressive 
increase in FFA, heart rate and RPE (after the 108 min), and glycerol, epinephrine and cortisol 
(after 144 min) and a significant decrease in blood glucose (after 108 min) and insulin (144 min). 
However, blood glucose remained above 4 mmollL. The results showed a temporary increase in 
P300 amplitude between the 1st and the 2nd hour (an indication of an improvement in cognitive 
function) and an increase in latency after the 2 h of exercise concomitant with some hormonal 
changes, including an increase in cortisol and epinephrine and a decrease in blood glucose (an 
indication of an alteration of information processing speed with fatigue). These findings suggest 
a combined effect of arousal and central fatigue on electrocortical indices of cognitive function 
during acute physical exercise 177. Very recently, Grego et al. 178 examined the influence of 3 h of 
cycling at 60% V02 max on simple and complex cognitive performance in 8 well-trained male 
subjects before, every 20 min during, and immediately after the exercise task. A Significant 
improvement in speed of response and a decrease in error number during the map recognition 
task were recorded between 80 min and 120 min when compared with the first 20 min of 
exercise. After 120 min the number of recorded errors was Significantly greater indicating a shift 
in the accuracy-speed trade-off. These results provide some evidence for exercise-induced 
facilitation of cognitive function. However this positive effect disappears during prolonged 
exercise - as evidenced by an increase in errors during the complex task and an alteration in 
perceptual response (Le. the appearance of symptoms of central fatigue). 
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During prolonged exercise. apart from marked increases in metabolic load. symptoms of central 
(e.g. reduced neural drive) and peripheral (e.g. decreased muscle excitability) fatigue are also 
commonly reported 177. which may negatively affect cognitive functioning 46 and attenuate the 
perception of effort towards the latter stages of prolonged exercise 420. However. it is yet unclear 
what relationship exists between cognitive function. metabolic and hormonal responses. 
perceived exertion and endurance exercise performance. In addition, it is not yet clear how 
cognitive function may be affected at the end of prolonged exercise and after prior recent 
exposure to hypoglycemia (which may alter neuro-endocrine, metabolic. and cognitive 
responses) in well-trained men. In the present study. antecedent exposure to hypoglycemia 
compared to euglycemia had no effect on cognitive functioning or effort perception. It may be 
that any likely effect of antecedent hypoglycemia on cognitive functioning at the end of the 
exercise bout on day 2 were masked by the overall effect of exercise on improving cognitive 
function, however, this remains speculative. 
Furthermore, there was no association between the perception of effort. cortisol response and 
exercise performance. Similar to the present study. Viru et at 428 reported that 2 h of running 
exercise increased the responsiveness of components of the HPA-axis (such as cortisol 
response) in some subjects, whilst it remained unchanged in others. As a whole, power output 
measured in a 1-min maximal test performed before and after the 2 h run was not different. 
However, the higher cortisol responses in the subgroup of subjects were associated with 
increased performance (power output), whilst power output was significantly lower after 
compared to before the 2 h run in the group where cortisol concentrations were the same or 
lower before and after the 2 h run. This may indicate that increased HPA-axis activation is 
related to a strong nerve influence on the muscle recruitment and performance 428. However, in 
contrast to these findings, the present study found no relationship between n performance and 
cortisol responses. In addition. similar to the findings of Viru et at 428, RPE increased 
progressively over the exercise period, but no relationship between overall or individual cortisol 
and RPE responses were found. Differences in mode and duration of exercise protocols may 
explain the discrepancy in results. however. more research is needed to further investigate the 
potential link between individual responsiveness in HPA-axis activation, RPE and exercise 
performance. 
In conclusion. in overnight-fasted, healthy, well-trained individuals recent antecedent exposure to 
hypoglycemia and elevation in cortisol concentrations have no effect on counterregulatory 
responses to subsequent prolonged exercise performed at 70% V02 max, nor is RPE or exercise 
performance affected. 
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CHAPTER 6 
IL-6 RESPONSE DURING EXPOSURE TO TWO PROLONGED BOUTS 
OF HYPOGLYCEMIA WITHIN ONE DAY FOLLOWED BY PROLONGED 
EXERCISE THE NEXT DAY 
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6.1 INTRODUCTION 
Traditionally, fatigue during exercise has been attributed mainly to physiological and biochemical 
changes such as metabolite (lactate) accumulation 148, substrate (glycogen) depletion 148,240 and 
pH changes 148, Though a strong association between CHO (liver and muscle glycogen) 
depletion and fatigue development during prolonged submaximal exercise has been observed, 
the exact mechanisms regarding CHO regulation and its role in fatigue development is still not 
fully understood, 
Recent evidence indicate that interleukin-6 (IL-6) may playa role as a possible regulator of blood 
glucose homeostasis and fatty acid mobilization during exercise 143,424. IL-6 concentrations have 
been shown to markedly increase during exercise and skeletal muscle has been identified as the 
major source of this IL-6 production 143,336, The brain 327, peritendon 266 and adipose tissue 244 
have also been identified as sites of IL-6 production in response to exercise, Helge et al. 201 
recently demonstrated that the amounts of IL-6 released from contracting skeletal muscle was 
positively related to work intensity, glucose uptake and plasma epinephrine concentrations, 
Furthermore, an inverse correlation between IL-6 release and muscle glycogen content has also 
been observed 140,201.397.399, From these observations, it has been suggested 170,400 that IL-6 may 
serve as an energy status hormone in muscle in response to exercise, acting as a Signal to the 
liver or adipose tissue to increase glycogenolysis or lipolysis, respectively, thereby contributing 
towards glucose homeostasis 244,246. 
It has been proposed that IL-6 can act in a "hormone-like" manner by regulating glucose 
homeostasis during exercise 140. Studies have shown that IL-6 can partly mediate the hepatic 
glucose output necessary to maintain blood glucose homeostasis during exercise 394, IL-6 is a 
potent activator of the hypothalamic-pituitary adrenal (HPA) axis 335, but does not Simply mediate 
blood glucose concentrations through its effect on glucose-regulating hormones. The liver is 
capable of producing IL-6, which seems to have a regulatory function by directly acting on 
hepatocytes to increase hepatic glucose release 357. Thus, the liver may produce IL-6 to 
stimulate hepatic glucose output if blood glucose concentrations are compromised. In addition, it 
has been shown that IL-6 induces an increase in appearance and disappearance of free fatty 
acids (FFA) 244, and it has been suggested that the increased IL-6 production in adipose tissue 
late in exercise may provide a link from the contracting skeletal muscle to enhance fat 
metabolism, thereby contributing FFA oxidation to the energy demand (at a time when glycogen 
stores are reduced). 
Furthermore, data obtained from a performance related study has indicated that IL-6 may playa 
role in affecting the sensation of fatigue during exercise 359, In this study, recombinant human IL-
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6 was administered subcutaneously prior to a 10 km running time-trial in amounts equivalent to 
those produced during 2 hrs of running (9±2 pg/ml vs. baseline concentrations of 1±O.5 pg/ml) 
394. With IL-6 infusion (compared to placebo), subjects reported an increased sensation of 
fatigue, which ultimately resulted in a decrement in running performance. This has led to the 
suggestion that IL-6 may possibly act as a circulating "fatiguogen" during exercise. In recent 
years, the role of the central nervous system (CNS) in the development during exercise has 
received increasing attention 59. It is suggested that afferent signals relating the physiological 
and metabolic status of the body are relayed back to the CNS. Based on these signals, efferent 
signals from the CNS I brain are related back to the appropriate bodily structures, and in respect 
to exercising skeletal muscle, result in a de-recruitment of skeletal muscle (reduced exercise 
capacity) in order to maintain a homeostatic environment 163. Exercise induced changes in 
various brain neurotransmitters (serotonin, dopamine and acetylcholine) and neuromodulators 
(ammonia and various cytokines such as IL-6) have been suggested to be possible mediators in 
the onset of exercise related fatigue 59. 
The hypothesis of the role of IL-6 as a possible "fatiguogen" is further supported by the findings 
of Spath-Schwalbe et al. 390 where low doses of rh-IL-6, were administered to healthy individuals 
at rest and the elevated IL-6 levels were associated with increased cortisol and 
adrenocorticotrophic hormone (ACTH) concentrations and an increased heart rate. In addition, 
subjects reported an increased sensation of fatigue, altered ability to concentrate and disrupted 
sleep pattems. Furthermore, when an IL-6 antagonist (humanized anti-IL-6 receptor antibody) 
was administered to patients diagnosed with IL-6 related immune-inflammatory diseases 
(Castleman's disease and rheumatoid arthritis) subjects reported an immediate attenuation of 
fatigue symptoms 320. Changes associated with elevated levels of plasma IL-6 include malaise, 
fatigue, elevated levels of adrenocorticotrophic hormone and cortisol, and increases in heart rate 
and core temperature 217,351,417. It has therefore, at least in part, been suggested that cytokines, 
and in particular IL-6, may playa role in the development or perception of fatigue. 
Recent exposure to a stressful event such as hypoglycemia and exercise have been shown to 
alter (blunt) neuro-endocrine and metabolic glucose counterregulatory responses to following 
(next-day) exposure to a similar stress 102,160,205. Elevated IL-6 concentrations are also 
associated with increased cortisol and adrenocorticotrophic hormone (ACTH) concentrations, yet 
it is unknown if and how IL-6 responses are affected by antecedent and subsequent exposures 
to physiological stresses such as hypoglycemia and exercise. 
Accordingly, the aim of this study was to determine the effect of an antecedent bout of 
hypoglycemia on IL-6 and glucose counterregulatory hormone responses, metabolism, liver 
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glucose output, perception of effort and endurance performance during a subsequent (next-day) 
bout of endurance exercise. 
6.2 METHODS 
(As explained in detail in CHAPTER 5) 
6.2.1 Subjects 
Nine of the 10 subjects reported in Chapter 5 were included in the investigation of IL-6 
responses. One subject's data were lost during the IL-6 analysis procedure and were therefore 
excluded from the analysis. Subject characteristics (n=9) are presented in Table 6.1. 
6.2.2 Research design 
Similar to that reported in Chapter 5. In brief, each subject completed two separate, randomized, 
single-blind, experimental trials, repeated at least one month apart. Each experimental trial 
consisted of two consecutive days of testing. Each day of testing commenced after a 10-h 
overnight fast. On day 1, subjects were either exposed to hypoglycemia (HYPO) or, on the other 
occasion, euglycemia (EU) by means of a similar hyperinsulinemic glucose clamp procedure. On 
day 2, subjects performed 90 minutes of cycling exercise at 70% of V02 max followed by a cycling 
time-trial (TT) consisting of time to complete 200 kJ of work. No blood glucose manipulations 
were done during day 2. The day prior to each round of testing, subjects were required to 
abstain from exercise, and to keep a detailed food diary, which were to be repeated the day prior 
to the second experimental trial. During the course of the study subjects were instructed to 
maintain their habitual training schedule and weight-maintaining diet. 
6.2.3 Preliminary testing 
As reported in detail in Chapter 5. 
6.2.4 Experiment proper 
6.2.4.1 DAY 1: Blood Glucose Clamping Procedure 
As reported in detail in Chapter 5. 
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6.2.4.2 DAY 2: Exercise experiment 
As reported in detail in Chapter 5. In brief, the next moming after the glucose clamp procedure, 
subjects again reported to the laboratory after a 10-h overnight fast. One cannula (Jelco; 
Johnson and Johnson, Halfway House, South Africa) was placed in a forearm vein to enable 
blood sampling. A second cannula was placed in the contralateral arm to enable infusion of the 
[3-3H]glucose tracer. A primed, continuous infusion of [3-3H]glucose was started -45 min prior to 
the start of exercise (whilst subjects remained rested), and continued for 90 min during steady-
state exercise in order to measure hepatic glucose output. 
The exercise protocol consisted of 90 min of steady-state cycling at 70% V02 max, with sprints 
performed every 15 min (after measurements of the various parameters (see below) were 
performed). Each sprint consisted of the time to complete 10 kJ of work (-15-20 sec). At the 
end of the 90 min of cycling, subjects were given 2 minutes to rest followed by a cycling time trial 
conSisting of time to complete 200 kJ of work. Subjects were allowed to ingest water ad lib, and 
were cooled by using an electric fan. Environmental conditions in the laboratory were controlled 
(20°C). 
6.2.4.2.1 Metabolic measurements 
As reported in detail in Chapter 5. In brief, venous blood, on-line respiratory gas exchange and 
RPE determinations were done at baseline, at 15 min intervals during steady-state cycling 
(before performing the sprint), and at the end of the n. Blood samples were collected and 
analyzed (as explained in Chapter 5) for plasma glucose, [3-3H]glucose, and lactate; and serum 
IL-6, FFA, cortisol and insulin concentrations. Serum IL-6 concentrations were measured using 
high-sensitivity enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, 
MN, USA). 
6.2.5 Statistical Analyses 
The statistical software package STATISTICA 7.0 (2004; Stat Soft, Inc., Tulsa, OK, USA) was 
used for the statistical analysis of the data. All results are presented as means ± SD. Statistical 
significance (p<0.05) of between-group differences was assessed by a two-way analyses of 
variance (ANOVA) for repeated measures over time during the blood glucose clamp procedure 
and exercise protocol. In order to determine which means were Significantly different, Tukey's 
honest significance difference post hoc analysis was used. Paired t Tests were performed for 
comparisons between groups of variables at the end of the time trial. 
6.3 RESULTS 














IL-6 concentrations during the euglycemic (EU) trial (Figure 6.1) remained at baseline 
concentrations (-0.5 pg/ml) up to 160 min, where after it displayed a Significant increase (-1.0 
pg/ml) towards the end of the trial (240 min; p=0.05). During the hypoglycemic (HYPO) clamp, 
IL-6 concentrations increased progressively over the first 120 min (the end of the first HYPO 
exposure), then remained at this level (-1.0 pg/ml) throughout the following 40 min (when 
euglycemia was restored) and throughout the second HYPO exposure up to the end of the trial 
(240 min). There was a significant (p<0.05) interaction (trial x time) effect between the HYPO 
and EU trial. 
IL-6 concentrations were similar at the start of the exercise trial on Day 2 following antecedent 
HYPO vs. EU exposure on Day 1 , and displayed a similar significant increase over time towards 
the end of exercise (p<0.05). IL-6 concentrations at the end of the TT tended to be lower after 
Day 1 antecedent HYPO exposure, yet insignificantly so. This result is interesting in the light that 
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Figure 6.1: Serum IL-6 concentrations from arterialized venous blood during the hyperinsulinemic blood 
glucose clamp (Day 1). n=9. * Significant trial x time effect (p=O.03). 
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Figure 6.2: IL-6 concentrations during steady-state exercise and at the end of the time-trial (Day 2). n=9. 
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Figure 6.3: Plasma glucose concentrations during exercise (Day 2). n=9. 
Blood glucose concentrations were similar between trials and remained within the euglycemic 
range throughout the exercise protocol. Blood glucose concentrations at the end of the IT were 
higher compared to any point during the 90 min steady-state cycle protocol, most likely due to 
the known effect of increased glucose production during/immediately after a high-intensity 
exercise bout. Though the general trend was for the blood glucose concentration at the end of 
the IT to be lower following antecedent EU exposure, it was not significantly different compared 




As a whole (mean data from group), the altered IL-6 responses during antecedent HYPO vs. EU 
exposure on Day 1 had no effect on the rate of hepatic glucose output, cortisol, insulin, FF A or 
lactate concentrations or overall rates of CHO and fat oxidation (determined from RER) during 
the Day 2 exercise experiment. Furthermore, RPE, sprint and IT performance were unaffected 
by antecedent HYPO vs. EU exposure (data presented in Chapter 5). IL-6 concentrations at the 
end of the IT were significantly correlated to cortisol concentrations at the end of the IT (r=0.77, 
p<0.05). 
Interestingly, in all parameters presented (IL-6, plasma glucose), the individual range in response 
was large. When looking at individual IL-6 and blood glucose responses, the one subject 
(subject I) with the highest IL-6 response during exercise also displayed the highest plasma 
glucose concentrations, showing increases of above 6 mmol/L beyond 60 min of exercise 
towards 12 mmollL at the end of exercise (Figure 6.4 A & B; Figure 6.5 A & B). 
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Figure 6.4 A & B: IndivlduallL-6 response during exercise (Day 2) after the antecedent HYPO (A) and 
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Figure 6.5 A & B: Individual plasma glucose response during exercise (Day 2) after the antecedent 







Exposure to hypoglycemia elicited a significant increase in IL-6 concentrations compared to 
euglycemic exposure. However, the IL-6 response during moderate- to high-intensity exercise 
appears to be unaltered by recent, antecedent exposure to hypoglycemia. 
Exposure to any stressful event provides a "challenge" to the HPA-axis with a resultant increase 
in stress hormones such as cortisol and catecholamines. With respect to hypoglycemia, these 
hormones act to help restore blood glucose concentrations by increasing hepatic glucose output 
(e.g. increase gluconeogenesis). IL-6 has also been shown to be a powerful activator of the 
HPA-axis 335, and to playa role in glucose homeostasis 143.337.424. To our knowledge, the present 
study is the first to document the IL-6 response during two consecutive bouts of hypoglycemia at 
rest in healthy well-trained men. In accordance with this literature, the present study 
demonstrated that the first SO-min bout of hypoglycemia produced a Significant cortisol response 
during exposure to hypoglycemia (HYPO trial; data presented in Chapter 5). This is in contrast 
to findings by Davis et al. 109 who demonstrated that one episode of 2-h hypoglycemia (2.9 
mmol/L) in the morning produced SUbstantial blunting of the cortisol and other associated 
neuroendocrine responses to a subsequent 2-h bout of hypoglycemia elicited 2 h later in healthy 
men. In the present study, the cortisol response was accompanied by a significant systemic IL-6 
response over the initial 120 min, which then reached a plateau at -1 pg/ml, and were 
maintained at this level throughout the second SO-min bout of hypoglycemia. 
Recent antecedent exposure to raised glucocorticoids, such as elicited by prior stress such as 
hypoglycemia 102.106.109 or exercise 160 have been shown to alter (blunt) the symptomatic and 
glucose counterregulatory hormone response (e.g. blunted cortisol release) to next-day exposure 
to a similar stress 102,160.205. In fact, it has recently been demonstrated that any stress that can 
cause prior elevations of cortisol and activation of the HPA-axis can produce blunted responses 
to subsequent hypoglycemia in healthy men 102.106.106,107.160.205.300. In contrast to these findings, 
our results demonstrated that antecedent exposure to hypoglycemia (compared to euglycemia) 
and the concomitant elevation in cortisol and IL-6 had no effect on subsequent metabolic, 
hormonal or IL-6 responses during next-day exercise (-2 h at 70% V02 max) in healthy, well-
trained men. 
In the present study, serum IL-6 concentrations increased progressively during the 90 min 
exercise bout, with a further increase at the end of the n. This is in agreement with the findings 
from Helge et al. 201 and Febbraio et al. 140 where it was shown that IL-6 release from the human 
muscle is positively related to exercise intensity. In the study of Helge et al. 201 seven untrained 
healthy males performed knee extension exercise, kicking with both legs, each at 25% of 
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maximal power output for 45 min and then simultaneously with one leg at 65% and the other leg 
at 85% maximal power output for 35 min. Blood was sampled from a femoral artery and both 
femoral veins, and blood flow was determined by thermodilution. Thigh IL-6 release was 
positively related to exercise intensity. plasma epinephrine concentration and muscle glucose 
uptake, whilst IL-6 release during the final 35 min of exercise was inversely related to the 
postexercise glycogen concentrations. Though muscle glycogen and catecholamine 
concentrations were not measured in the present study. it is likely that the 90 min of exercise. 
combined with -20 sec sprints every 15 min, followed by the IT resulted in some degree of 
muscle glycogen depletion, which may have, in part, contributed to the increased IL-6 
concentrations towards the end of the exercise trial. 
Furthermore, the increase in IL-6 concentrations in the present study may have contributed to the 
maintenance of euglycemia seen throughout the exercise experiment. IL-6 have been suggested 
to contribute to glucose homeostasis by directly acting on hepatocytes to increase hepatic 
glucose output 357, and/or to stimulate the HPA-axis and increase glucoregulatory hormones 
291,335,398. These findings are supported by the strong relationship found in the present study 
between the progressive increase in cortisol and IL-6 concentrations towards the end of the 
exercise experiment. 
The findings from the present study indicated that recent antecedent exposure to antecedent 
hypoglycemia and stimulation of the IL-6 response and HPA-axis did not alter subsequent IL-6 
and cortisol responses, nor the tracer-determined rate of hepatic glucose output during 
subsequent exercise. Though the glucose rate of appearance appeared to be higher during the 
last 45 min of exercise in the antecedent HYPO trial, it was not Significantly increased above the 
starting value nor was it significantly different compared to the antecedent EU trial. An 
interesting observation was that the glucose rate of disappearance (Rd), on the other hand, 
increased significantly over time from 45 min onwards in the antecedent HYPO trial. Though Rd 
showed a similar increase in the antecedent EU trial over the 90 min exercise period, it appeared 
that there was more of a delay in increase compared to the antecedent HYPO trial, and a 
significant increase compared to the 15 min exercise value was only established towards the end 
of the 90 min exercise period. Hence. the increase in Rd showed a co-incident increase with IL-6 
concentrations during the exercise period, however, this relationship was not significant. This co-
incident relationship between glucose Rd and circulating IL-6 concentrations is in agreement with 
the findings from Helge et al. 201 who demonstrated a strong relationship between IL-6 release by 
the thigh and glucose uptake. It is also in agreement with recent findings by Febbraio et al. 140 
where IL-6 infusion (matching circulating IL-6 concentrations seen with exercise at 70% V02 max) 
during 2 h of cycling at 40% V02 max increased whole-body glucose disposal compared to 
exercise at 40% V02 max without IL-6 infusion. The authors suggested that an increase in glucose 
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disposal may indeed be the primary effect of Il-6, and that the increase in endogenous glucose 
production may be secondary to the increase whole-body glucose disposal 140. 
The progressive increase in circulating Il-6 in the present study did not result in a significant 
increase (over time) in hepatic glucose production during 90 min of exercise. In the recent study 
of Febbraio et al. 140 increase in glucose production and clearance were shown to be unrelated to 
changes in the hormonal milieu, hence, concentrations of insulin, glucagon, catecholamines and 
cortisol were identical with and without Il-6 infusion at 40% V02 max. However, the 
concentrations of these hormones were significantly higher during exercise at 70% V02 max 
(without Il-6 infusion). indicating that exercise per se elicits the release of glucoregulatory 
hormones unrelated to Il-6 responses. This again highlights the fact that glucose homeostasis 
during exercise encompass a complex interplay of several regulatory responses. dictated to a 
large degree by the exercise intensity and dUration. 
In conclusion. the results from the present study indicate that prior exposure to hypoglycemia 
and stimUlation of the Il-6 and cortisol response in healthy, well-trained men has no effect on 
metabolic and neuroendocrine responses to a subsequent bout of hypoglycemia, nor to exercise 




SUMMARY AND CONCLUSIONS 
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The main aims of this thesis were to investigate the effect of altered endogenous glycogen 
availability, mainly achieved by pre-exercise dietary manipulation and antecedent exercise 
exposure, on inter-individual variability in metabolic and neuro-humoral responses to dynamic, 
steady-state exercise. Further, this thesis examined the impact of altered glucose availability 
and neurohormonal responses on fatigue development during prolonged exercise. We 
hypothesized that endogenous CHO availability and the associated metabolic sequelae would 
impact on effort perception during exercise and fatigue development. We further hypothesized 
that prior fatiguing exercise and local muscle glycogen depletion would provide some neural 
and/or humoral signal, thereby altering resistance to fatigue. Finally we proposed that 
antecedent exposure to hypoglycemia will reduce neuroendocrine and metabolic responses 
during subsequent (next-day) prolonged exercise, and that this would translate into reduced 
effort perception and improved exercise performance. 
In the first study we examined the effect of varying the glycemic index (GI) of the pre-exercise 
carbohydrate-rich meal, combined with carbohydrate (CHO) ingestion during exercise on 
metabolism and endurance exercise performance. Varying the GI of the preexercise CHO-rich 
meal is known to alter substrate availability and hormonal responses (insulin in particular), and 
has been proposed to be of potential benefit to athletes in manipulation of their exercise 
metabolism and performance. We demonstrated that despite differences in preexercise 
glucose, insulin and free fatty acid (FFA) concentrations between trials, as soon as exercise 
commenced, these metabolic and hormonal effects were negated. Furthermore, varying the GI 
of the pre-exercise meal had no distinguishable effect on tracer-determined rate of exogenous 
CHO oxidation, nor respiratory exchange ration (RER), nor was exercise performance or ratings 
of perceived exertion (RPE) altered. It was concluded that when CHO is ingested during 
endurance exercise in amounts recommended by sports nutrition guidelines, then varying the GI 
of the preexercise CHO meal and the concomitant metabolic and hormonal responses it elicits 
have no effect on endurance (-2.5 h) exercise metabolism or performance. 
The third study aimed to examine the role of local muscle glycogen depletion on fatigue 
development. A single limb exercise model was used to explore whether fatigue development, 
combined with muscle glycogen depletion and the concomitant metabolic and neurohumoral 
responses elicited during exercise with the first limb but circulating throughout the whole body, 
affect exercise capacity of the second limb. Exercise time to fatigue was significantly shorter with 
Leg 2 compared to Leg 1, whilst the muscle glycogen content at exhaustion in Leg 2 was 
significantly higher than in Leg 1. Plasma glucose concentrations at the point of fatigue were 
variable and there was no clear pattern to suggest that fatigue development was related to 
hypoglycemia. Catecholamine concentrations were higher at the start of exercise with Leg 2 
compared to Leg 1. It was concluded that the difference in exercise capacity between legs was 
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unrelated to muscle glycogen depletion or development of hypoglycemia, but may be related to 
increased sympathetic nervous system activation at the onset of exercise, and a faster absolute 
rate of increase in RPE. 
The next study we aimed to further examine the role of glycogen depletion, as achieved by 
glycogen-depleting exercise followed by a low CHO diet, on exercise metabolism and 
performance when combined with, or without exogenous CHO supplementation. This 
experimental design allowed the opportunity to examine the effect of maintenance of glucose 
(fuel) supply compared to declining blood glucose concentrations on metabolism and exercise 
capacity in persons starting exercise in a glycogen-depleted state. The results demonstrated 
that though glucose infusion increased endurance capacity by 28±26%, the inter-individual 
variability for improvement in endurance capacity was large. Furthermore, there was an inverse 
relationship between exercise duration and blood glucose concentrations at exhaustion in the 
placebo trial. This study showed that the maintenance of glucose availability in the CHO 
depleted state may have an ergogenic effect, however, the effect is highly variable between 
subjects and independent of changes in the rate of total CHO oxidation. Further, despite 
maintenance of euglycemia (constant fuel supply) in a glycogen depleted state, the majority of 
these endurance-trained subjects still could not complete the 2.5 h exercise task, suggesting that 
some other aspect, most likely related to intra-hepatic or intra-muscular glycogen depletion and 
unrelated to fuel availability per sa, could have contributed to fatigue development. Interestingly, 
the results indicated a differential sensitivity to declining blood glucose concentrations and that 
performance in some subjects might be affected with even a small drop in blood glucose whilst 
others are able to maintain exercise in the face of hypoglycemia (plasma glucose <3.5 mmoI/L). 
This suggests, but do not establish, that those subjects with superior endurance capacity under 
glycogen-depleted conditions, are somewhat resistant to the potential ergolytic effects of 
declining blood glucose concentrations, and have a superior ability to utilize alternative fuel 
sources such as FFA's. 
To explore the hypothesis of an altered sensitivity to hypoglycemia, the final study aimed to 
determine the effect of an antecedent exposure to two 80-min bouts of hypoglycemia (separated 
by 40 min of euglycemia), on the concomitant gluco-counterregulatory, symptomatic and 
cognitive function responses during each bout of hypoglycemia in healthy, well-trained men. 
Furthermore, we wanted to assess the impact of antecedent exposure to hypoglycemia, on next-
day metabolic and neuroendocrine and IL-6 responses during prolonged, steady-state exercise 
in well-trained men, and how these responses relate to exercise performance, perceived 
exertion, and cognitive function. This study indicated that in a well-trained, healthy study 
population cortisol, IL and symptomatic responses were significantly higher during the day 1 
HYPO compared to EU trial, indicative of normal counterregulation and symptomatic awareness. 
170 
However, there was a strong positive relation between individual cortisol response and 
symptomatic awareness i.e. those subjects with a low symptom score rating ("hypoglycemic 
unaware") also had a reduced cortisol response during Day 1 HYPO. During the day 2 exercise 
trial, plasma glucose concentrations were effectively maintained (>4.5 mmol/L), and isotope-
determined hepatic glucose output, RER, insulin, cortisol, and IL-6 responses were comparable 
between antecedent HYPO and EU exposure. Individual inspection of the data revealed that 7 
(of 10) subjects' average sprint times and 6 (of 10) subjects' TT performance were improved after 
antecedent HYPO vs. EU exposure, however, these differences were not statistically significant. 
These results demonstrated that prior exposure to hypoglycemia (and stimUlation of the HPA-
axis and gluco-counterregulatory responses) in healthy, well-trained men had no effect on 
metabolic and neuroendocrine responses to a subsequent bout of hypoglycemia, nor to exercise 
performed within 24 h, and that the ability to regulate blood glucose homeostasis is effectively 
maintained. Furthermore, antecedent exposure to hypoglycemia has no impact on next-day 
exercise performance, RPE or cognitive performance. 
In conclusion, in accordance with our original hypothesis this thesis demonstrated that when 
commencing exercise with normal glycogen stores combined with CHO ingestion during 
exercise, the altered metabolic (glucose, FFA) and hormonal (insulin) milieu elicited by 
preexercise CHO meals with differing GI is rapidly negated and has no impact on exercise 
metabolism and performance. However, it was demonstrated that there is a large variability in 
postprandial glucose responses between and within individuals. This variability may explain the 
inconsistent findings noted in the literature on the metabolic and performance effects of 
preexercise CHO intake, and questions the validity and clinical "usefulness" of the GI, particularly 
in sports nutrition education. 
This thesis also demonstrated an individual range in sensitivity to declining blood glucose 
concentrations, which in tum differentially affects fatigue development. In addition, though this 
thesis supports evidence on the ergogenic potential of CHO supplementation, it indicates that the 
ergogenic potential is highly variable between subjects, specifically when exercising in a CHO-
depleted state. In contrast to our original hypothesis, CHO oxidation was similar in the placebo 
and glucose infusion trial, and maintenance of glucose availability with glucose infusion did not 
enable the majority of well-trained subjects to complete 2.5 h of exercise in a glycogen depleted 
state. Hence, in contrast to what is commonly been suggested in the literature, these results 
indicate that ergogenic effect of CHO cannot simply be explained by the maintenance of 
euglycemia and CHO oxidation at a time when muscle glycogen concentrations are low. These 
data are in support of a different mechanism whereby glycogen content per sa may affect fatigue 
development. 
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Lastly, this thesis demonstrated that exposure to acute bouts of hypoglycemia in well-trained 
athletes at rest mounts a significant cortisol and IL-6 response, and that individual symptomatic 
responsiveness and aspects of cognitive performance were significantly correlated to the cortisol 
response. Furthermore, prior exposure to hypoglycemia in well-trained athletes did not alter their 
ability to mount gluco-regulatory metabolic and neuroendocrine responses needed for effective 
maintenance of glucose homeostasis during subsequent (next-day) prolonged exercise, neither 
did it alter perceived exertion and exercise performance during or cognitive function immediately 
after prolonged exercise. 
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ADDENDUM A 
INTRA- AND INTER SUBJECT VARIABILITY IN GLUCOSE RESPONSE 
DURING REST AND EXERCISE AFTER INGESTION OF A 
CARBOHYDRATE MEAL: 




In 1981, the glycemic index (GI) was introduced by Jenkins et a!. 226 as a classification system 
that could provide a comparison of the blood glucose response to different carbohydrate (CHO) 
containing foods. The GI is calculated as a percent~ge value based on the incremental area 
under the blood glucose curve following the ingestion of a food containing 50 g of available CHO 
(the test food), divided by the incremental area under the blood glucose curve in response to 50 
g CHO in a reference food (glucose or white bread), multiplied by 100 226. The test food hence 
receives a numeric value and is then classified as having a high, moderate or low GI 451. The 
test food and reference food are given on separate days after an ovemight fast and, typically, GI 
values are calculated from the group mean of a sample size of about 10 subjects 413. Tables of 
the measured GI of a large number of CHO-rich foods have now been published internationally 
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Furthermore, the GI has been proposed as a clinical nutritional tool to manipulate meals or diets 
to produce a desired metabolic outcome 225, In this regard, dietary advice to limit the intake of 
high GI. and favor the intake of low GI CHO-rich foods have been proposed to be of benefit in the 
treatment of disorders of metabolism such as diabetes, hyperlipidemia, and overweight (for 
review see Jenkins et at. 225). However, there is not consensus regarding the utility of the GI to 
human health and nutrition and many clinicians and researchers have questioned the relevance 
and practicality of the GI 339, Some feel that there is insufficient valid scientific data to launch 
recommendations to the general public that foods with high GI should be avoided (for review see 
339). and that proof of the clinical value of low GI diets in the prevention and treatment of relevant 
diseases awaits prospective, long-term clinical trials 164.274. 
In recent years, the GI has also been proposed as a nutritional tool in sports nutrition to 
manipulate exercise metabolism and ultimately performance 384. It is especially the area of CHO 
intake prior to endurance exercise where manipulation of GI has been proposed as a means of 
altering CHO and fat oxidation during exercise in order to delay the onset of fatigue and hence 
increase performance. Studies in this regard have yielded inconsistent results, Some found that 
the ingestion of a low compared to high GI pre-exercise meal reduced CHO oxidation 
141,389,408,409,439 whilst others found no difference in CHO oxidation 145,210.251 or rate of muscle 
glycogenolysis 141,145,251. Whilst some studies reported an improvement in exercise performance 
(time to exhaustion) with a low GI pre-exercise meal 117,249.251,408, the majority found no effect on 
exercise performance (time to complete a set amount of work) 141,145,389,409,439. 
One of the potential confounding factors for the discrepancy in these results is the large intra-
and inter-individual variability in postprandial glycemic responses and GI values noted 65,347,348,451. 
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An inherent day-to-day variation in glycemic-insulinemic response exists within the same subject 
and between different subjects 273,452. Furthermore, work from several laboratories around the 
world have highlighted the fact that the metabolic responses to pre-exercise CHO ingestion is 
complex and responses are largely individual 141,145,251,266,369.4G9,439. The extent to which this 
variability impacts on the potential benefits of manipulating the GI of the diet for sports 
performance has not been documented. 
Other factors that can contribute to the variability of the GI include food-related factors that may 
affect the rate of digestion and absorption such as gelatinization, amylose-to-amylopectin ratio, 
the fat and fiber contents of the food 18.323. Methodologically-related factors such as choice of 
reference food (glucose or white bread), differences in fasting blood glucose concentrations, 
timing and frequency of blood sampling, time of day of testing, the use of venous or capillary 
blood, method of calculating the area under the blood glucose curve (for review see 451) can 
further affect the variability in GI values. Clearly, the interaction of these factors within in a food 
makes it difficult to predict the final rate of its digestion and absorption, and therefore its effect on 
blood glucose levels and ultimately the GI of that particular food. 
Though food and methodologically-related factors can be controlled for, the inter- and intra-
individual variability remain a major concern as one can not predict how one person would 
respond on a particular day, nor how one person would differ from another in glycemic response. 
Factors that may affect intra- and inter-individual variability include age, race, gender 45\ 
however, these factors have not been studied comprehensively. Furthermore, physical exercise 
and training status may also contribute to intra-and inter-individual variability in postprandial 
glucose responses, yet this area has received little consideration in terms of GI research. For 
example, one might expect a difference in response between trained athletes and sedentary 
individuals due to increased sympathetic drive, increased insulin sensitivity (for review see 
Borghouts & Keizer 34) and enhanced glucose disposal in the former 265. Additionally, athletes 
typically ingest a CHO-rich meal followed by an exercise bout, which may alter the glycemic and 
subsequent metabolic and hormonal responses. To our knowledge, the effect of the trained vs. 
untrained state and exercise per se on the variability of the GI in healthy subjects have not been 
stUdied. 
For the GI to be used with confidence as an effective nutritional tool in clinical dietary therapy 
and as a supplement on food labels, a greater understanding of the extent of the variation in GI 
need to be established. Repeated testing of the same meal in each subject is required to 
determine whether the variation in glycemic responses is due to consistent differences between 
subjects or due to day-to-day variation within the subjects themselves. 
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Therefore the aim of this study is to investigate the effect of untrained vs. trained state of healthy 
males on intra- and inter-individual variability in glycemic response after ingestion of the GI 
reference food (white bread), when food- and methodologically-related factors are stringently 
controlled for. Furthermore, we wanted to investigate the effect of a moderate-intensity exercise 
bout performed 1 h postprandially on the glycemic response and determination of the GI. Such 
an investigation will allow determination of the variation existing solely due to day-te-day related 
factors within and between trained and untrained individuals. The hypothesis was that the 
trained athletes would display a less pronounced postprandial glucose response (due to 
increased insulin sensitivity and glucose disposal), and that the exercise bout in the second h 
would further attenuate the postprandial glucose response. It was further hypothesized that 
these attenuations in the postprandial glucose responses would reduce the intra- and inter-




8 Healthy, untrained males volunteered to participate in part 1 (Study A), and 8 healthy, well-
trained male endurance cyclists volunteered to participate in part 2 (Study B) of this study. 
Subject characteristics are given in Table 1. Subjects were recruited based on the following 
criteria: (a) Untrained, healthy males were not to have participated in regular exercise training of 
any sort, nor to have participated in any organized or recreational sports, and were matched to 
trained males according to age and body mass index (BMI); (b) Trained males were to engage 
in regular cycling training consisting of at least 2 h of cycling, 4 sessions per week; and to have 
completed a local 105 km cycle race in less than 3 h 30 min. All study procedures were carefully 
explained to the subjects, and their informed, written consent was obtained before the study 
commenced. The study was approved by the Research and Ethics Committee of the University 
of Cape Town, South Africa. 
A.2.2 Preliminary testing 
A.2.2.1 Oral glucose tolerance test (OGT7): 
Before subjects could participate in the study, they were required to undergo an oral glucose 
tolerance test (OGTT) in order to ensure normal glucose tolerance by all the study participants. 
Blood were sampled via venous forearm catheter at baseline and at 15 min intervals for a period 
of 2 h after ingestion of 75 g of glucose dissolved in 250 ml water. Glucose response-curves 
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were calculated and subjects displaying signs of glucose intolerance or diabetes were excluded 
from the study. 
A.2.2.2 Anthropometry: 
Mass and stature were predetermined and body mass index (BMI) was calculated for subjects 
participating in both the studies. These results were used to match study participants for Study 
Asedentaty and Study Bexereise. Subjects participating in Study Bexercise also had an anthropometric 
assessment done. Body fat was calculated using the equation of Durnin & Womersley 127 and 
from the sum of seven skinfolds (biceps, triceps, subscapularis, abdominal, thigh and calf). 
A.2.2.3 Peak sustained power output (Wpea,J test: 
The 8 trained cyclists (Study B) were requested to perform an incremental cycle test to 
exhaustion in order to determine each subject's individual working capacity (peak sustained 
power output (Wpeak) test). On arrival at the cycle laboratory, a full anthropometric analysis was 
performed (as mentioned above), followed by a 10 min warm-up exercise bout on an 
electronically braked cycle ergometer (Lode, Groningen, The Netherlands). After the warm-up, 
the Wpeak test was started at a workload equivalent to 3.3 Wattslkg body mass and increased first 
by 50 Watts (W) after 150 sec and then by 25 W every 150 sec until the pedaling frequency 
dropped below 50 revolutions/min. This information was used to adjust the work rate in the 
subsequent phases of the trial so that each subject (in Study B) exercised at an intensity 
corresponding to 63% of Wpeak (corresponding to 70% of V02 max 197). 
A.2.3 Research Design 
The glycemic response to white bread (GI standard) was tested on 3 separate occasions, one 
week apart. In Study A, subjects remained rested for 2 h postprandially, in Study B subjects 
remained rested for 1 h postprandially, followed by 1 h of cycling at 70% of their predetermined 
maximal oxygen consumption (V02 max; corresponding to 63% of their predetermined Wpeak 197). 
A single batch of white bread was used in order to minimize food-related variability. All testing 
and data analysis procedures were stringently controlled for and standardized in order to 
minimize methodologically-related variability. 
Habitual dietary intake and training regime were recorded and subjects were instructed to 
maintain their current dietary and training regime for the duration of the study. Food intake and 
training were standardized for the 24 h period prior to each trial. Subjects were asked to refrain 
from doing exercise, and avoid the intake of alcohol and caffeine-containing beverages. 
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A.2.4 Experimental procedure 
To allow for standardized, controlled conditions, subjects were required to sleep over at the 
Research Unit on the evening prior to each of the 3 trials. The day before the initial trial, subjects 
were instructed to record their dietary intake and to repeat this diet the day before subsequent 
trials. Subjects reported to the Research Unit by 8 pm the evening prior to the trial. Upon arrival 
they received a standardized snack (final meal for the day) consisting of two slices of white bread 
(high glycemic CHO) and two slices of cheddar cheese. This was provided to ensure that the 
initial plasma substrate concentrations and any metabolic differences between trials were 
standardized and not a consequence of the final meal 358. After ingestion of the snack subjects 
were allowed to drink water only. 
A.2.4.1 Blood sampling and analysis 
The following morning, the trial was started after a 10 h overnight fast. An 18-gauge Teflon 
cannula (Jelco; Johnson and Johnson, Halfway House, South Africa) was placed into the 
subject's right forearm vein and connected to a three-way stopcock (Uniflex; Mallinckrodt 
Medical, Hennef-Sieg, Germany). A baseline blood sample was obtained immediately prior to 
the start of the trial, and then repeated at 15 min intervals during the subsequent 2-h period (-12 
ml of blood was drawn at each time-point). After each blood sample was taken, the cannula was 
kept patent by flushing it with sterile saline. Aliquots of the blood sample were placed into tubes 
containing potassium oxalate and sodium fluoride (Midran; Novo Nordisk, Johannesburg, South 
Africa) for subsequent analysis of plasma glucose concentration. The tubes were immediately 
placed on ice and, after 20 min, centrifuged at 3 500 rpm for 12 min at 4 ec, and the 
supernatants were then stored at -20 ec for later analysis. Plasma glucose concentrations were 
determined by the glucose oxidase method using a glucose analyzer (Glucose analyzer 2; 
Beckman, Fullerton, CA). 
After collection of the baseline blood sample, a standardized test meal was ingested consisting of 
a 106 g portion of white bread, providing 50 g of available CHO. This amount was chosen 
according to the standardized protocol for determination of the GI as outlined by Wolever et al. 
451. A local bakery was asked to bake a single batch of white bread, of which the crusts were 
removed, then portioned and frozen prior to the study. This was done in order to minimize food-
related variability. Before each trial, each individually packed bread portion was defrosted 
overnight at room temperature. Subjects were asked to consume the test meal within 15 min, 
and along with 300 ml of water (room temperature). After 15 min had lapsed, another blood 
sample was taken and the clock was started at 0 min. The 8 untrained subjects were then 
requested to remain rested (in seated position) for the next 2 h, whilst the 8 trained cyclists were 
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requested to remain rested for 1 h, followed by 1 h of steady-state exercise at 70% V02 max (or 63 
% Wpeak). 
Before exercise was started, the cycle ergometer, fitted with racing saddle and handle bars, was 
set-up to fit the cyclist's normal riding position. Exercise was started exactly 1 h after the meal 
was consumed. Each cyclist was given 6 min to warm up (3 min at 100 W followed by 3 min at 
150 W). After 6 min, the workload was set at 63% of each subject's individual W peak and 1 h of 
steady-state cycling followed. During exercise, subjects were cooled by an electric fan, and 
could consume water ad libitum. 
A.2.4.2 Respiratory exchange measurements 
At baseline (fasting) and at 20 min intervals during exercise, V02 and VC02 were determined on-
line using a computerized system (Oxycon Alpha, Jaeger-Mijnhart, The Netherlands). Prior to 
each test, the flow meter of the Oxycon Alpha analyzer was calibrated using a Hans Rudolph 3 
liter syringe, and the gas analyzer was calibrated using a two-point calibration of fresh air and a 
4% CO2, 96% N2 gas mixture as per manufacturer specifications. The reliability of the Oxycon 
Alpha analyzer was tested on a weekly basis using the combustion of absolute ethanol (99 % 
Analytical Report, Associated Chemical Enterprises (Pty.) Ltd., Glenvista, South Africa) and its 
concomitant respiratory exchange ratio (RER) as a reference. 
A.2.S Statistical analysis 
The statistical software package STATISTICA 7.0 (2004; StatSoft, Inc., Tulsa, OK, USA) was 
used for the statistical analysis of the data. Area under the plasma glucose curve (AUCglucose) 
was determined by using the GraphPad PRISM software package, version 3.0 for Windows 
(Graph Pad Software, San Diego, CA, USA). The baseline plasma glucose concentration was 
used as the start of the curve, and only the area above the baseline plasma glucose 
concentration was considered i.e. incremental AUC (IAUCglucose). Statistical significance (p<0.05) 
of between-group differences for plasma glucose responses was assessed by a three-way 
analyses of variance (ANOVA) for repeated measures over time. In order to determine which 
means were significantly different, Tukey's honest significance difference post-hoc analysis was 
used. In order to determine intra-individual variability, the coefficient of variation (CV) for each 
subject was determined across the three trials (individual SO + individual mean); and to 
determine inter-individual variability, the CV for each trial was determined (trial SO + trial mean). 
For comparison (between studies) of the glycemic responses of the first and second h 
postprandially, the IAUCglucose of the first h was determined using the baseline plasma glucose 
sample as the start of the curve and the 15 min sample points up to the 60 min timepoint. For 
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the calrul.illloo of IAUC_ for the second hour, IheIAUC_ of the first hour was $ublfacled 
from the IOlal (120 min) IAUC_. F(l( comparisons be~n studies of AUe. Students' I·tell 
was used Data are presented as means f SO. 
A.3 RESULTS 
SutJ,ect dlaradenstics are plesented in table 3.1 Subjects Irom Study A and 8 were matched 
according 10 age and 8M1 
Table A. 1: SutJtecl charaderisllcs 
Untrained mile. (naS) Trilined males (na8) 
St1.ld~ A Study B 
Age (yrs) 21-:-1 23 :i 5 
Weight (kg) 69 % 8 71 :I: 8 
Height (m) 18 .t OI 18 .t Ol 
eM' 2h2 22 :1: 2 
Body Fal (%) \3 :1: 3 
w_ (W ) 
376 :r. 29 VO,_ (mltkglmio) 
66 :1: 0.6 
Total incremental area under lhe plasma gIuco$e curvl (IAUC_) 0V&f 120 min was 
slgn,flC&nltj hlghef in the untHl,ned 5oI1,111y populalion (Study N COlTlllilfed 10 tile trall1ed subject 
population (Study 8) during at three the elperimental lrials (p<O 05) (Figure 1) Wilen breakil'lg 
the analysis down Into the rll'5l and second hour j)OS\pI'andially, unlraUled subjects revealed a 
significantly higher gly!;:ermc response .,.,;uw, the firS! 60 min po5tpraooially 111 al three the tnals 
compered 10 trained subjects . Thefe was no difference between glycemic respOnSeS between 
Study A and B in the second hour postprandially. This 15 ~t surprisiog see.ng thai In 
Study B the trained lubJ8CIS performed \ h of s\ell(ly-sune cycling (10% V~ -J during tile 
second hOur Hence, most of the differeoce seen In !he overall 120 min glycemic response 
barweeo the two study populations can be attribute(! 10 a slgnifican\lv hogher glycemic respoose 
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inler-Ind,vidual CV lor the whole AUC_ (120 mill) over tile 3 trials was 44±10 YS 43:t2 lor 
Study A......- and Study 8..... _. fespeclive", (NS) 
A,. B 
i 
,. CSIud,A (unnoned) ,. CSW'8IQ....:I_t ... 1 
u 
,. []Stud' ... {""n ...... ) oSlud'8(n ........ _.j 
0 • • • • < • 
> • u • -.. ..,..:rt .. In "' ........ 
Flgu ...... ~ : IIl\ta;ndMQual (A) _ ~-IndM~ IB) coelficoenC of Wl\a1Hln (CV) 'DO' w!101e A~ 
{WAVe aru atxr.1.na beIowt. .. eline pInrN {gl~» R "' Rut, E"' Ste;,.;'y_state exe<(;I1Ie 
(70'11, vo,-J INS) 




The g!yoomic response followlI"Ig repeated Inges1ion of the GI reference food (while bread) 
showed a large intra- and inler-individual variability. Training status (and exercise) has ~ttle 
impa:;! on the Illter- and intra-Individual variability under stringently controned coml~K>r1s. 
compared to that round in untrained persons under resting conditions 
It has been demonstrated mill there is considerable variation bfllween Individual subJec1s WIth 
regard to Ihe absoJufe glycemic: response 10 a CHO-riI;h food . and variability also e~ lsl Within 
subjects due 10 day-Io-day fluctuations 01,)47,,.,,. ,,. f actors that may affect intra- and inte<'-
individual variability Include age, race. gender, presence of diabetes, the type and treatment of 
diabetes ' . , Regular exercise and training status may further affect glycemic: responses as they 
can a~er, amongst other. Insul in sensitivity and rate of glucose disposal )4.lOCI. The impact of 
many of these factOfS has nol been adequately stUdied, especially wrth regards to ~s Impact OIl 
the Gt, and needs funher Investigation The Pfesent study indicates that despite stringent 
s!andard=tion of methOdoJogk:al and food-related factors. the Intra- and Imer-indlvktual 
~ariabihty in glycemic response in trained and untrained subje<:ts remain large (CV of 30-40%) 
In practical terms, this wide range in glycemic response vanabifity can cause a CHO-nch food to 
produce a GI that vanes by 20-30% For example. If a GI is calculated lor the same pol1lOJ\ of 
wMe bread ingested durrng each of the three trials by using the a~erage of Ihe ;ndlVlduaIIAUC"s 
over the 3 trials as the standard. then lhe GI from the untrained SUbje<:1 population ~aries from 87 
to 114 (-20%) and from 88 10 118 (-30%) in the traIned subject population The 95% confidence 
Inlervals calculated from these GI values Wf!(e 87 10 113 in the untrained and 89 10 111 in the 
!lamed subject populatiOfl . This large ~ariabitity may cause Ihe food to shtft GI categories (low. 
moderate or hrgh GI) when tested repeatedly (on different occaSIOns) or when compared 
between lndl\llduals In the Pfesenl study, despi!e the 20-30% ~ariabillty in the GI response, the 
food (white bread) will stili remam in the high GI category This is in agreement with others 
showmg that there Is good agreement between Ihe relalive magnitude of responses to varIOus 
CHO-rich foods between IndMduals ' '', hence though the absolute numbers may differ, lhe food 
WIll still remain in high GI category (GI >70) or moderate GI category (GI 55-69) or low GI 
category (GI <54) 
However, in the recent study by Chlup et al . .. the GI determination for wMe bread (providing 50 
g availab~ C HO, tested OIl 5 occaSIons) resu~ed Tn a GI of 70. with a sTmllar range In ~ariabiity 
10 the present study 01 36%. WiTh 95% confidence intervals of 44 10 ge This would result in the 
GI classification for wh,te bread to completely shift catellones from a low 10 a high GI 
classification , from one test to the ne~t It seems ~ke ly thal if The glycemIC responses and 
cak;ulation of the GIIO a single balch of white bread (tested under controlled and standardized 
'" 
COI'IdrtIOllS) is I/IIS vatiable, then one can e~pect the vanabilily in response to be even larger and 
hence less predictable when GI determinations are made on generally-available CHO-Iich 100(!s 
where variablrJly in food· related factors (8 II plant variety and degree 01 riperll!SS plocesSIOg 
cookong. fat. fiber and pro/em cootent) will lead \0 further variability In rates 01 d'll!!$!1OIl and 
absorpbOn and uhll'llalety g~1I; responses. ThiS belies the concept that a food has a 
delinrtlve GJ andlor Ihal the glycemic response can be accurately prndlctt!il Furthermore, ~ 
raises coocem over ltIe validity of labeling CHO-rich food ~ems with abSOlute num~ and 
basmg dietary advice there-upon 
In the present study. healltly SI.Ibjects were matched for age, race and gender, but ditleF&d ., 
exerCise IlaInlllQ SIaIUS. II ~ wei doc;umenled that indMduals who !;Ingage In regular exercise 
tlCll1irlg can be eKPOCted to have a Iowef body lat contsl1t. "'creased insulm sensllivrty. increased 
sympathetic dove aod enhanced gl\Jc:Ose disposal compared to habitua lly sedentary IndIviduals 
Indeed, In the present in'0'eSb03llOn the !rained subjects (Study 8) had 8 significantly 
reduced glycemIC response (IAUC-l compared 10 thaI 01 untrained subjects \SWdy A) When 
the 2·h postpnmdl3t gIu<:ose reS900M is diVIded Inlo the first end second hour, It becomes 
apparenl that most of Ihe dlfferl!ll'lQ! In response Is dlJ8 10 a signlflCallUy reduced glycemic 
response in Ihe trained subj&a group within Ihe ~rst hour poSlPflindleHy The glycemIC response 
between groups in Ihe se<:onod houl W8f8 comparable. and Ihls desPIte performing exercise 
WIthin the second hour in Study B These results can be subSlanliated by the recent find ings o f 
Schenk eI aI JIll 
Schenk e1 OIl JIll was Ihe first and only study \0 our knowledge that has 10 date meaSllred the 
actual glycemic effect 01 II CHO food by directly measunng It1e plasma glucose kinetics. V<tIich is 
iii funC!lon 01 both glucose IIppcal8l1ce (~) into. and gtucose disappearance (R~) from 
the systemIC cuculallon A fundamental assumphon reg.ardtng Ihe GI concept, ~ that a low GI 
food. lor e~lImpie. means Ihat the food produces a low gtycemlC response merely as a result 01 a 
slower rale 01 dlgestlOr'l . resul\Jng In II slower rate 01 absorp(iOl'l onto the ClfOJlatton (I e. Ra-l 
111110'" HOWOll8f, the plasma glucose concentrillion is alundlOll 01 both ~ and Rd"..... 
1In.d the ImpaC! 01 a CHO food on plasma glucose concefItratIon can only be inferred by directly 
measuring glucose kinetICS (Ra and Rd), and not from the GI - Though oertaon ontMSIC 
propertIeS 01 the CHO food can affect r.l\e of absorption and Inlluence Ra-. the Rd_ 
(glucose uptake) Is primarily innuanced by insulin seCJelion and acbOn on Ilssue ,\l A food may 
for example. demonstrate a low GI as a resu~ 01 ha1l1ng eilh8f a low R~ or ,eiatNety high 
R~ - DueC! measurement of glucose klletics can furthe, explain Ihe underlying fadors 
responsible for differences In lhe GI of foods and will pl'OVlde a belle, undenlandmo and 
5ubstanlliliIOn fo, 115 poIentialtherapeutic applicability tha n only con$idemg gtocose and onsu~n 
concentrallons. 
" .. 
Schenk et al. >6. !n~es!lgated the glucose kinetics in response 10 ingesijon of a low GI bran cereal 
compared 10 high GI com Hilkes in healthy men Data on the fitness level of the subjects are r'IOl 
reported, bUl subjects performed 60 min of exercise (a\ -60% of maximal heart rale) the day 
before ead1 trial, perhaps Indicating thai il was not an untrained I sedentary study population 
Though lhe GI of the coin flakes (1321.33) was aimosl twice Ihal 01 bran cereal (55t7), the 
Ra"...- was Similar for bolh cereais over a 180 min postprandial period. Instead, the lower GI at 
the bran celeal was atuibuled to an earlier and marked Insulin response during the Initial 2Q-mln 
postprandial period combined wnh an earlier Increase III Rd_ (esp9<:lally over the 30-60 min 
penod). which attenuated the plasma glucose concentratlOfL This study demonstrated thai a low 
Gllood does not necessari ly have a lower Ra,.,-. ... 
The higher plasma insulin concentrations for bran cereal in the 0-30 min postprandial period was 
allrrbuted to the -3.5 times more protein 1I13t ~ contains {t5 g protein} compared 10 com flakes {4 
9 protein} .... 1\ has previously been demonstrated that the addition of protein to CHO allenuates 
the glycemic responses due to augmented insulin secre\ioo (for reView see =). indicating that 
the presence of macronutrienls olher than CHO can also impact and aller glucose kinetiCS and 
hence the GI. The earlier rise in insulin concentration seen In the bran cereal experiment 
appears runctiona~y Imporlant for Increasing Rd_ earty in the postprandial period. mereby 
reducing postprandial hyperglycemia '" ThiS Is further supponed by the strong rorrelation 
(I""O 7. p<0.OO9) found between the 30-60 min glllCOse clearance rate (an Index of insulln-
med~ted glurose uptake) and the Initial (0-30 min) insulin response In allenuating poslprand~1 
hypoglycemia.... In the present study. though Insuhn concentrations were not measured, the 
lower glycemic response Within the first hour postprandia l ~ in the trained compared to untrained 
subject population IS likely due 10 increased insulin sensitivrty and Rd_ (uplalle by the 
muscle) In the trained group" l00 This suggestion is supponed by studies demonstra~ng that 
individuals who are more insulin-sensitive show a more rapid rise In poslprandlal Insulin 
secretion compared to individuals With impaired glucose tolerance "" 1 
Based on the findings of Schenk el al .... il seems that the g~cemic potential of a food is largety 
determined by 1I1e Insulin response It elicds within the 0-30 min postprandially. and that ractors 
influenCIng Insuhn release (such as inherent food-related factors) and the responsiveness 10 
Insulin (such as degree of Insulin sensitivity) play an important ~e In the ultimate glucose 
response. The findings at this and other studies ... 11 suggest Ihalthe glycemic poten~al of a 
CHO-rldl food vary between study populations With variable Insuhn sensitivity. In add~ion. it also 
indicates 1I1atthe major impact of a CHO-rich food is elic~ed over the firsl 60 min POSlprandial~ , 
but when on~ the AUC O'Ier the fun 2 h period (or klnger) is considered. the impaC! and 
imponance of the po1enlial underlying faclors may be O'Ierlooked. This prO'lldes justmcation lor 
'" 
more lrequero1 blood sampling (e 9 every 10 min) (Nef the il'lilial60 min period, which allaws fOf 
belief as_nl or insulin concentrations specifically x . It is the flrst-phil5e Insulin response 
in paIllcular, and not $0 much 1he lOlaI AUC that seems impOrtant in a~ering postprandial 
tlyJIeI'lg~m.a and hence !he G' -
The choice to codify the glucose response UUIg the 2 h postprandial period was based mainly 
becal.lSe of employing this ume penod In the diagnosbC claSSIfication for Idenbl)'ing Impaired 
g~ tolerance or ~ 2 dlabeles Howevef , as can be seen from tne present inl'estiga~on. 
postprandial glucose disposal can be mocB rapid (as apparent in healthy. Ifaine<t indIVIduals). or 
more prolonged (e.g. In the presence 01 diabe~ .. ,...,'), The ~me-peonod 01 measuring the 
pos\pfandial glucose response can again hilve iIIl impact on !he final GI as shown by Gannon 
and Nunali ' .. who demonstraled thai differences in GI between foods is reduced as long« 
postprandial time frames afB used. fui'1t1eflTlOfB. seeong that GI delerrnillations are prlmari/y 
calculated from only consldenng the area above the baseline plasma glucose CI,lIVe, • laloe 
p/opor1l011 01 tile glycemic response may be dfsoounled. par1ieularty In a tralfle'd or Insulin-
sensitive subject population whl!fe glucose concenlralions may deCline below ba$ellne 
concenlrabons. Though lAUe has been chosen as !he plefeffed melhod of cab~811ng lhe 
glucose response and GI, some experts IilVOf using lhe wtIoIe AUC as !he real measure 01 
glucose availability Inslead ''','''' Pi-Sunyi!f »I r>OIed !hal dilfefences In the GI be1Ween roods 
would be greally anenua1ed If Ihe whole AUC are u5ed and piO'llded an e18mple 1ha! if a per!lOn 
wIIh a fasting blood glucose of 4.2 mmolll ingesl 2 1001:11 and tM lAUe is used. then !he GI would 
be 100 and the oIher 72 If the whole AUC is used, then Ihe diffl!fence would be 100 and 92. 
respectively"" Intl!fesbngly, when the whole AUC_ i, used an !he caleu1aliOn altha Gt In the 
plesent study, the vanabUity In GI lnaeases In Che unlralned subject popIJ1al>On from -20 unlts 
(GI 87 to 114, IAUC-.jto 40 Un1!S (GI 8410 120). II has the opposite effect in !he tratned 
subject populalon ,n tIlatthe variability In GI was reduced Irom a -30 unl! dillerence betwoon Ihe 
3 lnals (86 10 118 IAUC_) 10 a difference of -20 unils (90 10 118) when whole AUC_ was ..... 
Apao1 from an lnaease In insulol'l sel\Sill'llly, an enhanced capacity for glucose up1ake (R~) 
In !he trained aubJect populalJon may atso be achieved by other mechanisms, such as highef 
skeleLaI mUSCle GLUT -4 protein expresslOll, ineteased activity of hexokinase and olher oJddative 
enzymes, a hoghef proportion 01 type F $kaIetal muscle flbefs, and grealer capillary density thai 
may 81 account !Of a grea!ef ability for gluco5e uplake n. , .. 1M 
When plasma gluoo$e reSpotl5eS of Indl'lKluai subjec1s are evalualed, one subjed in the trained 
populallon showed a reduction In pla5fNI glucose below 3.5 mmotr\. in alltllres Inals al lhe 90 
min bmepoonll e 30 min af\ef Ihe onsel of ell8fCl5e (also referred 10 as rebound hypoglycemia), 
'" 
WIth a relum \0 ~4.0 mrnollL al 120 min A further one subject showed a similar panern of 
rebound hypoglycemia (plasma glucose <3.5 mmollL). but only In two of the three trials (WIth 
plasma glucose ~4.0 mmollL al 90 min In the other \l'ialj, and another subject displayed rebo\Jnd 
Mypootyceml>l (fl'''sm'' (Ihf(>')se <3 5 mmoln ) In only one of the three trials (wtIh pla~ma glucose 
of 3.8 mrnoVL in each of the olher two trIals). Only two of Ihe trained subjects did not have a 
blood glucose concentrations of below 4.0 mmoVL at Iha 90 min Umepoinl (or any olhef 
tlmepoinl) In any of Ihe 3 trials, the other subjects varyiflQ from 3 8 to 4 7 mmolll... between trials 
This is conslslent with findings from alher studies where CHO ir.ges~ol\ WIthin the hour prior to 
exercise resu~ed In rebound hypoglycemia In a subset 01 subjects ,02.'*'_.-,>0< .... bul In 
contrast to studies where ~ was no1 observed •• ,,, ,.7 .• 11.'.,",,'".'''''',''' It should further be 
noted thai when only Ihe incremental area above the baseline glucose concentration Is used in 
the calculalion of Ihe glycemic response curve , then an important pan of the glucose response 
(below baseline) would be discounted, particularly In those individuals who develop reboUnd 
hypog~mja. This may !unher impact 011 the valiability in GI calculations (as noted prevlOOSly) 
ReboUnd hypoglycemia is most likely the result of the combin.ed effe<:ts of msul'" and muscle 
contraction on increasing muscle gluoo59 upta~e at the onset of exercise "'.'" However, one of 
the untrained subjects In Study A also had a blOOd glucose below 3 5 mmoVL in one of the th ree 
tnals, and coincidently, at the 90 and 120 min timepoints (despile remaining in the rested state). 
It is not yet known why some individuals afe Pfedisposed to the development 01 rebound 
hypoglycemia foUowll1g CHO ingesllon and others not, especia lly when ingested Within Ihe 60-
min period prior to performing physical exercise 
Higher i1sulin sens~jyity. as may resu~ hom dlfferl!tlCel> in training status " -""", has been 
suggested as the reason why some individuals (especially in the trained Sllbject population) 
develop rebound hypoglycemia and others not - However, one study recently discounted thls 
theory when a similar range in insulin sensil.v~y was demonstrated belween subjects who varied 
In traming slatus and developed rebound hypoglycemia, and those who did not develop rebound 
hypoglycemia .. t. In the present study we do not have data 10 support Of refute any 01 these 
suggestions Our main aim was a descriptroe ctlaracteriulbOn of the poslprandial glycemic 
lesponses i1 trained and untrained indIViduals and measurements 01 insulin and insulin 
sensitivity were not done. The plesent data does indicate that there is also an Intra-iodiVldual 
variabit~y in the development of rebound hypoglycemia i.e , the same amount and source 01 high 
glycemic CHO (50 g of white bread), ingested 60 min PfIoI" to e~ercise of moderate-intensity 
(70% VO, _) in well-trained subjects does not consistently cause rebound hypoglycemia In tha 
same indrvidual. This again demonslr.ltes that regulation of blood glucose concentrations are 
complex and cannot be accurately predicted, especially not when many 01 the key mechanisms 
and regulating !actors are not fully elucidated 
'" 
In concIusoon, IhI$ 51udy oemonstratu \hat desp~e sUlligent standardizaTion of food anI;! 
methodologically related flIc:Iors (knowo \D affect variatIOn" the GI), the companson at intr9- and 
Inl!r-indivldual glycemic response is hoghly variable both In untrained and trained IndIViduals (eV 
of JQ-4O%, esl1l'n8ted GI varymg by 20-30 units) The variation In response between Ind,vKluals 
seems 10 be IIIgher \han the vanalion within ndiVoduals, and both the inter- and Intra-Individual 
responses are more vanable In the lfallled compared 10 unlr3lned subject populatIOn The 
IItycemlc response curve In the lrau1ed subject population is significantly reduced compared to 
lhal of tile untraHled subJeCl popula\lOl'l, lafget)t due 10 a sig/Uficalllly reduced glucose respoose 
wltllin tne CJ..6O min postprandial period. with less of a difleret'lC:e In the 60-120 min poslplllndial 
period, and like ly due 10 tile known eflecl of d,ffefenoes in insuin senSlIJV;1y between the 
untrained a nd Iralned stucly pOpuiabOOs The exefCise performed from 60-120 min POI5lpfllndially 
by tile traJned stlldy popuiat!on had no mar1<ed effed 00 the LAUC_ compared 10 that ofllle 
untrained study POPUlatlOO wilD rern<lu1ed rested, SuggestIng that Itle ().60 mIn peflod after 
Ingesllon of a h~h glycemic CHO is when glucose kinetics are ~tIv affected 1\ remaIns to be 
tIelermined whether a CHO·food ..mil 8 lOwer glycemic f'eSI)OI"Ise would show a 'lI'l'I~ar pattern, 
as slower insulinemla may "delaY" glucose klnelic5 into the 60-120 min pelfod This study lurt!\ef 
suggests that Inges~on of the same amount 01 high glyc:emic CHO 60 mm prior to exercise 01 
moderate-intensity (70% VO, .... ) In wel~tralned subjects dOlI not COMlStently cause rebound 
hypoglyceml8 in the same Individual I e that lhere IS also an Intra-indIVIdual variability In the 
proneness to Gellelop rebound hypoglycemia, 
ThIs study, albeIt mostly descriW .. e in Mlure, hlljlhllght$ the need lot further I!1l1estlgabOn 
!;WoundIng \tie use of the GI as a credible , reprodUCIble clinical tool lor use in nutmJOn 
InterveJItion eSplClaily with applicability to dlilerenl ~ludy population~ wrth pOlenllally different 
glyce:mlC-lnsulinemlc responses seeing lhat the actuat uOOer1ying glucose ktnetlcs may be 
v8flabtt affected by CHO Inges~Of1 In different study populations, ~ remams to be determ..,.d 
whether the at currently oetermlned by using either healthy sedentary or diabetic study 
populations can be extrapolated lor use in. for example trained athletes. For the GI to halle 
relevance as a cIImcal toot. rt must be proven to be reHable and 10 be capable of attemg 
metabolic respoI1M$ 10 lood in\.8ke 10 a degree thai 15 clinically Of phYSIologically relevant 
Fufthermore, for the GI 10 be used 'Mlh confidence as an effective nutr~lonal 1001 In clinical 
dIetary therapy aOO as a supplement on lood labels, a greater understanding of the e,;lent of the 
\'3l1alion In GI ~ 10 be established 
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ADDENDUM B 
DIFFERENTIAL EFFECTS OF ACUTE HYPOGLYCEMIA ON COGNITIVE 
RESPONSE SPEED AND VARIABILITY. 
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B.1 INTRODUCTION 
OPlunal management of lnsui Mreated diabetes is ollen compromISed by Itle inaeased nsIl of 
hypog~mia assooated WIth IoglIl glycemIC control "" Sevefe hypoglycemoa occurs commooty 
among type 1 diabetic palienm, with 0fIe study rej)Of1lng an incidellCE' of 150 epISOdes per 100 
pa\Jefll years "" There IS lION $I.lbslanbal ~ that hypoglycelTlla can have both acute and 
lastIng effects on cogmtlOl\ LI .. ' .. ' .... ,. ... AQlte tTypoglycerroa Induces cognitive dysfuoc1!On as 
a consequence 01 newoglycopema Including changes WI psychomotor func1iorl, auenlion and 
lXIfICeIl1fallOl1, learnmg and ml!rTIOfY 1II.IH.W A pallern of cogn itIve dysfunctIon dunng sCOle 
hypoglycemoa IS emeryll'lI from recent researcn utilizing the hyperinsulinemlC damp procedure ,n 
both healthy and diabetic subjects llllW.mltUU:"" 1a While some authors have observed 
global changes in cognrtlO!1 " ', several studies have reported performance dedlnes on tests of 
sunple cogn~ive fundion (for examplE! simple r&adion time. decision making, a!!ention) while 
more complex or 'hjghef arde( cognition remains unimpaired m.,.. 
McAulay and colleagues "" observed changes in aUe!lbon and speed of lIlforma\ion proces!IInli 
during hypoglycemia while scores 01'1 a nOl'l-Wfbal inteUlgence lest (Raven's ProgreSSIVe 
Matrices) remained unchanged AnoIher sludy observed that unpalrments on an at!enlJOnal task 
(4-cholce reaction \Jme) remained ItIlPQlfed durll'lg reoovelY ffom hypoglyremia while 
performance on more complex language-based tasks returned to normal ' 51 FIA1het'more, 
impainnents on lests of anenlJOn and nformatlOfl proc;essing tasks can be iden~1ied at blood 
glucose levels of 2.9 _ 3.1 mmolll , whereas Impairments In other aspacls of cogn~ion reqUire a 
grealer blood glucose decline Co< 25 mmolll)· Th&se rlfldings suggest that aa.J!e changes In 
blood glucose may differentially affect Slmp4e over lTIOfe complex cogMlve functions. 
Cbnical Observation of severely hypoglycemic individuals !lUg{lests a slow,ng of motor responses 
associalad with a dimmuhon of attentlonal capacity. which may be associated WI!h the syndfome 
of 'hypoglycemia unawareness' ' H Recanl exposure to hypoglyoel1lla can attenuate 
cwnlerregula!ory responses and may impair \he symplOfTl a_enaM al lhe physiolog.cat 
lIueshold of -35 mmollL dunng subsequent hrPOgi)'Cemic exposures 10'. While there is 
agreement In the lilerMure !hal neuroendoa-fle responses are bt.Inted by pOO( hypOglyoenuc 
exposure ',M.m, what is less clear is whether Inos change i$ coupled WIlh symplomatic response 
failure and cogn~ive Impamlefll Pflor hypogfycerTlia has been repor1ad to have either no effect 
on threshol<ls for hypogl~mk: symploms " - , or to signiflCiMllly reduce the capacrty to 
recogmze hypoglycemic s~oms dufing subsequent exposures in boIh diabetic •• and healthy 
indMduais ,01 ,., , .. 
''0 
A common fifld,ng from studies 01 II'IdtvlCluals With lriIflll(tnUy impa,red attenllon (e,g. due 10 
fa\l9Ue Of alcohol impalnnen\) IS thai slcmng of respot\Se$ on motor and attcnl.on tasks is 
acc:ompanied by sogmficant inaeases in the llariabilily 01 responses '" II has been 
defTIonstrated thaI changes in mean estimates 01 response speed between groups or between 
assessments In healthy ondlYiduals anse 85 a consequence of an Increased proportion of slow 
fespoose5 (or i llC(eas.ed 'tna/-Io-trial variabihty') rather than any change In tJte ma~"""um speed 01 
responses m,m ... , Tile contribution of alterations in response variabi~ty 10 the commool)' 
ob$erved slowmg of motor and alten~onal speed during hypoglycemia is yellO be lo~eSlIga:ed 
This study !Klugh! to examine performance on motor alld al1entioo tasks In llealthy iOOi'o'lduals 
during two con!leCUwe boots of hypoglycemia (2.9 mmot/l ) pet10rmed WIIhIn the same day II 
was hypothesczed that s.Io'Mng of pefformarn:e on these lask$ WQlJId be ac:compamed by an 
Increase In the proportion of slow responses in the leadioo Ime dlslnb!lllOn (i.e . lnaeased 
skewne!>s) Furthermore. we sought 10 detewune the Impact of a second bout of hypogtycemia 
perlormed within ShOll $ueceukln to the firS! one. on symptomatIC awa«!lIess arod cogni~ve 
funcbon 
B.2 METHODS 
8 .2.1 Subjecls 
Ten healthy. ph)'SlC3liy active males aged between 19 and 35 years were recruited to panlcJpate 
In If"s study (age 24J:4 years 8M1 23~1 kg!m'. body fal 91;3 %J. Eillht panidpanls were righl_ 
handed None had any chrome diseases. ~lel'ClJrrenl illnesses. were takln9 any medica~OI'I or 
had a pet'sooal or family hillOl'1 01 olllbeleS. Each volunteer gave their written, inl()lTl'll!{! consenl 
belofe participatIOn irllhe study. which was approved by the Research Ethics Committee 01 the 
Facully of Heatth Soences of Ihe Unlversily of Cape Town (South Africa ), 
B.2.2 Maleria/s 
CogStaleTll is a software program comprising rove non-verbal computerized neurOpsychologlC3l 
tests assessmg reac1ion time. decision malt.Jng. sustained arod dIVided anen1Kln. worIung memory 
and new learning " For the purposes oIlhl$ study. 1e$IS of ample and dloooe reacbOn ~me were 
reponed This test ba1tery requires the par1leopaOl to respond manually (via 100 keyboard) to 
playing cards presented on the compIJ\ef screen Although the physical response remains 
consistent between tasks (the same 2 keys IIle used). eactl 01 the tasl<.$ ~ sel In a different 
conteid and requires use 01 ddlerenl cognibve pnx:esses For example. the IlImple reaction time 
(SRT) task requires pcVIidpanls 10 press II key as soon as the presented card lums face-up. The 
'" 
cn.04ce relilCllOfl IllTle (CIlRT) task requlfes participants 10 pess one oIlwo ke-p depending upotl 
the color of the presentee card Tllllty acwrate responses are required 1(1 complete each task 
The SRT and ChRT tasks are htghly reliable When adrTllnislered senally to healthy adu~s and 
cnlldren ", anti have do(:umenled sensltlVllY to the effects or fatigue or sustained wakefulness 
"I, ttIcohoi Intoxication nl, mild <XlgnilJVe Impairment or the earty stelleS 01 Alzheimer's disease 
", sportHelaled head IOjury ''', stimulant medication"', and cardiovascular disease '" 
8 .2.3 Procedure 
Each r.ubjecl was Studied on 1'Il1O sepa-ate occasions (In random order, counter-balanced), 
separated by alleast one month On ooe OCC3sio11. subjects were eitlleo' IIxposed to two eo.mln 
bouts 01 hypoglyoemia (HYPO blat) sepa<3led by 40 mn of eug¥cem.a on Ihe OItlef OCC8SKlIl, 
euglycelTll3 was m8'n1alOed Itvoughout (EU !nail. Studies were ,deo()C81 other tnan the plasma 
glUOOSfI pl'ofi lH (detailed below) SubJects were bli'lded to tt. Otdet 01 the studies as wei as 
1M' plasma glucose con<:.eI1tration at aI tirrles. On the day prior 10 each laSl day. subjects were 
requlfed to abstain from alcohol and exercise. and were asked to keep a detailed Jood diary, 
which were to be fepeated the day prior to the second experimentat1rial Dunng the course of 
Itle sWdy subjects were ~truded to maintain their habilUal eX8fdse sch&dule sod diet 
8 .2.3 f Blood G/I.ICOS8 Clllmpmg ProoodUffi 
o n the morning of each Ilial (8:00 AM.), subjects reponed to the lesting laboratory after a 10-
hour overnlghl last T'Ml IntraverlOus C31heter.l were Insen8{j Into the non-dominant arm. One 
caMlJla was placad In retrograde lashion distally In Ihe lorearm lor blood sampling and kept 
patent Wltn , slow inlus.ion of normal saline The oIhef cannula was placed In the antecubital 
lossa to enable adm.n.stralton of ,"&IIlin and glucose The forearm was \hen placed In II heated 
box (55-80 "C) to artl!!flahle the 'o'eIlOUS blood samples The heal ed box was exchanged lor a 
heillll'lg blanket during IIloII 5-fllWI it look 10 perform the computenzed cognttlve test. A pIlmed, 
oontwlUOUS intravenous infusoon of regular In&llhn (Human Actrapld Novo Nordlsll), 'fttIic:h made 
up to 55 mlin 0.9'110 sodium chlonde to wtwch 2 mI of the SlJbjed's blood MIl been added. was 
Infused at a maintef'lance rBle 011 5 mUlkg BMlmin The clock was started as soon as 0.5 mI of 
tne insulin SOlU tion had been delivered. Plasma glucose (measured at lhe bedSIde evllfY 5 
mirlutes (Glucose analyz.ef 2; Beckman InSIlUmeots Fullerton, CAl) was mal1talned at \he 
reqwroo conccntrotion during HYPO ""d £U UGing :;I v:;lrj:;l~rat. intr9v.""u. Infusion of 20% 
dextrose" Plasma glucose was maintained at eugJycemla (5 mmolll ) for the first 40 fTIIf1l11es of 
each of the glucose clamping tria ls (HYPO and EU) In the HYPO Ilial plasma glucose was 
reduced (by redUCing !he glucose infusion rate) to 2.9 mmollL and majntalned at this level for SO 
min This was follow&d by 40 min of euglycemla (5 mmoVL), and a w bsequent second 80-mln 
'" 
bout 01 hypoglycell'llil (2.9 mrrollL). The clamp lasted a IOtal 01 240 min In the EU \1181 
euglycemia (5 mmollL) was maintained throughout the 240 mon, 
Of\ compleliofl 01 the lrials (at 240 min), the Insulin infusKln was slOpped The plasma IiIUcoee 
wtlS re.sloreO 10 euglycemill if roece""J'f. lind subjects ...... n: given" meol \0 COnlUmll PIas .... 
glucose monilonng continued until euglycemia was maintamed spontaneously. after which aU 
Iint)S were wdhdrawn and subjects could return home 
8.2 J 2 CognItive testmg 
All pa l1k:ipants compleled a baseline cognitive test consls\lng of a pl'adice lrial and a baseline 
trial (performed '·2 weeks before the stan of the expenmental Ina!) Baseline testing was 
conducted In a quiet, we~lll enVIronment and was supefVIsed by one of the Sludy IflVesligatoB 
CogMive te$tulg was condUCIe<l Iowards the end 0( the first 80 min bout of hypoglycemia (at 
lome 115 rrun). and again althe end 0( the second bout of hypoglycemra (at time 230 m'"l. before 
euglycemoa was restored Cognlttve testing was conduCled ill equlVillent time points in the EU 
trial. ElQhl 01 len paroc.par!ls completed a second baselioe lest, pefformed 2 weells atter 
completion of the eXpeillTlentill \tIaI In ack:IibGn 10 the cognitive lestrng, symptoms were 
assessed by !he use 0( a qoe$U()flBa!re (administered every 20 min). asking subjeds 10 rank 
sweatIng warmth, palpitatront. tlngbng, anJUely trembirng. lIunger, btr.lrred ",sron, drowsiness, 
confuSlOll weakness, headache, difficulty speakIng, dizzrness, and lmlabUit)l individually on a 
~near al'lalog scale AutonomIC 5ymp1om SQOfU ware deriVed from tile first 7 symptoms lisled, 
and oourog!yc:openic scores from tile latter 8 5ymptomS with symptoms beIng ranked from 0 (nol 
at all) 10 6 (very sevefelmannal) thrwghout each of tile trials nl_ 
The statIstical softwanr package STATtSTtCA 70 (2()().i, StatSoft, II'IC, Tulsa, OK, USA) was 
used for tile SlatlSllcal analySIs 01 the data. To ensure Ihat data met the assumptions 0( 
normality lor paramelrlc srgmflcanoe lestlng, all reaction lIme CRT) data were transformed USIng a 
Iogallthmrc base 10 (10910) translormation prior to analysis A.Hhough aU stausllCal al'lalyslS was 
conducted on Irans/Ofn'led data, raw data Is shown In Teble 81 for ease of klterpretallOn For 
each indIvidual participant, ctrange from baseline was cak:ulal8d by subttaCtlng performance 
dunng each experimental condItion from perfOlmanoe at tile fltSt baseline lest Data was then 
submilted to a 2 (condition: HYPO, EU) by 2 (lest first, Second), repeated measures analysas 01 
variance (ANOVA) for bolh SRT and ChRT tasks As tile maIn hypotheSIS concerned the 
ct.lferenoe between hypoglycemia and euglycemia condloons, post·hoe HeslS were conducted 
wtlen either a signifICant main effact of condilron or a Slgnrficant interactIOn were obselYed 
'" 
To elUlmine the magnrtude of change in RT between baseline and experimental eol1d~kms a 
ell,mge statistiC was calculated !Of each experimental condition. For each indi~odual. 
performance in the baseline condition was subtracted from performance in the EU and HYPO 
conditions. This d,Herence was e>cpressed as a raHo of Ihe within subjects stafldard deviation 
(WSO, o' l caiculaled between Ihe two baseline tests. The resulting statistic is interpreted as a z· 
score, WIll! values greater Ihan 1.64 (p<O.05 Ol1e-lailed) oonsidered a significant decline For 
ead! task. the group mean change score is reported htlre, as well as the number of ir.diVlduals 
shovving decline In eilch experimental cor.d~ion 
FiMI~, we sought 10 test the hyPOthesis that RT slowing ,n hypoglycemia Is caused by an 
lncreasa in the numl>er of slow responses (l.e. slIewoossj in the RT distribution. The sl<ewness of 
the RT distributions fOl each irl(lividual was calculated for both tasks under ail conditions. In this 
case, a large positive value lor skewness \\(luld indicate a long right tail to the distribution Cilused 
by outlying slow responses. Change from baseline was ca lculated by subtracting skewness 
during each e~pcrimenlal condition from baseline This data was then submitted to a 2 
(cond ition: HYPO. EU) by 2 (test firsl. second) repeated measures ANOVA. 
8 .3 RESULTS 
B.3. 1 Cogoili vfI dala 
Table 8 1 presents the group mean (tSDJ performance on SRT and ChRT tasks at baseline and 
In all experimental COnditions No s;gnificant differences were observed on the SRT task. For 
the ChRT task, ANOVA revealed a significant main effect of condibon [F{t.9J"t2.54, p"O.OO6] . 
Post-hoC I-tesls reve al e<! significant slowing of ChRT during the first bout of hypoglycemia 
compared to baseline [t{I .9)'"3.38. p=OOO8]. and both tests undertaken dunng evglycemia 
[1(1 ,9)"224, p"005 lor bout t , and 1(1,9)"'3.04, p=0.014 for bout 2] . Significant ChRT 51o"";ng 
was also observed during the second bout of hypoglycemIa compared to baseline [1(1.9)"3.17, 
p"O.OII J and both bouts of euglycemla [t{ t . 9):2.59. p" O 029 lor bout t . and I{ 1.9)" 2 74 , 1>"0.023 
lor boul 21 Performance between the baseHJ'\e and euglvcemic conditions was not different. 
Further. performance did not differ signmcanUy between the two bauts 01 hypoglycemia. r.cr 
under cond itions of euglycemla. 
194 
T"bl, B.1: Performance on SImple and ehoioo RT tasks during baseline, euglyoemia and 
h~1a cond~lOI'Is, 
Ta! k BaseUne EU trial HYPO trial p 
Bout 1 BouI2 
120 min 240 min 
Simple Rnllsk 
(120 min) (240 min) 
MeantSO 2936: 673 295 8.t38 2. 293 9.t22 8 294.5:1:354 309.5t46.4 NS 
Skewness 1.8:1: 1.4 1 3 ill 1 1 :I: 0.7 1 0:1: 1 1 10tO.9 NS 
Cho«;e RTtask 
Mean:tSD 481 .5:52.5 502.2i 65,9 4921:46.0 5450H9.2 569.9:102,8 iI,b,c.d 
Skewness 0.6:1: 0 4 0.7106 0.5 1 0,7 0.2:t 0.6 0 4:1: 0.5 NS 
RT. reac:\lon _ a. p<C OS Iloehwen IlIoHione end HYPO bovIl \120 min); b .p~005 baI'fflIen 
baseline "rid HYPO bouI2 (2040 mini· C· p<O OS bet_n both EU eondlllon, and HYPO boll! 1. d· 
p<0,05 blttwHn boIh EU condibon. ,,11(1 HYPO bolA 2 
Flgu(e 8.1 displays Ihe group mean ehanoo scores for eoch e~penmenHll conr:hhon No 
sobslanlial changes from baseline wEtfe observed during the euglycemlc conditions for eilher 
SRT 01 ChRT tasks. Performance on the ChRT laiill slowed wbstantiaHy dUMg both 
hypoglycemic exposure • . The gfOlJp mean z·acores recorded were 1 28 during the r.rsl bou1 of 
hypoglycemia and 1.77 (p"'0,05) during the ~ bout 0' hypoglycemia. These cN!I"I\JOS 
represent a largo mean change in performance according to CQnven\Jonal SlaUsheal crilell8 
Performance al$O slowed dunng the SRT tasl<. . w~h group mean z·SCOt'es recorded as 0 63 and 
0,10 during the first and second bout of hypoglycemia re$pl!'Cllvety However these changes 
were not sufficient to reilCh statisllcal5lgll1licance. as Indl(;ated above 
" 
" os.rn"" fiT I " 
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F III~" B.l : Grwp mean z·SOOfe (dlaroge from bMellne) on slmpIe Nod choIo;:e reacuon ~me talkl kIr II 
ku hl*JfIIIIruI """'*-'s No!e ~t p;»ItIve vA.es irlOQ/e ;II slowing ... _ bme 1MI4I ~ • 
s.tll>ie ruction tine Black bin " Choice ,UC\IOO time. 
'" 
Analysis of Ifldi'lidual Z-SCOIes indicated thilt 4 of 10 partidpaots displayed a Sl{jnff.catll cha~ In 
pl!ffO!Tllanat (> . 64) on the SRT \aSk LIIIdef both tlypogJycemla coodrtlOlls. Further. 3 01 10 
partICIpants dISplayed 5Ignificaru ella., on the ChRT task dllritlg bout 1, and 4 of 10 dunng 
bout 2 of hypog/yoemla On the ChRT \MIt. a !vittle, 2 paniapanls approached BlallStJcal 
SIgfllficaoce duling tne $flCOIId bouI 01 hypogtyoemIa with Z-ICOfH bel'M:!en 1.20 ami 164 In 
the eug~ coodItlOl'l f_ iodivtduals displayed sIOnIrlC8nt impairment dunng hypoglyce!roa 
(Table 8.2) 
Skewness stall$tics lor boI/'I tasks life presented In Table 9 .1 BoIh the SRT and ChRT tasks 
dISplay posIlNely skewed dIStributions Such sk_ II common in RT drslnbUllQrl!; and IS a 
consequence of a small proportoOn of slow responses'" However, ANOVA indICated that there 
wefe no s.gnlrlCant changes in skewness between e~perimental oonartions lor either !he SRT 01 
ChRT task 
Table 8 .2 : NlXT1ber 01 people meeMg SlatlSllCal criten.a lor aignificanl decline in each 
e~pellmental condkl!)l1 for both simple al'ld choice reaclion \me tasks 
Condition Simple RT Choice RT 
Hypoglycemia (HYPO) 
HYPO boo11 (120 INn) • , HYPO bouI2 (240 ....... ) • • 
Eug/yc(lm//l lEU) 
120 min , , 
240m,n , • 
B.3.2 Symptoms 
Symptom rallngs remained urlChanged tnloughOUl the EU lrial Aulonomic symploms ratlllgs 
taken al equivalent tinepolnts as Ihe cogn~lVe function lests (120 and 240 min), were 
signlflCan~y higher al the end 01 both bouts 01 HVPO compared 10 Ihat obtarned In the EU trial 
(Boot t 8.17 vs 211 (p.004); 6oot2 ' 12.ihs 2.t.2 (p-0.0005). for HVPOvs. EU respectively) 
Neuroglyc:open~ symptom ratings atlhe elld 01 bout 1 of HVPO (7.1:9) _,e nol signifICantly 
different 10 thai of the EU trial (3i2) , bul were sign~icanUy higher at the end 01 bout 2 of HVPO 
compared 10 thai 01 the EU trial (9 .. 8 vs 2.1:3 for HYPO VI EU, respectively , p-001) The 
secood bout of HYPO elioted significantly hlgher IliMgs of autonomic symptoms compared to 
the firs! bout of HVPO (p"o 04) The neurog~penic symptom ratings, however, did not drffer 
siynir"",,,uy I>t:t .. """ U"" filii ",nil ~Id HYPO bout 
Aulonomic symplom ratrngs at the end of the second bout 01 hypoglycemia were POS~lVeIy 
corretated to SRT performance al the same tmepolnt (I""O 10: p"'0.03). However, no signifICant 
relaUOfIsh.lp between neuroglycopenic symp!Oml and cognibve functton lest results were found 
". 
8 .4 DISCUSSION 
Performance on an allention tesl (choice Rn completed at tile end of 2 consecubve 8O-min 
bouts 01 hypogIy<:emla. was ~nilicantly slower I~ 1M! observed during bolt! basetine and 
euglycemie conditions In COIltras1. 1'10 d,fferences were obsefved on a psydlomotor task (S<mPie 
RT). suggestIng that ~mlll affeds attenoon, but nOI motor speed in neatthy )'OII1'lg 
IndIVldual$. These findings are conSIStent Wllh previous research suggesnng thai choice RT tasks 
are mOle sensitive to e~posure to moderate hypoglycemia tllaf1 simple RT taSks (for dISCUSsion 
see ref 'l. However, Impaired molor functIOn has previOUsly been noted dunng hypog¥:2m1(1 
.,.:, unlike OI,j' fondlflgs. One explanallOll for this discrepancy is lhallt1e depth of hypoglyoorma 
induced during the two bouts of hypogtyremia in the present study (2 9 mmoIIL) was lfISufflClll11t1y 
low to induce motor impairments Evans and colleagues 1)1 obseIvad thai the glucose tlvestlQld 
fer motor speed impairment (USing the Finger tapping taslr.) was below 22 • 24 mmoIIl duliog 
acute hypoglycemia, while OIhefs have observed that the bkXld glucose threshold for dysful\CllClf1 
on chok:e reac!1OIl time taSks was 2 8-31 mmolA. "UM 
Fatigue or drOWSiness is one of the most commonty reported symptoms of hypoglYCIIITlIiI, and 
llioog WIth cognillve dySlunctioo, is cooSlderoo to occur as a consequence of nE!ilroglycopelll<l 
- Furthermore, fatigue nas been previOlisly associated with an increased \lariabi~1y in cogmtive 
performance 1)7 n. and !hus it would be reasonable to exped tllat hypoglycemic indiv!duals, 
presenting with fatigue, wOliId display similar perfOfTTlance variability In the present study, ChRT 
test results were Significantly ImpaIred wh~st alJlonOll1lc symptom awareness was inaeased al 
the end 01 both bouts 01 hypoglycemia compared to the eugJycemic trial However toymptoms 
indicative o f neuroglyoopenia were Slglllficantly Increased above that observed in ttl!! euglyoemic 
Inal only at the end 01 the second bout 01 hypoglycemia. Overan, cognluve test resu~s were 
statistically unretated 10 e~ller autonomiC or neuroglycopenic symptom responses AOOllIonaty, 
the response slow1ng observed on an attention taSk was not accompanied by a change In !he 
skewness 01 the RT distnbullOl1 This suggests that alten~onal slowing during hypogtyoemle Is 
;pssOClated WIth a general increase in tile time to complete the task, rather ttlan an Inaease In 
the proportion 01 slow responses. We are unawilre 01 prevlOlis studies examining cognitIVe 
performance variability dUring acute hypoglycemIiI. 
The magnitude or the impairments In altentional slowing was Iluge according 10 conventional 
statistical standards. Intelll"Stlngly. desPIte these large grOlip meil" changes only a mlnonty 01 
partocpants displayed statlslk:ally significant slowing 01 anention (Table B.2). Thus suggesting 
that the cognilive response to hypoglycemia may vaty widely between IndiVidualS. This r,nd,ng 
is further supported by the iarge inter-ind ividual variability In symptom rabngs reported during the 
hypoglycemic exposures. It is a~o consIstent with prior research suggesting that the blood 
'" 
glucose threshold (Of cogn~1ve Impalrmenl during hypogtycemia may vary between Individuals 
'-, ar'ld lila! prior exposure to hypoglycemia may result In cognillve adaplabOfl '.. Howevttr. a 
larger p;ample $lze than Ihal ~crulled In Ihe presen! study is required 10 adequalllly investigate 
this hypolhesi5 
We were also Inleres16d 10 see whether a second exposure (bout) of hypoglycemia III sOOn 
succession to the Oml exposure v,()uld alief cogn~<ve functIOn and/or sympklmaIJC responses 
compare<! 10 Ihe firsl exposure To OOf kn(Mtedge, though other studies have I!fT1p1oyed smilar 
prolocols where two boulS 01 hypoglpmia (of varKlous duralioos) were elicited with .. one day 
Ihe SyrT1plomalie and cognftive responses Itlereof have \fadibofla/ly only been compared 10 
responses during ne)(l·day 81q)OSure 10 hypog~emia ,., •. ,,'> ...... 0) These studies reported thai 
prior (previous-day) hypoglycemia had ellher no e!fecl 01\ Ihresllolds for hypog!.,.cemlC symplOlTlS 
",44' or produced a significant blunrifJg of symptomabc awareoess dUllI1g subsequent exposure 
(for review 'M ref") Add~!onally. bluntang of oeo.:roendooifle respooses have beet'! observed 
whilst cognl~ve lunchOl'l was Pf6served to,,," tn the present study. each bout of hypoglycemoa 
produce<! autonomIC symptoms that were SJgOiflCllnlly hogher compared 10 that ~ the eugtyoermc 
tnal Neuroglycopenlc symptom awalflJ'lftSS, 0/'1 the othel' hand, wele s'gmncaolly increased 
above that in the euglycemlC trial only after the second ao.m.n boI.It of hypoglycemIa was 
mduce<l I hIS IS m agreement WIth !he res.uRS Dy TOWler el al . ,. W'IICfl Oemoostral1Kl1l1at !he 
awareness 01 hypoglycemIa is INgely. pem.aps eXdusNely, the res.uh of perceptoon of aulOnomic 
rather than ne,Jlogl)'CClplnic symplOmS. medialed to a large extetlt by mUSC3fl1lic cholineiglC 
mechanisms 
The present study funller irldlCates lIlal a second 8O-min exposure to moderate hypoglycemia. 
eliCIted v.l1t1i1'1 shon (4().mm) sucx:eHion to an iOentlClll priof exposure, resulls in a slQrlrlicant 
increase In aulonomic (but nof neuroglyeopenlC) S'(nlPlom awareness COfflpai'ed 10 the rlflt 
elq)OSure NeurogtvoopenlC symptom awareness as wei as anentlonal ~ (indicated by Ihe 
ChRT cogniWe test) WIre slatl$llcally eqUIValent at the efld of the two 6O-mln exposures 10 
hypoglycemia These ftndings are ~teres~ In the light of other studies where prior (previollS' 
claV) exposu/e 10 h)'llOglyc.tr1'118 resulted in a blUJ'Itil'lg of subsequent (next4...,.) autonomic 
5)'ITlptom awareness The role played by the duration of prior hypoglycemlil. !he lime peliod 
belweel\ elq)OSures and the differenbal effeels on !he magnitude of autonomic af10d 
neurog~ symptomatic awareness or 'unawareness' thereof needs l unher investigation. 
In summaIY, the respoose slOWing obseIVed commonly OIl choice reae1iort lime tasks In 
hypogtycemic individuals is not itSSOCIaled with an Increase In the numbef of slow responses 
Rather. such d~uncbon appears 10 result from a geoeral slowll'lg of responses The~ flfldlngs 
_e appalent 011 !asks !hal requIre both attenbortill and molor ptocesses. bul not on tasks 
". 
requirWig $lmpIe rno\Of responses alone FurthemlOll!. a second SO-min e~jXl5ure 10 moderate 
hypoglycemia. elicited wnhin $hOM 5.uCCl!SSIOO \0 the first exposure, resu~s m a slgnlflcant 
.ncrease In autonomoc (bul not /l8uroglycopernc) symptom awarl!'lK!SS, WIth 110 relabon beIweeI1 
symptomatoC: _eness and chOICe RT re~ 
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